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Student: Karen E. Charlton, Department of Medicine, University of Cape Town, 
Faculty of Health Sciences, South Africa. 
Thesis title: The impact of dietary manipulation of sodium, potassium, calcium 
and magnesium on blood pressure in hypertensive black South 
Africans 
Date: October 2006. 
Brief description of thesis content 
Black South Africans are at high risk of hypertension, stroke and blood pressure-related 
target-organ damage. In South Africa, the limited resources at primary health care level 
allocated to the prevention, early diagnosis and management of hypertension 
necessitate a non-pharmacological population-based approach to curb the escalating 
burden of cardiovascular disease, for which raised blood pressure is an important major 
contributory risk factor. 
The series of five studies included in the thesis provide a systematic approach to 
developing an appropriate nutritional population-based approach to lowering blood 
pressure in a high risk population. Firstly, valid, reliable, and updated information was 
obtained to identify habitual intake of sodium, potassium, magnesium and calcium in the 
target population, using the gold standard method of assessing sodium intake, namely 
24-hour urinary excretion collections (Chapter 3). This information was necessary to 
inform the levels of sodium and other cation modification required in order to obtain a 
physiologically relevant change in blood pressure. As well as quantitative data on levels 
of sodium intake, the food sources that are the most important contributors to overall 
non-discretionary salt intake, and the pattern of intake of these foods, is described 
(Chapter 4). This data allowed identification of commonly consumed foods that could be 
targeted for modification of their cation content. 
The collection of 24-hr urinary samples to determine sodium intake is not feasible on a 
large scale in a developing country such as South Africa due to cost constraints, 
methodological difficulties and generally low education levels. Since dietary surveys are 
time-consuming and costly, a rapid questionnaire that is able to estimate salt intake in 
the local population and that is useful for both research and clinical purposes was 
developed and validated (Chapter 5). Together with secondary analyses of previously 
published dietary surveys, data obtained in the dietary and urinary studies in this body of 
work were used to develop such a tool. 
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Next, in partnership with the food industry, the identified important commonly consumed 
food sources of salt were altered in cation content and tested for sensory properties, 
product quality and nutritional content (Chapter 6). Finally, the blood-pressure lowering 
effect of substitution of these novel food products for the standard varieties were 
investigated in an 8-week, randomised double-blind controlled community-based 
intervention (Chapter 7) in 80 black hypertensive patients aged 50 - 75 years. It is 
noteworthy that the effectiveness of the health benefits of the products were evaluated in 
the context of a community-based dietary intervention in which subjects were free-living 
within their usual socioeconomic living conditions. 
This group of studies which culminated in a randomised controlled trial showed that free­
living black hypertensive patients that are taking anti-hypertensive medication can lower 
their blood pressure further by consuming their usual foods which have been modified to 
contain lower levels of sodium and higher levels of potassium, magnesium and calcium. 
These findings have shown, for the first time in South Africa, that the improvement of 
commonly consumed foods can lower blood pressure. An imperative need for South African 
food companies to improve staple food products in the country, particularly bread, has been 
identified. The recommended public health strategy approach also identifies a need for the 
Department of Health to ensure that the necessary regulations are in place to enforce such 















Objectives: (1) To determine habitual urinary excretion and dietary intake of sodium, 
potassium, magnesium and calcium in three South African ethnic groups; (2) To assess 
the proportion of salt intake which is discretionary; (3) To investigate whether the BP­
cation association varies, according to ethnic status; (4) To assess inter- and intra­
individual variability in BP and urinary Na excretion; (5) To determine renin and 
aldosterone status across ethnic and hypertensive groups. 
Design: A cross-sectional study of 325 black, white and mixed ancestry men and 
women, conveniently sampled in Cape Town. 
Methods: 24-hr urine samples were collected on three separate occasions for 
assessment of urinary cations, and three 24-hour dietary recalls for the corresponding 
urine collection times were administered by two trained fieldworkers. Para-amino benzoic 
acid was used as a marker of completeness of urine collection. Blood pressure was 
measured on 3 occasions using an Omron automated device. BMI was measured, and 
plasma renin and aldosterone concentrations determined. Inter-individual variability was 
calculated as the coefficient of variation (CV ;;; SD./mean), expressed as a percentage, 
between subjects for an average of 3 measurements. Intra-individual CV is calculated as 
the variation in each subject between the 3 repeated measurements. 
Results: Mean urinary Na values equate to a daily salt (NaCI) intake of 7.8g, 8.5g and 
9.5g in black, mixed ancestry and white subjects, respectively. Between 33 % and 46 % 
of total Na intake was discretionary. In normotensive subjects, both black and mixed 
ancestry subjects had significantly lower median urinary Na concentrations than white 
subjects, but these differences were not evident between black and white hypertensive 
subjects. No ethnic differences were found for urinary potassium, except for mixed 
ancestry normotensives having a lower excretion than white normotensives. Urinary Mg 
excretion did not differ across ethnic groups. In both normotensives and hypertensives, 
urinary calcium concentrations differed between all three ethnic groups, with black 
subjects having the lowest values of all groups, approximately less than half that of white 
subjects. No association was found between any of the urinary cations and BP. Inter­
individual CV was 15 % and 13 % for systolic and diastolic BP, respectively, while intra­
individual CV was 5.2 and 5.3 %, respectively, and was higher in hypertensives 
compared to normotensives. For urinary Na, inter-individual CV was 41.5 % and intra­
individual CV was 33.7 %. Black and mixed ancestry hypertensives had lower plasma 
renin and aldosterone:renin ratio values compared to their normotensive counterparts, 



















between renin and systolic and diastolic BP was found, controlling for ethnic group, age, 
sex and BMI. 
Conclusion: White South Africans have higher habitual intakes of sodium, but also 
higher calcium intakes, than their black and mixed ancestry counterparts. All ethnic 
groups had sodium intakes in excess of 6 g salt/day, while potassium intakes in all 
groups fell below the recommended 90 mmollday. Dietary differences may contribute to 
ethnic-related differences in blood pressure. 
Study 2 
Objectives: To identify which food sources are the major contributors to sodium, 
potassium, calcium and magnesium intake in the South African population. Research 
methods: Cross-sectional study of 324 black, white and mixed ancestry hypertensive 
and normotensive subjects. Three repeated 24-hr urine samples were collected for 
assessment of urinary Na, and 3 corresponding 24-hour dietary recalls were 
administered by trained fieldworkers. Additionally, secondary analyses was performed-on 
existing dietary databases obtained from 4 regional surveys undertaken on adults in 
South Africa. 
Results: Between 33 % and 46 % of total Na intake was discretionary, while of the non­
discretionary sources, bread was the single greatest contributor to Na intake in all 
groups. Urban/rural differences exist regarding sources of dietary Na, with over 70 % of 
total non-discretionary Na being provided by the bread and cereals food group in rural 
black South Africans, compared to 49 - 54 % in urban dwellers. Bread also provided the 
most K and Mg and, after maas (fermented milk), Ca in black subjects. Ethnic 
differences in calcium intake were evident, with black subjects having particularly low 
intakes. 
Conclusion: The cereals food group is the largest contributor to non-discretionary Na 
intake and bread is the single food item which provides the highest proportion of Na in 
the diets of South Africans, particularly in the black population. It is recommended that 
the food industry be lobbied to lower the sodium content of bread, while simultaneously 
increasing K, Mg and possibly Ca, and that the impact of this intervention on blood 
pressure be tested in randomized controlled trials. 
Study 3 
Objectives: To develop and validate a short, food frequency questionnaire to assess 
habitual dietary salt intake in South Africans and to allow classification of individuals 
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according to intakes above and below the maximum recommended level of 6 g salt per 
day. 
Design: A cross-sectional validation study in 324 black, white and mixed ancestry men 
and women, conveniently sampled in Cape Town. 
Methods: 24-hr urine samples were collected on three separate occasions for 
assessment of urinary Na, and three 24-hour dietary recalls for the corresponding urine 
collection times were administered by two trained fieldworkers. All individual food items 
consumed by more than 5% of the sample and which contributed ~ 50 mg Na/serving 
were included in the questionnaire and collapsed into 42 separate categories. The 
questionnaire was scored by calculating the Na content of an index food in each 
category (divided by 50 and rounded to the nearest integer) and multiplying it by a 
frequency factor (1 - 6) calculated from subjects' repeated dietary recall data. Internal 
consistency of the final questionnaire was assessed in a new sample of 80 black 
hypertensive South Africans using the same data collection methodology. 
Results: Positive and significant correlations were found between the Na content of 35 
of the 42 food groups in the questionnaire and tot l Na intake, calculated using the 24-hr 
recall data. A positive association was found between total Na content of the 
questionnaire and Na estimations from the 24-hr recalls (Spearman r = 0.750; P 
<0.0001; N =328) and urinary Na excretion (r =0.152; P =0.0105; N =284). r =0.750 
(P <0.0001) (N = 328). Comparing tertiles of questionnaire Na score, urinary Na was 
significantly higher for subjects in tertile 3 than those in tertile 1. Stanines of 
questionnaire Na content were combined into three groups (1 +2+3; 4+5+6; 7+8+9) which 
yielded significant differences in urinary Na between Groups 1 and 3 (P <0.05). Two 
groups were created for questionnaire Na content: < and ~ 2 400 mg (6 g NaCI)/day 
which equated to a reference cut-off score of 48. According to this categorisation, a 
significant difference in urinary Na was found (144.8 (68.4) mmol/day vs 176.4 (99.4) 
mmol/day; P<0.05). Sensitivity and specificity against urinary l'Ja ~ and < 100 mmol/day 
was 14.2 % and 92.4%, respectively. Positive and negative predictive value was 86.1 % 
and 24.6 %, respectively. In a new sample, the questionnaire Na score was correlated 
with Na intake estimated from repeated 24-hr dietary recall (r = 0.5606; P<0.0001) but 
not with urinary Na. 
Conclusion: A 42-item food frequency questionnaire has been shown to have content, 
construct and criterion-related validity, as well as internal consistency, with regard to 
categorising individuals according to their habitual salt intake. Due to its high specificity, 
the questionnaire can identify individuals with an excessive salt consumption. The 
instrument will be useful in research and clinical settings. The devised categorical 


















instrument should be undertaken in different geographical areas (i.e. urban and rural) 
where local communities are known to have different eating patters with regard to 
processed foods and salt use. 
Study 4 
Objectives: To favourably modify the cation content (Na, K, Mg, Ca) of food items which 
are commonly consumed by the black urban South African population. Methods: 
Partnerships were forged between academics from two institutions (Medical Research 
Council and University of Cape Town) and three food industry members. The 
experimental bread was compared against standard brown bread, after a drop test (to 
assess whether bread quality deteriorates with abuse) and after usual baking practices 
for baking properties (volume, crust colour, crumb colour and cell structure), sensory 
properties and nutritional composition. Plant production feasibility was evaluated in an 
industrial plant. Breads produced there were subjected to sensory evaluation using 
triangulation tests in a panel of 122 consumers. Twenty-four samples of both the 
standard and the experimental bread were laboratory-analysed for Na, K, Mg and Ca 
content using standard methods laboratory. A reduced salt version of Knorr soup mix, 
Knorrex stock cubes, Aromat (monosodium-glutamate based flavour enhancer) and a 
brick margarine was developed by Unilever Foods South Africa. Two types of salt 
replacements were used in the development of these products. 
Results: A 32.3 % reduced Na brown bread was developed which was acceptable in 
terms of baking qualities, appearance, texture and taste. Potassium, magnesium and 
calcium content of the bread were increased by 55.2 %, 69.0 %, and 34.8 %, 
respectively. Sodium was reduced by 68.8 % in the soup mix, 23.6 % in the stock cube, 
51.1 % in Aromat, and 62.1 % in margarine. All products were similar to the standard 
versions in terms of appearance, structure and taste (evaluated by expert research and 
development staff). 
Conclusion: Reduced Na versions of brown bread, brick margarine, soup mix, stock 
cube and a flavour enhancer (Aromat) were successfully developed. The impact on 
blood pressure of substitution of these items for the regular varieties requires testing in a 

















Objective: To assess the impact of a food-based intervention on blood pressure in 
treated hypertensive individuals. 
Design: Randomized, double blind, parallel group controlled trial. 
Setting: Community-based, peri-urban area of Cape Town, South Africa. Participants: 
Free-living black South African men and women aged 50 - ,75 y, with drug-treated mild­
to-moderate hypertension (Systolic BP ::; 160 mmHg and Diastolic BP ::; 95 mm Hg), 
were recruited from a church-based luncheon club and by advertising in a local 
community newspaper. Subjects were randomly allocated to a control group (n = 40) or 
a reduced sodium, increased potassium, magnesium and calcium diet group (n = 40) in a 
2-staged design. 
Intervention: 8-week provision of 6 commonly consumed food items (salt replacement 
(Solo TM), bread, margarine, stock cubes, soup mixes, Aromat (flavour enhancer}) which 
had a modified cation content (reduced in Na, and increased in potassium, magnesium 
and calcium content). In addition, 500 ml/day of maas (fermented milk) was provided. 
The control diet provided the same quantities of these foods to subjects, but which were 
of standard commerical composition. Instead of maas, 500 ml/day of artificially 
sweetened cooldrink was given. Compared to control foods, intervention foods provided 
41 % less Na and 826 %, 388 %, 368 % more K, Ca and Mg, respectively. 
Main outcome measures: Between-diet difference in change in ol:Fice blood pressure 
(Omron automated BP monitor) and 24h ambulatory blood pressure monitoring (ABPM) 
between baseline and mean of 4-week and 8-week intervention readings ("Post"). 
Results: The intervention effect, as measured by the Omron automated monitor, for 
systolic BP is a reduction of 6.19 (SEM =2.64) mmHg (95% CI: -11.44 to -0.94 mmHg) 
(P=0.021) for systolic BP and a non-significant reduction of 0.60 (1.22) mmHg (95% CI: ­
3.02 to 1.83 mmHg) for diastolic BP. Mean 24-h ABPM between-diet change was a 
reduction in both systolic BP of 4.53 (2.27) mmHg (95 % CI = -9.05 to -0.006 mmHg; P = 
0.050) and diastolic BP of 2.49 (1.34) mmHg (95 % CI = -5.16 to 0.17; P =0.066). The 
largest change in 24-h ABPM was demonstrated for wake systolic BP (-5.14 (2.40) 
mmHg; 95 % CI = -9.93 to -0.35; P = 0.036) and wake diastolic BP (-2.66 (1.46) mmHg; 
95 % CI =-5.56 to 024; P =0.072). 
Conclusions: An 8-week dietary intervention, in which high salt foods with a modified 
Na, K, Mg and Ca content are provided, together with a fermented milk drink, resulted in 
clinically significant reductions in systolic BP in treated South African hypertensive 

























































































1.1 Overview of hypertension in South Africa: prevalence, treatment 
status and risk factors 
The estimated leading cause of death in South Africa is non-communicable diseases, 
which accounted for 37 % of all deaths in the country in 2000, followed by HIV/AIDS (30 
% of deaths) and pre-transitional causes (communicable diseases, maternal causes, 
perinatal conditions and nutritional deficiencies) (21 %).1 Regarding specific cause of 
death, cardiovascular disease is the second leading cause of death after HIV/AIDS, and 
accounts for 17 % of all deaths.l Approximately 6 million of the total population of 41 
million South Africans are estimated to be hypertensive « 140/90 mmHg),2 placing 
them at high risk for developing cerebral haemorrhage, malignant hypertension, 
kidney disease leading to uraemia and congestive heart failure.3.4 Coronary heart 
disease (CHD) is relatively uncommon in the black population, in contrast to it being 
the major outcome related to hypertension in the white and Indian communities.3 
Diagnosis and management of hypertension is poor. Local studies suggest that only 
about half of all hypertensive patients in South African communities are known to 
health services; only half of those who are diagnosed are treated; and only between 16 
% to 35 % of treated hypertensives are "controlled" «160/95 mmHg).5.6,7 The 
comprehensive Demographic and Health Survey (DHS), conducted in almost 14 000 
adults in 1998, reported that in the hypertensive (BP ;;::140/90 mmHg,8) urban black 
population, less than a fifth (17.5 %) of hypertensive men and 35.6 % of hypertensive 
women were receiving treatment for their condition, while only 8.2 % and 18.7 %, 
respectively, had controlled BP levels « 140/90 mmHg).9 
Hypertension poses a health and economic burden on South Africans by virtue of its 
morbidity, costly complications, and predisposition to premature mortality.10 The 
impact of hypertension on mortality was assessed in an African population in 1996 by 
Kaufman et al.11 The risk of death increased by 60% with an increase of 20 mmHg in 
diastolic blood pressure (BP) in rural Nigeria and the authors estimated that the 
population attributable risk (the reduction in total mortality that would have been 
observed if hypertension were not present) was 7%. Available evidence suggests an 
escalating risk for not only hypertension but also for a deterioration of the global CVD 
risk factor profile of black South Africans. Data from a birth cohort study conducted in 
the greater Johannesburg area (Birth-to-Ten study) has shown that black children aged 
as young as 5 years already have significantly higher BP levels than Indian and white 

























The consistent finding of a higher prevalence of hypertension and its related 
sequelae in US blacks compared to whites has led to speculation that African-origin 
populations are particularly susceptible to this condition. 13,14 This conventional 
wisdom has been challenged in a recent analysis of data from 8 white and 3 black 
populations that has demonstrated a wide variation in hypertension prevalence 
among both ethnic groupS.15 The rates among black populations are not unusually 
high when viewed internationally. Instead, the analysis suggests that the impact of 
environmental factors among both ethnic groups may have previously been under­
estimated. The gradient in hypertension prevalence among black populations from 
Nigeria. Jamaica and the US is consistent with transition to an industrialized 
lifestyle.15 In this regard, the age-adjusted prevalence of hypertension of 23.5 % and 
25.0 % for South African black men and women. respectively. could possibly be 
expected to rise by 25 % if a typical Westernized lifestyle is adopted by both urban 
and rural dwellers alike.16 In South Africa, as in other countries experiencing 
economic transition from underdeveloped to more developed such as Brazil and 
China, increased rates of obesity accompany the nutrition transition taking place.17 
The already alarmingly high overweight and obesity rates in urban black South 
African women {52 %)18 probably explain why hypertension prevalence has 
exceeded that of white women. 
In addition to obesity being a major risk factor for hypertension. dietary factors other 
than excessive energy intake. are also important determinants of raised blood 
pressure in African communities. Data from the THUSA study has identified factors 
related to hypertension in a black sample undergoing the health transition in the 
North West province of South Africa. 19 Factors related to urbanisation were positively 
associated with hypertension in this population. Steyn et a/.2O reported similar findings 
whereby the duration of urbanisation independently predicted the presence of 
hypertension in the black community of Cape Town. However, other authors have not 
found an urban/rural difference in the prevalence of hypertension in the black South 
African population.21 In the THUSA study, blood pressure correlated positively with 
age. level or urbanisation, waisthip ratio and tobacco smoking. Additional factor 
analyses of the data found that, of the clusters of risk factors relating to hypertension, 
the most important was the malnutrition cluster which included high intakes of 
saturated fat, animal protein, sodium, vitamin A and B6. 22 A second cluster identified 
had characteristics of the metabolic syndrome. A third cluster consisted of an 
hypercholesterolaemic and obesity group of factors that included ageing, total, LDL 












The reported dietary patterns of the majority of South Africans indicate a low 
24carbohydrate, low dietary fibre, and marginal micronutrient intake.23. Consumption 
of fruits and vegetables (and therefore potassium) is inadequate and falls far below 
the internationally recommended guideline of at least 5 portions (400g) of fruits and 
vegetables per day.25 A meta-analysis of cohort studies has provided evidence that 
an even greater intake of fruit and vegetables may reduce the risk of both ischaemic 
and haemorrhagic stroke.26 Compared with individuals who had less than three 
servings of fruit and vegetables per day, the relative risk of stroke was 0.89 (95% CI 
=0.83 - 0.97) for those with three to five servings per day, and 0.74 (95 % CI =0.69 ­
0.79) for those with more than five servings per day. 
It is estimated that South African adults and children aged 10 + years consume, on 
average, 93g/day of vegetables and 61 g/day of fruit.27 Black urban dwellers are 
reported to eat fruits and vegetables in small amounts, usually one small portion 
twice a day.23.28.29.3o Some studies have reported negligible fruit and vegetable 
intakes in this group, such as in Cape Town where 29% of black adults in a peri­
31urban setting reported eating no fruit or vegetables in the previous 24 hour period.
Reliable information on habitual dietary intakes of sodium in the South African 
population is sparse. Elderly residents of West Coast fishing villages were found to 
have a 24-hour urinary sodium excretion which corresponded to a dietary intake of 
about 9g of salt per day,32 which exceeds the recommended value of 6g or less per 
day of the US National High Blood Pressure Education Program.33 
1.2 	 Concept of salt sensitivity and its role in blood pressure 
regulation 
Blood pressure is a function of cardiac output and peripheral vascular resistance. 
The kidneys, which excrete almost all ingested electrolytes and much of the water 
consumed daily, are responsible for managing the electrolyte and water content in 
the body. Volume content is tightly controlled by the regulation of sodium (and 
thereby chloride) excretion. Almost all people living in westernized societies ingest a 
high-sodium diet, however not all individuals respond similarly to a high-salt intake. A 
relationship between renal salt and water excretion and blood pressure can be 
created for any level of blood pressure and is termed the renal pressure-natriuresis 
or diuresis relationship, first described by Guyton.34 According to his hypothesis, the 


















cause initiating the hypertensive process. All forms of hypertension in animal models 
tested to date feature a shift in the pressure-natriuresis relationship to the right. so 
that a higher level of pressure is required to excrete any given amount of salt and 
water. In normotensive individuals the relationship between salt and water intake 
(and excretion) is very steep, so that little change in blood pressure occurs when salt 
and water intake (and excretion) are modified over a large range. Conversely, a fairly 
flat pressure-natriuresis curve indicates a sensitivity to salt. Kimura and Brenner35 
have extended this approach and described the various pressure-natriuresis curves 
in sodium-sensitive and sodium-resistant forms of secondary hypertension. They 
have proposed three major renal mechanisms leading to the development of 
hypertension, namely an increased pre-glomerular vascular resistance, a decrease in 
whole kidney ultrafiltration, and an increase in tubular sodium reabsorption. They 
< 
suggest that pre-glomerular vasoconstriction leads to a salt-resistant hypertension 
whereas a reduced nephron mass and alterations of renal sodium handling result in 
the development of salt-sensitive forms of hypertension. Johnson and Schreiner36 
emphasize the role of microvascular injury and tubulointerstitial fibrosis in shifting the 
pressure-natriuresis curve to the right, to result in the development of salt-sensitive 
11 37hypertension. These authors have shown that transient angiotensin and 
phenylephrine infusions38 can induce renal microvascular injury and tUbulointerstitial 
fibrosis and salt-dependent hypertension even when the hyperactivity of the 
sympathetic or renin-angiotensin system is no longer engaged. These various 
hypotheses, together with the results of renal transplantation experiments in 
animals39 and humans,4o identify the kidney to be the key determinant of the blood 
pressure response to salt. Yet salt sensitivity is a multifactorial phenomenon involving 
extrinsic, essentially hormonal, as well as intrinsic renal tubular and haemodynamic 
mechanisms, possibly modulated by genetic factors.41 
In most individuals a very wide range of salt intake is accompanied by only a modest 
and transient change in arterial blood pressure, as would be expected from the 
pressure-natriuresis relationship that dominates the long-term control of blood 
pressure.34 The concept of salt sensitivity and salt resistance in humans was first 
described by Kawasaki et al.42 and later by Weinberger et al.,43 in an attempt to 
explain the heterogeneity of the blood pressure response to salt. Salt sensitivity was 
initially defined as an increase in mean arterial pressure greater than 10% when a 
high-salt diet was administered, compared with a low-salt period.44 The methodology 
submitted subjects to extreme changes in sodium intake (from 10 mmol/day to 250 











protocols have been used to test the salt sensitivity of blood pressure in humans, 
including an acute protocol in which patients are salt-loaded with an intravenous 
43
infusion of saline and salt-depleted with the administration of frusemide. It has been 
suggested that acute changes in sodium balance may not adequately reflect long­
term changes in dietary sodium intake and that ambulatory blood pressure 
monitoring may be a more reliable way of measuring the salt-induced changes in 
blood pressure.45,46 As well as the route of sodium administration, other 
methodological discrepancies between investigators include the level of salt 
restriction and/or salt loading required to elicit a response, as well as the number of 
days on which subjects should be salt loaded or depleted. In addition, the validity of 
salt sensitivity as a clinical concept has been questioned with regard to its usefulness 
to dichotomize a population, when in fact salt-induced changes in blood pressure are 
normally, rather than bimodally distributed.41 Yet another major criticism of the 
concept of salt sensitivity relates to its low reproducibility,47,48,49 however this is 
contested by Campese and colleagues who maintain that salt sensitivity is a 
reproducible and persistent phenomenon over time when assessed according to 
rigorous protocols.50 
Since there is no quick and easy way to predict whether an individual is salt 
sensitive, the classification has remained in the research domain rather than being of 
practical or clinical importance. However, despite seemingly arbitrary and varied 
definitions of salt-sensitivity in the literature, several findings are consistently 
observed: hypertensive patients are more frequently salt sensitive than normotensive 
subjects and the prevalence of salt sensitivity is increased in older individuals, black 
populations, and patients with a low-renin hypertension such as diabetics.43 
Putative mechanisms for salt sensitivity are: alterations in circulating levels of (or 
renal responses to) atrial natriuretic factor, kallikrein, prostaglandins, and nitric oxide; 
increased levels of norepinephrine; abnormal suppression of both renin and 
aldosterone; genetic mechanisms; and acquired renal microvascular and tubular 
injury.51.52 
In the US, the greater susceptibility of African-Americans than whites to hypertension 
and pressure-related target-organ damage has been linked to a higher prevalence of 
salt sensitivity, as well as lower urinary potassium excretion, lower plasma renin 
activity, and higher circulating levels of immunoreactive parathyroid hormone and 
1,25 dihydroxyvitamin 0.53 Salt sensitivity has been reported to be present in 73% of 
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African American hypertensives, compared to 56% of Caucasian hypertensives but in 
the normotensive population, the frequency of salt sensitivity among blacks (36%) is 
similar to that seen among whites (29%).54 Similar observations of a greater 
frequency of salt sensitivity among blacks have been reported in other studies.55,56 A 
more recent study has demonstrated the prevalence of salt sensitivity to be similar in 
both races when subjects are closely matched, although the magnitude of BP 
increase is greater in African American hypertensives.57 Studies conducted in 
hypertensive patients. in both Johannesburg58 and Cape Town,59 South Africa, have 
also suggested diminished activity of the sodium-potassium ATPase pump in black 
hypertensives. The clinical observation that hypertension in black South Africans 
and African-Americans manifest higher average BP responses to calcium 
antagonists than to ACE inhibitors supports the hypothesis that hypertension 
amongst these groups may be salt sensitive.60,61 
1.3 	 Blood pressure and lifestyle modification: overview and 
introduction 
In patients with hypertension, consideration of the degree or stage of the condition is 
required, together with an assessment of the presence of other major cardiovascular 
disease risk factors, target organ damage, or clinical cardiovascular disease, in order 
to decide on a first line of management (Table 1). A new classification, 
"prehypertension" (120-139/80-89 mm Hg), has been included in the most recent 
version of the Joint National Council (JNC7) guidelines of the US National Heart 
Lung and Blood Institute,33 for which lifestyle modification is recommended. This 
identifies a need for increased education of health-care professionals and the public 
to reduce blood pressure levels and thus prevent the development of hypertension in 
the general population. 
Lifestyle modification (Table 2) is recommended for all patients with hypertension as 













Classification and management of blood pressure for adults* (JNC 7 Guidelines)33 
BP Classification Systolic Bp· Diastolic Lifestyle Initial drug therapy 
(mmHg) BP* (mmHg) modification Without With compelling 
compelling indications** 
indication 
Normal < 120 And < 80 No Drug(s) for 
antihypertensive compelling 
Prehypertension 120 - 139 Or 80 - 89 Yes drug indicated. indications.:t: 
Stage 1 140 - 159 Or 90 - 99 Yes Thiazide-type Drug(s) for 
Hypertension diuretics for most. compelling 
May consider indications.:t: 
ACEI, ARB, BB, Other 
CCBor antihypertensive 
combination. drugs (diuretics, 
Stage 2 
Hypertension 
~ 160 Or ~ 100 Yes Two-drug 
combination for 
ACEI, ARB, BB, 
CCB) as needed. 
mostt (usually 
thiazide-type 
diuretic and ACEI 
or ARB or BB or 
CCB). 
Drug abbreviations: ACEI =angiotensin converting enzyme inhibitor; ARB:: angiotensin receptor 
blocker; BB =beta-blocker; CCB =calcium channel blocker. 
• Treatment determined by highest BP category. 
Compelling indications include heart failure, postmyocardial infarction, high coronary disease 
risk, diabetes, chronic kidney disease, or recurrent stroke prevention. 
t Initial combined therapy should be used cautiously in those at risk for orthostatic hypotension. 
:j: Treat patients with chronic kidney disease or diabetes to BP goal of <130/80 mm Hg. 
Table 2 
Lifestyle modifications for hypertension prevention and management (JNC 7 
guidelines)33 
Modification Recommendation Average SystOlic BP 
reduction range t 
Weight reduction Maintain normal body weight (BMI = 
18.5 - 24.9 kg/m2) 
5 - 20 mm Hg/10kg 
DASH eating plan Adopt a diet rich in fruits, vegetables 
and low fat dairy products with 
reduced content of saturated and 
total fat. 
8 -14 mm Hg 
Dietary sodium restriction Reduce dietary sodium intake to s 
100 mmollday (2.4 g sodium or 6 g 
sodium chloride). 
2 - 8 mm Hg 
Aerobic physical activity Regular aerobic physical activity (eg. 
Brisk walking) at least 30 
minutes/day, most days of the week. 
4 - 9 mm Hg 
Moderation of alcohol 
consumption 
Men: limit to s 2 drinks*/day. 
Women and lighter weight persons: 
limit to s 1 drink/day. 
2 - 4 mm Hg 
t Effects are dose and time dependent. 











It is noteworthy that all of the recommended lifestyle modification measures are 
dietary related, with the exception of increased physical activity. However, physical 
activity, through its integral role in the energy balance equation together with energy 
intake, helps regulate body weight. 
The publication of the findings of the landmark Dietary Approaches to Stop 
Hypertension (DASH) clinical trial62 signalled a move by health professionals away 
from a preoccupation with salt to the role of a holistic, composite diet in the 
prevention and management of hypertension. The rest of this literature review will 
consider the evidence relating to the influence of individual nutrients on blood 
pressure, and then review the role of various dietary patterns, as well as other 
behavioural factors. 
1.4. Diet and blood pressure 
1.4.1. Sodium 
Salt restriction as a form of treatment for hypertension was introduced at the 
beginning of the century when chloride could first be measured. Interestingly almost 
100 years later, the merits of the salt hypothesis and the utility of its application are 
still being debated. The medical community is seldom as bewildered and polarized 
about a public health policy issue as it is regarding the role of salt in health and 
disease. In 2000, two opposing arguments (for63 and against64) regarding the 
appropriateness of the current US dietary guideline for sodium (Na), which 
recommends less than 6g sodium chloride (or < 2.4 g Na) per day, were published 
back-to-back in the American Journal of Clinical Nutrition. 
During the 1930s and 1940s, it was shown by Grollman et al. (1953)65 that if renal 
mass and blood flow were reduced in experimental animals, blood pressure 
increased predictably_ At the same time, Kempner (1948)66 demonstrated that 
malignant hypertension associated with renal insufficiency could be greatly 
attenuated by an extremely low sodium diet, consisting predominantly of rice. In the 
early 1950s, Tobian and Binion67 observed that the sodium content of blood vessels 
correlated with arterial pressure, however other investigators at the time who tried to 
reproduce salt-induced hypertension found that extreme manipulation of vertebrate 
physiology and nutritional intake was required to observe such an effect. Typically, 
salt intakes needed to be increased by 10 - 20 times in rodent models (even in Dahl 
and colleagues' genetically salt sensitive rat), renal mass reduced to less than half, 






















studies of the haemodynamic and hormonal effect of short term manipulations of salt 
over the physiological range were not conducted in either normotensive or 
hypertensive subjects until the late 1970's, over twenty years since the first reported 
observations between salt and blood pressure.69.70 
The salt-blood pressure hypothesis states that excessive salt intake [in physiological 
terms] leads to an increase in blood pressure [BP] in genetically susceptible persons 
and, if the high intake is maintained over the long-term, ultimately leads to sustained 
hypertension.71 The hypothesis regards salt as the essential pathogenic factor, 
however, the influence of supraphysiological salt intake on blood pressure interacts with 
both genetic predisposition as well as other environmental factors.72,73,74,75 
The INTERSALT ecological study,76 conducted in over 10,000 individuals from 52 
centres around the world, demonstrated that, across populations, level of blood 
pressure, increment in blood pressure with age (See Figure 1), and the prevalence of 
hypertension are related to salt intake, measured using 24-hr urinary sodium 
excretion. However, the within-population analyses indicated that wide variation in 
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Figure 1 
The relation of salt excretion to the slope of the rise in systolic blood pressure with age 











The main observations in the INTERSAL T study are that: (i) for individuals, a 
difference of 100 mmolld of sodium (6 g NaCI) intake is associated with an average 
difference of between 3 and 6 mm Hg in systolic blood pressure, and (ii) for 
populations, a 100 mmolld lower sodium intake is associated with attenuation of the 
age-associated rise in systolic blood pressure by 10 mm Hg in persons aged 25-55y. 
It is noteworthy that in four remote INTERSAL T study sites who consumed less than 
3 grams of salt per day, both sodium excretion and blood pressure were low, there 
was little or no upward slope of blood pressure with age, and little or no hypertension. 
Similarly, there are over 40 studies in unacculturated human populations who at one 
time consumed, or continue to consume, less than 3 grams of salt per day.79 In these 
populations, blood pressure did not and does not rise with age. For example, the 
Yanomamo Indians from southern Venezuela consume a diet that is very low in salt 
(1 mmol Na/day) as well as saturated fat and that is high in fruit, vegetables and 
roots, yielding a potassium intake of 200 - 300 mmollday. In this tribe, blood pressure 
does not rise with age, and vascular disease is not found, despite the fact that much 
of their time is spent fighting under stressful conditions.8o,81, However, if this group 
migrate to a Venezuelan or Brazilian town and adopt a western lifestyle, they, like 
native Americans, become overweight and develop diabetes and premature vascular 
disease. 
Several systematic reviews have reported that restricting sodium intake in people 
with hypertension reduces their blood pressure.82,83,84,85,86 Generally, a 100 mmollday 
reduction in sodium intake is associated with an average reduction in diastolic blood 
pressure of 1.4 to 2.5 mm Hg, which could result in a 15 % reduction in stroke risk.87 
However, most of the studies included in these reviews have been short in duration 
and have not followed subjects up over the long term to assess whether dietary 
changes are sustainable. 
Most of the large dietary intervention blood pressure trials have been conducted in 
the Unites States or Europe. However, a recently published study has shown that 
short-term Na restriction can be achieved in two developing countries, namely 
Jamaica and Nigeria.88 Normotensive subjects randomly followed a low salt and a 
high salt diet for 3 weeks each, with a 2-week washout in between. Subjects were 
counselled on dietary Na sources and on behavioural techniques to lower dietary Na. 
In Nigeria, rock salt (potash), stock cubes and fermented locust beans (iru) are the 











were provided with pre-packaged, low sodium spices for cooking and had the option 
of purchasing low sodium food at a local vendor. The BP reduction associated with 
the low salt intake was similar in both groups, at approximately 5 mmHg for systolic 
BP. This study suggests that the efficacy of sodium reduction in developing countries 
equals those noted in more affluent cultures. 
As well as human studies which show a salt-blood pressure relationship, there are 
also numerous studies in the rat, dog, chicken, rabbit, baboon and chimpanzee, all of 
which demonstrate an increase in blood pressure in the presence of a prolonged 
increase in salt intake.89 In all forms of experimental hypertension, whatever the 
animal model, a high salt intake is essential for the blood pressure to rise. A study 
conducted in chimpanzees, man's closest relative, showed that when salt intake was 
increased from their usual intake of < 0.5 g/day to 15g/day, the blood pressure rose 
slowly, to a significant increase after one year, and continued to rise thereafter.9o 
Blood pressure returned to normal when salt intake was reduced to pre-trial levels. 
Is dietary sodium intake a modulator between hypertension and end organ 
damage? 
In addition to its influence on arterial pressure, there is some evidence that dietary 
sodium may exert some nonpressure-related effects on left ventricular mass in 
experimental models of hypertension,91 as well as in human essential 
hypertension.92,93,94 As long ago as 1972, it was observed that the addition of salt to 
food before tasting (proxy for high salt intake) was associated with an increase in the 
. 
prevalence of electrocardiographic evidence of left ventricular hypertrophy (LVH) in 
95hypertensive men. Recently, it has been demonstrated that dietary sodium 
amplifies the effect of arterial pressure on target organ damage (microalbuminaemia 
and left ventricular mass), even in normotensive humans, thus it can be considered 
to be an independent factor of cardiovascular risk.96 Further, moderate sodium 
restriction in patients with mild-to-moderate essential hypertension has been shown 
to decrease LVH.97 
Is dietary sodium intake associated with cardiovascular disease risk and all­
cause mortality? 
It has been argued for decades that a high salt intake may not be detrimental in 
subjects who are not sensitive to the blood pressure elevating-effects of sodium. 
However, a prospective study of 1173 men and 1263 women in Finland found that 
coronary heart disease, cardiovascular disease and all-cause mortality all rose 
12 
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significantly with increasing 24-hour urinary sodium excretion, independently of other 
98cardiovascular risk factors, including blood pressure. In another 19-year cohort 
study, high reported dietary sodium intake at baseline was strongly and 
independently associated with an increased risk of cardiovascular disease and all­
cause mortality in overweight persons.99 
Dietary sources of sodium and recommended levels of salt restriction 
Sodium chloride is approximately 40% sodium and 60% chloride. The mean daily 
sodium intake of Americans adults is 3290 mg (equivalent to a salt intake of about 8 
grams),100 which greatly exceeds the estimated minimum requirements of healthy 
nonpregnant, nonlactating adults of about 500 mg.101 It is estimated that about three­
quarters of sodium intake comes from food processing, about 15% is discretionary 
(half of which is contributed by table salt and half by added salt in cooking), 10-11 % 
is naturally occurring (inherent) in foods, while less than one percent is provided by 
water. 102,103,104,105 The largest single source of sodium in the American diet comes 
from grain products, including bread, which contributes about a quarter of total 
intake.105 
Cultural practices may contribute to salt intake patterns as the following example 
illustrates. A 10-fold difference in sodium intake has been reported between two 
populations of the Solomon Islands which has been attributed to the practice by one 
group's of steaming foods with fresh water whereas the other group cooks with sea 
water. 106 
In South Africa, the habitual sodium intake of the population is not known. Many 
dietary surveys have been conducted in various sub-groups of the population,23,24 
however it is notoriously difficult to accurately assesses sodium intake from dietary 
reports, since added salt (i.e. discretionary) usage cannot be easily quantified. 
Undoubtedly, the gold standard method for assessment of salt intake is repeated 
analyses of 24-hr urinary sodium. Studies conducted in black and white 
normotensives in Johannesburg in 1982,107 demonstrated ethnic differences in 24-hr 
urinary sodium excretion, with black subjects having significantly lower values than 
their white counterparts (127 ± 55 mmol/day and 167 ± 63 mmol/day, respectively). 
The urinary Na estimations equate to a daily salt intake of 7.5g and 9.8g in black and 
white South Africans, respectively. However, dramatic lifestyle-related changes 
associated with urbanisation and rapidly increasing economic growth have resulted in 











rise in overweight and obesity, and accompanying prevalence of non-communicable 
diseases, such as coronary heart disease, stroke and diabetes mellitus, has been 
shown to be associated with these dietary and lifestyle changes.10g Updated, reliable 
information on amounts and sources of dietary salt intake is thus required in order for 
population-wide non-pharmacological interventions to be developed and successfully 
implemented. 
The Joint National Council (JNC) 7 guidelines of the US National Heart Lung and 
Blood Institute33 recommends a maximum sodium intake of 100 mmol (2400 mg) per 
day, which equates to about 6 g salt (Table 1). If an individual is prepared to give up 
salt added to food and to avoid eating salt-rich processed foods, salt intake can be 
reduced from the average intake of around 9 g (144 mmol or 3310 mg sodium) to 
about 6 g per day. This is the level of sodium restriction which is usually referred to 
as "No added salt" regimen (I.e., 80-100 mmol/d). The World Health Organization's 
(2003) dietary goals for the prevention of cardiovascular disease, including the 
prevention of hypertension and stroke, recommend more stringent restrictions of 
sodium, namely an optimal intake of 70 mmol per day (4g sodium chloride).110 That 
body does however advise that a more realistic population goal is 5 g salt per day. 
Minimal consumption of other forms of Na consumption, such as food additives and 
preservatives (eg. monosodium glutamate) is cautioned. 
Can excessive salt restriction have adverse health effects? 
It may be argued that, providing widespread advice to the general public to reduce 
salt intake may be warranted 
~ 
if health benefits are gained by at least those 
individuals who are "salt sensitive," while at the same time those who are salt­
resistant experience neither benefit nor risk. There is a school of thought that 
proposes an increased morbidity to be associated with salt restriction. In this regard, 
a cohort study of 2 937 mildly and moderately hypertensive men which investigated 
the effects of a low salt intake on cardiovascular disease over an average of 3.8 
years of follow-up, demonstrated a significant, inverse association between baseline 
24 h urinary sodium excretion (anithypertensive therapy was discontinued for 3 to 4 
weeks before providing a urine collection) and myocardial infarction, independent of 
several known coronary heart disease risk factors. 111 The downfalls of observational 
studies, with regard to unmeasured confounder variables and the imprecision of the 
potential confounders which are measured, are well known and may have 

















A 20-year follow-up of the first National Health and Nutrition Examination Survey 
(1971 - 1975) baseline sample (N = 20 729 US adults aged 25-75 y) examined 
mortality in gender-specific quartiles of sodium intake in 11 346 persons. 113 The 
inverse association found between sodium intake at baseline and both all-cause and 
cardiovascular mortality was no longer apparent when sodium intake was expressed 
as a function of energy intake. Instead, a direct association between sodium intake 
and mortality was found 
Feasibility of salt restriction 
A systematic review of the long term effects of advice to restrict dietary sodium in 
adults, with and without hypertension, reported only small reductions in blood 
pressure (-1.1 mmHg (95 % CI = -0.4 to -1.8 mm Hg) for systolic BP and - 0.6 mm 
Hg (0.3 to -1.5 mmHg) for diastolic BP) at 13 to 60 months of follow-up.114 The 
disappointing long-term results are undoubtedly due to subjects' inability to comply 
with dietary advice to reduce salt intake. As follow-up in trials became longer, the 
difference in 24-hr urinary sodium excretion between intervention and control 
subjects became progressively smaller (reduction of 49 mmolld at 6-12 months of 
follow-up, compared to 35 mmol/d at 13 to 60 months, and 10 mmolld in trials which 
reported follow-up of over 60 months). The results of the review reflect the best-case 
scenario since the cited trials all used intensive interventions, which are probably 
unsuited to primary care or population-based prevention programs. However, it was 
concluded that advice to reduce sodium intake may help people on antihypertensive 
medication to stop taking their drugs while maintaining good blood pressure control. 
In this regard, moderate dietary sodium restriction (from 206 to 109 mmol urinary 
Na/24 h) has been shown to be as effective as the addition of a thiazide diuretic 
agent, as combination therapy, to the prescription of an ACE inhibitor.115 The 
particular advantage of sodium restriction over diuretic therapy is that urinary 
potassium excretion is not increased in the former. 
A randomized controlled trial in 47 elderly people aged 60 78 years who were not 
receiving anti-hypertensive medication found that a modest salt restriction from 10 g per 
day to 5g per day resulted in a reduction of systolic and diastolic blood pressure by 7.2 
and 3.2 mm Hg, respectively, over a four-week period.116 Importantly, unlike studies in 
younger subjects, similar falls in blood pressure were seen for both normotensive and 
hypertensive subjects. A low salt bread was provided to subjects which greatly 











The findings are consistent with the predictions of Law and colleagues, who estimate 
that a reduction in sodium intake of 50 mmol/day (about 3 g salt) in older people 
would lower the population's systolic blood pressure by an average of 5 mm Hg.117 
This magnitude of blood pressure reduction is similar to trials of drug therapy with 
thiazide diuretics in this age group, in which a 36 % reduction in the 5-year incidence 
of stroke has been estimated.118 To prevent one vascular event (particularly stroke) 
over a given period of time, four times as many younger people need to be treated 
than those over the age of 60. These studies provide convincing motivation for 
universal sodium restriction in all older people. 
The transduction of the salty taste involves passage of sodium through a specific ion 
channel in the apical membrane of receptor cells. The channel can be blocked with 
the drug amiloride, a potassium-sparing diuretic, and is specific; lithium, which can 
pass through readily, tastes salty, whereas other cations, such as potassium, which 
do not fit, do not taste salty. This specificity explains the difficulty in finding an 
acceptable salt substitute. There is some evidence that long-term adherence to a diet 
low in sodium can lead to a change in taste perception whereby both normotensive119 
and hypertensive120 persons develop an increased acceptance of foods with a 
reduced sodium content, presumably because the salt taste receptors become more 
sensitive, and a lower sodium concentration provides the same salty taste as 
previously. 
OVer two decades ago, it was suggested that a relatively easy way to lower habitual 
sodium intakes in Australians would be to encourage the food industry to use less 
sodium in bread.121 An example of a successful partnership in Australia between the 
food industry and professional bodies in lowering sodium content of foods has 
recently been reported. 122 In response to a 1982 government report in Australia in 
which lower levels of sodium intake were recommended for the general popUlation, 
together with national dietary guidelines in the country and the accreditation criterion 
of the National Heart Foundation's Pick the Tick programme (i.e < 400 mg Na per 
100g food), Kellogg's reformulated 12 of their breakfast cereal products to comprise, 
on average, 40 % less sodium. As a result, 235 tonnes of salt were removed annually 
from the Australian food supply. Importantly, consumer food appeal was not affected. 
In many countries, the food industry has been largely resistant to the call by public 
health advocates and food lobby groups to lower the salt content of processed foods. 
MacGregor and de Wardener72 have graphically depicted the economic importance 
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The commercial importance of salt in processed foods, as depicted by MacGregor and 
de Wardener72 
There are some encouraging examples of community-based interventions which 
have been successful in lowering salt intake. The North Karelia project in northern 
Finland, an area where the incidence of cardiovascular disease was very high, was 
able to reduce salt and fat intake, increase fruit and vegetable consumption and 
reduce cigarette smoking through a government-backed campaign which involved 
the food industry.123,124 These dietary and lifestyle changes resulted in a reduction in 
blood pressure and significant falls in stroke and coronary heart disease mortality. 
Three-quarters of the fall in coronary heart disease and two-thirds of the fall in stroke 
mortality have been attributed to the change in risk factors. 
A Portugese study of two villages has demonstrated that salt intake can be reduced 
by approximately half by providing a population with information on how to reduce 
salt intake, particularly from processed sources, and providing processed foods with 
a reduced salt content.125 Over two years, the intervention and control (no salt 
reduction) villages had a significant and substantial difference in blood pressure. 
1.4.2 Potassium 
Mechanisms of the blood pressure-lowering effect of potassium include its 
vasodilator activity,126,127 an increased loss of water and sodium,128 suppression of 











reduction in adrenergic tone.130 Data from over 60 reports of the blood pressure­
lowering effects of potassium supplementation, and from a meta-analysis of 
randomized clinical trials,131 suggest that potassium supplementation should be 
considered more widely in therapeutic and preventive strategies for hypertension, 
particularly in certain subgroups. A mean increase in urinary potassium excretion of 
53 mmol/d resulted in a decrease in systolic and diastolic blood pressure of 3.1 and 
2.0 mm Hg, respectively. In almost all the trials potassium was given as a chloride 
salt supplement, but both the JNC 7 and the 2003 World Health Organization 
(WHO)110 dietary guidelines recommend an increased intake of foods rich in 
potassium. The latest JNC 7 guidelines do not specify a recommended intake of 
potassium, however the earlier version (JNC 6, 1997)8 recommended an intake of 90 
mmol of potassium per day. The WHO report recommends a potassium intake which 
will keep the sodium:potassium ratio close to one (Le., a potassium intake of 70-80 
mmol/d, if their guidelines on sodium restriction are achieved).132 The WHO suggest 
that this potassium intake can be achieved through the adequate daily consumption 
(400 - 500 g per day) of fruit and vegetables (including beries, green leafy and 
cruciferous vegetables and legumes), as well as the use of K-enriched low sodium 
salt substitutes. 
The findings of a metabolically controlled study of 38 normotensive men (24 African­
American, 14 whites) found that in normotensive black, but not white, men an 
elevated blood pressure response to sodium occurred when dietary potassium was 
even marginally deficient, but was dose-dependently suppressed when dietary 
potassium was increased within its normal range.132 The study participants were 
given a basal diet low in sodium (15 mmol/day) and marginally deficient in potassium 
(30 minol/day) for six weeks; 250 mmol/day of sodium chloride was added to the diet 
during the last four weeks, accompanied by potassium supplementation (KHC03) to 
either mid~ or high-normal (70, or 120 mmol/day, respectively) levels throughout the 
last three weeks. On the low potassium intake, salt loading induced a mean increase 
in blood pressure only in black men. Even in the presence of moderate potassium 
supplementation, salt sensitivity was attenuated similarly in black and white subjects, 
while supplementation to 120 mmol/day suppressed the frequency and severity of 
salt sensitivity to levels similar to those in whites. 
In studies in which dietary potassium was controlled at normal intakes ranging from 
60 to 100 mmol/d throughout the dietary salt loading period, dietary intakes of salt as 













either black or white normotensive men.133,134,135,136 Similarly, a marginally deficient 
dietary. potassium intake has been shown to result in an enhanced vasopressor 
responsiveness to sympathetic stress, induced either by experimental cold or mental 
stress in normotensive African-American black men who were salt sensitive, but not 
in normotensive white men who were salt-resistant.137 
The level of dietary potassium intake which would confer the greatest benefit with 
regard to protection against sodium-induced pressor effects in different groups has 
yet to be described. Morris and colleagues 129 have proposed that a "normal" dietary 
intake of potassium may not be sufficient to suppress expression of salt sensitivity in 
a substantial number of normotensive black individuals and in fewer normotensive 
white subjects. In the US, dietary intake of potassium has been found to be lower in 
inner-city black groups compared to their white counterparts.138,139 
1.4.3 Calcium 
Resnick and colleagues 140 hypothesize that salt sensitivity interacts with calcium 
metabolism in patients with essential hypertension. A high sodium intake has been 
shown to be associated with higher blood pressure levels among persons consuming 
low-calcium diets.141 The inverse relationship between calcium intake and blood 
pressure is more convincing at low levels of calcium consumption, i.e. 300 - 600 
mg/day.142 In at least three animal models of hypertension, calcium supplementation 
has produced a significant decrease in blood pressure, while in human studies the 
most consistent pressure-low ring effect of calcium has been seen in subjects during 
a high sodium intake.143,144,145 Studies performed in normotensive offspring of 
hypertensive subjects demonstrated altered calcium metabolism when given a high 
salt diet. l46 
Two meta-analyses of controlled trials have shown that calcium supplementation 
(1000 to 2000 mg/day) results in small, but significant, reductions in systolic 
(between -1.7 and -4.3 mmHg) but not diastolic blood pressure.147,148 Weinberger 
and colleagues 149 have confirmed a heterogeneity of blood pressure responses of 
both normotensive and hypertensive humans to calcium supplementation. Among 
hypertensives, calcium supplementation is more likely to reduce blood pressure in 
older or black subjects.150,151,152,153,154 Hypertensives have been shown to have an 
increase in urinary calcium excretion despite a lower calcium intake,155 which has 












There is evidence, albeit indirect, from both experimental and metabolic studies, to 
suggest that an increased level of magnesium may be beneficial in lowering blood 
pressure in otherwise healthy free-living individuals. In vitro studies have shown that 
magnesium influences cell membrane sodium pump activity, which in turn affects 
sodium-potassium transport across cell membranes, and subsequently vascular tone 
and reactivity. 156 Clinical studies have demonstrated significant blood pressure 
reductions with parenteral high-dose magnesium in patients with eclampsia and 
glomerulonephritis.157.158 
In addition, observational epidemiological studies have reported an inverse 
association between dietary magnesium intake and blood pressure. 159 However, the 
imprecision of dietary intake reporting, together with the colinearity of magnesium 
intake with other dietary components that affect blood pressure, limit the 
interpretation of epidemiological data. Since 1983, many magnesium 
supplementation trials have been conducted in humans.16o.161,162 Results of these 
trials have been inconsistent, maybe due to small sample sizes or other design 
limitations. 
A meta-analysis of 20 randomized clinical trials was conducted by Jee and 
colleagues to determine whether magnesium supplementation reduces blood 
pressure, to identify the dose-response relationship, and to determine trial 
163characteristics associated with the greatest reductions in blood pressure. The 
pooled estimate of the effect of magnesium supplementation on systolic blood 
pressure was a small reduction of 0.6 mm Hg (95 % CI: -2.2 to 1.0 mm Hg). There 
was a net decrease of 0.8 mm Hg for diastolic blood pressure, but this was not 
significant (95 % CI: -2.1 to 0.5). A dose-dependent effect of magnesium was found, 
with reductions of 4.3 rnm Hg and 2.3 mm Hg in systolic and diastolic blood pressure, 
respectively, for each 10 mmol/day increase in magnesium dose. However, few of 
the studies were conducted in the higher dose range of magnesium (20 to 40 mmol 
per day) and the authors of the meta-analysis recommended that properly designed 
and adequately powered trials at higher dose ranges be performed in order to 
confirm the inverse dose-response relationship that was detected. The median 
amount of magnesium administered in the trials included in the meta-analysis was 15 
mmol/day (range =10 - 40 mmol/day), which results in about a doubling of usual 
magnesium intake derived from the diet (median =15.6 mmol or 375 mg/day for men 
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in the United States). This dosage may not, however, be sufficiently large enough to 
produce a clinically relevant effect. 
Another limitation identified by the authors of the meta-analysis was the lack of data 
on dietary intake of magnesium. In studies that enrolled participants diagnosed with 
hypertension, subjects may have already increased intake of magnesium-rich foods 
as a result of advice given by health professionals. In summary, the meta-analysis77 
demonstrated only a small overall reduction in blood pressure associated with 
magnesium supplementation, but identified an apparent dose-dependent effect of 
magnesium. 
In South Africa, a study published in 1987 reported on the relationship between 
serum and erythrocyte electrolytes, specifically magnesium and calcium, and blood 
pressure in 296 urbanized black male labourers in Johannesburg.164 A significant, 
inverse association was found between both serum and erythrocyte magnesium and 
blood pressure, as well as between both serum calcium and potassium and blood 
pressure. Of all the electrolytes assessed, magnesium (either serum or erythrocyte) 
correlated most closely with blood pressure. The authors concluded that body 
magnesium status, and its interactions with calcium, sodium and potassium, may 
play an important role in the development and maintenance of elevated blood 
pressure in the South African black population. 
1.4.5 	 Composite dietary . interventions to prevent and manage 
hypertension 
The Dietary Approaches to Stop Hypertension (DASH) randomized controlled trial 
provided unequivocal evidence that non-pharmacological methods can reduce blood 
pressure as much as some anti-hypertensive drugs.62 Subjects fed a diet rich in fruit 
and vegetables for 8 weeks significantly reduced systolic and diastolic blood pressure 
by 2.8 and 1.1 mm Hg more, respectively, than subjects on a typical American control 
diet. Subjects randomized to the DASH diet, rich in fruit, vegetables and low fat dairy 
products, and with a reduced saturated and total fat intake (Table 3), had an even 
greater reduction in both systOliC and diastolic blood pressure (5.5 and 3.0 mm Hg, 
respectively). It was estimated that a population-wide reduction in systolic or diastolic 
blood pressure of the magnitude observed with the DASH diet would reduce incident 
coronary heart disease by approximately 15 % and stroke by about 27 %. It is 












African-American sub-group, in which a blood pressure reduction of 13.2/6.1 mmHg 
was demonstrated.165 Increased efficacy of the DASH diet among African Americans 
supports other data suggesting racial differences in blood pressure response to diet. 
For example, African Americans tend to consume less potassium than their white 
counterparts which may explain some of the increased efficacy of an increased fruit and 
vegetable intake, together with an increased dairy food (calcium) intake in this segment 
of the population.166 
Table 3 
The Dietary Attempts to Stop Hypertension (DASH) diet62 
Food group Daily 
servings 
Serving sizes Examples and notes Significance 
to the DASH 
diet pattern 
Grains and grain 
products 
7-8 1 slice bread 
14 cup dry cereal 
14 cup cooked rice, 
pasta or cereal 
Wholewheat bread, muffin, 
pita bread, bagel, cereals, 
oatmeal 
Major sources of 
energy and fibre 
Vegetables 4-5 1 cup raw, leafy 
vegetables 
14 cup cooked 
vegetables 
6 02 vegetable juice 
Tomatoes, potatoes, carrots, 
peas, squash, broccoli, turnip 
greens, kale, spinach, 
artichokes, green beans, 
sweet potatoes 




Fruits 4-5 1 medium fruit 
Y.. cup dried fruit 
6 oz fruit juice 
14 cup fresh, frozen or 
canned fruit 
Apricots, bananas, dates, 












• Low-fat or non-fat 2-3 8 oz milk Skim or low fat (2 %) milk, Major sources of 
dairy foods 1 cup yoghurt skim or low fat buttermilk, calcium 
and I1.5 oz cheese nonfat or low-fat yoghurt, 
nonfat or low fat cheeses 
protein 
Meats, poultry, and 
fish 
:::;2 3 oz cooked meats, 
poultry or fish 
Select only lean meats; trim 
away visible fats; broil, roast, 
or boil, instead of frying; 
. remove skin from poultry 
Rich sources of i 
protein and 
magnesium 
Nuts, seeds and 4-5/wk 1.5 oz 1/3 cup nuts Almonds, mixed nuts, peanuts, Rich sources of 
legumes 1/2 oz or 2 Tbsp seeds, walnuts, sunflower seeds, energy, 





The DASH eating plan shown above is based on 2000 kcal a day (8 400 kJ/d). Depending on energy 

needs, the number of daily servings in a food group may vary from those listed. 

*Table adapted from the seventh report of the Joint National Committee on Prevention, Detection, 














The follow-up DASH Sodium study investigated the additional benefits of salt restriction 
over and above the merits of the DASH diet.167 Reducing sodium intake from a high 
(150 mmol/day) to either an intermediate (100 mmol/day) or low (65 mmol/day) intake 
resulted in a stepwise reduction in blood pressure, which was approximately twice as 
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High Intermediate Low 
Sodium Intake 
Figure 3 
The effect on systolic blood pressure (panel A) and diastolic blood pressure (panel B) 
of reduced sodium intake and the DASH diet (Taken from Sacks et al., N Engl J Med 
2001 ;344:4.167) • 
Asterisks (P<0.05), daggers (P<0.01), and double daggers (P<0.001) indicate significant 











Sodium restriction from high to low intake in those following the DASH diet resulted in a 
relatively small additional drop in blood pressure of 3.0 and 1.6 mm Hg for systolic and 
diastolic blood pressure, respectively. It may be concluded that the greatest benefits in 
sodium restriction are seen in those with a poor diet (ie. typical "American" high-fat, low 
nutrient-dense diet), and that subjects who include a large amount of fruit and 
vegetables, together with low fat diary products, may be able to tolerate higher amounts 
of salt. This compelling evidence further supports the shifting paradigm in provision of 
nutrition messages to the (often confused) public, in that a holistic approach needs to be 
taken, rather than the targeting of individual messages. 
In a subsequent study, the Diet, Exercise and Weight loss Intervention Trial (DEW­
IT),168 overweight hypertensives demonstrated a net change of 9.5/5.3 mm Hg in 
ambulatory blood pressure, using a low-calorie version of the DASH diet, in combination 
with weight loss. In a fourth dietary intervention trial (PREMIER) which included the 
DASH diet, the effects of combining the DASH diet with "established" lifestyle 
modification recommendations (weight loss, exercise, and restriction of Na and alcohol) 
was investigated.169 Surprisingly, the addition of the DASH diet to lifestyle modification 
resulted in an incremental decrease of blood pressure of only 0.6/0.9 mmHg (1.7/1.6 
mmHg in hypertensive individuals). 
Pickering, in an editorial which appeared in the same issue of the JAMA as the 
PREMIER results,170 offers possible explanations why the effects of combined 
interventions on blood pressure do not appear to be additive. Patients in the PREMIER 
study were not following the DASH diet as closely as in the three earlier DASH studies. 
PREMIER is the first study to intentionally investigate the effects of the DASH diet when 
patients are required to purchase their own food, rather than be provided with carefully 
prepared meals. In the original DASH study, patients were provided with 9.6 daily 
servings of fruits and vegetables, whereas in the PREMIER study, the intake increased 
from 4.8 servings at baseline to 7.8 servings. This was evident in the difference in 
urinary potassium excretion in the two studies, whereby there was a 105 % increase in 
the original DASH study, but only a 28 % increase in the PREMIER study. Similarly, the 
effects of sodium restriction in the DASH Sodium follow-up study greatly exceeded the 
changes observed in almost all other studies in which partiCipants prepared their own 
low salt meals, presumably due to greater compliance with a low sodium regimen. 
The authors of the PREMIER study suggest a "subadditivity of intervention effects." In 
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pressure than the sum of the effects of the individual interventions. In the DEW-IT study, 
in which obese hypertensives were given a hypocaloric version of the DASH diet and a 
mean weight loss of 5.5 kg was achieved, the net reduction in blood pressure was 
comparable to the effects of the DASH diet alone. In the Trials of Hypertension 
Prevention II (TOHP II) study, the effect of adding sodium restriction to weight loss 
produced no further decrease of blood pressure, even though moderate sodium 
restriction alone produced a modest, but Significant, decrease.171 Similarly, the DASH 
Sodium trial demonstrated that although the DASH diet had an additive blood-pressure 
lowering effect when combined with sodium restriction, the combined effect was not as 
great as that estimated on the basis of strict additivity.167 
It is often assumed that most individuals are not capable of changing more than one 
lifestyle factor at a time. However, it is probable that participants in the DASH Sodium 
trial were diligently consuming the prescribed diet since all food was provided. 
Similarly, in the Trials of Hypertension Prevention Trial (TOHP) II trial,171 which 
comprised three intervention groups (weight loss, sodium restriction, and 
combination), the magnitude of weight loss and reductions in urinary Na excretion 
were only marginally less in the combined group than the other two single 
intervention groups. This indicates that subjects were able to simultaneously achieve 
both lifestyle changes. 
An alternative explanation for a lack of additive effects is that different lifestyle 
interventions may act through the same physiological interventions, thus resulting in 
a nonlinear dose-response relationship. 170 Much the same way as doubling the dose 
of anti-hypertensive drugs produces only a small further decline in blood pressure,172 
a combination of lifestyle modifications (such as weight loss, increase in physical 
activity patterns and altering the cation composition of the diet) may all be operating 
through the same physiological pathway. However, much remains to be learned 
regarding the mechanisms by which obesity and other lifestyle factors increase blood 
pressure.173 
It has conSistently been shown, in intervention studies conducted in the United 
States, that African-American individuals with raised blood pressure benefit the most 
from non-pharmacologial interventions, such as dietary changes and weight loss. 
Evidence of the impact of such interventions on blood pressure is awaited from other 
ethnic populations. It is likely that the DASH diet cannot be applied to ethnically 
diverse populations in a "one size fits all" manner. As with all food-based dietary 
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guidelines, recommendations for dietary change need to take into account 
affordability, accessibility, and sustainability, as well as cultural acceptability of the 
dietary patterns being promoted. To date, no dietary intervention to lower blood 
pressure has been conducted in the South African black population. 
1.5 Alcohol and blood pressure 
Epidemiological studies over the past two decades have firmly established a 
relationship between regular, excessive alcohol consumption and hypertension. This 
association has been found in both sexes and in those of differing ethnicity, and is 
independent of the type of alcoholic beverage, adiposity, education, smoking, salt 
intake, and several other factors.174 It has been shown that a habitual intake of 
alcohol greater than 30 to 60 g per day (Le., about 2.5 - 5 alcoholic drinks) results in 
blood pressure elevation in both men and women. A rule of thumb can be derived: for 
subjects who consume an habitual intake of 30 g (about 2.5 drinks) or more of 
alcohol per day, an increment of 10 g alcohol per day increases systolic blood 
pressure by an average of 1-2 mm Hg and diastolic blood pressure by 1 mm Hg. As 
well as its direct effect on blood pressure, alcohol can cause resistance to 
antihypertensive therapy 175 and is a risk factor for stroke.176 The US National High 
Blood Pressure Education Program (NHBPEP) recommends that in those who drink 
alcohol, an intake of no more than25 g of alcohol (2 drinks) be consumed a day for 
men and no more than 15 g of alcohol per day for women and lighter-weight people 
(see Table 2).33 
1.6 Weight reduction and blood pressure 
Weight reduction has been the single most effective component utilized in large-scale 
lifestyle approaches to the reduction of blood pressure, such as in the Trials of 
Hypertension Prevention (TOHP) Phases 1177 and 11171 studies and the Trial of 
Antihypertensive Interventions and Management (TAIM) study.178 A systematic 
review of all randomized trials of non pharmacological interventions that included at 
least 6 months of follow-up revealed that net blood pressure reductions were greatest 
for trials of the effects of weight loss, averaging a 5.2 mm Hg reduction in systolic 
blood pressure. 179 It has been estimated that for every 1 kg decrease in body weight, 
obese hypertensive patients can expect a decrease in blood pressure of 2.4/1.5 mm 
Hg.180 A subsequent meta-analysis reported that a loss of 3 to 9% of body weight in 
overweight hypertensive subjects is associated with blood pressure reductions of 
















Weight reduction may decrease dosage requirements for antihypertensive 
medications. It is not yet clearly established whether weight reduction is superior to 
sodium restriction and/or potassium supplementation and/or exercise in reducing 
blood pressure. It is unlikely that weight loss alone will achieve blood pressure 
control in patients with Stage 2 hypertension, or in those who are not sufficiently 
motivated to lose weight. 
Various explanations have been proposed to describe the mechanisms between 
obesity, increased sensitivity to dietary sodium and increased blood pressure levels. 
Obesity has been linked with suppressed kallikrein levels, an enzymatic precursor of 
bradykinin and nitric oxide formation,182,183 as well as with increased serum 
angiotensin converting enzyme (ACE) or kinnase II activity. Compared with their 
nonobese counterparts, obese Jamaicans (8M I >31 kg/m2) have been shown to have 
higher serum ACE activity and angiotensinogen levels than their non-obese 
counterparts.184 It is hypothesized that obese persons have more renin substrate (Le. 
angiotensinogen) and maybe greater conversion of angiotenSin I to angiotensin II, 
along with accelerated breakdown of bradykinin to inactive metabolites, leading to 
impaired nitric oxide (NO) production. 
There is limited evidence regarding the genotype-phenotype association of obesity 
and hypertension in black South Africans. Angiotensinogen (AGT) is expressed in 
adipose tissue, and obesity is a powerful risk factor for hypertension. Tiago and 
colleagues185 investigated whether some AGT gene variants may influence blood 
pressure in our local population. Five hundred and twenty one black hypertensive 
South Africans with a high 8MI were compared with 547 normotensive black control 
subjects. The AGT promoter region variant gene was present with a highly 
significant Odds Ratio in those black hypertensives with a 8MI of over 27 Kg/m2. 
The AGT gene expressed in adipose tissue would directly accelerate the production 
of angiotensin II, as well as increase leptin production, The sympathetic nervous 
system would thus be stimulated, resulting in vasoconstriction and increased plasma 
volume, leading to hypertension. Promising work that suggests that genetic 
determinants of hypertension may be located at the adipocyte level and influence 
local renin-angiotensin production is increasing. However, the complex, multifactorial 
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Adiposity has been shown to be associated with central sympathetic overactivity 
(which is a recognized intermediate phenotype for incident hypertension) in young, 
normotensive African American women. 186 Adiposity accounted for one third of the 
inter-individual variability in sympathetic nerve discharge rates. In lean African­
American men, on the other hand, sympathetic nerve discharge rate is 20 - 40 % 
higher than in lean white men or in either lean black or white women, and the 
sympathetic overactivity is independent of body mass index.186 Thus, there is 
microneurographic evidence of differences in sympathetic nerve activity (at least in 
the skeletal muscle vasculature) between black and white Americans, however 
similar studies have yet to be performed in the South African context. 
Another emerging body of evidence relates to the low birthweight hypothesis, 
whereby an adverse intrauterine environment programs the! foetus to an increased 
susceptibility in later life to components of the metabolic syndrome, such as 
hypertension. An inverse association between birthweight and blood pressure was 
first described by Barker and colleagues,187 and this has now been confirmed in 
many other studies around the world.188,189,190,191,192 In developing countries, one 
possible method of primordial prevention of hypertension may be to ensure adequate 
weight gain and appropriate nutrient intake in women during pregnancy. 
Obesity has been linked with sensitivity to sodium. Findings from phase 1 of the 
Trials of Hypertension Prevention (TOHP) study, a randomized non-pharmacological 
trial conducted in 2 182 normotensive adults aged 35-54 y, have shown that weight 
loss and sodium reduction were well-tolerated and produced significant declines in 
systolic and diastolic blood pressures (-2.9/-2.4 and -2.1/-1.2 mmHg for weight loss 
and sodium restriction, respectively). 193 Data from the Coronary Artery Risk 
Development in Young Adults [CARDIAJ study indicate that African-American women 
have a 2.7 kg/m2 higher age-adjusted mean BMI than white American women, a 
Significantly higher energy intake, lower levels of physical activity and lower physical 
fitness (assessed according to duration on exercise treadmill test).194 Similarly, black 
South African women have been shown to have the highest prevalence of obesity 
(BMI .<! 30) compared to other population groups in the country (34 % in the 15 - 64 Y 
age group, riSing to 59 % in adults aged 45-54 y).18 
As well as differences in the prevalence of overweight or obesity in African-American 
and black South African women compared to their white counterparts, differences in 


























free mass because of a heavier and denser skeletal mass and denser muscle 
195mass. ,196 Mueller197 found that African-American children have a more central 
pattem of fat deposition than do white children from pre-school age through 
adolescence and into adulthood, and that these trends in fat deposition pattems were 
independent of fitness, socioeconomic status and age. It is well established that 
upper body obesity, and particularly visceral adipose tissue (VAT), is associated with 
increased metabolic and cardiovascular risk in white women. 198 However, little is 
known about patterns of intra-abdominal deposition of VAT and subcutaneous 
adipose tissue (SAT) in both African-American women and black South African 
women, and more specifically, how regional body fat composition affects blood 
pressure response to dietary manipulations. 
A study by Lovejoy et al. 199 has shown that in a sample of 37 African-American and 
22 white women, matched for age and 8MI, visceral fat area (measured by computed 
tomographic scans) was smaller in the African-American women, despite a similar 
waist-to-hip ratio. Visceral fat correlated with metabolic risk factors, such as insulin 
resistance, but subcutaneous abdominal fat sensitivity was significantly correlated 
with insulin resistance and fasting insulin only in African-American subjects, 
suggesting that total adiposity rather than intra-abdominal fat stores influence 
metabolic risk in this population. 
1.7 Physical activity and blood pressure 
To complete the discussion on lifestyle modification to reduce blood pressure, the 
effects of physical activity is briefly reviewed (Table 2). The JNC 733 guidelines on 
lifestyle modification provide guidelines on intensity and duration of recommended 
activity levels for the control of blood pressure. It is well established that lack of 
physical activity is associated with at least a 1.5-2.0 fold higher risk of hypertension 
and coronary heart disease.2oo A meta-analysis which included only trials in which the 
exercise intervention had lasted 4 wk or longer concluded that exercise reduced 
systoliC blood pressure by 4.7 mm Hg and diastolic blood pressure by 3.1 mm Hg.201 
In another meta-analyses of over 68 studies, representing more than 1500 patients, 
the effect of exercise training on blood pressure in normotensive subjects has been 
shown to average about 3.0 and 1.7 mmHg for systolic and diastolic blood pressure, 
respectively.202 Changes in blood pressure associated with exercise training are even 
more marked in those who are already hypertensive (7.8 and 5.8 mmHg for systolic 

















patients, it was found that blood pressure response to an increasing dose of physical 
activity was sigmoidal with a peak effect at 90 minutes, after which there was no 
further improvement.2°3 Mechanisms which have been implicated in the effect of 
chronic exercise on blood pressure control include reductions in vascular resistance 
secondary to neurohumoral and structural adaptations.204 
Ideal exercise intensity for blood pressure-lowering effects ranges between 40-70% 
of maximal, age-predicted heart rate.205 There is little or no evidence for extra benefit 
from higher-intensity exercise (>70% maximal oxygen uptake) or from more than 
three bouts of exercise per week. However, regarding acute effects of exercise on 
the attenuation of post-exercise blood pressure, higher intensity (75% maximum) 
exercise has been shown to be associated with a more marked and prolonged 
reduction in blood pressure in the post-exercise window, compared to lower intensity 
exercise (50% maximum).206 In the acute post-exercise period, the reduction in blood 
pressure has been linked to a sympathetic inhibition and increased release of 
vasodilator substances.207 
The challenge for most individuals is to maintain long-term compliance with exercise 
programmes. In this regard, the encouragement of low-intensity activities which can 
be incorporated into everyday lifestyle (such as walking instead of using the car), 
rather than structured high-intensity aerobic exercise programs, shows more promise 
and appears to result in comparable reductions in blood pressure.20B For previously 
sedentary individuals, a prudent approach would be to commence exercise 
cautiously and at low intensity (40-50% of maximal oxygen uptake). In high-risk 
individuals, an initial, thorough medical evaluation, including an electrocardiogram is 
advised prior to beginning an exercise program. 
For both the prevention and management of hypertension, the current JNC 7 
guidelines are based on those of the American College of Sports Medicine 
(ACSM).209 Moderately intense physical activity (40-60% maximal oxygen uptake) is 
recommended on most or preferably all days of the week, for greater than 30 minutes 
of continuous or accumulated moderate physical activity per day. For maximum 
benefit, the type of exercise for hypertensives should be predominantly endurance 
physical activity including walking, jogging, cycling, swimming, or dancing, 
supplemented by resistance exercise, prescribed according to the ACSM or 





















Undoubtedly, nonpharmacological lifestyle changes, mostly diet related, represent a 
safe and effective approach to blood pressure reduction, and offer broad advantages 
for lowering cardiovascular risk. Furthermore, using this approach, the need for 
antihypertensive medications can be decreased in subjects with established 
hypertension. Dietary advice for the prevention and management of hypertension 
needs to address changes in dietary patterns as a whole, rather than focusing on one 
or more nutrients. It appears that the most beneficial dietary pattern is a DASH-type 
diet that is low in total and saturated fat and alcohol (and reduced in total energy, if 
the subject is obese), and high in fibre, potassium, calcium, and magnesium, and 
moderately high in protein. In terms of foods, this translates into a diet rich in fruit and 
vegetables and low-fat dairy foods. Regarding sodium restriction, the greatest benefits 
are seen in those with a diet of poor quality (high in fat and low in nutrient density), 
However various subgroups, such as elderly hypertensives, obese individuals, and 
subjects of African descent, may particularly benefit from reducing dietary sodium 
intake. 
In order to empower and encourage individuals to make sustainable, lifestyle 
changes, a systematic team approach is required, utilizing health-care professionals 
and community resources wherever possible, so as to provide necessary education, 
support, and follow-up. Nutrition professionals and legislators involved in food policy 
development need to work closely with the food industry to develop and market 
products which are reduced in sodium, or which contain an optimal combination of 
cations known to be beneficial to blood pressure reduction, namely potassium, 
magnesium, and calcium. 
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Black South Africans are at high risk of hypertension, stroke and blood pressure-related 
target-organ damage. In South Africa, the limited resources at primary health care level 
allocated to the prevention, early diagnosis and management of hypertension 
necessitate a non-pharmacological population-based approach to curb the escalating 
burden of cardiovascular disease, for which raised blood pressure is an important major 
contributory risk factor. 
It has been shown. in other populations. that dietary changes are able to lower blood 
pressure in both subjects with and without hypertension. The most important dietary 
component influencing blood pressure is dietary sodium. Law and colleagues estimate that 
a reduction in sodium intake of 50 mmol/day (about 3 g salt) in older people would lower a 
population's systoliC blood pressure by an average of 5 mm Hg.1 This magnitude of blood 
pressure reduction is similar to trials of drug therapy with thiazide diuretics in this age group, 
in which a 36 % reduction in the 5-year incidence of stroke has been estimated.2 Other 
dietary factors which may contribute to lowered blood pressure levels (if their intakes are 
increased) are potassium, magnesium and calcium. 
The effect of lowering dietary sodium intake, while simultaneously increasing potassium, 
calcium and magnesium intake, on blood pressure is presently unknown in the black South 
African population. The identification of a dietary pattern which involves relatively few 
behavioural changes and which is based on commonly consumed food items that are 
affordable and culturally aq<;eptable to the poorer section of the black South African 
population is paramount to the long-term sustainability and thus effectiveness of diet-related 
strategies to lower blood pressure in this target group. 
The series of studies included in this thesis provide a systematic approach to developing 
an appropriate nutritional population-based approach to lowering blood pressure in a 
high risk population. Firstly, valid, reliable, and updated information is required to identify 
habitual intake of sodium, potassium, magnesium and calcium in the target population, 
using the gold standard method of assessing sodium intake, namely 24-hour urinary 
excretion collections. This information is necessary to inform the levels of sodium and 
other cation modification required in order to obtain a physiologically relevant change in 
blood pressure. As well as quantitative data on levels of sodium intake, information is· 
also required on which food sources are the most important contributors to overall non­
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identification of commonly consumed foods that can be targeted for modification of their 
cation content. 
The collection of 24-hr urinary samples to determine sodium intake is not feasible on a 
large scale in a developing country such as South Africa due to cost constraints, 
methodological difficulties and generally low education levels. Since dietary surveys are 
time-consuming and costly, the development of a rapid questionnaire that is able to 
accurately assess salt intake in the local population would be useful for both research 
and clinical purposes. Together with secondary analyses of previously published dietary 
surveys, data obtained in the dietary and urinary studies in this body of work will be used 
to develop such a tool. 
Next, in partnership with the food industry, the identified important commonly consumed 
food sources of salt will be altered in cation content and tested for sensory properties, 
product quality and nutritional content. Finally, the blood-pressure lowering effect of 
sUbstitution of these novel food products for the standard varieties will be investigated in 
a randomised controlled human feeding trial. The effectiveness of the health benefits of 
the products will be evaluated in the context of a community-based dietary intervention in 
which subjects are free-living within their usual socioeconomic living conditions. 
Results of the studies included in this thesis which have been planned and partly funded by 
two large food companies will be used to lobby the food industry to develop new products 
and to reformulate existing products which will improve blood pressure profiles in the 
country. It is anticipated that the food industry will embrace the opportunity to use the 
scientific data to develop widespread marketing campaigns in this regard, and provide a 
competitive edge in the market, while at the same time, enabling them to be socially 
responsible in terms of promoting health. 
2.1 Overall aim 
To identify pattems of food consumption in the black South African population in order to 
improve the cation content of commonly consumed food items and to evaluate the 
impact on blood pressure of these foods when substituted for the standard varieties. 
The ultimate aim is to lower blood pressure on a population level through a food-based 


















The thesis comprises five separate studies, the content of which will be published as 
individual manuscripts in peer-reviewed indexed scientific journals. The data presented 
in Chapters 3 and 4 has already been published in international peer-reviewed 
journals,3.4 in a shorter, modified format. In both these papers, Karen Charlton was the 
principal author who was responsible for the study design and conceptualization, 
fieldwork execution, data analyses and write-up of the work. Co-authors of the papers 
included doctoral supervisors, fieldworkers and a consultant statistician. 
The titles and objectives of the studies are outlined below: 
Study 1 
Ethnic differences in dietary intake and urinary excretion of sodium, potassium, 
calcium and magnesium in South Africans 
(1) To quantify the habitual dietary intake and urinary excretion of sodium, potassium, 
calcium and magnesium in three South African ethnic groups; 
(2) To investigate whether cation intake and excretion differs according to ethnic and 
hypertensive status; 
(3) To investigate whether cation excretion is a predictor of BP according to ethnic and 
hypertensive status. 
Study 2 
The contribution of foods to total sodium, potassium, calcium and magnesium 
intake in the South African diet 
(1) To identify which food sources are the major contributors to sodium, potassium, 
calcium and magnesium intake; 
(2) To perform secondary analyses on existing dietary databases of South African adults 
in order to identify ethnic and urban:rural differences in sources of sodium intake. 
Study 3 
Development and validation of a questionnaire to assess sodium intake 
(1) 	To develop a food frequency-type short questionnaire to assess habitual dietary salt 
intake in South Africans, using secondary dietary data analyses and data from a new, 
multi-ethnic study. 
(2) To determine 	a simplified scoring system for the questionnaire which will allow 
classification into two categories of intake (desirable and excessive). 
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(3) 	To demonstrate criterion validity of the questionnaire by comparing it with 24-hr 
urinary Na excretion data and reported Na intake obtained from repeated 24-hr 
dietary recalls; 
(4) 	To demonstrate internal consistency and reliability of the questionnaire. 
Study 4 

Development of foods with altered cation content: bread, margarine, stock cubes, 

soup mix and monosodium glutamate-based flavour enhancer (Aromat) 

(1) To develop reduced sodium (with increased 	potassium, magnesium and calcium 
content) varieties of five commonly consumed food items that are major contributors 
to overall non-discretionary sodium intake in the diet of the black South African 
population. 
(2) To evaluate 	 the sensory properties and physical qualities of the products with a 
modified cation content, compared to the standard varieties thereof. 
Study 5 
The impact of dietary manipulation of sodium, potassium, magnesium and calcium 
on blood pressure in hypertensive black South Africans: a randomised controlled 
trial 
(1) 	To investigate the impact on blood pressure in black hypertensives of a randomised, 
parallel arm, double blind controlled trial of 8 weeks duration, in which a dietary 
intervention of reduced sodium and simultaneous increase of potassium, magnesium 
and calcium is achieved by providing commonly consumed foods with a modified 
cation content. 
Each of the papers is described in entirety in a separate chapter (Chapters 3 - 7) in the 
thesis, and a combined conclusion of the main results is provided, in the context of their 
public health impact, in Chapter 8. Abstracts of the papers have been combined in a 
single Executive Summary at the beginning of the thesis. Challenges facing the various 
sectors are also outlined in Chapter 8, as are recommendations regarding policy 
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It is estimated that approximately 6 million of the total population of 41 million South 
Africans are hypertensive. 1 Black hypertensive patients in South Africa are prone to 
cerebral haemorrhage, malignant hypertension, kidney disease leading to uraemia and 
congestive heart failure, whereas coronary heart disease (CHO) is relatively 
uncommon.2 This contrasts with the situation in the white and Indian communities, where 
CHO is the major outcome related to hypertension. The prevalence of hypertension (age­
adjusted to the world population) in the adult black population (24.4 %) is almost as 
common as in the white population (27.6 %).3 However, the absolute number of 
hypertensives is almost four times higher in the black compared to white population in the 
country,3 which places a major burden on health services in the public sector. Not only is 
hypertension common in the black population, but diagnosis and management of the 
condition in this group is particularly poor.3,4.5.6 
Regarding lifestyle-related risk factors for hypertension, the Kenyan Luo migration study 
of Poulter et ae demonstrated that migration of people living in traditional rural villages 
on the shores of Lake Victoria to the urban settings of Nairobi was associated with an 
increase in BP. Urban migrants had higher body weights, pulse rates and urinary 
sodium/potassium ratios than those who remained in the rural areas. This data suggests 
a marked change in the diet of the new arrivals in Nairobi, namely a higher salt and 
kilojoule intake together with a reduced potassium intake due to the consumption of less 
fruit and vegetables.4.8 Duration of urbanisation independently predicted the presence of 
hypertension in black peri-urban communities in Cape Town,9 but other authors have not 
found urban/rural differences in the prevalence of hypertension in black South Africans. 1o 
More recently, the THUSA study conducted in the North West province of South Africa 
found that the highest level of BP was observed in the group of newcomers to the urban 
setting and that factors related to urbanisation were positively associated with 
hypertension. 11 Factor analyses of the data demonstrated that a high sodium intake, 
together with high intakes of saturated fat, animal protein, vitamin A and B6 , was 
identified as the most important cluster of risk factors relating to hypertension in this 
population. 12 
Steyn and colleagues 13 have highlighted the importance of adjusting for differences in 
age, gender and socioeconomic factors when considering whether or not ethnic 
differences exist regarding the risk of developing hypertension. Logistic regression 



















demonstrated that, apart from a lower prevalence of hypertension in rural African 
participants, no other ethnic differences were apparent after the influence of gender, 
education, urbanisation (in the African group), BMI, family history and excessive alcohol 
use were included. This is consistent with the between-population epidemiological 
stUdies of Cooper et al. which have demonstrated a wide variation in hypertension 
prevalence among both white and black ethnic groups internationally. 14 A gradient in the 
prevalence of hypertension among black populations from Nigeria, Jamaica and the US 
provides evidence of the association between blood pressure levels and transition to an 
industrialized Iifestyle.14 The authors suggest that the impact of environmental factors 
among both ethnic groups may have previously been under-estimated and that African­
origin populations are not inherently at increased risk of developing hypertension. This 
shift in conventional wisdom highlights the importance of promoting a healthy lifestyle in 
an attempt to halt the deterioration of the global cardiovascular disease risk factor profile 
of populations undergoing transition. 
The literature review of this thesis (Chapter 1) has provided extensive evidence that 
dietary factors are related to hypertension, particularly a high sodium intake, a low 
potassium intake (mostly due to too few fruits and vegetables) and an excessive alcohol 
and kilojoule intake. Seedae5 suggests that black people of African origin have an 
abnormal transport mechanism of sodium, accompanied by a low renin activity. Studies 
conducted in hypertensive patients in South Africa16•17 have found diminished activity of the 
sodium-potassium ATPase pump in black hypertensives. The clinical observation that black 
South African18 and. African-American19 hypertensives manifest higher average BP 
responses to calcium antagonists than to ACE inhibitors supports the hypothesis that 
hypertension amongst these groups is often salt-sensitive. 
Meta-analyses of intervention trials of either Na restriction20.21.22.23,24,25 or K 
supplementation26 have provided evidence that dietary manipulation of these two factors 
is key in the BP-diet relationship. In order to plan appropriate public health interventions 
to prevent and manage hypertension in South Africa, information is required on the 
habitual intake of sodium, potassium and other nutrients which are important 
determinants of blood pressure. The main objectives of the study were (1) to determine 
whether the habitual urinary excretion and dietary intake of sodium, potassium, calcium 
and magnesium differs in three South African ethnic groups; (2) to assess the proportion 
of salt intake which is discretionary; (3) to investigate whether the BP-cation association 
varies, according to ethnic status. Other secondary objectives were to assess inter- and 

















determination in dietary intervention trials), and to determine renin and aldosterone 
status across ethnic and hypertensive groups. 
Methods 
Subjects and sampling 
Sample size was determined using published data (1982) on mean urinary Na excretion 
values in black normotensive South Africans.27 Assuming a mean Na excretion value of 
126.8 (SO = 55) mmollday, a desired standard error of 5.47 mmollday (acceptable 
margin of error in expected mean is 30 mmollday) and a precision of 95 %, sample size 
was estimated as n = sd2/e2 where S2 is the between-subject variance and e is the 
desired standard error (a measure of precision required for the estimate of the mean).28 
A sample size of 100 was required. In order to compare urinary Na excretion across 
ethnic groups, 100 subjects per group was required. In total, three hundred and twenty 
five normotensive and hypertensive (BP C'!140/90 mm Hg and/or on antihypertensive 
medication) men and women (black, mixed ancestry and white), aged 20 - 65 years, 
were recruited from their place of work using a stratified, convenience sampling method. 
The study was designed so that there were approximately 50 people in each ethnic and 
sex group stratum, and that equal numbers of hypertensive and normotensive subjects 
would be recruited in each of the 6 strata. The sampling frame comprised employees of 
the Cape Town City Council, which includes a total of about 4 000 people. Eligible 
volunteers were invited to attend for blood pressure screening. Compliance with the 
study protocol was improved by having two fieldworkers (nurses) housed within the in­
house clinic facility of the office building where all data collection took place. Approval to 
conduct the study was obtained from the management of City Council, as well as from 
representative trade unions of employees. The Research and Ethics Committee of the 
University of Cape Town approved the study protocol, and written informed consent was 
obtained from all partiCipating subjects. 
To determine habitual urinary Na, K, Ca and Mg excretion, subjects were required to 
collect three 24-hour urinary volumes over a consecutive 3-week period. As a marker of 
completeness of collection, 3 tablets (450 mg/day) of non-metabolizable para­
aminobenzoic acid (PABA; Laboratories for Applied Biology, London) were given to the 
subjects, to be taken with meals during the collection period.29 Urinary electrolyte 
concentration was measured using flame photometry and PABA measured 
calorimetrically. Urine collections were excluded from the analyses for that day of 



















values <0.2 mmol/kg/day and PABA S 97 % or (2) urinary creatinine values =0.2 - 0.3 
mmol/kg/day and PABA::;; 75 % (n =24).30 Three complete collections were obtained in 
44.3 %; two in 27.8 %; and one in 16 % of subjects. Twelve percent of subjects had no 
usable urinary data. 
Dietary intake was assessed using an interviewer-administered 24-hour recall method, 
for each of the three urinary collection periods. Standard household measuring utensils, 
rulers and food photographs of typical South African foods (developed and validated by 
Venter et al., 200031 ) were used to quantify food portion sizes. The recorded quantities 
of food consumed were converted to gram weights using the Medical Research 
Council (MRC) Food Quantities Manual.32 Average daily nutrient intake was calculated 
using the Foodfinder III computerised dietary assessment programme, based on MRC 
34Food Composition Tables.33. Discretionary salt use was not quantified in the dietary 
assessments. Regarding added salt consumption, subjects were asked whether salt was 
usually added to their food during cooking, whether salt was usually added to food 
before tasting and whether they liked their food to taste "very salty," "a little salty" or "not 
at all salty." 
Blood pressure was measured on each of the three occasions when urine samples were 
returned to the data collection office, using an automated Omron M1 electronic blood 
pressure manometer (Omron Life Science Co. Ltd, Tokyo, Japan). Blood pressure 
measurements were taken three times from the left arm, with the palm upward, resting 
on a table or support at the level of the heart, after the partiCipant had been seated for at 
least 5 min. A large cuff size was used for subjects with a mid-arm circumference ~ 33 
cm. Weight was recorded on a calibrated scale, to the nearest 100g, in duplicate, and 
standing height recorded as the vertical distance from the floor to the vertex of the head, 
with the subject barefoot. Body Mass Index was calculated as weight (kg)/ (height (m)).2 
Anthropometrical measurements were taken in duplicate, at the first visit only, by two 
trained professional nurses. Weight was measured to the nearest 0.5 kg on a portable 
electronic scale and height was measured, barefoot, with head in the Frankfort plane.35 
Body Mass Index (BMI) calculated as weight (kg)/(height (m))2. Waist circumference was 
measured at the level of the umbilicus. Whole body bio-electrical impedance was 
measured at 50 kHz using a standard tetrapolar bioimpedance monitor (Bodystat 
2000,™ Douglas, British Isles), with the subject lying supine. Equations derived from a 
South African population, and validated by the Dunn Nutritional Centre, Cambridge, UK, 
were used to estimate % body fat (Anthony Bunn, personal communication). 
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Active renin was measured in EDTA plasma samples using a Nichols Institute 
Diagnostics two-site immunoradiometric assay. Plasma aldosterone was measured using 
a Diagnostic Products Corporation coated tube kit. Samples were frozen at -20°C and 
batch analyses of renin and aldosterone were performed. 
Subjects were asked, in open-ended unprompted questions how they controlled their 
blood pressure and whether they thought that salt was good or bad for them. Verbatim 
responses were transcribed and summarized according to themes. 
Statistical analyses 
For each of the urinary and dietary variables, values are expressed as the mean of three 
separate measurements. Differences between ethnic groups for numerical variables 
were assessed using either One-Way ANOVA (parametric data) or the Kruskal-Wallis 
test (non-parametric data). For categorical data, ethnic differences were assessed using 
the X2 test. For differences between hypertensives and normotensives, independent t­
tests or Mann-Whitney tests were used. General linear modelling was performed to 
assess ethnic differences in Na excretion, while co-varying for BP and BMI. Spearman 
correlation coefficients were calculated to investigate univariate relationships between 
BP and urinary and dietary cations. Multiple regression modelling was used to 
investigate predictors of systolic and diastolic blood pressure, while controlling for age, 
sex, ethnicity and BMI. Multiple regression models were performed for each ethnic 
group, to assess the relationship between urinary Ca and urinary Na, controlling for 
" 
systolic BP. All statistical analyses were considered significant at the P<O.05 level. 
For the variables BP and urinary Na excretion, inter- (between-subject) and intra- (within­
subject) individual variation is calculated as the coefficient of variation (CV =(SD/mean)) 
and expressed as a percentage, according to ethnic group and hypertensive status. 
Intra-individual CV is calculated as the variation within each subject between the three 
repeated measurements for each of the variables. Analyses on variability were 
conducted only in subjects for whom data from all three of the repeated measurements 
was available. 
Results 
Mean urinary excretion and reported dietary intake of electrolytes are shown, according 
















ethnic groups were comparable, in terms of blood pressure and proportion of men to 
women, however white subjects were significantly older than either black or mixed 
ancestry subjects. Black women had higher BMI values than white and mixed ancestry 
women and a greater percentage were obese (BMI 2! 30). In men, the only inter-ethnic 
difference in anthropometrical status was a lower BMI and a lower proportion of subjects 
who were obese in white, compared to other, men. 
Table 1 
Anthropometric characteristics of subjects, and urinary excretion and dietary intake of 
cations, according to ethnic group: mean (SO) 
Black Mixed ancestry White 
{N=110} {N=112} {N =103} 
Age* 39.7 (10.5) 39.4 (10.5) 46.9 (9.5) D,C 
Sex (M/F) 54/56 51/61 54/49 
Normotensive/Hypertensive subjects 51/59 48/64 46/57 
BMI (kg/m2) 
Men 28.0 (4.9) 29.8 (5.3) 27.6 (4.6)c 
Women·· 33.5 (7.4) 28.5 (6.1)a 30.5 (7.9) b 
% Subjects obese (BMf =:: 30)t 
Men· 37.7 47.1 18.5 
Women** 67.9 34.4 36.7 
Waist circumference (em) 
Men 92.6 (13.3) 97.4 (13.4) 96.0 (13.2) 
Women 92.4 (20.0) 84.1 (16.7)a 92.8 (18.8)c 
% Fat 
Men 24.3 (6.7) 24.0 (6.8) 22.8 (5.9) 
Women 42.6 (8.6) 37.6 (7.6)a 40.0 (8.8) 
Dietary energy intake (kJ/day) 
Men 8098 (2908) 9158(3241) 9031 (2567) 
Women 6654 (2154) 6567 (1689) 6850 (2609) 
Sodium 
Dietary Na (mg/day)** 1 467 (891) 1 761 (885) a 1 922 (911) b 
Dietary Na/4 200 kJ (mg/day)** 808 (347) 952 (287) a 1019 (324)b 
Urinary Na (mmol/day) * 135.3 (50.1) 147.5 (73.5) 164.8 (91.0) b.c 
Potassium 
Dietary K (mg/day)** 2058 (831) 2092 (648) 2513 (903) b 
Urinary K (mmol/day) 55.6 (23.4) 54.3 (26.9) 61.9 (23.1) 
53.8 (29.3) t 47.2 (40.0) 59.9 (32.0) b,c 
Na:K ratio 
Urinary Na:K ratiot 2.66 (1.00) 3.14 (1.83)a 2.85 (1.43) 
Magnesium 
Dietary Mg (mg/day)* 261 (110) 228 (105) a 285 (122)C 
Urinary Mg (mmol/day) 21.8 (18.6) 23.2 (19.6) 22.9 (23.1) 
Calcium 
Dietary Ca (mg/day)** 436 (332) 464 (215) 577 (274)b,C 
Urinary Ca (mmol/day)** 1.47 (1.26) 2.38 (2.16)a 3.28 (5.0) b,c 
PABA {%}1 74.8 {17.8) 76.2 (19.3} 80.3 (15.5} b 
*P<0.05; ** P<0.001; :j: P = 0.0536: ANOVA for differences between ethnic groups (a Black vs Mixed 

ancestry; b Black vs White; C Mixed ancestry vs White; Post-hoc analyses). 

t Median (IQR); Kruskall-Wallis test performed. 

1 Mean PABA value calculated for the "complete" urine collections which were used in the final analyses 
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Urinary and dietary cations 
Sodium 
Mean reported dietary Na intake (ie. non-discretionary sources - sodium inherent in 
foods or added in processed foods)) was significantly lower in black subjects than either 
mixed ancestry or white subjects (Table 1), even accounting for differences in energy 
intake across groups. Normotensive white subjects had Significantly higher urinary Na 
excretion and reported dietary Na intake than black normotensives, but in hypertensives, 
only dietary Na levels differed between the ethnic groups (Table 2). In both black and 
white subjects, reported Na intake was significantly (P<0.05) lower in hypertensives 
compared to normotensives (1 263 (972) vs 1 675 (805) mg, respectively, for black 
subjects and 1 729 (833) vs 2 048 (971) mg. respectively, for white subjects). However 
Na intake remained significantly higher in white than black subjects, regardless of blood 
pressure. 
The ratio of urinary excretion to reported dietary intake of Na was 2.93 (4.80), and 
differed between ethnic groups (3.89 (7.44),2.26 (1.39) and 2.55 (2.81) in black, mixed 
ancestry and white subjects, respectively; P<0.05 (ANOVA); P= 0.051 for black vs white 
(Bonferroni test». The discrepancy between reported dietary Na intake and' urinary 
excretion of Na (urinary Na taken as proxy for total Na intake) suggests that salt added 
to food at the table and in cooking (ie. discretionary) makes up 45.5 %, 32.8 % and 42.2 
% of total sodium intake in black, mixed ancestry and white subjects, respectively. This 
equates to a daily added salt (NaCI) amount of 4.08 g. 4.15 g, and 4.76 g in black, mixed 
ancestry and white subjects, respectively. 
Urinary Na excretion was significantly higher in white subjects, compared to the other 
two groups (Table 1). Mean urinary Na excretion equates to a daily salt (NaCI) intake of 
7.8g, 8.5g and 9.5g in black, mixed ancestry and white subjects, respectively. Twenty­
three percent of subjects had urinary Na concentrations < 100 rnmol/day36 and this 
proportion did not differ between ethnic groups (Table 3). Urinary Na was associated 
with BMI in men and women (Spearman r = 0.196 and r = 0.176; P<0.05, respectively). 
General linear modelling found that ethnicity (ie. black versus white; P = 0.005) was 
associated with lower urinary Na excretion, independently of blood pressure, and co­
varying for BM' (whole model adjusted ~ = 0.0545; P = 0.0014). No differences were 






















Urinary excretion and dietary intake of electrolytes, according to ethnic and hypertensive status: mean (SO) 

Black Mixed ancestry White 
Hyperten sives Normotensives Hypertensives Normotensives Hypertensives Normotensives 
N 51 59 48 57 
Age 47.1 (8.2) 33.3 (7.7) 46.6 (7.0) 34.0 (9.5) 50.7 (5.9) b.c 43.9 (10.8) b.c 
Sex (MenlWomen) 27/24 27/32 23/25 28/36 24/22 30/27 
Systolic BP (mm Hg)* 135 (19) 114.1 (11.9) 142 (21)S 117.4 (12.0) 137 (14) 117.6 (12.5) 
Diastolic BP (mm Hg) 84.6 (10.0) 73.4 (7.1) 89.0 (10.7) 75.6 (7.6) 86.2 (8.8) 75.4 (7.7) 
Mean Arterial Pressure (mmHg) 102 (12) 86.5 (8.1) 107(13) 89.9 (9.0) 103(10) 88.9 (91.7) 
Sodium 
Dietary Na intake (mg/day)* 1 263 (972) 1 675 (805) 1 760 (1 082) S 1 778 (723) 1 729 (833) b 2048 (971) b 
Na (mmol/day) 140 (44) 131.0 (56.0) 162 (78) 135.1 (67.6) 163 (114) 166.1 (63.1)b.c 
134 (42)t 128 (65)t 156 (83) 127 (80) 126 (84) 154 (85) b.c 
Potassium 
Dietary K intake (mg/day)* 1 849 (621) 2269 (982) 2 152 (691) a 1 981 (533)::1: 2370 (825) b 2601 (943)c 
K (mmol/day) 60.1 (25.2) 51.2 (20.9) 62.2 (27.9) 47.6 (24.0) 64.8 (23.2) 59.0 (22.1) c 
55.3 (34.9)t 46.8 (31.4)t 69.9 (41.8) 42.8 (26.2) 64.5 (32.3) 56.0 (33.6) c 
Na:K ratio 
Dietary Na:K ratio 0.66 (0.42) 0.78 (0.32) 0.82 (0.37) 0.89 (0.35) 0.75 (0.31) 0.84 (0.40) 
Urinary Na:K ratio 2.57 (0.93) 2.74 (1.08) 3.04 (1.54) 3.23 (2.07) 2.62 (1.35) 3.07 (1.48) 
2.37 (0.97)t 2.74 (2.02) 2.62 (1.39) 
Calcium 
Dietary Ca intake (mg/day)** 331 (183) 534 (413) 460 (210)a 471 (225) 477 (202) b 650 (285) c 
Urinary Ca (mmol/day)** 1.45 (1.40) . 1.49 (1.12) 2.60 (2.65)s 2.19 (1.61) 2.64 (1.36) b 3.89 (6.78) b.c 
1.06 {1.34)t 1.27 (1.55)t 1.73 (2.47)a 1.73 (1.92) a 2.45 (1.63) b 2.67 (2.32)b.C 
Magnesium 
Dietary Mg intake (mg/day) 263 (89) 263 (131) 253 (134) 210 (72)a 253 (103) 314 (1 35) b,c 
UrinarYl{lglrnmollday} 18.9 (17.2) 24.7 (19.6) 18.8(17.2) ~I.QJ20~ 24.2 (21.5) 21.7 (24.7) 
*P<0.05; ** P<O.001; ***P<O.0001: ANOVA test for differences between ethnic groups. 
Post-hoc analyses: a Black vs Mixed ancestry; b Black vs White; C Mixed ancestry vs White; t P =0.055 for Black vs Mixed ancestry. 












Proportion of sample with urinary Na and K concentrations (mean of three 24hr 
collections) which meet the ,JNC34,35 dietary guidelines, according to ethnic group: % (n) 
Black Mixed White Total 
(N=101) ancestry (N =87) (N =285) 
(N=97) 
Urinary Na <: 100 mmollday 
Men 22.9 % (11) 23.3 % (10) 15.6%(7) 20.6 % (28) 
Women 20.8 % (11) 33.3 % (18) 21.4 % (9) 25.5 % (38) 
Total 21.8 % (22) 28.9 % (28) 18.4 % (16) 23.2 % (66) 
Urinary K ;::: 90 mmol/day 
Men 10.4 % (5) 14.0 % (6) 11.1 % (5) 11.8 % (16) 
Women 5.7 % (3) 5.6 % (3) 11.9%(5) 7.4 % (11) 
Tolal 7.9 %(8) 9.3 % (9) 11.5%(10) 9.5 % (27) 
No significant differences between ethnic groups for any of the categories. 
Significantly more black and mixed ancestry subjects reported adding salt to food in 
cooking than their white counterparts (98.2 %, 93.8 % and 83.4 %, respectively; P<0.05), 
more of the black subjects (50.4 %) than either the mixed ancestry (25.0 %) or white 
(31.0 %) subjects reported that they added salt to their food before tasting it (P<0.005). 
and more black subjects (20.2 %) than either mixed ancestry (6.3 %) or white (11.7 %) 
subjects reported that they liked their food to taste "very salty" (P<0.05). Within each 
ethnic group, neither urinary Na excretion nor reported dietary Na intake differed across 
categories of responses to the questions on salt taste preferences and the practice of 
adding salt to food before tasting it (data not shown). 
Potassium 
Reported dietary K intake was Significantly lower in black compared to white subjects 
(P<0.001) (Table 1), but aggregated according to hypertensive status, this ethnic 
difference was only evident for hypertensive subjects (Table 2). Median urinary K was 
significantly lower in black and mixed ancestry groups, compared to white subjects 
(Table 1). Few subjects (9.5 %) had urinary K values which met or exceeded the 
reference optimal dietary intake value of 90 mmolldal7 (Table 3). According to 
hypertensive status, no ethnic differences were found for urinary potassium, except for 
mixed ancestry normotensives having a lower excretion than white normotensives (Table 
2). In black subjects only, reported K intake was lower in hypertensives compared to 
normotensive subjects (P<0.05). 
Na:K ratio 
Urinary Na:K ratio was significantly higher in the mixed ancestry group compared to the 











normotensive or hypertensive subjects (Table 2). Comparisons are made in Table 4 
between our data and findings from a 1982 study of black and South Africans in 
Johnannesburg, for urinary Na, K and Na:K ratio.27,38 
Table 4 
Urinary Na and K in normotensive black and white South Africans, and in hypertensive 
black South Africans: comparison with other studies: mean (SO) 
Urinary Na Urinary K Na:K ratio Equivalent salt 
(mmol/24ht (mmoI/24h) intake 
(g NaCl/day) 
Normotensives 
Cape Town, 2002 
Present study 
Blacks (N = 51) 131.0 (56.0)* 51.2 (20.9) 2.7(1.1) 7.5 
Whites (N = 45) 166.1 (63.1) 59.0 (22.1) 3.1(1.5) 9.5 
Johannesburg, 1982 
Barlow et al?7 
Blacks (N = 71) 126.8 (55) 30.9 (13)* 4.3 (1.0)* 7.5 
Whites (N = 34 ) 166.8 (63) 59.3 (19) 2.9 (0.8) 9.8 
Hypertensives - black 
subjects only 
Cape Town, 2002 
Present study (N = 49) 140 (44) 60 (25) 2.6 (0.9) 8.0 
Johannesburg, 1982 112 (42) 35 (16) 3.2 6.6 
Cohen et al. 38 (N =33} 
• P<O.05. Independent t-test for differences between black and white subjects in the same study. 
Calcium 
Mean dietary calcium was higher in white subjects compared to either the black or mixed 
ancestry groups, however in all groups calcium intake was low (about half of Dietary 
Reference Intake (DRI)39 of 1000 mg/day) (Table 1). Inadequate « 67 % DRI) calcium 
intakes were evident in 84.4 %, 88.4 % and 78.6 % of black, mixed ancestry and white 
subjects, respectively. Calcium intake was significantly (P<0.005) lower in hypertensive 
than normotensive subjects, for both black and white ethnic groups, and more 
hypertensive compared to normotensives had inadequate dietary intakes of calcium (92 
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Figure 1 
Mean daily dietary calcium intake, according to ethnic and hypertensive status (*P<O.05 for 
differences between ethnic groups) 
Urinary Ca excretion was significantly higher in white, compared to either black or mixed 
ancestry, subjects (Table 1). In normotensives, urinary calcium concentrations differed 
between all three ethnic groups, with black subjects having the lowest values of all 
groups (median =1.06 (lOR =1.34) mmol/day), approximately less than half that of white 
subjects (median = 2.45 (1.63) mmol/day) (Table 2). Similarly, inter-ethnic differences 
were found for urinary calcium in hypertensive subjects (Table 2). 
A positive association was found between reported dietary protein intake and urinary 
calcium for white subjects only (r =0.266 (P<0.01», who had a higher protein intake than 
black subjects (70.8 (25.4) g/d) and 62.2 (28.5) g/d, respectively (P<0.05». In black and 
mixed ancestry subjects, urinary Ca was significantly and positively associated with 
urinary Na (r = 0.422 (P<0.0001) and r = 0.632 (P<0.0001), respectively), however no 
association was found for white subjects. Regression modeling was conducted by ethnic 
and sex group, since these were confounding variables in the urinary Ca-Na relationship. 
In models which included systolic BP and dietary Na intake, urinary Na was significantly 
and independently associated with urinary Ca in black and mixed ancestry men and 
women, and in white men only (Table 5). A 100 mmol increase in 24-h urinary Na 
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and 1.76 mmol (mixed ancestry men). No association was found between urinary and 
dietary Ca intake in any ethnic group. 
Table 5 
Relationship of daily urinary Ca excretion (mmoIl24-h) with urinary Na, controlling for 
systolic BP in each ethnic group 
Men Women 
B SE {B} P-value B SE (B} P-vall 
Blacks 
Adjusted r2 of model (P-value) 0.1799 (0.0048) 0.1226 (0.0142) 
Intercept -1.4125 1.496 0.3501 0.9626 1.1521 0.407 
24-h Urinary Na 0.0108 0.0032 0.0014 0.0103 0.0037 0.007 
Systolic BP 0.0110 0.0103 0.2917 -0.0081 0.0086 0.348 
Mixed ancestry 
Adjusted r2 of model (P-value) 0.3215 (0.0002) 0.3673 «0.0001) 
Intercept 0.4282 3.2524 0.8959 -0.8105 0.9970 0.420 
24-h Urinary Na 0.0176 0.0039 <0.0001 0.0169 0.0030 <O.OO( 
Systolic BP -0.0030 0.0256 0.9061 0.0034 0.0073 0.642 
Whites 
Adjusted r2 of model (P-value) 0.1844 (0.0052) -0.0283 (0.6415) 
Intercept -2.3492 2.0663 0.2620 1.9180 1.2555 0.134 
24-h Urinary Na 0.0116 0.0036 0.0023 -0.0011 0.0096 0.482 
Systolic BP 0.0276 0.0141 0.0571 0.0053 0.0096 0.587 
a Multiple regression models, performed by ethnic and sex group. 
Abbreviations: BP= blood pressure; 11 = beta; SE = standard error. 
Magnesium 
Reported dietary magnesium intake did not differ between black and white subjects, but 
was Significantly lower in mixed ancestry subjects (Table 1). More of the mixed ancestry, 
compared to black or white subjects, had Mg intakes below 67 % DRI38 (67.9 %, 51.8 %, 
and 43.7 %, respectively; P<O.05). In normotensives, mixed ancestry and black subjects 
had significantly lower reported dietary Mg intakes than white counterparts, but this 
difference was not evident in hypertensive subjects (Table .2). Urinary Mg excretion did 
not differ across ethnic groups (Table 1), nor across ethnic groups aggregated according 
to hypertensive or normotensive status (Table 2). 
Treatment status effect on urinary electrolytes 
Both treated and untreated hypertensives were included in this study. Ethnic differences 
in urinary excretion and dietary intake of cations were investigated in hypertensives, 
according to whether or not they were taking medication that may affect electrolyte 
excretion (Le. diuretics and ACE inhibitors). Thirty percent (n =44) of hypertensives were 











electrolytes, were found between treated and untreated hypertensives for both black and 
mixed ancestry hypertensives, with the exception that in mixed ancestry hypertensives, 
urinary calcium was significantly lower in treated individuals (Table 6). In the white group, 
treated subjects had significantly higher values than untreated hypertensives for urinary 
Na (258 (180) vs. 130 (51) mmollday) and K (83.8 (22.8) vs. 58.3 (21.0) mmol/day). In 
both black and white treated hypertensives, plasma renin concentrations were higher in 
treated versus untreated subjects, while the aldosterone:renin ratio was significantly 
lower. 
Table 6 
Urinary cations and aldosterone and renin concentrations of hypertensives, according to 
ethnic and treatment status (mean (SO» 
Black Mixed ancestry White 
Treated' Not treated Treated' Not treated Treated' Not treated 
N 16 35 17 31 11 35 
Systolic BP (mm Hg) 140 (19) 133(19) 148 (23) 139 (20) 137(15) 139 (16) 
Diastolic BP (mm Hg) 85.6 (9.2) 84.3 (10.7) 92.1 (13.4) 87.4 (9.0) 84.0 (7.9) 86.7 (9.5) 
Urinary Na (mmol/day) 137 (56) 132 (50) 152 (66) 151 (96) 258 (180) b.c 130 (51)· 
Urinary K (mmol/day) 53.8 (25.7) 61.2 (26.6) 64.9 (28.5) 54.7 (32.2) 83.8 (22.8) b 58.3 (21.0)· 
Na/K ratio 2.72 (0.80) 2.45 (0.93) 2.68 (1.33) 3.27 (1.34) 3.05 (2.04) 2.42 (0.93) C 
Urinary Ca (mmol/day) 1.46 (2.0) 1.40 (1.07) 2.35 (2.01) 2.75 (3.01)a 2.58 (1.67) 2.68 (1.21 )b.C 
Renin (uU/ml) 89.4 (122.7) 24.8 (37.0)t 25.6 (27.9) 43.1 (62.4) 126.4 42.4 (59.7)· 
(140.0t 
Aldosterone (pmol/ml) 258(316) 231 (155) 278 (224) 253 (172) 272 (157) 278 (232) 
Aldosterone:renin 14.6 (26.7) 19.0 (19.7)* 16.6 (11.6) 14.8 (14.3) 7.8 (10.7) 15.9 (15.9)+ 
1Treated =prescription of diuretics and/or ACE inhibitors. 
• P<0.05; t P 0.086; + P = 0.0685; Difference between treated and not treated for that ethnic group 

(Independent t-test). For variables not normally distributed (renin, aldo, urinary Ca in blacks; uriflary Na and 

renin in mixed ancestry; and urinary Na and renin in whites), the Mann Whitney test assessed differences 

between treatment groups. 

a Black vs Mixed ancestry; b Black vs White; C Mixed ancestry vs White; Post-hoc analyses (Bonferroni test) 

for differences between ethnic groups for that treatment group (P<0.05). 

In untreated hypertensives (n=1 01), ethnic differences (P<0.05) were found for the 
following urinary variables: K higher in black compared to white subjects; Na:K ratio 
higher in mixed ancestry than in white subjects; Ca higher in mixed ancestry and white 
subjects than in black subjects. 
Predictors of blood pressure 
Neither urinary nor dietary Na, K, or Mg were associated with either systolic or diastolic 
blood pressure. Results did not change when white treated hypertensives were excluded 
from the analyses. In the normotensive group only, urinary calcium was positively 












In white subjects, reported dietary calcium intake was negatively associated with both 

systolic (r = -0.224 (P<0.05» and diastolic blood pressure (r =-0.254 (P<0.01» (Figure 

2). A similar inverse trend was seen for the other ethnic groups, but this did not reach 

significance. In the total group combined, reported dietary calcium intake was inversely 

associated with both systolic and diastolic BP (r =-0.127 for each; P<0.05). 

ContrOlling for age, sex and ethnic group in regression modes, neither Na, K, Ca or Mg 

excretion predicted blood pressure in either normotensive or hypertensive subjects. 

Controlling for age, ethnic group, sex, and BMI, it was found that renin was inversely 

associated with systolic and diastolic BP: 

SystoliC BP = 98.648 - 0.614 (ethnic group) - 9.794 (sex) +0.534 (BMI) -0.032 (renin) + 

0.711 (age). Adjusted,-2 =0.286; model is significant at P<0.0001. 

Diastolic BP =63.838 + 0.392 (ethnic group) - 5.376 (sex) +0.413 (BMI) -0.022 (renin) + 

0.305 (age). Adjusted,-2 = 0.257; model is significant at P<0.0001. 

In both models, sex (1 = men; 2 = women), BMI, age and renin are significant (P<0.01), 
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Figure 2 
Association between blood pressure and mean daily reported calcium intake in white 
South Africans (purple triangles denote systolic BP; yellow circles denote diastolic BP)~ 
Inter- and intra-individual variability in blood pressure and urinary Na excretion 
For the total group, inter-individual CV for systolic and diastolic BP was 15.95 % and 
13.17 %, respectively. Inter-individual CV was similar across ethnic groups for mean 
systolic blood pressure (13.18 % to 16.0T %) and diastolic blood pressure (12.14 % to 
13.86 %) (Table 7). Intra-individual CV for BP for the three repeated days of 
measurements was 5.15 % and 5.27 % for systolic and diastolic BP, respectively (total 
group) and was similar between ethnic groups, according to hypertensive status. Systolic 
BP intra-individual CV was higher in hypertensive compared to normotensive subjects 
(6.08 % and 4.64 %, respectively; P<0.0001). Similarly, intra-individual variation in 
diastolic BP was higher in hypertensive than normotensive subjects (was 6.03 % and 
4.64 %, respectively; P<0.0001). 
Inter-individual CV in mean 3-day urinary Na excretion for the total group (N = 143) was 
41.5 %. Inter-individual CV, by ethnic group, was 31.5 %, 29.8 % and 52.4 % for black (n 
= 50), mixed ancestry (n = 45) and white (n =48) subjects, respectively. In the total 
group, intra-individual variation in Na excretion over the three separate 24-hour collection 
periods was 33.7 % (95 % CI = 30.6 - 36.8 %). Within-subject variation in urinary Na was 
similar between ethnic groups (31.7 %, 34.0 % and 35.6 % in black (n = 50), mixed 
ancestry (n = 45) and white (n = 48) subjects, respectively. Normotensive subjects (n = 











30.3 % respectively, P= 0.073). The ratio of intra- to inter-individual variation was 1.01, 
1,14 and 0.68 for black, mixed ancestry and white subjects, respectively. 
Table 7 
Inter- and intra-individual variation in blood pressure for three repeated measurements, 
according to ethnic group and hypertensive status: mean (SO) coefficient of variation (CV)a 
Black Mixed ancestry White Total 
N = 108 N = 112 N= 102 N =322 
Systolic BP (mm Hg)* 123 (22) 128 (21) 127 (17) 126 (19) 
Diastolic BP (mm Hg) 78 (13) 81 (11) 80 (10) 80 (10) 
INTER-INDIVIDUAL CV (%) 
Hypertensives N = 51 N=48 N =46 N = 145 
CV SystOliC BP 13.73 14.86 10.51 13.31 
CV Diastolic BP 11.84 12.00 10.17 11.52 
Normotensives N = 57 N=64 N = 56 N = 177 
CV Systolic BP 10.43 10.48 10.43 10.51 
CV Diastolic BP 9.96 10.30 10.05 10.17 
Total 
CV Systolic BP 15.21 16.07 13.18 14.95 
CV Diastolic BP 13.22 13.86 12.14 13.17 
INTRA-INDIVIDUAL CV (%) 
Hypertensives N = 51 N =48 N=46 N = 145 
CV Systolic BP 5.99 6.27* 5.98* 6.08** 
CV Diastolic BP 6.32 * 5.87*t 5.87* 6.03** 
Normotensives N =57 N=64 N = 56 N = 177 
CV Systolic BP 4.68 4.09 4.45 4.40 
CV Diastolic BP 4.95 4.60 4.38 4.64 
Total 
CV Systolic BP 5.30 5.02 5.14 5.15 
CV Diastolic BP 5.60 5.14 5.05 5.26 
a CV = (SO/mean) * 100 




** P<0.0001; Mann-Whitney test for differences between hypertensive and normotensive subjects, for 

combined ethnic groups. 

Renin and aldosterone concentrations 
Renin and/or aldosterone data was missing for 19 subjects (6 black; 7 mixed ancestry 
and 6 white subjects). Fifty-one subjects (17.5 %) had low renin (s 10uU/ml) 
concentrations. In each of the ethnic groups, significantly more of the hypertensive 
subjects had low renin status, compared to normotensives (29.5 % vs % 8.4 %, 











ancestry or white, hypertensives to have a low renin status (40.4 %, 22.0 % and 24.4 %, 
respectively), however this difference did not reach significance (P = 0.114). Three 
subjects (2 hypertensive black; 1 normotensive mixed ancestry) had suspected primary 
aldosteronism (i.e. aldosterone> 500 pmol/ml and aldosterone:renin ratio >=70).40 Forty­
five subjects (15.5 %) had low aldosterone concentrations «111 pmollml), while four 
subjects (1.4 %) had aldosterone levels> 860 pmollml, and the remainder (83.2 %) had 
levels in the normal range of 111 - 860 pmolii. Eleven subjects (3.8 %) had both low 
renin (S; 10 uUlml) and low aldosterone «111 pmolll) concentrations, of whom 8 subjects 
were black (8 % of total black sample), and the remaining 3 subjects were white (3.3 % 
of white sample) (Table 8). 
Table 8 
Active renin and aldosterone concentrations in normotensive and hypertensive subjects 
in Cape Town: n (% total sample) 
Renin Aldosterone Total 
concentrations 
Low Normal range High 
« 111 pmollml) (111 - 860pmol/ml) (>860 pmol/ml) 
Low (S 10 uU/ml) 11 (3.8 %) 40 (13.8 %) 0 51 (31.3 %) 
> 10 uU/ml 34 (11.7 %) 202 (69.4 %) 4 (1.4 %) 240 (82.4 %) 
Total 45 {15.5 %} 242 {83.2%~ 4 {1.4 %} 291 
Six of the eight black subjects with low reninllow aldosterone levels were hypertensive 
(13.3 % of all hypertensive blacks), while all 3 of the white subjects were hypertensive 
(7.5 % of total white hypertensive group). Using the less stringent criteria for low 
aldosterone levels described by Rayner and colleagues41 (Le. < 225 pmoIlL), 26.7 % of 
black hypertensive subjects in our study had low renin and low aldosterone levels, 
compared to 10.9 % of black normotensive subjects. In the hypertensives, significantly 
more black than either white (7.5 %) or mixed ancestry subjects (7.5 %) had low 
reninllow aldosterone concentrations in this range (P<0.05). 
A significantly lower plasma renin concentration and a higher aldosterone:renin ratio was 
found in hypertensives compared to normotensives in the black and mixed ancestry 
(P<0.005) groups, but not in white subjects (Table 9). The only ethnic group difference 
was a lower plasma aldosterone concentration in black normotensives, compared to 
either their mixed ancestry or white normotensive counterparts (Mann-Whitney test; 
P<0.005). In the hypertensive group, 29 % of black, compared to 20 % of mixed ancestry 













Active renin and aldosterone in normotensive and hypertensive subjects from three ethnic 
groups in Cape Town 
t P<O.0001; Mann-Whitney test for differences between the total hypertensive and normotensive groups (all 

ethnic groups combined in each group). 

tt P<O.005; Mann-Whitney test for differences between the hypertensive and normotensive groups, 

according to that ethnic group. 

a P<O.005; Mann Whitney test for differences between black and mixed ancestry normotensives. 

b P<O.005; Mann Whitney test for differences between black and white normotensives. 

Use of health facilities for hypertension care 

More of the black hypertensives (66.7 %), compared to either their mixed ancestry (27.7 

%) or white (34.1 %) counterparts attended a public sector clinic for hypertension care, 

while fewer black hypertensives (25 %) than the other two ethnic groups (56.8 %) 

attended a private doctor. The remaining subjects either attended a clinic in the 

workplace, or were not currently receiving treatment. 

Self-reported strategies to control blood pressure in hypertensives 

Regarding dietary factors which were identified by hypertensives as being important in 

blood pressure control, "avoidance of salt and salty foods" was the most common 

response (20.6 %), followed by "avoidance of fatty foods" (16.5 %), and consumption of 

"a balanced diet" (6.2 %) (open-ended, unprompted responses). Fewer black 

hypertensives (9.8 %) than mixed ancestry (22.9 %) or white (26.1 %) hypertensives 

reported that they avoided salUsalty foods (P<0.05). Few subjects (4.1 %) reported an 

increased intake of vegetables, and none mentioned fruit, as being a method of blood 













subjects thought that salt was good or bad for them, it was evident that there was a fairly 
low awareness regarding the salt-BP association. Of the 195 subjects (60.2 %) who 
reported that salt was bad for them, 46.7 % (n = 91) identified that salt raised blood 
pressure. Other responses were water retention (10.3 %, n :::: 20), salt is unhealthy if 
eaten in excess (14.9 %, n :::: 29), causes heart disease (8.2 %, n :::: 16), causes 
dehydration (5.1 %, n :::: 10), spoils taste of food (5.1 %, n :::: 10), and medical advice (5.1 
%, n :::: 10). More of the white subjects (72.8 %), compared to either mixed ancestry (58.9 
%) or black (48.2 %) subjects reported that salt was bad for them. However, responses 
linking salt to raised blood pressure were similar across ethnic groups (22.7 %, 29.5 % 
and 31.1 % of the black, mixed ancestry and white samples, respectively (28 % of total 
sample)). 
Discussion 
Similar to findings of studies conducted in black and white normotensives in 
Johannesburg in the early 1980'S38.27 (see Table 4), ethnic differences exist in urinary 
sodium excretion, with black subjects having significantly lower values than their white 
counterparts. In our study, black and mixed ancestry subjects have excretion values 
indicative of a daily salt intake of 7.8 g and 8.5 g, respectively, compared to 9.5 g in the 
white sub-sample. Urinary sodium does not appear to have changed over time in either 
black or white groups, compared to the earlier Johannesburg study.27 The salt intake of 
the white subjects is similar to that reported in the adult American42 and British 
population.43 
The "finding that ethnic differences in urinary Na concentrations were evident only in 
normotensive subjects suggests that in the hypertensive subjects, there may have been 
confounding between ethnic groups, with regard to access to dietary advice previolJsly 
given by a health professional to reduce salt intake after diagnosis of the condition. 
White hypertensives may have had greater access to nutrition education since they were 
more likely than black hypertensives to receive medical care at private, rather than 
public, health facilities. In this regard, a quarter of white and mixed ancestry 
hypertensives, compared to only a tenth of black hypertensives reported the avoidance 
of salt and salty foods in their diet, but despite this, these groups still had a significantly 
higher reported Na intake than their black counterparts with hypertension. Only in the 
white sub-sample was urinary Na excretio.n significantly lower in hypertensive (those not 
being treated with agents that affect urinary electrolyte excretion) compared to 




















reflect a change in their dietary patterns. Our data suggests that under-reporting of food 
sources of Na (excluding salt added to foods at the table and in cooking) may have 
occurred in both black and white hypertensives, but that actual dietary changes in terms 
of sodium reduction were evident only in the white group. 
The contribution of discretionary salt to total Na intake (33 - 46 %) in the South African 
population appears to be much higher than that reported in affluent western countries, in 
which 75 - 85 % of salt is estimated to come from processed foods. 44,45,46 This finding 
suggests a need to educate South Africans to add less salt to foods and in cooking. It is 
noteworthy that in all three ethnic groups, there was a low awareness of salt as being 
pathogenic in the development of hypertension (28 % of total sample reported 
(unprompted) that high blood pressure was related to an excessive salt intake). The use 
of dietary data to estimate actual sodium intake across populations is limited by the inability 
to accurately quantify discretionary (added) salt usage. Our data suggests that, as a rule of 
thumb, reported dietary sodium intake data should be doubled to account for salt added to 
food at the table and in cooking, at least in black South Africans living in urban areas. 
However, caution needs to be exercised as under-reporting of non-discretionary sources of 
Na would falsely elevate our estimation of added salt in the diet. Other studies' have 
demonstrated that hypertensive patients tend to underestimate their sodium intaKe by 
between 22 %47 and 50 %48 using 24-hour dietary recall methods. A Japanese study which 
used a self-administered diet history questionnaire, rather than repeated 24-hour dietary 
recalls, reported ratios of urinary excretion to dietary intake of Na close to one (0.84 to 
0.97).49 In the present study, the higher ratios (2.26 to 3.89) suggest a greater degree of 
under-reporting of habitual dietary Na intake. 
Within subject variation in urinary Na excretion is evident. even in individuals provided 
with a constant dietary Na intake. A Dutch study in which subjects were provided with a 
constant Na intake for 60 days while 24-h urine samples were collected daily found a 
relatively high intra-individual coefficient of variability (CV) in Na excretion of 16 %.50 The 
level of CV did not improve when the excretion was expressed on the basis of urinary 
creatinine. The ratio of intra- to inter-individual variation in urinary Na provides some 
indication of the number of 24-h urine specimens required to obtain accurate 
assessments of habitual Na excretion. The smaller the ratio, the lower the number of 24­
h urine samples required.51 The ratio of 1.01 and 1.14 for black and mixed ancestry 
subjects is considerably lower than that reported for Chinese (1.48)50 populations, and 
similar to that reported for a sample of Italian men (1.12).52 The Chinese and Italian 
















reduce to 10 - 15 % the diminution of the correlation coefficient between urinary Na and 
51another related physiological variable.5o• In our study, an even lower ratio of intra- to 
inter-individual ratio was found for white subjects (0.68), which suggests that in all ethnic 
groups, three repeated 24-hour urine collections is sufficient to appropriately 
characterize dietary Na intake. 
Urinary potassium excretion in black subjects in the present study has almost doubled 
since those reported in 198238 and, surprisingly, we did not find a difference in urinary 
excretion of potassium between black and white subjects (either normotensive or 
hypertensive) in the present study. As a result of this increase in potassium excretion, 
the previously reported higher urinary sodium/potassium ratio in black, compared to 
white South Africans,27 no longer exists. 
Optimal reference values for urinary excretion of Na and K are not available and since 
more than 98 % and 85 % of the daily ingested amount, respectively, is excreted in the 
urine,53 our results are compared with optimal recommended dietary intakes. In all ethnic 
groups, urinary sodium excretion exceeded the recommended maximum dietary intake 
value of 100 mmol per day (2.4 g sodium or 6g sodium chloride )36 and less than a 
quarter of subjects had urinary sodium values below this level. In addition, in all ethnic 
groups, potassium excretion values fell far below the recommended dietary intake of 90 
mmol per day37 and less than ten percent of subjects met this recommendation. The 
most recent dietary guidelines of the World Health Organization recommend even more 
stringent restrictions of sodium for the prevention of cardiovascular disease (coronary 
heart disease, hypertension, and stroke), namely 70 mmol per day (4 g sodium chloride). 
These guidelines suggest a potassium intake which will keep the sodium:potassium ratio 
close to one, I.e. 70 - 80 mmol/day, if sodium recommendations are followed. 54 It has 
been demonstrated in hypertensive black South African women (with a baseline K 
excretion similar to that reported in black subjects in the present study) that 
supplementation with 65 mmol/day of potassium chloride reduces blood pressure by an 
average of 7/3 mmHg.55 
The use of anti-hypertensive medication which affects electrolyte excretion (e.g. diuretics 
and ACE inhibitors) is a potential effect modifier. No differences in 24-hour urinary 
electrolyte excretion were found in either black or mixed ancestry hypertensives when 
analyses were performed according to whether or not they were prescribed these types 
of drugs. However, in white subjects, both urinary sodium and potassium values were 

















have either been more compliant with taking prescribed medications or that the 
prescribing pattern of these medications (Le. dosage and frequency) differed in this 
group. However, analyses of hypertensive subjects who were not being treated with such 
medications still demonstrated no difference in Na excretion between black and white 
subjects, suggesting a lack of an ethnic-related difference in dietary intake patterns in 
hypertensives. 
Intracellular calcium is an important determinant of arteriolar tone and it has been 
suggested that low dietary calcium intakes may predispose susceptible individuals to the 
pressor effect of sodium. The findings of the DASH study convincingly showed an 
additional benefit on blood pressure in subjects consuming a diet rich in fruit, vegetables 
and low fat dairy products compared to those on the high fruit and vegetables diet 
alone.56 In the present study, we found that, of a/l the urinary and dietary cations 
investigated, the strongest (inverse) association with blood pressure was found for 
dietary calcium intake, and, in each ethnic group, hypertensives had a significantly lower 
reported intake of calcium than normotensives. Low reported calcium intakes in black 
subjects in the present study are consistent with data from dietary surveys conducted in 
black South Africans since 1975.57 
Meta-analyses of randomized controlled trials in which the relationship between calcium 
supplementation and BP have been investigated have demonstrated only small 
reductions in systolic BP (-0.53 to -1.68 mm Hg) and diastolic BP (zero change to -0.84 
mm Hg).58.59 To date, no interventions of simUltaneous dietary manipulation of calcium 
and potassium have been undertaken in South Africans. Extrapolations from 
interventions conducted in populations with vastly different eating habits may not be 
appropriate. 
It has previously been reported that a higher urinary calcium excretion (and consequent 
secondary increase in parathyroid activity) is evident in essential hypertension.60 
However, in our study, no difference in urinary Ca was found between hypertensive and 
normotensive subjects in any of the three ethnic groups. The underlying mechanism of 
hypertension was not investigated in our hypertensive subjects, and the lack of data on 
parathyroid hormone levels further limits interpretation in this regard. In both 
hypertensive and normotensive groups, black subjects had the lowest urinary calcium, 
followed by mixed ancestry and then white subjects. Urinary calcium excretion is variable 
and is not a marker of habitual calcium intake within an individual.61 In our study, 24-h 











Africans, and in white men, but not white women. The urinary Na-Ca relationship has 
previously been studied extensivelyB2 and exists in different ethnic groupS.63 Blackwood 
and colleagues (2001 )62 demonstrated lower urinary Ca excretion in black, compared to 
South Asian or white, hypertensives in the UK. Blood pressure, salt intake and ethnic 
origin were independent predictors of urinary Ca in this multi-ethnic population. The 
authors concluded that ethnic differences in renal tubular handling may exist, rather than 
differences in Ca intake or intestinal Ca absorption since the relationships remained in 
subjects who had undergone an overnight fast. The lack of an association between 
urinary Na and Ca in white women in our study, even after controlling for reported Na 
intake and BP, as well as for treatment with diuretic agents (data not shown), cannot be 
explained and warrants further investigation. 
Regarding magnesium status, no differences in either urinary magnesium excretion or 
dietary magnesium intake were found between black and white subjects in the present 
study, however in all ethnic groups, intakes were low. A significant, inverse association 
between both serum and erythrocyte magnesium and blood pressure has been reported 
in urban black male labourers in Johannesburg.64 The authors concluded that body 
magnesium status, and its interactions with calcium, sodium. and potassium, may play 
an important role in the development and maintenance of elevated blood pressure in the 
South African black population. 
It has been demonstrated that hypertensive black South Africans have intracellular Na 
and Ca overload, accompanied by intracellular Mg depletion.65 These findings are in 
contrast to published studies of reported dietary intake patterns of the South African 
black population, in which a similar Na and Mg intake between black and white subjects, 
accompanied by a lower K and Ca intake, is generally demonstrated.56 Milne66 
hypothesizes that the difficulty in reconciling dietary intake data with the marked 
intracellular changes (Le. increased Na and Ca, decreased Mg) may be due to an 
inherited abnormality of one or all three of the cation pumps. In this regard, a decrease in 
both platelet and erythrocyte membrane activity has been found for Na-K-A TPase, Ca­
ATPase and Mg-ATPase in hypertensive blacks compared to either white hypertensives 
or normotensive blacks.62 The authors reported an inverse association between platelet 
membrane ATPase activity and blood pressure in black subjects, and the lowest 
activities were found in those with malignant phase hypertension. Alternatively, over­
expression of endothelin, a vasoactive peptide, has been shown in African-American 


















In our study, more hypertensives than normotensives had a low renin status (Le. active 
renin <10 uU/ml) and there was a trend for low renin concentrations to be more common 
in black subjects. The trend for lower renin concentrations in black, compared to either 
mixed ancestry or white, hypertensive subjects suggests salt and water overload as a 
pathogenetic mechanism and renin-angiotensin-aldosterone suppression as a normal 
physiological response. In addition, a higher aJdosterone:renin ratio was found in black 
hypertensive, compared to normotensive subjects, but not in white subjects. We 
identified that over a quarter of our sample (29 %) of black hypertensives had low renin 
hypertension (LRHT) (low renin and normal aldosterone concentrations) which is 
consistent with other studies that have described this entity to be common in black 
hypertensives elsewhere.68•69 
Our findings are similar to those of Cohen et al. 37 who reported that black South Africans 
with mild-to-moderate hypertension had significantly lower mean plasma renin levels 
than their normotensive counterparts. In the Cohen study, the severely hypertensive 
group had low renin levels, and only in the group with malignant hypertension and 
advanced renal failure did renin rise. In the present study, plasma renin concent~ations 
did not differ across stages of hypertension in black subjects, however none of our 
subjects had blood pressure measurements higher than the classification of stage 2 
hypertension (data not shown). A study of urban and rural Xhosas70 found that in the 
urban, as well as rural normotensive and hypertensive subjects, the plasma renin 
concentrations were significantly lower than those reported for white populations. 
The epithelial sodium channel (ENaC) is the principal site for regulating the amount of 
sodium reabsorbed by the kidney, and increased activity of this channel is the final 
common abnormality in several forms of low-renin hypertension: primary aldosteronism, 
glucocorticoid remediable aldosteronism, Liddle's syndrome, and 11-I3-hydroxysteroid-2 
dehydrogenase deficiency.71 Activating mutations of either the !3 or y ENaC subunits can 
result in Liddle's syndrome,72.73 where constitutive reabsorbtion of Na leads to 
hypertension, low plasma levels of renin and aldosterone, and hypokalemia. Rayner and 
colleagues have demonstrated an association between the R563Q mutation in the 13­
subunit of the ENaC and low-renin, low-aldosterone hypertension in black and mixed­
ancestry South African patients.4o They studied patients from different ethnic groups who 
had a tightly defined low renin (PRA < 0.5 ng/ml/hr) and low aldosterone « 225 pmol/L) 
profile. These highly selected patients were contrasted to subjects with normal or high 



















more frequently in low renin hypertensive (LRHT) black patients than in LRHT white 
patients. Within the black group the gene mutation was found in 28.6% of the LRHT 
group compared to 5.5% of the normal or high renin hypertensives. None of the 103 
black normotensive controls, nor any of the 136 white hypertensives, had the mutation. 
The same authors have subsequently reported a strong and unequivocal association of 
this mutation with apparent essential hypertension, but not Liddle's syndrome, in family 
members.74 
In the present study, very few subjects had both a low renin and low aldosterone « 111 
pmollL) status (n =11; 3.8 %), however most (8/11) of these subjects were black. Using 
the less stringent criteria for defining a low aldosterone concentration « 225 pmol/L) 
used by Rayner et al., 40 over a quarter (27 %) of. black hypertensives, compared to a 
tenth of black normotensives, had a low renin/low aldosterone status. 
A number of factors limit the interpretation of our data. Antihypertensive therapy may 
have influenced the renin and aldosterone levels.7s Indeed, as expected, we found higher 
plasma renin and aldosterone:renin concentrations in hypertensive black and white 
subjects being treated with either diuretics or ACE inhibitors, compared to those that 
were not using these agents. It is impractical and inappropriate in a non-clinical setting to 
withdraw antihypertensive medication due to potential unacceptable risks. Further, since 
the primary objective of this study was to determine habitual intakes of Na, no 
standardization of salt intake was undertaken .. 
Regarding the influence of being overweight on blood pressure, BMI and waist 
circumference (data not shown) were positively and significantly associated with blood 
pressure in this sample of multi-ethnic South Africans. Similar to previously reported data 
from both urban and rural Zulu South Africans/6 a positive association was 
demonstrated between BMI and urinary Na excretion. Adipocytes locally synthesize 
components of the renin-angiotensin system; obesity is a volume overloaded state and 
the resultant hypertension could be due to abnormal polymorphisms of the local renin­
angiotensin system, or of the angiotensinogen gene. In this regard, a study by Tiago et 
a/.n found that the angiotensinogen (AGT) promoter region variant gene was present 
with a highly significant Odds Ratio in black hypertensive South Africans with a BMI of 
over 27 kg/m2 compared to normotensive :controls. The AGT gene expressed in adipose 
tissue would directly accelerate the production of angiotensin II as well as increase leptin 
production, thus stimulating the sympathetic nervous system with vasoconstriction and 




















that, compared with their non-obese counterparts, obese Jamaicans (BMI >31) have 
higher serum ACE activity and angiotensinogen levels (the latter is expressed in adipose 
tissue).78 
There are methodological limitations to the cross sectional nature of the study that need 
to be considered. Observational studies that consider risk factors (in this case, the 
exposure is considered to be urinary Na excretion) for certain diseases (in this case, 
raised BP) are distinct from randomised controlled trials because the researcher does 
not manipulate the exposure. The exposure is merely measured and its association with 
the outcome is analysed. In a cross sectional study such as the present one, data on 
exposure and outcome are measured at the same point in time, on the same individuals. 
The major limitation of cross sectional study designs is that they are unable to confirm 
causality.79 However, data obtained from observational studies may still play an 
important role in describing trends and generating hypotheses about associations. 
The type of non-random sampling used (ie. convenient, stratified) may have introduced 
selection bias which, together with sample size impacts on the generalizability of the 
findings. For example, significant differences in the mineral intakes between individuals 
who responded and those that did not may be present. However, it is not possible to 
answer this question retrospectively since non-responders were not followed up further. 
Every effort was made to encourage eligible subjects to participate in the study. 
Fieldworkers set up a research facility within the workplace clinic and remained in regular 
contact with subjects, either through visits or telephonic contact. 
The results are applicable to economically active adults working in Cape Town. The 
sampling frame (ie. Cape Town City Council offices) was purposively selected in order to 
obtain sufficient numbers of subjects from the three ethnic groups who had a similar 
socioeconomic status. The sample size was calculated using the only available 
published data on urinary Na excretion values in normotensive black South Africans. The 
relatively small numbers for comparison in the ethnic/hypertension strata may have 
resulted in the demonstrated differences being due to chance. However, the 
conventional statistical significance level of P =0.05 was used and, where indicated, 
potential confounding variables were controlled for in regression analyses. 
In order to improve the validity of the study findings, the gold standard measure for 
assessment of habitual sodium intake, namely 24-hr urinary Na assessment, was used. 











metabolizable para-aminobenzoic acid is administered during the collection period was 
used. Three repeated 24-hr urine collections measurements may not have been 
sufficient to accurately estimate habitual Na excretion. Indeed, Simpson et afo estimated 
that fifteen 24-hr urine collections are required to characterize an individual's sodium 
output with 95 % accuracy. It was not possible in the present study to increase the 
number of repeated urine collections due to logistical limitations and respondent burden 
associated with the. procedure in free-living subjects. A more detailed discussion of the 
validity of both dietary and urinary estimations of Na intake is provided in Chapter 5. 
Despite these limitations, the findings of this study have identified that black South 
Africans have a dietary pattern which is low in Ca, K, and Mg, but high in Na. Against 
this context, together with a possible predisposition to inherited abnormalities in cation 
pump activity, an investigation of the impact on blood pressure of dietary modification of 
the cation content of commonly consumed foods appears warranted. The low awareness 
of dietary factors being influential in the development of hypertension further indicates a 
need for population-based approaches. In this regard, this study has provided useful 
information on inter- and intra-individual variation in blood pressure, as well as urinary Na 
excretion and reported dietary Na intake across three ethnic groups. Such data is 
required in order to calculate sample size-requirements in intervention studies. 
Conclusions 
White normotensive subjects in Cape Town have higher habitual intakes of sodium, but 
also higher calcium intakes, than their black or mixed ancestry counterparts In all three 
ethnic groups investigated, sodium intake exceeded the recommended maximum of6 
g/day, while potassium intake fell far below the recommended minimum of 90 mmollday. 
These findings indicate a need for population-based approaches to change dietary 
behaviour in order to both prevent the development of hypertension and to improve 
blood pressure control in hypertensives. 
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The causes of hypertension are complex and multifactorial, however the adoption of an 
unhealthy lifestyle is recognized as being a major risk factor in its development.1 As 
outlined in detail in the literature review of this thesis (Chapter 1), the nutrients of most 
interest in the diet-blood pressure relationship, apart from energy and alcohol, are sodium, 
potassium, magnesium and calcium. 
The Dietary Approaches to Stop Hypertension (DASH) randomized controlled trial provided 
evidence that adoption of a dietary pattern that is rich in fruit, vegetables and low fat dairy 
products can reduce blood pressure as much as some anti-hypertensive drugs.2 Increased 
efficacy of the DASH diet among African Americans3 supports other data suggesting ethnic 
differences in blood pressure response to diet, which may be related to differences in 
habitual di~tary patterns.4 The follow-up DASH Sodium study demonstrated additional 
blood-pressure lowering benefits of salt restriction over and above the merits of the DASH 
dief although the greatest benefits in sodium restriction are seen in those with a high fat 
and micronutrient-poor diet (i.e. typical American control diet). 
In South Africa, a diversity of ethnic and cultural groups exists, each with different eating 
patterns and at different stages in the nutrition transition.6 The reported dietary patterns 
of the majority of South Africans indicate a marginal micronutrient intake and an 
inadequate dietary fibre intake.7 ,s Due to high levels of food insecurity that exist in the poor 
sector of the population9 and the very low intake of fruit, vegetables and dairy products by 
the majority of the population,8 promotion of the DASH eating plan in the South" African 
context is unrealistic at this time. 
Regarding salt intake, in the early 1980's urinary excretion studies in Johannesburg 
demonstrated a lower sodium intake in black normotensive and hypertensive South 
Africans, compared to their white counterparts. 10,11 However, at that time, mean sodium 
excretion of the black groups exceeded the current international recommendation of a 
maximum of 6 g salt per day. 12 Potassium excretion of black subjects was low, suggesting 
an inadequate intake of potassium-rich foods, such as fruit and vegetables. 10,11 
In many other countries, the food industry has gradually reduced the amount of salt in 
many of their products, as a result of collaboration between food manufacturers and their 
trade bodies, governmental organizations, retailers, the catering and food service sector, 
academia, and consumer groups. In order to facilitate a population-wide strategy to 















sodium in the local diet. Further, identification of food sources of potassium, magnesium 
and calcium in different ethnic groups would enable nutrition education activities to be 
culturally appropriate in terms of the types of foods that could be promoted to improve 
blood pressure levels. 
Thus, the present study was undertaken to identify which food sources are the major 
contributors to sodium, potassium, calcium and magnesium intake. 
Methods 
Subjects and sampling 
Three hundred and twenty five men and women from three different ethnic groups 
(black, mixed ancestry and white), aged between 20 and 65 years, were recruited from 
their place of work, Cape Town City Council offices in central Cape Town, South Africa. 
Equal numbers of hypertensive (BP ~140/90 mm Hg and/or on antihypertensive 
medication) and normotensive (BP <140/90mm Hg) men and women were planned (n = 
150 in each group; 50 from each ethnic group). Approval for the study was granted from 
the Research and Ethics Committee of the University of Cape Town and written informed 
consent was obtained from all participating subjects. 
Dietary intake 
• 
Dietary intake was assessed using an interviewer-administered 24-hour recall method, 
for each of the three urinary collection periods. Fieldworkers were trained in the 24-hour 
recall procedure and standard hOlJsehold measuring utensils, rulers and validated food 
photographs of typical South African foods 13 were used to quantify food portion sizes. 
The recorded quantities of food consumed were converted to gram weights using the 
Medical Research Council (MRC) Food Quantities Manual. 14 Average daily nutrient 
intake was calculated using the Foodfinder III computerised dietary assessment 
programme, which is based on the MRC Food Composition Tables. 15•16 Added salt 
intake was not quantified in the 24-hour dietary recall assessments, therefore data on 
sources of sodium intake refer only to non-discretionary sources (I.e. naturally 
inherent Na in food and drink, and/or salt added in food processing). 
Foods and beverages were classified into food categories according to the GEMS/Food 
(Global Evaluation Monitoring System/ Food Contamination Monitoring and Assessment 
Programme) commodities of the World Health Organization,17 namely: cereals; sugars 

















and tubers; vegetables; fish and seafood; eggs; fruit; milk and milk products; meat and 
offal; animal oils and fats. New groups were created for alcoholic beverages, dietary 
supplements and soup mixes. Detailed methodology is described elsewhere. 18 
Contribution of intakes from the various food groups towards total Na, K, Mg and Ca 
intake was assessed, by ethnic group. Thereafter, the contribution of individual food 
items to mean total daily intake of Na, K, Mg and Ca was determined, by ethnic group, 
by ranking foods in descending order for cation content of mean group intake of that food 
item. 
For comparative purposes, secondary data analyses of other dietary surveys undertaken 
in adult South Africans, which utilized a 24-hour recall method, were conducted to 
assess quantities and food sources of sodium intake. The databases included two 
studies of rural black subjects (Lebowa (1998; n =292; age =10 - 25 yrs)19,20 and 
Dikgale (1992; n = 209; 19 + yr)21.22, a study of urban black residents in Cape Town 
(BRISK study: 1990; n =1 243; 10 - 89 yr)23,24 and a study of rural white subjects in the 
Western Cape (1989; n = 1 784; 15 - 99 yr).25,26.27 The same dataset, together with the 
Cape Town study, was used to assess the frequency of intake of servings from the main 
food groups of the DASH diet in an attempt to assess the proportion of the South African 
population who have intakes in line with the DASH diet recommendations. 
Statistical analyses 
For each of the dietary variables, values are expressed as means of the three separate 
measurements (or the maximum number of valid measurements obtained for each 
subject). Differences between ethnic groups for numerical variables were assessed 
using either the ANOVA or the Krusal-Wallis ANOVA (non-parametric data) tests. The 
inter- (between-subject) and intra- (within-subject) individual variation in reporting of 
dietary Na, K, Mg and Ca intake is calculated as the coefficient of variation (CV = 
(SD/mean» and expressed as a percentage. Intra-individual CV is calculated as the 
variation within each subject between the three repeated dietary assessments for each 
of the variables. Analyses on variability were conducted only in subjects for whom data 
from all three of the repeated measurements was available. 
Results 
Characteristics and dietary cation and energy intake of sample 
A total of 110, 112 and 103 subjects were recruited from black, mixed ancestry and white 





















terms of proportion of hypertensives and proportion of men to women, however white 
subjects were significantly older than either black or mixed ancestry subjects (Table1). It 
has been reported elsewhere in this thesis (Chapter 3) that mean urinary Na excretion in 
this sample equates to a daily salt (sodium chloride) intake of 7.8g, 8.5g and 9.5g in 
black, mixed ancestry and white subjects, respectively, and that 23 % of the total sample 
had urinary Na concentrations which met the JNC 7 guidelines (ie. < 100 mmollday).28 
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7994 (2 798) 




a Black vs Mixed ancestry; b Black vs White; C Mixed ancestry vs White. 

Dietary sources ofsodium 
The contribution of food groups ~i.e. non-discretionary salt intake) to total sodium intake 
is shown in Table 2, by ethnic group. In all three sub-samples, cereals were the main 
contributor to total reported dietary sodium intake (45.9 - 48.6 %), followed by meat and 
meat products (20.3 - 23.6 %) and milk and dairy products (6.3 - 8.1 %). 
The top twenty individual food items which contributed to total percentage Na intake are 
shown, for each ethnic group, in Tables 3 a-c. In all groups, bread was the major 
source of dietary sodium (25.2 - 40.5 %), while meat products such as processed meats 
(po/any (a pork-based product), vienna sausages, salami, ham, other sausages) and 













Percentage contribution of food groups and bread to total Na intake in South African adults 

------­
Ethnic group Black Black Urban Black Black White White Mixed 
urban (BRISK) Rural Rural Urban Rural (CORIS) ancestry 
{present (present Urban 
study) study) (present 
study) 
Place and year of study Cape Town Cape Town Dikgale Lebowa Cape Western Cape Cape Town 
2002 1990 1998 1992 Town province 2002 
2002 1983 
N 110 1 243 209 292 103 1 784 112 
Age (years) 20 - 65 10 - 89 19 + 10 - 25 20 - 65 15 - 99 20 - 65 
Total reported Na intake (mg/day) 1 459 1 258 759 1 070 1 922 2293 1 761 
Cereal and cereal products 48.6 53.9 74.8 70.3 45.9 37.2 45.9 
Bread (All types) 40.5 51.9 73.1 66.4 25.2 24.6 30.7 
Bread (Brown) 17.3 18.9 57.3 46.6 5.7 9.7 6.7 
Bread (White) 22.3 32.6 15.8 19.6 15.0 12.0 22.0 
Meat and meat products 20.3 19.9 10.2 10.4 23.6 28.9 22.6 
Milk and milk products 6.3 7.8 0.9 3.3 7.0 12.3 8.1 
Soups 5.9 2.7 1.8 0.4 2.5 1.5 3.4 
------­
Roots 4.5 1.4 0.4 0.3 5.1 2.8 3.7 
Fats and oils 4.3 6.3 1.3 2.9 3.9 6.7 3.9 
Fish and seafood 2.1 1.9 1.3 5.1 4.3 2.6 2.4 
Sauces, seasonings and flavourings* 1.9 0.09 0.08 - 0.5 1.2 2.3 
Eggs 1.2 1.6 1.6 2.2 1.1 1.7 1.1 
Legumes and legume products 1.1 0.7 2.3 0.6 1.3 0.7 0.3 
------­
Vegetables 0.9 0.8 2.0 2.8 1.4 1.6 1.7 
Stimulants 0.7 0.6 1.9 0.7 1.1 1.2 1.6 
Sugar, syrups and sweets 0.7 1.1 0.09 0.1 1.0 0.9 1.1 
Fruit 0.6 0.2 0.07 0.06 0.3 0.3 0.4 
Nuts and seeds 0.6 0.5 1.1 0.9 0.6 0.3 0.7 
Alcohol 0.3 0.6 0.3 0.02 0.3 0.3 0.7 
Supplements - - - 0.04 - 0.05 -
------­











Table 3 (a) 

Contribution of top 20 individual food items to total non-discretionary Na intake3 - black 

subjects ((n =110) 

Rank- Food item % Cons- Mean portion Mean Na % Total 
ing umers size (g) (mg/day) Na intake 
(Consumers) (Consumers) (Group) 
Bread - all types 93.6 134.6 631.9 40.54 
1 Bread/rolls - white 74.6 89.0 435.9 22.26 
2 Bread/rolls - brown 59.1 94.6 426.5 17.27 
3 Beef sausage - Boerewors 12.7 59.1 475.3 4.15 
4 Steak and kidney pie 13.6 71.8 366.1 3.42 
(commercial) 
5 Soup powder (reconstituted) 10.9 90.8 391.5 2.93 
6 Margarine - brick/hard 57.3 9.2 73.8 2.90 
7 Polony 20 18.2 185.0 2.53 
8 Maas/sour milk 26.4 189.9 134.9 2.44 
9 Potato chips/french fries 28.2 57.9 114.6 2.21 
10 Milk - full cream, fresh 53.6 120.4 57.8 2.12 
11 Potato crisps 12.7 22.4 224.3 1.96 
12 Popcorn, plain 1.8 58.3 1131.7 1.41 
13 Salami, pork/beef (Russian) 4.6 23.8 442.7 1.38 
14 Sausage roll (commercial) 7.3 64.4 276.4 1.38 
15 Breakfast cereal - All Bran 3.6 61.1 491.1 1.22 
flakes 
16 Soup - vegetable (canned) 3.6 140.4 478.8 1.19 
17 Vienna sausage (canned) 6.4 27.4 260.9 1.14 
18 Chickenpie (commercial) 4.6 68.3 363.9 1.13 
19 Aromat 3.6 1.2 453.3 1.13 
20 Bread/rolls - wholewheat 9.1 42.7 162.1 1.01 
a Arranged in descending order of % total Na intake (group).Together, these,20 food items make up 
75.2 % of total reported Na intake for the group. 
Table 3 (b) 

Contribution of top 20 individual food items to total non-discretionary Na intake3 - mixed 

ancestry subjects (n =112) 

Rank- Food item % Cons- Mean portion Mean Na % Total 
ing umers size (g) (mg/day) Na intake 
(Consumers) (Consumers) (Group) 
Bread - all types 97.3 117.7 555.7 30.70 
1 Bread/rolls - white 87.5 90.5 443.4 22.03 
2 Bread/rolls - brown 30.4 86.0 387.8 6.68 
3 Beef sausage - Boerewors 23.2 62.4 502.1 6.62 
4 Breakfast cereal - Cornflakes 10.7 39.4 476.7 2.90 
5 Potato crisps 24.1 19.9 199.1 2.73 
6 Polony 26.8 14.0 143.0 2.17 











Rank- Food item % Cons- Mean portion Mean Na % Total 
ing umers size (g) (mg/day) Na intake 
{Consumers} {Consumers) (Group) 
8 Cheese - cheddar 42.0 16.6 80.6 1.92 
9 Milk - full cream, fresh 72.3 96.5 46.3 1.90 
10 Margarine - brick/hard 65.2 6.4 51.1 1.89 
11 Potato chips/french fries 34.8 42.1 83.4 1.65 
12 Savoury snack - corn chips 17.0 14.9 158.7 1.53 
(eg. Niknaks) 
13 Breakfast cereal - All Bran 5.4 61.8 497.1 1.51 
flakes 
14 Steak and kidney pie 10.7 41.5 211.5 1.29 
(commercial) 
15 Fish biltong (salted, dried 0.9 33.3 2342.3 1.19 
cod) 
16 Vienna sausage (canned) 12.5 16.9 161.1 1.14 
17 Chicken pie (commercial) 7.1 52.1 277.6 1.13 
18 Baked beans (canned) 17.0 26.5 105.2 1.01 
19 Salami, pork/beef (Russian) 1.8 51.7 961.0 0.97 
20 Sausage roll (commercial) 7.1 52.0 223.3 0.91 
a Arranged in descending order of % total Na intake (group).Together, these 20 food items make up 
63.2 % of total reported Na intake for the group. 
Table 3 (c) 
Contribution of top 20 individual food items to total non-discretionary Na intakea - white 
subjects (n = 103) 
Rank- Food item % Cons- Mean portion Mean Na % Total 
ing umers size (g) (mg/day) Na intake 
(Consumers) (Consumers) (Group) 
Bread - all types 96.1 109.8 503.5 25.18 
1 Bread/rolls - white 76.7 76.3 376.0 15.24 
2 Bread/rolls - brown 37.9 64.6 291.4 5.74 
3 Bread/rols - wholewheat 35.0 60.8 231.0 4.20 
4 Breakfast cereal - All Bran 9.7 103.2 829.5 4.19 
Flakes 
5 Breakfast cereal - Corn 7.8 62.6 758.4 3.06 
Flakes 
6 Vienna sausage (canned) 13.6 37.9 360.8 2.55 
7 Beef sausage - Boerewors 16.5 35.1 282.5 2.43 
8 Sausage - pork 7.8 36.9 477.2 1.93 
9 Cheese - cheddar 53.4 13.9 67.8 1.88 
10 Pizza 8.7 67.8 386.3 1.76 
11 Steak and kidney pie 9.7 65.9 335.9 1.70 
(commercial) 
12 Milk - fuJI cream, fresh 68.9 90.4 43.4 1.56 
13 Potato chips/french fries 27.2 55.5 109.8 1.55 
14 Margarine - brick/hard 52.4 6.9 55.5 1.51 
15 Soup - vegetable 5.8 145.8 497.3 1.51 
16 Ham - cokked/canned 20.4 9.4 124.4 1.32 
17 Potato crisps 14.6 17.2 171.8 1.30 
18 ProVita crackers 12.6 27.8 197.5 1.30 
19 Bacon - fried, lean 4.9 22.0 501.6 1.27 
20 Low fat spread ­ 26.2 10.3 87.5 1.19 
~ol}',unsaturated 
a Arranged in descending order of % tota'i Na intake (group).Together, these 20 food items make up 
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Figure 1 
Proportion of Na provided by cereals food group in South Africans 
Potassium 
Only 8 % of subjects had reported K intakes which met or exceeded the 
recommendation of 90 mmol/day29 (3 330 mg), with significantly more (P<0.001) white 
(16.5 %) than black (3.6 %) or mixed ancestry (4.5 %) subjects meeting this goal. 
Reported dietary K intake was significantly (P<0.0001) lower in black compared to white 
subjects (Table 1). In black subjects only, reported K intake was lower in hypertensives 
compared to normotensive subjects (P<0.05) (data not shown). 
The cereals food group contributed the highest proportion of total dietary K intake (ie. 
17.1 % - 26.8 %) (Tables 6a - c) across all ethnic groups. and provided a higher absolute 
amount of K in black subjects (548 mg/day). compared to mixed ancestry (358 mg) or 
white subjects (435 mg/day). Fruit provided a similar amount of K across ethnic groups 
(mean = 210 - 259 mg/day; 10.0 - 12.6 % total K). but in white subjects the vegetables 
food group provided almost double that of black subjects (189 and 97 mg/day. 
respectively). Potatoes were included in the roots food group, which provided 11.3 - 13.9 
% of K (mean = 260 - 291 mg/day), while milk and dairy foods contributed about 11 % of 
K intake. Stimulants, which include coffee and tea. contributed 17.2 % of K intake in 
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Table 6 (a) 

Contribution of food groups to total K, Mg and Ca intake in black subjects (N =110) 

Food group K intake of group Mg intake of group Ca intake of group 
% total Mean % total Mean % total Mean 
K {mg/da}'} Mg 1!!!g/da}') Ca (mg/da~) 
Cereal and cereal products 26.8 548.0 54.5 141.2 29.2 126.4 
Meat and meat products 12.9 263.5 8.4 21.9 5.2 22.6 
Roots 12.7 259.9 5.4 14.0 1.9 8.1 
Milk and milk products 11.4 232.4 7.1 18.3 46.7 201.8 
Fruit 12.6 258.1 5.5 14.2 3.1 13.2 
Vegetables 4.7 96.5 2.8 7.3 3.2 14.1 
Fish and seafood 2.6 52.5 1.2 3.2 3.5 15.1 
Stimulants 8.9 181.8 6.3 16.3 1.2 5.4 
Eggs 0.7 14.0 0.5 1.2 1.3 5.8 
Pulses (Legumes and 2.5 50.2 2.9 7.4 1.1 4.8 
legume products) 
Vegetable fats and oils 1.3 26.0 0.08 0.2 0.3 1.2 
Nuts and seeds 0.9 18.5 1.8 4.5 0.4 1.7 
Soups 0.7 14.8 0.3 0.8 0.8 3.4 
Sugar, s}'rups and sweets 0.4 8.9 0.9 2.4 1.4 6.2 
Alcohol 0.9 18.6 2.2 5.7 0.5 2.4 
Condiments (Sauces, 0.2 3.2 0.2 0.4 0.08 0.3 
seasonings and flavourings) 
Spices 
Total intake (mg/da}') 2046.8 259.0 432.5 
Table 6 (b) 





Food group K intake of group Mg intake of group Ca intake of group 
% total Mean % total Mean % total Mean 
K (mg/da}') Mg (mg/da~} Ca (mg/da},) 
Cereal and cereal products 17.1 358.1 40.9 93.3 26.7 124.0 
Meat and meat products 17.5 366.9 12.8 29.1 5.1 23.7 
Roots 13.9 290.9 6.9 15.8 2.2 10.0 
Milk and milk products 10.6 221.1 8.3 18.9 49.1 228.1 
Fruit 10.0 209.8 5.3 12.0 2.1 9.7 
Vegetables 6.2 129.5 4.1 9.4 2.6 11.9 
Fish and seafood 5.3 111.0 3.3 7.5 3.5 16.4 
Stimulants 12.7 266.0 10.6 24.2 2.4 11.0 
Eggs 0.7 14.3 0.5 1.2 1.3 6.2 
Pulses (Legumes and 1.5 30.5 1.5 3.3 0.8 3.7 
legume products) 
Vegetable fats and oils 1.4 29.1 0.2 0.4 0.6 2.7 
Nuts and seeds 0.9 18.1 1.9 4.2 0.3 1.6 
Soups 0.5 10.3 0.2 0.4 0.3 1.6 
Sugar, syrups and sweets 0.4 8.7 1.3 3.0 2.2 10.2 
Alcohol 1.2 26.0 2.3 5.2 0.6 2.9 
Condiments (Sauces, 0.08 1.8 0.1 0.2 0.1 0.3 
seasonings and flavourings) 
Spices 0.01 0.27 0.02 0.04 












Table 6 (c) 

Contribution of food groups to total K, Mg and Ca intake in white subjects (N =110) 

Food group K intake of group Mg intake of group Ca intake of group 
% total Mean % total Mean % total Mean 
K (mg/da~l Mg (m9/da~} Ca {mg/day) 
Cereal and cereal products 17.3 434.6 40.4 115.3 27.4 147.8 
Meat and meat products 13.8 346.6 9.8 27.9 4.0 21.7 
Roots 11.3 284.8 5.4 15.5 1.9 10.3 
Milk and milk products 10.9 273.1 8.3 23.6 47.9 258.2 
Fruit 10.3 259.1 5.7 16.2 2.8 14.9 
Vegetables 7.5 189.2 4.5 12.8 3.2 17.1 
Fish and seafood 3.0 76.3 1.8 5.1 2.2 12.0 
Stimulants 17.2 431.0 14.2 40.4 3.7 20.1 
Eggs 0.7 16.6 0.5 1.4 1.3 6.9 
Pulses (Legumes and 0.8 20.2 1.3 3.8 0.4 2.1 
legume products) 
Vegetable fats and oils 0.9 21.3 0.2 0.5 0.6 3.3 
Nuts and seeds 0.7 17.7 1.4 4.1 0.3 1.5 
Soups 0.5 0.6 0.2 0.6 0.4 2.2 
Sugar, syrups and sweets 0.7 16.7 1.1 1.8 2.0 10.6 
Alcohol 3.8 94.9 4.8 13.5 1.7 8.9 
Condiments (Sauces, 0.6 14.4 0.4 1.1 0.1 0.7 
seasonings and flavourings) 
Spices 0.07 1.9 0.1 0.1 0.1 0.7 
Total intake (mg/dav 2512.3 285.2 539.1 
The top twenty individual food items which contributed to total percentage K intake are 
shown, for each ethnic group, in Tables 7a - c. 
Table 7a 

Contribution of top 20 individual food items to total K intakea - black subjects (n = 110) 

Ranking Food item % Mean portion MeanK % Total K 
Cons- size (g) (mg/day) intake 
umers {Consumers} {Consumers} {Grou~} 
Bread - all types 93.6 134.6 10.94 
1 Bread/rolls, brown 59.1 94.6 209.9 6.06 
2 Coffee, brewed/instant 68.2 309.3 167.0 5.56 
3 Potato chips/french fries 28.2 57.9 398.9 5.49 
4 Samp and beans (1 :1) 22.7 263.3 484.5 5.38 
5 Milk, full fat, fresh 53.6 120.4 189.0 4.95 
6 Maas/sour milk 26.4 189.9 360.9 4.65 
7 Maize meal, cooked, stiff 56.4 277.5 166.5 4.58 
porridge 
8 Bread/rolls - white 74.6 89.0 122.8 4.47 
9 Potato (boiled) 49.1 50.2 140.0 3.36 
10 Tea 54.6 321.8 119.1 3.17 
11 Banana 29.1 64.1 154.4 2.19 
12 Potato crisps 12.7 22.4 324.5 2.02 
13 Samp and beans (1 :2) 5.5 220.4 615.3 1.64 
14 Peach 14.6 107.5 216.2 1.54 
15 Grapes 12.7 110.0 236.5 1.47 
16 Beef, steak, grilled 9.1 87.0 294.8 1.31 
17 Rice, white, cooked 76.4 89.2 34.8 1.30 












Ranking Food item % Mean portion Mean K % Total K 
Cons- size (g) (mg/day) intake 
umers (Consumers} (Consumers} (Group} 
19 Beef, braised topside 5.5 139.7 430.3 1.15 
20 Orange 9.1 128.2 225.6 1.00 
a Arranged in descending order of % total K intake (group).Together. these 20 food items make up 62.5 % of 
total reported K intake for the group. 
Table 7 b 
Contribution of top 20 individual food items to total K intake3 - mixed ancestry subjects (n 
= 112) 
Ranking Food item % Mean portion Mean K % Total K 
Cons- size (g) (mg/day) intake 
umers (Consumers} {Consumers} (Group} 
Bread - all types 97.3 117.7 8.96 
1 Coffee, brewed/ instant 70.5 380.2 205.3 6.92 
2 Milk, full fat, fresh 72.3 96.5 151.5 5.24 
3 Bread/rolls - white '87.5 90.5 124.9 5.22 
4 Tea 74.1 397.2 147.0 5.21 

































Milk, low fat, fresh 
Sausage, boerewors 
Non-dairy coffee creamer 
Chicken, roasted 
Mutton, loin chop, grilled 
Potato (sauteed) 
Rice, white, cooked 
Mutton stew 













































a Arranged in descending order of % total K intake (group).Together. these 20 food items make up 51.1 % of 
total reported K intake for the group. 
Table 7 c 

Contribution of top 20 individual food items to total K intake
3 
- white subjects (n =103) 







% Total K 
intake 










Bread - all types 
Coffee, brewed/ instant 
Tea 
Potato chips/french fries 
Milk, full fat, fresh 
Bread/rolls - brown 
Milk, low fat, fresh 
Wine - red/white/rose 
Bread/rolls - white 

























































% Total K 
intake 
umers (Consumers} (Consumersl {Grou~} 
10 Bread/rolls ­ 35.0 60.8 45.3 1.80 
wholewheat 
11 Potato crisps 14.6 17.2 36.2 1.44 
12 Potato (boiled) 27.2 43.8 33.2 1.32 
13 Tomato, raw 51.5 27.2 32.3 1.29 
14 Fish, medium fat, fried 12.6 55.3 31.0 1.23 
15 Banana 26.2 46:7 29.5 1.17 
16 Milk, skim, fresh 11.7 147.6 28.6 1.14 
17 Avocado 15.5 27.1 24.5 0.98 
18 Beer 19.4 363.2 23.3 0.93 
19 Orange juice 6.8 165.5 22.5 0.90 
20 Breakfast cereal, muesli 9.7 60.7 20.3 0.81 
a Arranged in descending order of % total K intake (group).Together, these 20 food items make up 49.4 % of 
total reported K intake for the group. 
In all three ethnic groups, coffee and tea, bread, milk and potatoes (french fries, crisps or 
boiled) were important sources of overall K intake. Notably different to the other groups 
was the appearance of alcoholic drinks (beer and wine) and breakfast cereals (All Bran 
flakes, muesli) in the top 20 list in white subjects. Consistent with the food group 
analysis (Table 6a - c), few fruits or vegetables (with the exception of banana, grapes 
and orange/juice) were in the top 20 list of contributors to total K intake. 
Magnesium 
Reported dietary magnesium intake did not differ between black and white subjects, but 
was significantly lower in mixed ancestry subjects (Table 1). More black and mixed 
ancestry, compared to white, subjects had Mg intakes below 67 % DRI27 (51.8 %, 67.9 % 
and 43.7 %, respectively; P<0.05). In normotensives, mixed ancestry and black subjects 
had Significantly lower reported dietary Mg intakes than their white counterparts, but this 
difference was not evident in hypertensive subjects (data not shown). The cereals food 
group provided the majority of Mg intake (40.4 - 54.5 %, followed by the meat (8.4 - 12.8 
%), milk (7.1 - 8.3 %) and roots (5.4 - 6.9 %) food groups (Tables 6 a-c). Stimulants 
contributed 6.3 - 14.2 % of total Mg intake. The top twenty individual food items which 












Table 8 a 

Contribution of top 20 individual food items to total Mg intake3 - black subjects (N = 110) 

Ranking Food item % Cons- Mean portion Mean % Total Mg 
umers size (g) Mg(mg/day) intake 
(Consumers} {Consumers) (Group} 
Bread - all types 93.6 134.6 67.8 24.50 
1 Bread/rolls - brown 59.2 94.6 70.0 15.97 
2 Maize meal, cooked, stiff 56.4 277.5 49.9 10.87 
porridge 
3 Bread/rolls - white 74.6 89.0 25.8 7.43 
4 Samp and beans (1:1) 22.7 263.3 76.4 6.70 
5 Coffee 68.2 309.3 15.5 4.07 
6 Rice, white, cooked 76.4 89.2 11.6 3.42 
7 Milk - full fat, fresh 53.6 120.4 14.5 2.99 
8 Maas/sour milk 26.4 189.9 26.6 2.71 
9 Potato chips/french fries 28.2 57.9 22.6 2.46 
10 Samp and beans (1 :2) 5.5 220.4 100.4 2.11 
11 Tea 54.6 321.8 9.7 2.03 
12 Breakfast cereal, Weetbix 15.5 26.9 31.2 1.86 
13 Breakfast cereal, All Bran 3.6 61.1 111.2 1.56 
Flakes 
14 Banana 29.1 64.1 13.5 1.51 
15 Beer 5.5 717.2 64.6 1.36 
16 Potato, boiled 49.1 50.2 6.0 1.14 
17 Bread/rolls - wholewheat 9.1 42.7 31.6 1.11 
18 Potato crisps 12.7 22.4 18.8 0.93 
19 Orange juice 10.9 196.5 19.6 0.83 
20 Peanut butter, smooth 16.4 8.3 13.1 0.82 
a Arranged in descending order of % total Mg intake (group).Together. these 20 food items make up 71.9 % 
of total reported Mg intake for the group. 
Table 8b . 





Ranking Food item % Cons- Mean portion Mean Mg % Total Mg 
umers size (g) (mg/day) intake 
{Consumers} (Consumers} (Group) 
Bread - all types 97.3 118.0 50.7 21.61 
1 Bread/rolls - white 87.5 90.5 26.2 10.06 
2 Bread/rolls - brown 30.4 86.0 63.6 8.46 
3 Coffee 70.5 380.2 19.0 5.88 
4 Tea 74.1 397.2 11.9 3.87 
5 Milk - full fat, fresh 72.3 96.5 11.6 3.67 
6 Rice, white, cooked 74.1 71.5 9.3 3.02 
7 Bread/rolls - wholewheat 17.9 51.7 38.2 2.99 
8 Breakfast cereal, All Bran 5.4 61.8 112.5 2.64 
Flakes 
9 Potato chips/french fries 34.8 42.1 16.4 2.51 
10 Breakfast cereal, Weetbix ,26.8 17.1 19.8 2.33 
11 Beer 5.4 870.0 78.3 1.84 
12 Potato crisps 24.1 19.9 16.7 1.77 
13 Banana ;26.8 66.2 13.9 1.63 
14 Oats/oatmeal - cooked 9.8 128.8 30.9 1.33 
15 Milk - 2 'Yo, low fat, fresh '23.2 83.8 10.1 1.02 
16 Fish, medium fat, fried 24.1 51.4 9.3 0.98 
17 Chicken, roasted 17.0 48.3 12.5 0.93 











Ranking Food item % Cons- Mean portion Mean Mg % Total Mg 
umers size (g) (mg/day) intake 
(Consumers} {Consumers} (Grou~) 
porridge 
19 Cheese, cheddar type 42.0 16.6 5.0 0.91 
20 Peanut butter, smooth 24.1 5.3 8.3 0.88 
a Arranged in descending order of % total Mg intake (group).Together. these 20 food items make up 57.7 % 
of total reported Mg intake for the group. 
Table 8c 

Contribution of top 20 individual food items to total Mg intakel!l - white subjects (N =103) 

Ranking Food item % Cons- Mean portion Mean Mg % Total Mg 
umers size (g) (mg/day) intake 
{ConsLimers} {Consumers} (Group) 
Bread - all types 96.1 111.9 54.4 18.32 
1 Coffee 86.4 629.5 31.5 9.54 
2 Breakfast cereal, All Bran 9.7 103.2 187.8 6.39 
Flakes 
3 Bread/rolls - brown 37.9 64.6 47.8 6.35 
4 Bread/rolls - white 76.7 76.7 22.3 5.99 
5 Bread/rolls - wholewheat 35.0 60.8 45.0 5.51 
6 Tea 60.2 508.5 15.3 3.22 
7 Milk - full fat, fresh 68.9 90.4 10.9 2.62 
8 Wine, all types 26.2 253.0 25.3 2.33 
9 Beer 19.4 363.2 32.7 2.23 
10 Breakfast cereal, muesli 9.7 60.7 61.9 2.11 
11 Potato chips/french fries 27.2 55.5 21.6 2.06 
12 Breakfast cereal, Weetbix 19.4 22.6 26.2 1.79 
13 Milk - 2 %, low fat, fresh 37.9 107.9 13.0 1.72 
14 Rice, white, cooked 62.1 60.5 7.9 1.71 
15 Banana 26.2 46.7 9.8 0.90 
16 Cheese,cheddartype 53.4 13.9 4.2 0.78 
17 Potato crisps 14.6 17.2 14.4 0.74 
18 Milk - skim, fresh 11.7 147.6 16.2 0.66 
19 Chicken, boiled 22.3 39.5 8.3 0.65 
20 Oats/oatmeal - cooked 6.8 111.4 26.7 0.64 
a Arranged in descending order of % total Mg intake (group).Together. these 20 food items make up 57.9 % 
of total reported Mg intake for the group. 
In all three groups, bread contributed the greatest proportion of total Mg intake, ranging 
from 18.3 % in white subjects to 24.5 % in black subjects (all bread types combined). In 
the black group, the staple foods maize meal porridge and dishes and samp (maize 
kernels) were important contributors to Mg intake (11.8 % and 7.7 % of total Mg intake, 
respectively). Coffee and tea, milk and maas (sour milk), white rice, and breakfast 
cereals were major sources of Mg common to all three ethnic groups. 
Calcium 
Mean dietary calcium was higher in white subjects compared to either the black or mixed 
ancestry groups, however in all groups calcium intake was low (about half of DRI of 1000 











78.6 %, respectively had inadequate « 67 % DRI) calcium intakes. Calcium intake was 
significantly (P<0.005) lower in hypertensive than normotensive subjects, for both black 
and white ethnic groups (data not shown). and more hypertensive compared to 
normotensive subjects had inadequate (< 67 % DRI) dietary intakes of calcium (89.0 % 
vs 73.9 %; P<0.05). 
The contribution of food groups to total Ca intake was similar across ethnic groups. The 
milk and milk products group provided the majority of Ca (46.7 - 49.1 % total Ca), 
followed by the cereal and cereal products group (26.7 - 29.2 % Ca) (Tables 6a - c). The 
top twenty individual food items which contributed to total percentage Ca intake are 
shown, for each ethnic group, in Tables 9 a-c. Notably, in the black sample, maas (sour 
milk) provided the most calcium. The milk and milk products food group provided 46.7 %, 
49.1 % and 47.8 % of total Ca in black, mixed ancestry and white groups, respectively. 
Bread (all types combined) was also an important source of Ca, providing 16.2 %, 13.8 
% and 10.6 % in black, mixed ancestry and white subjects, respectively. 
Table 9 (a) 

Contribution of top 20 individual food items to total Ca intakea - black subjects (n =110) 

Rank- Food item % Mean portion Mean Ca % Total 
ing Cons- size (g) (mg/day) Ca intake 
umers (Consumers) (Consumers) (Group) 
Bread - all types 93.6 134.6 75.8 16.20 
1 Maas, sour milk 26.4 189.9 307.7 18.76 
2 Milk, full fat, fresh 53.6 120.4 144.5 17.92 
3 Bread/rolls, white 74.5 89.0 49.8 8.59 
4 Bread/rolls, brown 59.1 94.6 52.0 7.11 
5 Cheese, cheddar-type 13.6 13.7 107.7 3.40 
6 Breakfast cereal, ProNutro Great 1.8 150.0 630.0 2.65 
Start 
7 Samp & bea s (1:1) 22.7 263.3 39.5 2.08 
8 Milk, low fat, fresh 10.9 64.9 79.1 2.00 
9 Rice, white 76.4 89.1 9.8 '1.73 
10 Muffin, plain 4.5 98.0 137.2 1.44 
11 Pilchards in brine 7.3 20.0 72.0 1.21 
12 Steak and kidney pie, 13.6 71.8 38.0 1.20 
commerical 
13 Mahewu/magou (traditional 4.5 266.7 98.7 1.04 
beer) 
14 Cabbage, sauteed in. sunflower 21.8 46.2 20.3 1.03 
oil 
15 Cold drink, carbonated 41.8 252.2 10.1 0.98 
16 Coffee 68.2 309.3 6.2 0.98 
17 Orange 9.1 128.2 38.5 0.81 
18 Offal 9.1 54.8 37.3 0.78 
19 Milk, skim, fresh 2.7 90.0 110.7 0.70 
Breakfast ProNutro 164. 
a Arranged in descending order of % total Ca intake (group).Together, these 20 food items make up 











Table 9 (b) 





Rank- Food item % Mean portion Mean Ca % Total 
ing Cons- size (g) (mg/day) Ca intake 
umers (Consumers) (Consumers) (Group) 
Bread· all types 97.3 118.0 66.0 13.84 
1 Milk, full fat, fresh 72.3 96.5 115.8 18.05 
2 Cheese, cheddar.type 42.0 16.6 130.4 11.80 
3 Bread/rolls, white 87.5 90.5 50.7 9.56 
4 Milk, low fat, fresh 23.2 83.8 102.2 5.11 
5 Bread/rolls, brown 30.4 86.0 47.3 3.09 
6 Yoghurt, fruit, low fat 13.4 63.9 92.7 2.68 
7 Cheese, Gouda/Edam/Swiss-type 7.1 18.5 149.1 2.30 
8 Muffin, plain 10.7 58.6 82.0 1.89 
9 Cold drink, carbonated 63.4 304.0 12.2 1.66 
10 Breakfast cereal, ProNutro 0.9 166.7 766.7 1.48 
11 Rice, white 74.1 71.5 7.9 1.26 
12 Coffee 70.5 380.2 7.6 1.16 
13 Bread/rolls, wholewheat 17.9 51.7 29.5 1.13 
14 Fish, medium fat, fried 24.1 51.4 21.1 1.09 
15 Ice cream, commercial 8.9 39.0 51.5 0.99 
16 Dairy fruit juice mix 3.6 139.6 110.3 0.85 
17 Milkshake, vanilla, purchased 1.8 135.0 197.1 0.76 
18 Doughnut, plain 17.0 25.9 19.7 0.72 
19 Milk, skim, fresh 7.1 37.9 46.6 0.72 
20 Milk, ~owder, low fat 0.9 30.0 357.3 0.69 
a 	 Arranged in descending order of % total Ca intake (group).Together. these 20 food items make up 
67.0% of total reported Ca intake for the group. 
Table 9 (c) 

Contribution of top 20 individual food items to total Ca intakea - white subjects (n =103) 

Rank- Food item % Mean portion Mean Ca % Total 
ing Cons- size (g) (mg/day) Ca intake 
umers (Consumers) (Consumers) (Group) 
Bread - all types 96.1 111.9 63.4 10.56 
1 Milk, full fat, fresh 68.9 90.4 108.5 12.96 
2 Cheese, cheddar-type 53.4 13.9 109.7 10.15 
3 Milk, low fat, fresh 37.9 107.9 131.6 8.64 
4 Bread/rolls, white 76.7 76.7 43.0 5.71 
5 Milk, skim, fresh 11.7 147.6 181.6 3.67 
6 Rusk, commercial, buttermilk 3.9 83.3 448.3 3.02 
7 Bread/rolls, brown 37.9 64.6 35.5 2.33 
8 Ice cream, commercial 13.6 88.6 90.3 2.13 
9 Bread/rolls, wholewheat 35.0 60.8 34.6 2.10 
10 Pizza, cheese and tomato 8.7 67.8 128.8 1.95 
11 Coffee 86.4 629.5 12.6 1.88 
12 Cheese, Gouda/Edam/Swiss-type 7.8 16.2 130.6 1.76 
13 Muffin, plain 10.7 56.5 79.1 1.46 
14 Yoghurt, fruit, low fat 8.7 56.7 82.2 1.24 
15 Cold drink, carbonated 53.4 292.2 11.7 1.08 
16 Rusk, commercial, white 4.9 21.7 118.5 1.00 










Rank- Food item % Mean portion Mean Ca % Total 
ing Cons- size (g) (mg/day) Ca intake 
umers (Consumers) (Consumers) (Group) 
18 Breakfast cereal, All Bran Flakes 9.7 103.2 51.6 0.87 
19 Sweets, chocolate coated bar 12.6 28.6 38.6 0.84 
20 Milkshake, vanilla, purchased 1.9 163.3 238.5 0.80 
a 	 Arranged in descending order of % total Ca intake (group).Together, these 20 food items make up 
64.5% of total reported Ca intake for the group. 
Inter- and intra-individual variation in dietary intakes 
Inter-individual coefficient of variation (CV) in the reporting of mean 3-day sodium intake 
for the total group was 52.8 %. Inter-individual CV, by ethnic group, was 59.2 %, 50.2 % 
and 47.0 % for black, mixed ancestry and white subjects, respectively. As expected, the 
inter-individual CV in Na intake was markedly higher if each of the single days of dietary 
reporting was considered in isolation (68.3 % - 77.6 for the total group; 69.9 % - 96.5 % 
for black subjects; 60.7 % - 85.7 % in mixed ancestry subjects; and 51.6 % - 71.3 % in 
white subjects). In the total group, intra-individual variation in reported Na intake over the 
three separate 24-hour recall periods was 44.4 % (95 % CI = 41.5 -47.3 %). Black 
subjects had the highest between-subject variation in reported Na intake (CV =50.9 %, 
44.4 % and 37.6 % in black, mixed ancestry and white subjects, respectively (P<0.005». 
The inter-individual CV for reporting of potassium, magnesium and calcium intake within 
ethnic groups was 45.9 - 46.7 %, 43.0 - 45.9 % and 70.6 - 74.6 %, respectively. Intra­
individual CV in 3-day reporting of potassium, magnesium and calcium intake was 35.7 
%, 30.5 % and 54.3 %, respectively. 
Proportion of the South African population consuming recommended number of 
servings in food groups, according to the DASH diet 
Further secondary analyses of the 4 other South African dietary datasets demonstrated 

that the mean number of servings from the cereals, vegetables, fruit and dairy product 

food groups was low in the black populations sampled, particularly in the rural studies 

(Table 7). For these food groups, no rural black subjects had intakes that met the DASH 

. diet recommendations, except for 6 % of the Lebowa sample meeting the dairy 

recommendation of at least 2 servings per day. In the BRISK urban black sample, more 
dairy foods were consumed, however less than a third of this group had 2 or more 
servings per day. Notably, over a quarter of Dikgale subjects were consuming one or 











proportions of any of the samples consumed 4 or more servings of vegetables and of 
fruit per day, except for the case of the two white groups. 
Table 7 
Mean number of times (SO) per day that items were consumed from the various food 
groups in the DASH diet, and proportion (%) of the sample consuming recommended 
number of servingsa according to DASH diett 
Food group Dikgale Lebowa BRISK CORIS Cape Town (current study) 
Black Black Black White Urban, 2002 
rural, rural, urban, rural, Black Mixed White 
199821 ,22 199219,20 199023,24 197925 -27 ancestry 
Cereals/cereal products 2.30 (0.86) 3.37 (0.88) 2.55 (0.98) 3.83 (2.20) 2.61 (1.03) 3.17 (1.16) 2.84 (1.17) 
















% ~ 4 servings 0.5 1 8.1 35.7 0.9 8.9 21.4 
Fruits 0.16 (0.44) 0.21 (0.53) 0.43 (0.80) 1.51 (1.71) 0.79 (0.89) 0.83 (0.91) 1.04 (1.16) 
% ~ 4 servings 0 0.3 0.9 10.1 0.9 2.7 7.8 
Dairy foods 0.11 (0.34) 0.28 (0.59) 1.06 (1.15) 4.32 (3.09) 0.88 (1.01) 1.89 (1.24) 3.10 (1.88) 
% ~ 2 servings 0.9 5.8 29.5 69.9 15.4 57.1 75.7 
Meats, poultry, fish 0.67 (0.79) 0.84 (0.80) 1.38 (1.08) 2.36 (1.62) 1.12 (0.66) 1.73 (0.79) 1.54 (0.74) 
% :5 2 servings 98.6 100 86.1 65.6 96.4 85.7 90.3 
Nuts, seeds, legumesC 0.34 (0.63) 0.14 (0.44) 0.05(0.25) 0.27 (0.57) 0.19 (0.33) 0.33 (0.37) 0.25 (0.35) 
% ~ 1 serving 27.3 12.7 4.4 22.3 5.5 10.7 6.8 
a One serving taken as each reported frequency of consumption of items from that food group per day. 

tThe DASH eating plan shown above' is based on 2000 kcal a day (8 400 kJ/d). Depending on energy 

needs, the number of daily servings in a food group may vary from those listed. 

b Potatoes and root vegetables included in this group. 

e DASH diet recommends 4-5 servings per week, but 21-hr recall methodology used in South African surveys 

allows only mean number of servings per day to be calculated therefore recommended serving of once per 

day was used in calculations. 

Discussion 
Data obtained from a multi-ethnic, economically active sample of South Africans in Cape 
Town, demonstrates that the bread and cereals food group is by far the largest 
contributor of non-discretionary dietary sodium intake (45.9 - 48.6) in this population. 
Bread was identified as the single food item that provided the greatest contribution to 
total dietary (non-discretionary) sodium intake, particularly in the black sub-sample. 
Other important food sources of sodium in black subjects included meat products, such 
as commercial meat pies, beef sausage (boerewors) , and processed meats (polony, 
vienna, salami, ham, other sausages), as well as soup powders and margarine (brick). 
Together, these food items made up 64 % of total non-discretionary salt intake. In white 
subjects, a much more varied intake of individual food items was found, demonstrated by 
the much lower percentage of Na intake contributed by 20 foods (57.0 %), compared to 
mixed ancestry (63.2 %) and black subjects (75.2 %). Important differences in this group 
were that breakfast cereals made a substantial contribution to Na intake (fourth and fifth 











top twenty foods list. Dietary information such as this provides the basis for the targeting 
of specific commonly eaten foods in population-based non-pharmacological approaches 
to lowering blood pressure. 
Secondary analyses of four regional dietary datasets from other South African populations, 
reported here for the first time, have demonstrated an urban/rural difference with regard to 
the contribution of food groups to total, non-discretionary Na intake in the diets of the black 
population. The bread and cereals food group contributes over 70 % of Na intake in rural 
areas,19-22 while in black South Africans in urban Cape Town (present study and BRISK 
study23.24) this food group provides between 48.6 and 53.4 % of total Na intake. This 
suggests that rural dwellers have a less varied diet than do their urban counterparts. The 
meat and meat products food group provides double the amount of total non-discretionary 
salt intake in urban, compared to rural black subjects (10 % and 20 %, respectively), which 
probably reflects a higher purchasing P9wer of these more expensive food items in the 
urban centres. No clear time trend in dietary patterns of salt intake from food sources is 
evident in black urban dwellers. The proportion of sodium provided by the" meat and meat 
products" and the "milk and milk products" groups was higher in white rural South Africans 
in the CORIS study conducted in 197925-27 (41.2 %), compared to the present (2002) sub­
group of white subjects (30.6 %). 
In terms of absolute amounts of habitually ingested sodium from non-discretionary sources, 
the lowest reported intakes are found in rural black subjects (759 - 1 070 mglday), followed 
by urban black subjects (1 258 - 1459 mg/day), mixed ancestry subjects (1 761 mg/day) 
and then white subjects (1 922 - 2 293 mg/day). This finding suggests a greater reliance on 
processed foods by white South Africans, compared to the black population, in which maize 
meal (naturally low in sodium) remains the staple food item. 
Subjective reporting of dietary intake is the tool most frequently used by the dietitian to 
determine baseline habitual intakes and to assess compliance of patients with dietary 
advice. Fifty-three percent variation was found, on average, between individuals for 
reported sodium intake, whereas in ah individual, his/her reported dietary intake of 
sodium over a three-day period differed on average by 44 %. Variations are similar for 
calcium intake, but lower for reported potassium and magnesium intake. In large 
I 
epidemiological surveys, a single 24-nr dietary recall is commonly used to assess 
nutrient intake. In this regard, our data ;demonstrate that the inter-individual variation in 
reporting of sodium intake, using a single 24-hr recall, can be as much as 71 % in white, 



















required in order to obtain a reliable estimate of usual Na intake. Indeed, it has been 
estimated that 81 days of dietary recording would be required to estimate an individual's 
intake within 10 % of the observed mean.31 Our data is similar to previously reported 
estimates of high intra- (45 %) and inter- (45 - 56 %) subject variability for reporting of 
non-discretionary sources of Na (Le. salt intake which excludes table salt and salt added 
in cooking).31 Simple questions on habitual salt intake which are often included in studies 
as proxy measures for the true salt intake (e.g. salt taste preferences and the practice of 
adding salt to foods before tasting) were not found to be useful in distinguishing between 
either urinary Na excretion or reported dietary Na intake values in the present sample 
(see Chapter 3 - page 56). 
As well as sodium intake, this study also investigated food sources of other nutrients 
known to be important in the diet-blood pressure relationship, namely potassium, calcium 
and magnesium. 
In order to achieve a daily K intake of 4 700 mg per day, the DASH diet2 recommends 
the consumption of 4 - 5 servings of fruit (providing about 620 - 780 mg Klday), as well 
as 4 - 5 servings of vegetables per day (860 - 1070 mg Klday). In the present study, the 
amount of K provided by fruits equates to only 1 - 2 servings daily, while potassium 
consumption from the vegetables group equates to less than one vegetable serving 
daily. Mean intake of root vegetables, including potatoes, contributed an additional 
vegetable serving to K intake, but overall K intake remained less than half of the amount 
included in the DASH diet.1 Foods which were the single-most main contributors to total 
K intake across all three ethnic groups were coffee and tea, bread, milk and potatoes. 
The only published South African intervention study of potassium supplementation, 
conducted in 32 hypertensive black women, found that an additional 65 mmollday of 
potassium chloride (Le. 2 535 mg K - the amount which would make up the DASH diet 
deficit) reduced blood pressure by 7/3 mmHg over a 6-week period.32 
Regarding calcium intake, our findings are similar to those reported in a study of older 
Chinese vegetarians who were habitually consuming a diet rich in sodium but deficient in 
calcium, and who had similar reported dietary calcium intakes to the black group in the 
present study.33 Calcium intakes across all three ethnic groups were much lower than the 
recommended daily intakes.34 Intake of dietary salt, as well as protein and caffeine, 
aggravate obligatory urinary calcium loss.35 It is noteworthy that the addition of oral 
potassium citrate (90 mmollday) to a high-salt diet (225 mmol Na/day) has been shown 
to prevent an increased urinary calcium excretion in posmenopausal women. 36 Our 
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findings suggest that the benefits of sodium restriction, together with an increased intake. 
of potassium-rich fruits and vegetables, on blood pressure may be greatest in the black 
and mixed ancestry South African populations, in light of their extremely low calcium 
intakes. 
An alternative approach would be to encourage an increased intake of calcium-rich 
foods. As expected, the main source of calcium intake in the present study was the milk 
and milk products food group, and a similar contribution to total calcium intake from this 
food group was found across all three ethnic groups. Nationally representative estimates 
of usual food consumption of the South African population have been undertaken by 
Steyn and colleagues using data from existing dietary surveys.18 The authors reported 
that 30.6 % of the adult population consume items from the milk and dairy products food 
group, and average consumption (of consumers) is 239 g per day which equates to 
approximately one serving, providing around 280 mg Ca per day.18 
In order to promote an increased intake of dietary calcium, it is necessary to identify 
which foods are rich sources thereof in the target population. This is in keeping with the 
food-based dietary guidelines approach proposed by the Food and Agricultural 
Organization and the World Health Organization (1998),37 and recently adopted by South 
African Department of Health for the purpose of nutrition education in the country.38.39 
Maas (fermented, sour milk - commercially available) was the highest single contributor 
of calcium in our black sample and was consumed by over a quarter of the sample. As 
well as milk and cheese, bread was an important contributor of calcium intake in all three 
ethnic groups (13.8 % - 16.2 %). 
In our analyses (including secondary analyses of other dietary datasets) of the proportion 
of individuals consuming the recommended number of servings from the various food 
groups according to the DASH diet principles,2 we found a marked difference in dairy 
product intake between ethnic groups in the country. Mean frequency of intake from this 
food group was 3.1 - 4.3 times per day in white samples, compared to 0.9 to 1.1 times a 
day in black urban dwellers, and less than once a day, on average, in black rural groups. 
Over 70 % of the white samples consumed dairy products two or more times a day, but 
this number dropped to 15.4 - 29.5 % iril black South Africans in urban areas, and was 
0.9 - 5.8 % for black communities in rura,l areas. A limitation of our analyses is that in the 
secondary analyses of only reported frequency of intake was considered, rather than 
calculation of average number of servin£)s according to pre-determined portion sizes. An 


















cereals food group. The black sample in Cape Town had an average intake of 499 g/day, 
compared to 280g per day for their white counterparts, however average reported 
frequency of consumption was similar between groups (2.61 and 2.80, respectively). 
This is probably explained by larger portions of maize meal (staple food) being 
consumed by the black population than bread, rice, pasta or breakfast cereals in the 
white group. The analysis does however provide insight into dietary trends across area 
of residence (urban/rural) and according to ethnic and cultural preferences. 
The role of magnesium in the prevention of hypertension is considered to be small and 
probably not of public health importance. A meta-analysis of trials of magnesium 
supplementation found a pooled estimate effect of a reduction in systolic BP of only 0.6 
mm Hg (95 % CI: -2.2 to 1.0 mm Hg). and no effect on diastolic blood pressure.40 
However. few of the studies were conducted in the higher dose range of magnesium (20 
to 40 mmol per day). An inverse dose-response was observed; each 10 mmol/day 
increase in magnesium dose was associated with reductions of 4.3 mm Hg and 2.3 mm 
Hg in systolic and diastolic blood pressure, respectively. In South Africa. a significant, 
inverse association between both serum and erythrocyte magnesium and blood pressure 
has been reported in urban black male labourers in Johannesburg.41 To date, no 
supplementation trials of magnesium have been conducted locally. 
In all ethnic groups in the present study magnesium intake was low (43.7 - 67.9 % had < 
67 % DRI) and, on average, only about half of the amount of 500 mg/day which is 
achieved by the DASH diet. 2 No differences in magnesium intake were found between 
black and white subjects, however in black subjects, a greater proportion of dietary 
magnesium is provided from the bread and cereals group than in either of the other two 
ethnic groups. The most important individual food items in this regard. in the black sub­
sample, are bread (24.5 % total Mg) and maize porridge and dishes (19.5 %). 
Since compliance with advice to restrict dietary sodium in adults. over the long term, 
appears to be poor,42 it has been proposed that the only effective way to lower salt intake 
on a population level is through the reduction of the sodium content of processed foods. 
The findings of the present study have identified that bread is the obvious food to be 
targeted in order to achieve a reduction in total sodium intake in the South African 
population. 
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The findings of this study demonstrate that the cereals food group is the largest 
contributor to non-discretionary Na intake, and bread is the single food item which 
provides the highest proportion of Na in the diets of South Africans, particularly in the 
black population. It is recommended that the food industry be lobbied to lower the 
sodium content of bread, while simultaneously increasing K, Mg and possibly Ca, and 
that the impact of this intervention on blood pressure be tested in randomized controlled 
trials. 
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Development and validation of a 












Epidemiological studies demonstrate that the prevalence of hypertension and its 
associated cardiovascular consequences are directly related to the level of dietary salt 
intake in societies throughout the world in whom the intake is above a level of 50-100 
mmol/day.1 It has been estimated, in a meta-analysis of the contributions of behavioural 
factors to the prevalence of hypertension in Finland, Italy, the Netherlands, United 
Kingdom and USA, that a high sodium (Na) intake makes the second largest contribution 
to hypertension (after being overweight). with population attributable risk percentages 
(PAR%) of between 9 and 17 %.4 
In order for advice to reduce salt intake to be targeted to those with excessive intakes, 
reliable estimations of habitual intake are required. Accurate assessments of salt intake 
are also necessary in epidemiological surveys and clinical trials in which diet-blood 
pressure associations are being investigated. The INTERSAL T study demonstrated that 
in order to assess diet-blood pressure relationships, high-quality dietary information is 
required, together with controlling of multiple confounding variables, modern multivariate 
methods of data analyses, and correction of observed associations for within-person 
variation in intake.2 
Measurement of dietary sodium, either on a population or individual level, is fraught with 
methodological difficulties. High intra- (45 %) and inter- (45 - 56 %) subject variability for 
reporting of non-discretionary sources (Le. salt intake which excludes table salt and salt 
added in cooking) has implications for the reliability of food record estimates. It has been 
estimated that 81 days of dietary recording would be required to estimate an individual's 
intake within 10 % of the observed mean.3 For this reason, the gold standard for 
assessment of salt intake is considered to be analysis of repeated 24-hour urinary Na 
estimations. However this method is not useful for large, community-based studies since 
it is time-consuming, inconvenient to the individual performing the collections, and under­
collections of urine are commonplace. In addition, urinary Na estimations will not identify 
specific dietary sources of salt. A simple method to estimate population mean levels of 
24-h urinary Na excretion from spot urine specimens collected at any time has been 
developed by Japanese investigators.4This method may be useful for comparing dietary 
Na intakes between different populations, as well as indicating annual trends of a 
particular population, but is not appropriCjte to estimate individual intakes. 
There have been various attempts at developing short questionnaires for classifying 





















abstinence from use of table salt is strongly correlated with actual behaviou~ but this is 
only useful in identifying practices relating to discretionary salt use. The unique dietary 
features of a population group limits the applicability of an instrument developed in 
another ethnic group, in which food availability and food preferences may substantially 
differ. In developing countries, reliance on processed foods may be relatively less than in 
more developed countries, a factor which would further affect total salt intake 
estimations. 
This aim of this study was to develop and validate a short, food frequency-type 
questionnaire to assess habitual dietary salt intake in South Africans and to enable 
classification of individuals into desirable and excessive categories of intake. 
Methods 
A systematic 8-step approach was undertaken to develop and validate a questionnaire­
based instrument to assess habitual sodium intake. Approval for all components of the 
study was granted by the Research and Ethics Committee of the University of Cape 
Town, and written informed consent was obtained from all participating subjects. 
Step 1: Identification of food categories to be included in the salt intake 
questionnaire 
To ensure construct validity of a questionnaire to assess dietary salt intake in the South 
African population, reported dietary intake of a multi-ethnic sample was used as the 
basis for identification of food categories to be included in the questionnaire. Three 
repeated 24-hr dietary recalls were conducted in a sample of 325 men and women from 
three different South African ethnic groups (black, mixed ancestry and white), aged 
between 20 and 65 years, who were recruited from their place of work at the Cape Town 
City Council offices in central Cape Town. Since a salt intake questionnaire will most 
likely be used either in clinical practice to determine intake in people who are 
hypertensive, or for preventive health promotion purposes on a public health level, it was 
necessary to include both hypertensive and normotensive individuals. The study design 
aimed to recruit equal numbers of hypertensive (BP ;;::140/90 mm Hg and/or on 
antihypertensive medication) and normotensive (BP <140/90mm Hg) men and women (n 
=150 in each group; 50 from each ethnic group). A total of 180 hypertensive and 145 
normotensive subjects were included in the final sample. Subjects were required to 
collect three 24-hour urinary volumes over a consecutive 3-week period, to correspond 

















tablets (450 mg/day) of non-metabolizable para-aminobenzoic acid (PABA; Laboratories 
for Applied Biology, London) were given to the subjects, to be taken with meals during 
9
the collection period. Urinary electrolyte concentration was measured using flame 
photometry and PABA measured calorimetrically. 
All individual food items which were consumed by more than 5% of the sample and 
which contributed at least 50 mg Na per serving of that item (i.e. average portion of 
consumers) were included in the draft questionnaire. Food items were combined into 42 
categories which included both food sources with inherent Na, such as milk, as well as 
those food items with a high added salt content, such as processed meat. The remaining 
items which fitted the inclusion criteria were combined into an "other" category. 
Step 2: Determination ofportion sizes of foods included in food categories 
Average serving sizes of the various items included in the 42 food categories was 
determined using data obtained from the three repeated 24-hr recalls, as well as from 
data previously obtained from secondary analyses of other dietary surveys undertaken in 
adult South Africans.1o.11 The surveys included in the secondary analyses all utilized a 
24-hour recall method, and included two studies of rural black subjects (Lebowa (1998; n 
= 292; age = 10 - 25 yrs)12.13 and Dikgale (1992; n =209; 19 + yr)14.15), a study of urban 
black residents in Cape Town (BRISK study: 1990; n = 1 243; 10 - 89 yr)16.17 and a study 
of white subjects in the Western Cape (CORIS study: 1989; n =1 784; 15 - 99 yr).18.19.20 In 
certain cases, common standard serving sizes of foods was assessed using the MRC 
Food Quantities Manual.21 
Step 3: Calculation of daily Na intake from questionnaire 
After perusal of many different food frequency questionnaire layouts, and due to the fact 
that some food items which are relatively low in sodium may be consumed very 
frequently (ie. more than once a day) and thus significantly contribute to overall Na 
intake, a possible range of 6 frequency responses were included in the questionnaire: 
Never; 1- 3 times per week; 4 - 6 times per week; once per day; twice per day; and 3 + 
times per day. Retrospective analyses were conducted on the repeated 24-hr recall data 
in order to assign one of these frequen~y factors to each of the 42 food categories for 
each subject. The average number of times ("times") a specific food is consumed daily 
per subject, calculated from data obtained in the three 24-hr recall periods was 





















The factors used to determine intakes, according to the frequency categories used in the 
final questionnaire, was calculated from the intake data obtained by the three repeated 
24hr recalls, as shown in Table 1 below: 
Table 1 
Average number of times that foods categories were consumed over three days, according 
to frequency categories used in the questionnaire 
Category of frequency of consumption in No. average times consumed by 
questionnaire subject in 3 repeated 24 hr recalls 
("times") 
1 - 3 times per week > 0 and <0.5 
4 - 6 times per week ;::: 0.5 and < 0.9286 
Once per day ;::: 0.9286 and < 1.5 
Twice per day ;::: 1.5 and < 2.5 
Three or more times per day ;:::2.5 
Absolute amounts of Na per serving size used for a single representative food in each of 
the 42 categories included in the final questionnaire were calculated from MRC Food 
Composition Tables.22 This amount (in mg) was multiplied by the frequency factor that 
each individual reported, in order to arrive at a total daily Na intake for each subject. 
Step 4: Reliability of the questionnaire 
Alternative~form reliability: This is assessed by measuring the same objects by two 
instruments that are designed to be as nearly alike as possible. A low degree of 
response similarity may reflect either an unreliable instrument or non-equivalent forms. 
To further investigate construct validity with regard to the grouping of food items in the 42 
food categories and the portion sizes used for the reference food items in each category, 
Spearman correlation coefficients were calculated between Na intake of individual food 
categories in the draft questionnaire, reported Na intake from repeated 24-hr recalls and 
24-hr urinary Na excretion. The correlation between the overall Na content of the 
questionnaire (total of 42 food categories) was compared with total reported Na intake 
from the 24-hr recall data (using 43 food groupings, including the 'other' category). 
Internal consistency/Internal-comparison reliability: This involves comparing the 
responses among the various items on a multiple-item index designed to measure a 
homogeneous concept. This is estimated by the inter-correlation among the scores of 
the items on a multiple-item index. All items on the index must be designed to measure 
the same thing. The Cronbach Alpha test (coefficient alpha) was also conducted for Na 
content of the various categories included in the questionnaire. This test produces the 











measurement instrument. Results can range from 0 to 1; a value of 0.6 or less is usually 
viewed as unsatisfactory. This indicates how the 42 food groupings perform in 
relationship to each other. 
Step 5: Ensuring criterion validity of the questionnaire 
Concurrent validity, a form of criterion validity, is the extent to which one measure of a 
variable can be used to estimate an individual's current score on a different measure of 
the same, or closely related variable. 23 To demonstrate concurrent validity, habitual 
urinary Na excretion was compared across tertiles of dietary Na intake, estimated using 
the questionnaire. Stanines (Le. 9 categories) of Na intake, assessed from the 
questionnaire, were also calculated and mean daily urinary Na was compared across 
various combinations of stanines. 
Step 6: Determination of a scoring system 
The· questionnaire uses the actual Na content value for each reference food item 
(according to its corresponding average serving size) in the 42 food categories. The Na 
content is multiplied by the frequency factor. The complexity of this scoring system would 
probably limit its widespread use by clinicians and academics, therefore a simpler 
scoring system, based on rounded integers for each food category, was devised. 
Step 7: Inter-rater reliability of the questionnaire 
I 
A reference cut-off value which equated to greater or less than 6 g salt/day was assigned 
to the questionnaire score. Using the cut-off scores for the questionnaire, and comparing 
these categories with 24-hr urinary Na concentrations of either <= 2 400 mg Na/day and 
> 2 400 mg Na/day, a kappa statistic was calculated. Sensitivity and specificity of the 
questionnaire was determined, as well as positive and negative predictive values. 
Step 8: Validation of the questionnair~ in another sample 
The objective of this step was to ensure reliability by means of internal consistency on an 
independent sample of the target group. The questionnaire was administered in a 
convenience sample of 80 black hypertensive South African subjects with mean age of 
61.7 (7.9) years, ranging from 50 - 76 years. All subjects were taking anti-hypertensive 
medication and were attending primary <hare facilities in Langa (a peri-urban township of 
Cape Town) for treatment of their hypertension. Subjects completed the salt intake 
questionnaire on one occasion and cbmpleted three interviewer-administered 24-hr 




















one week apart, according to the same methodology as described above for the original 
validation sample. 
Results 
Determination of food items and food groupings to be included in the 
questionnaire 
The various food items which were included in each of the 42 categories, the reference 
food item for each category, together with the accompanying serving size and Na 
content, are shown in Table 2. Throughout the results, the Na content of the 
questionnaire = sum of absolute Na intake per day for reported frequency of intake of 
food items from each of the 42 food categories. In order to simplify the scoring system of 
the questionnaire for future use in clinical practice or in dietary surveys, absolute 
amounts of Na per serving for each food category were divided by 50 and rounded to the 
nearest integer. 
In order to demonstrate that the food categories derived from the 24-hr recall data were 
valid for the purpose of estimating habitual Na consumption, internal consistency was 
assessed using Spearman correlations between the Na content of each of the food 
groups and total Na intake of the 24-hr recall data (Table 3). 
It is important to note that actual reported serving sizes of food items within the 
groupings was used for the purpose of this analysis (not the single assigned serving size 
of one reference food per category, as in the questionnaire). Positive and Significant 
correlations were found all of the food groups except the following: minimally processed 
breakfast cereal; crackers; roti/samoosa/springroll/doughnut; pizza; battered dipped 
chickenl chicken patties; gravy; maas; yoghurt; tinned fish; canned vegetables/baked 
beans; chutney; savoury sauces and marmite/bovril. A possible reason for a low 
correlation may be that some of these groups, such as breakfast cereal, maas and 
yoghurt may be associated with a healthier diet. Thus, individuals who consume large 
quantities of these food items may consume less of the foods that are higher in Na (such 
as bread, cookies, pies etc). Alternatively, few subjects may be consuming these items, 




















Food categories, index food items, serving size and Na content of each category included 
in the questionnaire 
Food category Index food Serving Serving Na Na Na 
size (g) content! content! Scor. 
100g serving 
BREAD AND GRAIN PRODUCTS 
1.white bread or rolls/croissants/pita breadl White bread 3 slices 75 490 367.5 7 
bread crumbs 
2.Brown & wholewheat bread or roils/health Brown bread 3 slices 90 451 405.9 8 
bread 
3.Breakfast Cereal: cornflakes/rice crispiest all Cornflakes 1 large 40 1211 484.4 10 
bran/hi bulk fibre bran/pro nutro/frosties/puffed bowl 
corn/special K 
4.Minimally processed Breakfast cereal: Weetbix 2 50 165 82.5 2 
weetbix, muesli, puffed wheat weetbix 
5.Provita/ crackers/rye bread and Pro Vita 5x6g 30 710 213 4 
crispbread/matzos crackers 
6.Cookies, rusks Commercial 3 x 10g 30 410 123 2 
plain biscuits 
7.Cake/scone! muffin! puddings(baked and Muffin, plain 1 unit 70 130 91 2 
instant)/ pancake / tarts/sweet breads and 
buns/semolina! koeksister/ 
8.RoW samoosa /springroll/ doughnuU DOL!ghnut, long, 130 90 230 207 4 
savoury tart! dumplings plaih mm 
9.Pizza Pizza Y:! unit 170 570 969 19 
10.Pasta /noodles dishes with cheese Mayaroni & 21adles 150 168 252 5 
(lasagne/ macaroni cheese/noodle Cheese, 
salad/spaghetti bolognaise) white sauce 
tyPE;! 
11.Popcorn Popcom, 2 cups 40 1940 776 16 
plain, salted 
12.Potato crisps/ Niknaks/Chipkins Pot~to Small 30 1000 300 6 
Crisps packet 
MEAT AND MEAT PRODUCTS 
13.Sausage boerewors Boerewors Average 100 805 805 16 
thick 
piece 
14. Processed, smoked, cooked and canned Polony Homecut 60 1019 611.4 12 
meat (Polony/salami/harnlcanned corned slice 
meaUvienna/bacon/frankfurter/luncheon meat) 
15.Meat or chicken pies, sausage rolls Steak and Commer­ 140 460 644 13 
Kidney pie cial pie 
16.Chicken burger patties and tried, battered Kentucky Thigh 100 292 292 6 
chicken dipped in batter dip (KFC etc.) 
17. Meat and meat dishes (minced beef, 
fried chicken 
Me9tballs Ladle 105 97 101.85 2 
cottage pie, meatballs, stew, chicken stew) 
18.Gravy, made with stock or gravy powder Brown gravy Level 35 4893 1712.55 34 
powder, ladle 
recGnstituted 
1 9.Biltong(beet, game, fish), dry beef sausage Biltong Short 60 2213 1327.8 27 
piece 
DAIRY PRODUCTS I EGGS 
20.Milk (all types, dairy fruit juice, malted milk, Full cream Y:! cup 120 48 57.6 
milk shakes, drinking chocolate, evaporated mil~ 
and condensed milk) 
21.Maas/sour milk! buttermilk Ma~s Small 500 71 355 7 
carton 



























24.Eggs (any preparation - boiled, fried, Egg fried in 1 egg 50 120 60 
scrambled, omelette) sun oil 
FISH 
25.Tinned fish (pilchards, tuna, salmon, Tuna canned % cup 100 338 338 7 
mackerel) in water 
26. Other fish and seafood (shrimp, Fish, Medium 120 94 112.8 2 
perlemoen, calamari, oyster, mussel, crab, medium fat, piece 
fish cake, battered fish, fish fingers, fish paste) fried in sun 
oil 
VEGETABLES/PULSES 
27.French fries and potato salad French Fries 1.5 120 198 237.6 5 
house hoi 
d serving 
28.Baked beans, canned vegetables, tomato Beaked Heaped 100 397 397 8 
paste, olives (canned) beans in ladle 
tomato 
sauce 
29.Soup (all types) Average Large 250 431 1077.5 22 
soup mug 
VEGETABLE OILS 
30.Salad dressing/mayonnaise Mayonnaise Level 15 755 113.25 2 
dessert-
spoon 
31.lce cream (sorbet or dairy) Soft Serve Large 150 61 91.5 2 
(13% Fat) serving 
32.Margarines, all types, butter, Sutro Brick Heaped 10 805 80.5 2 
margarine teaspoon 
CONDIMENTS, SPREADS AND OTHER 
33.Chutney / atchar/ worcester sauce Fruit chutney Heaped 30 811 243.3 5 
Tbs 
34.Savoury sauces (mushroom, pepper, Mushroom 2 level 40 575 230 5 
cheese, white) sauce Tbs 
35.Tomato sauce Tomato Level 20 582 116.4 2 
sauce Tbs 
36.Salt lodised salt Pinch 1 38850 388.5 8 
37.Aromat / seasoning /mustard Aromat 1 serving 1 24030 240.3 5 
38.Peanuts (salted, unsalted, raw) Salted Handful 30 433 129.9 3 
Peanuts 
39.Peanut butter Peanut Heaped 12 478 57.36 
butter teaspoon 
40.Marmite / SovrillFray Sentos Marmite 5ml 5 4500 225 5 
teaspoon 
41.Chocolate sweets/chocolate sauce Chocolate Average 40 165 66 1 
Bars bar 











Association between average Na content per individual food category and average total Na 
content (all items consumed) of 3 x 24-hr recalls 
Food category Spearman 
Correlation 
coefficient (r) 
1. White bread/rolls 
2. Brown bread/rolls, 
3. Breakfast Cereal (highly processed) 
4. Breakfast Cereal (weetbix, muesli) 
5. Crackers (ProVita etc) 
6. Cookies, biscuits, rusks 
7. Cake/scone/ muffin/ puddings/pancake/fruit pie/koeksister 
8. Rotil samoosa/springroll//doughnut 
9. Pizza 
10. Pasta/noodle dishes with cheese sauces (macaroni cheese, 
lasagne, noodle salad etc.) 
11. Popcorn 
12. Crisps (Simba and Niknaks etc.) 
13. Sausage (wors) 
14. Polony/satamilbacon/salami/pork suasages (processed meat, 
cooked, smoked and canned) 
15. Meat or chicken pies/sausage rolls 
16. Chicken - battered (KFC etc). and chicken burger only 
17. Meat and meat dishes (steaks, minced meat, cottage pie, mince, 
meatballs, stew, bobotie, etc.) 
18. Gravy, made with stock or gravy powder 
19. Biltong/dry wors/bokkems 





25. Tinned fish (pilchards/tuna, etc.) 
26. Other fish and seafood 
27. Potato chips/french fries and potato salad 
28. Canned vegetables, incl. Baked beans, tomato paste, sweetcorn. 
29. Soup (all types) 
30. Salad dressing/mayonnaise 
31. Ice cream (all types) 
32. Margarines, all types, also butter and Butro 
33. Chutney/ atchar/chakalaka / worcester sauce 
34. Savoury sauces (mushroom, monkey gland, white,cheese) 
35. Tomato sauce 
36. Salt - Not included in 24-hr data 
37. Aromat I Fondor Imustard 
38. Peanuts 
39. Peanut butter 
40. Marmite/Bovril 
41. Chocolate sweets and sauce 
42. Beer and cider . 






















































Reliability of the questionnaire 
Alternative-form reliability 
Table 4 shows Spearman correlation coefficients between Na intake of individual food 
categories in the questionnaire (using the determined serving size of the single reference 
food item per category as shown in Table 2), reported Na intake from repeated 24-hr 
recalls and mean daily urinary Na excretion. The very high correlation coefficients 
indicate a similar behaviour between the questionnaire and the actual 24-hr recalls. Only 
8 of the food categories were significantly associated with urinary Na (cookies; popcorn; 
processed meats; meat and meat dishes, fish (not tinned fish), canned vegetables; 
Aromat; and peanuts). 
Table 4 
Spearman correlation coefficients between Na intake of individual food categories in 
questionnaire, reported Na intake from repeated 24-hr recalls and 24·hr urinary Na excretion 
Individual food category Questionnaire vs Questionnaire Repeated 24­
repeated 24·hr vs urinary Na hr recalls vs 
recalls (per food urinary Na 
category) 
1. White bread/rolls 0.915*** 0.011 -0.013 
2. Brown bread/rolls, 0.966*** 0.020 0.025 
3. Breakfast Cereal (processed) 0.983*** 0.069 0.069 
4. Breakfast Cereal (weetbix, muesli) 0.989*** 0.036 0.032 
5. Crackers (ProVita etc) 0.997*** 0.037 0.042 
6. Cookies, biscuits,rusks 0.988*** 0.132* 0.129* 
7. Cake/scone/ muffin/ puddings/pancake/fruit 0.977*** 0.014 0.024 
pie/koeksister 
8. Rotil samoosa/springroll//doughnut 0.992*** -0.071 -0.071 
9. Pizza 0.999""* 0.080 0.080 
10. Pasta/noodle dishes with cheese sauces 0.999*** 0.110 0.110 
(macaroni cheese, lasagne, noodle salad etc.) 
11. Popcorn 0.999*** 0.128* 0.127* 
12. Crisps (Simba and Niknaks etc.) 0.992*** -0.079 -0.075 
13. Sausage (wors) 0.995*** -0.005 -0.006 
14. Polony/salam i/bacon/salam i/pork suasages 0.955*** 0.122* 0.119* 
(processed meat, cooked, smoked and 
canned) 
15. Meat or chicken pies/sausage rolls 0.995*** -0.010 -0.008 
16. Chicken - battered (KFC etc). and chicken 0.999*** 0.036 0.033 
burger only 
17. Meat and meat dishes (steaks, minced 0.760*** 0.121* 0.102 
meat, cottage pie, mince, meatballs, stew, 
bobotie, etc.) 
18. Gravy, made with stock or gravy powder 0.999*** 0.088 0.087 
19. Biltong/dry wors/bokkems 0.999*** 0.112 0.113 
20. Milk (all types, also dairy fruit juice, malted 0.781 *** -0.011 0.016 
milk, milk shakes) 
21. Maas 0.999*** 0.022 0.025 
22. Cheese 0.953""" 0.077 0.047 
23. Yoghurt 0.997*** 0.043 0.044 
24. Eggs 0.981*** 0.003 0.004 
25. Tinned fish (pilchards/tuna, etc.) 0.994....* 0.071 0.076 
26. Other fish and seafood 0.983*** 0.118* 0.125* 











Individual food category 	 Questionnaire vs Questionnaire Repeated 24­
repeated 24-hr vs urinary Na hr recalls vs 
recalls (per food urinary Na 
category) 
28. Canned vegetables, incl. Baked beans, 
tomato paste, sweetcorn, etc. 
29. Soup (all types) 
30. Salad dressing/mayonnaise 
31. Ice cream (all types) 
32. Margarines, all types, also butter and 
Butro 
33.Chutney/atchar/chakalaka/worcester sauce 
34. Savoury sauces (mushroom, monkey 
gland, white,cheese) 
35. Tomato sauce 
36. Salt 
37. Aromat / Fondor /mustard 
38. Peanuts 
39. Peanut butter 
40. Marmite/Bovril 
41. Chocolate sweets and sauce 






























***P<O.0001; **P<O.005; * P<O.05. 
Internal consistency/internal comparison reliability 
Spearman correlations were conducted between the Na content of each of the food 
categories and the overall Na content of the total questionnaire (Table 5). The Spearman 
correlation coefficient for the Na content of the total questionnaire (N = 42 categories) 
and the repeated 24-hr Na data was r = 0.683 (P <0.0001) (N = 328). Regarding urinary 
Na excretion, the association with total questionnaire Na was r = 0.173 (P = 0.0034) 
(n=284). The 24-hr recall data, which included the remaining reported food items in a 
very large "other" food group, did not perform better against the urinary Na data (r = 
0.141 (P = 0.0174); N = 284). Spearman correlation coefficients for the questionnaire 
score (ie. Na content divided by 50 and rounded to nearest integer) vs repeated 24-hr 
recall Na data was r = 0.684 (P<0.0001) and for questionnaire score vs urinary Na was r 
= 0.171 (P = 0.0039). 
The overall standardized Cronbach-a coefficient between the total questionnaire Na 
content and that calculated from the mean of 3 repeated 24-hr recalls was less than 
acceptable (ie. < 0.6) at 0.443. Cronbach-a coefficients for each of the individual food 
categories is shown in Table 5. Nine food categories had undesirable Cronbach-a 
coefficients which exceeded the overall coefficient of 0.443. Four of these nine 
categories were also not significantly c~rrelated with total Na content of 3 x 24-hr recalls 












Internal consistency of questionnaire: Na content of individual food categories compared 
to repeated 24-hr dietary recall values 
Individual food category 
1. White bread/rolls 
2. Brown breadlrolls, 
3. Breakfast Cereal (processed) 
4. Breakfast Cereal (weetbix, muesli) 
5. Crackers (ProVita etc) 
6. Cookies, biscuits,rusks 
7. Cake/scone/muffin/puddings/pancake/fruit pie/koeksister 
8. Roti/ samoosa/springroll//doughnut 
9. Pizza 
10. Pasta/noodle dishes with cheese sauces (macaroni 
cheese, lasagne, noodle salad etc.) 
11. Popcorn 
12. Crisps (Simba and Niknaks etc.) 
13. Sausage (wors) 
14. Polony/salami/bacon/salami/pork sausages (processed 
meat, cooked, smoked and canned) 
15. Meat or chicken pies/sausage rolls 
16. Chicken - battered (KFC etc). and chicken burger only 
17. Meat and meat dishes (steaks, minced meat, cottage pie, 
mince, meatballs, stew, bobotie, etc.) 
18. Gravy, made with stock or gravy powder 
19. Biltong/dry wors/bokkems 





25. Tinned fish (pilchards/tuna, etc.) 
26. Other fish and seafood 
27. Potato chips/french fries and potato salad 
28. Canned vegetables 
29. Soup (a" types) 
30. Salad dressing/mayonnaise 
31. Ice cream (all types) 
32. Margarines, all types, also butter and Butro 
33. Chutney / atchar/chakalaka / worcester sauce 
34. Savoury sauces (mushroom, white, cheese) 
35. Tomato sauce 
36. Salt 
37. Aromat / Fondor /mustard 
38. Peanuts 
39. Peanut butter 
40. Marmite/Bovril 
41. Chocolate sweets and sauce 
42. Beer and cider 
43. Other foods (not included in final questionnaire) 
Spearman 
correlation with 




























































































t Excluding Na content of that food category. 

'Cronbach Coefficient Alpha with deleted variable larger than Cronbach Coefficient Alpha of all variables (ie. 













No difference was found between Na intake, assessed using the questionnaire and that 
reported in the three repeated 24-hr recalls, when using non-parametric measures (Sign 
test: P ;:; 0.2040; Sign-rank test: P ;:; 0.7425). 
Factor analysis identified a number of di~t pattern groupings, with regard to intake of the 
food items included in the questionnaire {Table 6). 
Table 6 
Factor analysis of dietary patterns identified by salt intake questionnaire responses 











Final communality est. = 18.09; 
White bread, margarine, beef sausage (boerewors), eggs, 
soups 
Popcorn, (3romatlfondor, roti etc., potatoes 
Tomato sauce, pasta/noodle dishes, peanuts 
Cheese, preakfast cereal (weetbixlmuesli type), crackers, 
"other" food category, biltong. 
Brown bread, milk, peanut butter, marmite/bovril 
Yoghurt, savoury sauces,· ice cream, other fish and 
seafood, potato crisps 
Canned vegs, battered/fried chicken, chutney, processed 
meat, chocolate sweets, meat dishes, mayonnaise, maas 
Pizza, cake/cookies, beer/cider, tinned fish 
Breakfast cereals, meat pies 
Cookies, gravy 
18.09/43 categories = 42 % 
Sodium intake, estimated from both the questionnaire (1221 (641); 1853 (589); and 1873 
(663)mg/day) and the r peated 24-hr recalls (1459 (890); 1761 (884); and 1922 (911) 
mg/day) differed significantly (P<0.0001) between the black, mixed ancestry and white 
ethnic groups, respectively, included in the study. 
Criterion validity of the questionnaire 
Both Na intake from 24-hr recall data an<!l urinary Na were assessed, according to tertiles 
of the Na content of the questionnaire (Table 7). Urinary Na was significantly higher for 
subjects in tertile 3, compared to those in tertile 1 (Bonferroni, P;:;0.0312; Kruskal-Wa/lis, 
P;:;0.0635). However, dietary Na intake (24-hr recall data) differed significantly across all 
three tertiles (Bonferroni, P<0.05; Kruskal Wallis p<0.0001). Questionnaire Na score also· 
differed significantly between black, mixed ancestry and white subjects (24.2 (12.8); 36.6 
• I












Mean reported daily Na intake and 24-hr urinary Na excretion, according to tertiles of Na 
content of questionnaire 
Tertile of Na content of questionnaire 
Tertile 1 Tertile 2 Tertile 3 
< 1 255 mg/day 1259-1931 > 1 935 mg/day 
mg/day 
N 
Mean Na score (Mean (SO)) 
Range 
Dietary Na intake (24-hr dietary recall) 
(mg/day) 
Mean (SO) 
Range (Min - Max) 
Urinary Na excretion (mg/day) 
Mean (SO) 
Range (Min - Max) 




1 015 (548) 
54-4007 
3049 (1 182) 





1 693 (739) 
782 - 5 409 
3514 (1 659) 




38.0 - 76.7 
2382 (836)* 
1 084 - 6 114 
3 670 (2 039)** 
1 097 -14 173 
9.17** 
*P<0.05: Difference between Tertiles 1, 2 and 3, using General Linear Models (Bonferroni test). 
**P<0.05: Difference between Tertiles 1and 3, using General Linear Models (Bonferroni test); 
Kruskal Wallis p=0.0635). 
Stanines (Le. 9 categories) of Na intake, assessed from the questionnaire, were also 
calculated. Mean daily urinary Na was compared across the combination of stanines 1, 
2 and 3 together (Group 1); 4, 5 and 6 together (Group 2); and 7, 8 and 9 together 
(Group 3). A significant difference between Groups 1 and 3 was found for urinary Na, 
using General Linear Modelling (F = 3.95; P=O.0203) (Table 8). 
Table 8 
Difference in urinary Na according to three categories created using combined categories 
of stanines (1+2+3; 4+5+6; 7+8+9) of dietary Na intake, assessed from questionnaire 
Category (combined Difference between mean 95 % Confidence Intervals 
stanines) urinary Na (mmol/day) of differences 
3 vs 2 24.20 -2.47 to 50.85 
3 vs 1 35.55 4.35 to 66.74* 
2 vs 1 11.36 -14.12 to 36.83 
* P< 0.05 for difference between categories 1 and 3 (Bonferroni test: F=3.95: P=0.0203; Wilcoxon 
test; P=0.1003). 
Since the first group differed significantly from the third group, but no difference was 
found between the first and second groups, or the second and third groups, the 
questionnaire Na intake value corresponding to cut-off point of stanine 6 (upper limit) 











added salt intake (discretionary) was not quantified in the 24-hr recall data (from which 
the questionnaire food categories were developed), it was decided to account for this by 
increasing the cut-off value of the questionnaire from 2 133 mg to 2 400 mg. This is the 
value that equates to the current international dietary guideline for the maximum 
recommended amount of salt intake per day (Le. 6 grams NaGI per day).24 This 
categorisation yielded a significant difference in urinary Na, equivalent to 145 (68) 
mmol/day (3 335 (1 564) mg/day) vs 177 (103) mmol/day (4 071 (2 369) mg/day} 
(P=0.0225) (Table 9). 
Table 9 
Mean (SO) urinary Na according to two categories of dietary Na intake, assessed from 
questionnaire 
Grouping category Mean (SO) urinary Na 95 % Confidence Intervals 
Group 1 « 2 400 mg/day) 144.9 (6$.1) mmol/day 136.4 to 153.3 mmol/day 
N = 252 3 333 (1 566) mg/day 3 137 to 3 526 mg/day 
Group 2 (;:: 2 400 mg/day) 177.5 (102.9)* mmol/day 140.4 to 214.6 mmol/day 
N = 32 4 082 (2367)* mg/day 3 229 to 4 936 mg/day 
Mean difference in urinary -32.7 (72.7) mmol/day -59.5 to -5.8 mmol/day 
1\1 a between'-'---=G..:...:ro::.c:u::J:p.;;;;.s_____--'-75.;;.;;2..:...:(.>...:1~6'_'_7_=2CL).:...:.m....,9c..;/d;..c;.a.....y____"_1...:...36-,-9-,--,-to_-_1~33_m-,",9,-/d-"a.Ly__ 
* P=O.0225 for difference between categories (one-sided Wilcoxon approximation for t-test) 
(P=O.0450 for two-sided Wilcoxon approximation t-test) 
In keeping with the simplified scoring' system (see earlier), the reference value of 
2400mg l\Ia per day (ie. 6 grams of NaGI/day) was divided by 50, yielding a value of 48 
to indicate a cut-off score for desirable versus excessive Na intake. Both reported Na 
intake and urinary Na excretion differed significantly according to this classification 
(Table 10). 
The urinary Na excretion in terms of salt (NaGI) equivalents, according to this cut-off 
value was 8.33 g and 10.21 g per day. This indicates that the two-category scoring 
system of the questionnaire is able to differentiate between excessive salt users and 













Daily Na intake and excretion, according to two categories of Na intake estimated by 
aquestionnaire, using cut-off scores 
Group 1 Group 2 
Score < 48t Score ~ 48 
N (questionnaire) 
N (urinary Na) 
Dietary Na intake 
Questionnaire score (Mean (SO» 
Questionnaire dietary Na intake (mg/day) 
Mean (SO) 
24-hr recall dietary Na intake (mg/day) 
Mean (SO) 
Urinary Na excretion (mmol/day) 
Mean (SO) 
95%CI 




1 453 (556) 
1 553 (808) 
144.9 (67.9) 





2 788 (317)*** 
2 798 (862)*** 
178.4 (104.5)* 
140.1 - 216.7 
10.26 




t Score < 48 equates to a daily Na intake of < 2 400 mg/day. 

* P <0.05; ** P< 0.0001; Wilcoxon t-test for differences between score groups. 
Inter-rater variability 

A kappa statistic of 0.0318 was found between the questionnaire cut-off scores of « 48 





Sensitivity and specificity of questionnaire 

Sensitivity is the proportion of positive results that are correctly identified by the test (in 

this case, questionnaire). The questionnaire, using the cut-off score of:2: 48 to indicate an 

excessive Na intake ("positive test result") has a sensitivity of 12.4 % (27/218) against 

24-hr urinary Na values of :2: 100 mmollday ("disease") (Table 11). SpecifiCity is the 

proportion of negative results that are correctly identified by the test (in this case, 

questionnaire). The questionnaire, using the cut-off score of < 48 ("negative test result") 




















Frequency table of questionnaire score and reference urinary Na cut·off values (Cape 
Town City Council sample; N = 284) 
Questionnaire score Urinary Na (mmol/day) Total 
~100 <100 
~48 27 4 31 
<48 191 62 253 
Total 218 66 284 
Internal consistency of the final questionnaire in a new sample of 80 black 
hypertensives 
Three complete repeated 24-hr urinary Na excretion values were available in 79 of the 
80 subjects sampled, while data for the repeated dietary recalls and questionnaire were 
available in 80 subjects. Mean daily sodium intake, estimated using the questionnaire, is 
compared with intake estimated from 3 repeated 24-hr dietary recalls in Table 12. A 
positive Spearman correlation was found between the questionnaire Na score and (1) 
total Na intake calculated from the 24-hr dietary recall data (r =0.3618; P = 0.0010) and 
(2) Na intake calculated from the 24-hr recall data for only the 42 food item categories 
included in the questionnaire (r = 0.5606; P<0.0001). No association between 
questionnaire Na score and 24-hr urinary Na was found (r =-0.0004; P =0.985). 
Table 12 
Comparison of mean daily sodium intake, estimated from repeated 24-hr recalls and 24-hr 
urinary excretion, and salt questionnaire estimates (black hypertensives; N = 79) 
Mean (SO) Range 
Questionnaire (N =80) 

Total Na intake (mg/day) 1489.6 (512.3) 448.8 - 3038.1 

Na score 41.9 (17.0) 8.57 - 59.86 

24-hr Dietary recall (N = 80) 

Total Na intake (mg/day) 1 798 (836) 426·4093 

Nascoret 29.4(10.1) 8.6 - 59.8 

24·hr Urinary Na (N = 79) 

mmol/day 172.5 (52.7) 83.5 - 344.7 

~d=a~y______________________~3~9~6~8~(1=2~1~2)~________~1~9~20~-_7~9~2~8_________ 
t Estimated using only the 42 food item categorie,s that were included in the salt questionnaire. 
Using the cut-off score of;:::: 48 to indicate an excessive Na intake ("positive test result"), 
the questionnaire had a positive predictive value of 80 % (4/5) and a negative predictive 












Frequency table of questionnaire score and reference urinary Na cut-off values (black 
hypertensives; N =79) 
Questionnaire score Urinary Na (mmol/day) Total 
~100 <100 
Regarding performance against the repeated 24-hr recalls, the overall standardized 
Cronbach-a coefficient between the total questionnaire Na content and that of the recall 
data was not acceptable (ie. < 0.6) at 0.35. The Kappa statistic between questionnaire 
score categories «48 or 2!: 48) and 24hr recall categories of Na «2 400 or 2!: 2400 
mg/day) is 0.3333. Comparing the two methods, PPV was 100 % (n = 5/5) (Le. all 5 
subjects who scored 2!: 48 on the questionnaire also had Na intakes 2!: 2400 mg from the 
24-hour recall data), while NPV was 80 % (n =60/75). 
Discussion 
Accurate measurement of sodium intake is difficult due to extensive sodium distribution 
in foods and the widespread use of sodium compounds in food processing,25,26,27 the 
extensive use of sodium chloride as table salf8and the presence of sodium compounds 
in drinking water, either as a natural phenomenon or due to some types of water 
conditioning.29 In Europe and the United States, it has been shown that about three­
quarters of Na intake comes from food processing, 10 - 11 % is naturally occurring 
(inherent) in foods, about 15 % is discretionary (half of which is contributed by table salt 
and half by added salt in cooking) while less than one percent is provided by water. 
5,27,28,29,30 
We have developed a simplified food frequency-type questionnaire to assess habitual 
salt intake using representative dietary data from three ethnic groups of the South 
African population, and from secondary analyses of dietary datasets from other large 
surveys in the country. The final version of the questionnaire was further tested for 
internal consistency in a sample of older black hypertensive patients attending primary 
care facilities for blood pressure control. As well as being able to quantify sodium intake, 
as would be required for the purpose of epidemiological surveys and clinical trials, a 
rapid scoring system was developed to enable its use in public health-related activities. 











primary care clinics but there is a lack of health promotion tools to assist clinic staff in 
empowering patients to consume a diet which is low in sodium and high in potassium.31 
Despite hypertensive patients having a good knowledge of the role of salt intake in the 
development of hypertension,31 few are consuming diets comprising less than 6g salt per 
day.32 The availability of an instrument that does not require detailed dietary records may 
be used as a motivational tool to quantify salt intake and to set targets for lifestyle 
changes within a clinic setting. 
A significant, but poor, positive correlation was found between reported Na intake, 
estimated from either the questionnairt;:l or the repeated 24-hr dietary recall data, and 
urinary Na excretion. The discrepancy t;>etween the questionnaire estimations of sodium 
and the urinary excretion values highlights the difficulty in quantifying discretionary (ie. 
added) salt intake in dietary surveys. In this study, the average of three repeated 24-hr 
recall dietary assessments were used as the basis for identifying food items and food 
categories which were significant contributors to overall salt intake in South Africans. The 
obvious under-reporting of discretionary salt intake using this method is problematic. 
Low correlations between dietary reports and urinary estimations of Na excretion have 
been reported by other authors. In a cross-over study, participants were provided with 
either a 2 000 mg or 3 500 mg sodium diet for 7 days and sodium intake was estimated 
from seven 24-hr urinary Na collections per diet period.s The urinary Na analyses were 
significantly associated with duplicate chemical food analYSis (r = 0.61), but not with 
sodium intake estimated from food compOSition tables (r =0.05). Thus, even under 
strictly controlled conditions, whereby any food not provided by the research centre was 
obtained in duplicate and accounted for, where monitoring of intake and wastage took 
place daily, and where added salt intake was carefully measured, dietary analyses did 
not correlate with urinary Na excretion. These findings suggest that dietary assessment 
methods that rely on food composition tables are unable to accurately calculate the 
sodium content of foods, probably due· to the large variation in the sodium content of 
processed foods. 
In terms of reliability of the questionnaire, only 8 of the individual 42 food categories were 
significantly associated with urinary Na :(cookies; popcorn; processed meats; meat and 
meat dishes, fish (not tinned fish), canned vegetables; Aromat; and peanuts). The 















used in its entirety. In assessing sodium intake, both the sodium density of various foods 
as well as the frequency of consumption of those foods in the population of interest 
needs to be ascertained. We included all individual food items that were consumed by 
more than 5% of the sample and which contributed at least 50 mg Na per serving of that 
item in the questionnaire. Thus, some foods, such as popcorn and salted peanuts, 
which are consumed by few individuals but which are very high in salt may have skewed 
the relationship. 
Criterion validity of the questionnaire has been demonstrated however internal 
consistency is low. A possible reason why the Cronbach-a coefficient of the 
questionnaire is low could be related to the way in which the food choices of individuals 
in the sample are grouped together. For example, factor analysis identified that white 
bread consumption was associated with margarine, beef sausage (boerewors), eggs and 
soup intake, whereas consumers of brown bread were more likely to have peanut butter 
or marmite/bovril, together with milk. 
The point of developing an instrument to measure habitual dietary Na intake is to use it 
to distinguish between individuals with high and low salt intakes. The current scoring 
system categorises individuals into either a desirable or excessive salt intake category 
and has been shown to have a very high specificity (94 %) but a poor sensitivity (12 %), 
compared to 24-hr urinary Na excretion. Only four of the 66 subjects (6.1 %) with urinary 
Na values which fell below the maximum recommended intake of 6 grams of salt per day 
(100 mmol urinary Na/day) had scores 2! 48 on the new instrument. 
It is necessary to determine what the probability is of the instrument giving the correct 
assessment. In this regard, it is useful to know the positive and negative predictive 
values of the instrument. Positive predictive value (PPV) is the proportion of subjects 
with "positive" results using the instrument (Le. score 2! 48) who are correctly determined. 
The PPV of the questionnaire indicates that, given a positive result (Le. score 2! 48), 
there is 87.1 % chance that an individual will have a urinary Na concentration above 100 
mmol/day. Conversely, the negative predictive value (NPV) is the proportion of subjects 
with "negative" results using the instrument (i.e. score < 48) who are correctly 
determined. The NPV is low - given a score of < 48 on the instrument, there is 24.5 % 
chance that the urinary Na concentration will be less than 100 mmol/day. The 
instrument, using the current reference cut-off scores, is thus much more useful to 
determine high salt intakes rather than identifying people with habitually low/desirable 












according to the proposed scoring system will result in a large number of people being 
falsely classified as having desirably low salt intakes when, in fact, their urinary Na 
concentrations indicate otherwise. 
Agreement between categorical assessments is usually considered as a problem of 
comparing the ability of different observers or methods to classify subjects into one of 
several categories. The kappa statistic has a maximum value of 1.00 when agreement 
between two methods is perfect and a value of zero indicates no agreement better than 
chance. A kappa value of <0.20 is generally considered to reflect poor agreement while 
one of >0.60 and> 0.80 indicates good and very good agreement, respectively. The low 
kappa statistic between urinary Na reference values and questionnaire score categories 
indicates that the scoring system needs further refinement. 
The two-category scoring system of the questionnaire is able to differentiate a significant 
difference in urinary Na excretion, thul!) demonstrating a degree of construct validity. 
However, the corresponding urinary values are much higher than the reference cut-off 
value of either greater or less than 6g salt per day. Data in Chapter 3 of this thesis show 
that estimated added salt intake is 4.08 g per day or 45.5 % of total Na intake. If this 
value is used as a proxy in our study, corresponding urinary Na excretion values related 
to only non-discretionary salt intake would be 4.34 and 5.92 g per day according to 
reference score categories of < 48 and ~ 48 on the questionnaire (compared to the total 
24-hr values of 8.33 and 10.30 g/day that were obtained). These values are much closer 
to the mean estimated Na content of the questionnaire that corresponds to these cut-off 
scores, namely 3.65 and 6.95 g/day. 
We further attempted to account for disGretionary salt intake by extrapolating responses 
obtained from a set of qualitative que~tions included in the same sample (data not 
shown). Subjects were asked about the use of salt and flavour enhancers (Aromat or 
Fondor) in food preparation (yes/no response); whether they usually add salt to their 
food before tasting it (yes/no response); and about their preference for a saltiness taste 
in foods (very salty/a little salty/not at all salty). If either salt or Aromat were used in food 
preparation, then an additional 389 mg Na (score = 8) or 240 mg (score = 5), 
respectively was added to the composite, Na content of the questionnaire. If subjects also 
reported that they add salt before tastill9 food, then the salt and/or Aromat estimation 
was further multiplied by a factor of 2. Jf subjects liked their food to taste either "very 
salty" or "a little salty," these amounts were multiplied by a factor of 2 and 1.5, 















if they used salt in cooking and if they had a preference for a "very salty" taste. However, 
the addition of this data to the questionnaire score did not improve sensitivity of the 
questionnaire (data not shown), nor improve the kappa statistic. It is reported elsewhere 
in this thesis (Chapter 3) that such questions are not useful to determine between high 
and low salt consumers, and that their inclusion in epidemiological surveys, as a proxy 
for more detailed information on salt intake, is not warranted. 
Internal consistency of the questionnaire was re-tested in a new sample of 80 older black 
people with hypertension in Cape Town, all of whom were receiving drug treatment for 
blood pressure control. The most commonly prescribed antihypertensive medication was 
thiazide-type diuretics which may have affected (increased) urinary Na excretion, 
irrespective of dietary intake. However, after reaching equilibrium, urinary sodium 
excretion should reflect the dietary intake of salt. Urinary Na is much higher, indeed more 
than double, that estimated either from the 24hr recall data or questionnaire assessment 
of Na. Using the same scoring system as in the original sample, in this group the PPV 
was 80 %, however few individuals (n =5) scored 2! 48 on the questionnaire. Of concern 
is the very low negative predictive value (6.8 %). It is important to note that the original 
sample in which the questionnaire was developed and the scoring categories devised 
included economically active subjects, both hypertensive and normotensive, from three 
ethnic South African groups. In Chapters 3 and 4 of this thesis it has been shown that 
the habitual reported dietary Na intake of black subjects (mean = 1 467 (891) mg/day; N 
= 110) is significantly lower than either their mixed ancestry or white counterparts. Our 
data suggests that the reference cut-off score will need to be lowered for use in this 
group. Thus, the current proposed scoring system requires further testing in larger, more 
representative samples of the black population in order to improve its ability to categorize 
between high and low salt consumers. 
Limitations of the study need to be considered. The main benefits of the salt 
questionnaire are that it is simple, requires little participant time and effort, and is easy to 
score. The questionnaire reflects sodium intake over the past 7-day period which 
includes weekend days when sodium consumption patterns may differ. However, only a 
single nutrient is being measured. The current version of the questionnaire does not 
allow provision for the testing of hypotheses about other nutrients, such as potassium, 
calcium or magnesium, either singly or interactively with sodium, in the blood pressure­
diet relationship. The more food a person consumes, the more likely they are to have a 
higher intake of sodium, unless the diet is a traditional with no access to processed 


















intake nor did it consider sodium intake as a function of estimated energy requirements, 
as other methods have attempted to do.s 
As with all food frequency questionnair,es, the checklist of included food items may not 
necessarily be inclusive of all the important sources of sodium in another sample. 
Further, the serving sizes depicted in the questionnaire were based on a combination of 
average reported intakes in the pre~ent study and data previously obtained from 
secondary analyses of other dietary surveys undertaken in adult South Africans, 
including two rural populations.1O Where possible, the serving sizes were adapted to 
represent convenient portion sizes. The instrument may require modification for sub­
populations whose food habits differ substantially from the group of urban, economically 
active adults that were included in our study_ 
Consideration needs to be given to the validity of using three 24-hr urinary collections as 
the gold standard measure against which sodium intake using the questionnaire is 
assessed. Two decades ago, Luff and Colleagues cautioned against the use of single or 
occasional 24-hour urine collections to identify biologic correlations due to the presence 
of considerable intra-individual variability.33 Uu et al. suggested that 5 to 10 overnight 
collections are needed to characterize the urinary patterns of children.34 Several factors 
may account for low correlations between the two measures. Intra-individual variability 
was high for both the measures against which the instrument was being tested, namely 
urinary Na (Coefficient of variation (CV) =33.7 %) and 24-hr dietary recall Na estimates 
(CV = 44.4 %). The use of only three repeated measurements each of dietary recalls and 
urinary collections may not have been sufficient to accurately characterise the 
individual's usual sodium intake. 
Conclusion 
A short food frequency questionnaire to assess habitual Na intake has been developed 
using repeated 24-hour dietary from a multi-ethnic, economically active South African 
sample. The questionnaire demonstrates acceptable internal consistency and criterion 
validity against the gold standard indicator of repeated 24-hr urinary Na concentrations. It 
performs as well as three repeated 24-hr recalls against urinary sodium excretion and an 
acceptable correlation was demonstrat¢d between the questionnaire and the repeated 
24-hr recalls. However, the questionnaire considerably underestimates the dietary intake 
of Na in the studied population, presumably due to the large proportion of salt intake that 
is provided from salt added by individual~. The devised categorical scoring system needs 
to show improved sensitivity_ Further validation studies of the instrument should be 
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undertaken in different geographical areas (Le. urban and rural) where local communities 
are known to have different eating patters with regard to processed foods and salt use. 
The questionnaire may be used to monitor dietary compliance in research studies but in 
its current format cannot be used to estimate habitual dietary salt intake. 
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The nutrition transition which has accompanied the rapid urbanisation in South Africa 
over the past few decades 1 has resulted in the displacement of more traditional diets in 
favour of dietary patterns which include. more meat, fish, eggs, milk, cheese, bread, 
margarine, salt, oil, sugar and other sweets, often in the form of convenience foods. 2 
Such changes in eating patterns typically lead to increased intakes of total fat, animal 
protein, sugar and salt, and decreased intakes of plant protein, dietary fibre and other 
complex carbohydrates.3 Data on urinary Na excretion values reported elsewhere in this 
thesis (Chapter 3) indicates that the black population consume on average 7.8g of salt 
per day, which exceeds the JI\JC-7 g~idelines for the management and prevention of 
hypertension of less than 6 g salt per day.4 The urinary sodium:potassium ratio of the 
same group was 2.66 which indicates a substantially higher dietary intake of sodium 
compared to potassium. 
Compliance with dietary advice to reduce salt intake is generally poor. Over the long 
term (13 to 60 months), disappointingly small reductions in blood pressure (average of 
1.1/0.6 mm Hg) are associated with dietary Na restriction advice.5 This information 
provides motivation for a population-:wide reduction in salt in processed foods, in 
collaboration with the food industry. It has been demonstrated that non-personal health 
interventions, including government action to stimulate a reduction in the salt content of 
processed foods, are cost-effective ways to limit cardiovascular disease and could avert 
more than 21 million disability-adjusted ,life years per year worldwide.s 
In order for diet-related public health attempts to reduce hypertension to be effective in a 
developing country such as South Africa, the recommended dietary pattern needs to 
involve relatively few behavioural changes, has to be affordable and sustainable long­
term, and should be culturally acceptable. It is hypothesized that a reduction in the 
sodium content of various processed foods, together with a simultaneous increase in 
potassium (thereby reducing the sodium:potassium ratio) and other cations, would lead 
to an overall reduction in blood presswe levels in the South African population. In this 
regard, earlier work in this thesis has identified commonly consumed food items that are 
major contributors to overall non-discretionary sodium intake in the diets of the three 
ethnic South African groups. 
I 
I 
As in many other countries,7,15,8 bread! is the single major contributor to dietary sodium 
intake in South Africa (see Chapter 4). Bread is a staple food commodity, eaten by the 




















and white bread are the fourth and fifth most commonly consumed food items, 
respectively, by the adult population.9 Fifty-five percent of South African adults consume 
brown bread (average serving size of consumers is 165 g/day), and 28 % consume white 
bread (average serving size is 163 g/day). 9 Bread is also an important staple food in the 
diets of South African children.10 After maize, bread is the second highest contributor of 
total energy intake (14.8 % energy) and, prior to the mandatory fortification of maize and 
bread flour which was introduced in October 2003, was already an important source of 
micronutrients (15.6 % of iron; 16.9 % of zinc; 19.5 % of niacin; and 15.6% of thiamin 
intake) in children's diets. 
In addition to bread, other food items which are important contributors to the sodium 
intake of the black South African population are brick margarine, and dry goods which 
are used to flavour dishes, such as soup mix, stock cubes, and Aromat (flavour 
enhancer, based on monosodium glutamate) (Chapter 4). The objectives of this study 
are (1) to develop reduced sodium (with increased potassium and magnesium content) 
varieties of these five food items and (2) to ensure that the technological aspects and the 
taste of the experimental products are acceptable. The novel food products will be used 
in a randomised controlled food-based trial of blood pressure reduction in the target 
population (Chapter 7). 
Methods and Results 
Methods and results are reported separately for (1) bread and (2) dry goods and 
maragrine. For bread, a two-stage approach was followed, namely "bread development" 
(Stage 1) and "bread evaluation" (Stage 2). 
(1) Bread 
Stage 1: Bread development 
The third largest producer of bread in South Africa, Sasko Milling and Baking (Division of 
Pioneer Foods), partnered academics from the South African Medical Research Council, 
to develop a variation to their standard Sasko Sam brown bread (control), which contains 
2% non-iodated sodium chloride (salt). The aim of the development was to reduce the 
sodium content by a minimum of 25 %, while simultaneously increasing the potassium, 
magnesium and calcium content. This level of Na reduction is in line with proposed new 
food labeling legislation in the country (which is currently being finalized before 













packaging of a product only if the sodium content of the product is at least 25 % lower 
than the regular variety.ll 
Based on information from the literature regarding flavour considerations, baking 
performance, physical properties and cost, the highest sodium reduction that could be 
achieved after trial and error, without compromising taste and functionality of the dough, 
was 36 %. Four different formulations for experimental breads with 36 % Na reduction 
(1.28% salt) were theoretically calculated (Table 1). One of the experimental breads had 
its salt content replaced with SOLO® Low Sodium sea salt, a salt replacement produced 
from Icelandic water, which provides 60 % less sodium than ordinary table salt (see 
Table 7 later). The remaining three bread variants included salt mixes that were 
developed in the Research and Development (R & D) laboratory of Sasko, in an attempt 
to provide a local, more cost-effective alternative mix of ion salts. In these breads, the 
0.72% salt was replaced on a molecular basis with an equal quantity of other cations, 
including magnesium and potassium. The sources of magnesium and potassium, as well 
as the ratios of various mineral salts were evaluated by trial and error experimentation 
and the final compounds selected were based on expert discretion. A blend of 
magnesium chloride (6 hydrate), potassium chloride (dry) and magnesium sulphate (dry) 
was used to reach a target magnesium and potaSSium content in the final product (see 
Table 1). The experimental products also included additional calcium carbonate to 
increase the calcium content of the final product to a target calcium content of 200 
mg/100g (Table 1). Other than the reduction of salt and increase of magnesium, 
potassium and calcium addition, the rest of the formulation was kept standard. Similar 
quantities of yeast and improvers were used in all formulations. The cereal base of 
Sasko brown bread consists of brown bread flour made up of approximately 87.5% white 
bread flour plus 12.5% bran. 
Compared to the control brown loaf, all four experimental breads formulations were found 
to be acceptable in terms of taste and baking properties. This conclusion was reached 
after tasting by seven experienced bak~rs. 
All four of the experimental breads wEire significantly more expensive than the control , 
bread. Due to cost, the bread with the Solo salt replacement was eliminated as an 
option (deviance of 30.1 cents per loaf from standard brown bread). Out of the remaining 
, 
breads, the one with the most favour~ble cation content, in terms of K and Mg, was 
variant 3. This experimental bread was, taken to the next stage, where it was evaluated 
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Theoretical determination of the cation content and cost of various bread formulations 
Variation Accept. Nutritional information 11 OOg bread (39% moisture base) Cost (cents) 
Taste Unit Na K Mg Ca Per loaf Deviance ** 
Standard Sasko Brown Yes mg 519.98339 213.25984 71.086614 132.2800 
(Control) mmol 22.618034 5.4544531 2.9247733 3.3003992 92.294813 
% Increase' 
% Reduction* 












1.3182297 122.39333 30.098 




























R&D Brown 36 % Var 3 mg 401.87301 150.16207 210.7522 
mmol 14.360764 10.278529 6.1782379 5.2582889 101.18596 8.891 
% Increase' 88.442888 111.23818 59.322815 
% Reduction· 36.507459 
** A deviance of 0.7 cents from the standard Sasko Brown (control) bread is considered to be of 
significant economical consequence. 
a Var =Variant 
Stage 2: Bread evaluation 
After development, the experimental and control breads were compared, in terms of 
baking quality, sensory properties and nutritional profile. 
• Baking quality 
Methods 
Sample Control and Experimental were baked in the Sasko R&D laboratory, according to 
the straight dough process, and compared for quality. Each batch consisted of 2.5kg 
flour, 2.5% compressed yeast (of flour mass) and standard quantity of improvers. One 
batch yielded four loaves. Six batches of each bread type were baked in random order 
per day, consecutively for 5 days, yielding a total of 30 batches (120 loaves) of each 
variation over the testing period. 
Flour, yeast, mineral salts and improvers were all added in the mixing bowl and water 
added. The mixing time was defined as the time when the dough was optimally 











thereafter it was divided into 4 x 780g dough portions. Each portion was moulded 
(formed), placed in a baking tin and proofed (fermented) for sixty minutes at 80% relative 
humidity and 38°C. After proofing, bread height was measured in each loaf and the mean 
height calculated for each batch (lower bread height indicates a reduced fermentation 
rate). Before baking, two of the four breads, per batch, were randomly selected and 
subjected to a drop test12 to measure whether bread quality deteriorates with abuse. 
These breads were referred to as Control Abuse and Experimental Abuse while the 
remaining two breads were referred to as Control l\Iormal and Experimental Normal. 
Variables which were measured and compared between experimental and control 
breads, for both normal and abused versions, included volume, crust colour, crumb 
colour and cell structure. The difference in loaf volume between the normal and abused 
loaves of the control and experimental variations provides an indication of how the bread 
will perform in an industrial plant where dough is moved on conveyer belts that knock 
pans against each other, leading to defects such as excessive increase or decrease in 
volume. All breads were baked for 26 minutes at 260°C. After baking, breads were left to 
cool and thereafter the volume measured by displacement of rape-seed, and a mean 
value of two measurements was calculated per loaf per treatment. 
Finally bread was sliced and submitted for blind quality evaluation by a trained panel of 
five members, after which a consolidated decision on quality was made. Bread was 
scored on a scale from 1 to 10 for various quality characteristics, which included crust 
colour (the higher the score the lighter the bread), crumb colour (the higher the score the 
lighter the bread); and cell structure (the lower the ranking the finer the cell structure). 
Scores were converted to rankings for ~tatistical analyses. 
All statistical analyses were performed using the SAS statistical package.13 Variables 
were tested for normality of distribution using the Shapiro-Wilk W test. 14 Non-normality 
may be due to kurtosis (measure of flatness or peakedness) or skewness {measure of 
asymmetry).15 The normal distribution has a kurtosis value of three or less and a 
skewness value of zero. Kurtosis has no effect on the means and therefore allows 
standard statistical analysis. 11 Outliers were identified as values exceeding sample 
means by more than three standard deviations and were removed as a standard 
statistical procedure. General Linear Modelling (GLM) was used to construct analysis of 
variance (ANOVA) tables for the measured variables and interactions calculated where 
applicable. Thereafter, the least significant differences (LSD) were calculated according 
to the Student's t-LSD test16 to compare treatment means. The level of statistical 












All batches, irrespective of being control or experimental, had a mixing time of six 
minutes and required 49.49% water (of flour mass). The replacement of salt with a blend 
of mineral salts (experimental bread) had no effect on either the water absorption or on 
the time required to develop the dough. All measurements followed a normal distribution, 
except for volume difference between breads (P=0.0175) which was ascribed to kurtosis 
(Kurtosis = -1.0726), therefore ANOVA and LSD could still be applied. 
Table 2 

Comparison of baking properties between control and experimental breads: mean (SO) 

Variable Control Experimental LSD 
Normal Abuse Normal Abuse 
Proof height (mm) 138.3(7.6)a N/A 137.6 (8.6t N/A 2.05 
Volume (mm) 2913.5 (1 02.9)b 2828.5 (110.1)d 2966.0 (114.2)a 2874.8 (115.0)c 18.83 
Volume difference (mm)t 85.0 (6004) a 91.2 (48.8) a 19.79 
95 % CI of difference 62.3-107.5 73.0 - 109.4 
a-d Means with different superscripts in the same row differ at PsO.05. 
t (Normal- Abuse) for that bread type. 
There was no difference in proof height between the control and experimental breads 
(Table 2). In a model which included bread type (control or experimental), treatment 
(normal or abused) and replicate (30 batches for each bread type), bread volume 
differed significantly according to type (P<0.0001) and treatment (P<0.0001), but there 
was no significant evidence of interaction between bread type and treatment (P = 
0.7430). The experimental bread had a significantly higher loaf volume for both the 
normal and abused variations, compared to the control bread (Table 2). In both bread 
types, abuse (Le. drop test) results in a significantly lower bread volume than in normal 
bread. 
In GLM analyses, controlling for treatment and treatment*type interaction factors, both 
crust colour (P = 0.004) and crumb colour (P =0.0387) of the experimental bread was 
lighter than the control bread. In similar models, cell structure did not differ between 
breads. 
• Sensory properties 
Methods 
In order to test plant production feasibility, and for the purpose of sensory evaluation, 











consecutive batches of dough (three Control and three Experimental) were made from a 
single batch of flour. Each batch consisted of 130kg of brown bread flour, 3.2% (of flour 
mass) liquid yeast and a standard quantity of improvers. Each batch yielded 
approximately 420 loaves. After 24 hours, breads were subjected to sensory evaluation 
using triangle tests.17•18 Triangle testing is designed to answer only one question: "Do the 
judges detect a difference between samples?" Three samples are presented 
simultaneously to each panellist - two of the samples are identical and the other is 
different ("odd"). Each panellist is asked to indicate which sample is the odd one or 
which two samples are most similar. The probability of making a correct selection by 
chance alone is thus 1 in 3 (33 %). Panellists were not asked to evaluate specific 
characteristics, but were told that they could consider any aspect related to bread 
texture, taste, colour, and aroma. 
The study population was a consumer panel, made up of 122 volunteers (mean age = 
36 (9.27) years), including factory workers from the Worcester bakery and personnel 
from the Worcester regional offices. Volunteers were recruited through posters and 
word-of-mouth, and tasting panels were performed during breaks in working hours. Sixty­
eight percent of the volunteers were men (n =83), whose ethnicity included black (n = 
13), mixed ancestry (n =51) and white (n =19) subjects. The remaining 39 volunteers 
(32 %) were women, of which 12 were black, 14 were of mixed ancestry and 13 were 
white. The ethnic distribution of the volunteer sample reflects the ethnicity of the 
workforce employed by Sasko in the Western Cape. 
Half of the volunteers tasted the Sample Control first and Sample Experimental second, 
while the other half tasted Sample E~perimental first and Sample Control second, in a 
random fashion. Half of the volunteer~ were presented with Sample A being odd and the 
other half were presented with Sample B being odd, in a random fashion. The samples 
were presented in one of six random orders of presentation (AAB. ABA, BAA, BBA, BAB, 
ABB) and the adjusted chi-square test was performed. 
Results 
Of the 122 volunteers, 29 (23.8%) ¢orrectly identified the Sample Control, while 18 
(14.7%) correctly identified theSamplJ Experimental (Table 3). In total, 47 of 122 sample 




















Results of triangle test for detection of control and experimental bread types 
Triangle test {Sample A & B) 
Sample 
order Total N Correct N 


































BBA 20 6 3 9 2 4 
ABB 21 6 12 2 3 2 
BAB 19 6 2 4 8 0 3 
Total 
(Odd A} 60 18 6 6 29 4 5 9 
TOTAL 122 47 19 13 51 13 12 14 
The chi·square test yielded a calculated X2 value of 1.4795 in comparison to the X2. 
Distribution Table value of 2.706 required to prove significance at a probability level of 
0.2239 (Table 4). Thus, overall, no significant deference between Control and 
Experimental breads (P>0.05), as judged by a consumer panel, were detected. 
Table 4 
Chi-square calculation for the pooled data and sub-data sets 
Sample presented as odd 
Chi-square data set Pooled data 
Odd B Odd A 
Observed (01) 47.00 29.00 18.00 
Observed (02 ) 75.00 33.00 42.00 
Expected (E1) 40.67 20.67 20.00 
Ex~ected (E2} 81.33 41.33 40.00 
Calculated Chi-square 1.4795 5.0403 0.3000 
P value 0.2239 0.0248 0.5839 
Table value Chi-sguare 2.7060 
Respondents could however detect Sample B (experimental) when it was presented with 
two samples of Sample A (control) (see Table 4, Odd B, P = 0.0238). When Sample A 
was presented as being odd (see Table 4, Odd A), respondents could not detect a 
difference between samples (P = 0.5839). 
• Nutritional profile 
Methods 
The experimental bread was developed for a food·based randomised controlled trial 
(RCT) of reduced Na foods (See Chapter 7). Throughout the trial, between March 2004 











experimental bread were analysed for· Na, K, Mg and Ca content. Ten loaves were 
drawn at each of the 24 occasions a~d a composite prepared for analysis. At each 
occasion, samples of the pre-sliced bread, including crusts, were taken from all ten 
loaves, cross-sliced into smaller blocks land then hand-blended. Duplicate analyses were 
repeated in each of the 24 samples. M~thods of analyses for Na, K, Mg and Ca content 
differed across the various laboratories used for the study. The CSIR used atomic 
absorption, according to the methods outlined by the South African National Scientific 
Programme of the CSIR (1981).1~ The Woolworths Laboratory used an ion 
chromatography method, as outlined by the Metrohm Applications Bulletin No. 257/1 E.20 
Statistical tests for differences in cation content between the bread types were performed 
according to the methods described earlier. In the case of non-normally distributed data, 
outliers were identified and excluded from the analyses of differences between the 















After two sets of outliers were excluded, AI\JOVA indicated a significant difference for 
sodium content between breads (P<0.0001) (Table 5). Sodium content was reduced 
from a mean of 475 (75) mg/1 OOg to 322 (62) mg/1 OOg, which equates to a difference of 
32.3%. 
Table 5 
Laboratory analyses of sodium content of experimental and control breads 
. 
Laboratory Date Sodium content (mg/100g) 
Control Experimental % Reduction 
Target (calculated) 519.98 330.15 36.51 
CSIR 1-Mar-04 558.58 331.54 40.65 
CVAC 4-May-04 366.95 192.05 47.66 
CVAC 1-0ct-04 263.63 147.54 44.04 
WW 1-0ec-04 422.78 373.74 11.60 
WW 1-0ec-04 420.09 330.18 21.40 
WW 1-0ec-04 561.14 387.72 30.91 
WW 27-Jan-05 473.01 329.54 30.33 
WW 3-Feb-05 528.15t 702.90 -33.09 
WW 10-Feb-05 362.61 362.58 0.01 
WW 17-Feb-05 544.56 306.04 43.80 
WW 23-Feb-05 547.21 393.82 28.03 
WW 3-Mar-05 439.41 362.87 17.42 
WW 10-Mar-05 562.16 359.83 35.99 
WW 16-Mar-05 463.25 353.62 23.66 
WW 23-Mar-05 458.03 296.09 35.36 
CSIR 26-May-05 558.91 286.48 48.74 
CSIR 02-Jun-05 519.22 330.69 36.31 
CSIR 09-Jun-05 492.79 285.34 42.10 
CSIR 16-Jun-05 488.43t 696.54 -42.61 
CSIR 23-Jun-05 499.06 390.91 21.67 
CSIR 30-Jun-05 492.05 362.53 26.32 
CSIR 07-Jul-05 482.07 264.17 45.20 
CSIR 14-Jul-05 473.21 277.17 41.43 
CSIR 18-Jul-05 496.92 357.22 28.11 
Median 490.24 342.58 30.62 
Mean (SO) (n:::;22) 475.35 (75.34)a 321.89 (62.50) b 32.28 
Least Significant 
Difference (LSD) 29.17 
a-b Means with different superscripts in the same row differ at P s 0.05 . 
• CVAC 	 CV Analytical Consultants (Ply) Ltd., P.O. Box 4936, Atlasville. 
CSIR = Bio/Chemtek, Food, Biological and Chemical Technologies, 15 Lower Hope Road, Rosebank. 
WW = Woolworths, Wooltru House, 93 Long Market Street, Cape Town. 













Bread potassium content was significantly higher (P<O.0001) in the experimental 
compared to the control bread (331 (84) mg/100g vs 213. (51) mg/100g; mean difference 
of 117.6 mg/100g). The mean increas(3 in K content of 55.2% was considerably lower 
than the targeted increase of 88% (Table 6). 
Table 6 
Laboratory analyses of potassium content of control and experimental bread 
Laboratory 
. 
Date Potassium content (mg/100g) 









CVAC 4-May-04 131.48 240.29 82.76 
CVAC 1-0ct-04 40.34 42.68 5.81 
WW 1-0ec-04 216.35 473.57 118.90 
WW 1-0ec-04 ;206.65 395.59 91.43 
WW 1-0ec-04 ' 255.87 443.02 73.14 
WW 27-Jan-05 209.37 346.61 65.55 
WW 3-Feb-05 • 260.98 254.94 -2.31 
WW 10-Feb-05 344.16 349.50 1.55 
WW 17-Feb-05 231.96 348.57 50.27 
WW 23-Feb-05 ,226.87 368.81 62.56 
WW 3-Mar-05 204.71 313.34 53.06 
WW 10-Mar-05 231.42 320.92 38.68 
WW 16-Mar-05 196.65 358.82 82.47 
WW 23-Mar-05 ,200.69 340.11 69.47 
CSIR 26-May-05 231.76 358.07 54.50 
CSIR 02-Jun-05 ,200.27 330.60 65.08 
CSIR 09-Jun-05 216.89 373.77 72.34 
CSIR 16-Jun-05 215.54 217.46 0.89 
CSIR 23-Jun-05 ' 223.46 376.86 68.64 
CSIR 30-Jun-05 ' 211.02 353.77 67.65 
CSIR 07-Jul-05 208.06 341.77 64.26 
CSIR 14-Jul-05 210.01 361.70 72.23 
CSIR 18-Jul-05 233.69 368.84 57.84 
Median 213.28 349.04 64.67 
Mean (SO) (n=24) 213.02 (51 .26)a 330.59 (84.49)b 55.20 
~.b Means with different superscripts in the same row differ at P ~ 0.05. 
CVAC;: CV Analytical Consultants (Pty) Ltd' l P.O. Box 4936, Atlasville. 
CSIR;: Bio/Chemtek, Food, Biological and Chemical Technologies, 15 Lower Hope Road, Rosebank. 












Magnesium content was significantly higher (P<0.0001) in the experimental compared to 
the control bread (53.6 (14.7) mg/100g vs 90.7 (29.3) mg/100g; mean difference of 37.0 
mg/100g). The mean increase in magnesium content of 69 % was considerably lower 
than the targeted increase of 111 % (Table 7). 
Table 7 
Laboratory analyses of magnesium content of control and experimental bread 
Laboratory Date Magnesium content (mg/100g) 
Control Experimental % Increase 
Target (calculated) 71.09 150.16 111.23 
CSIR 1-Mar-04 63.72 93.08 46.08 
CVAC 4-May-04 54.11 122.06 125.55 
CVAC 1-0ct-04 55.35 106.71 92.78 
WW 1-0ec-04 32.76 98.27 199.95 
WW 1-0ec-04 31.91 81.51 155.41 
WW 1-0ec-04 45.71 68.36 49.55 
WW 27-Jan-05 48.60 76.38 57.18 
WW 3-Feb-05 58.73 51.61 -12.13 
WW 10-Feb-05 61.35 68.90 12.31 
WW 17-Feb-05 40.32 67.43 67.26 
WW 23-Feb-05 42.84 63.56 48.35 
WW 3-Mar-05 34.12 56.83 66.56 
WW 10-Mar-05 33.28 43.46 30.59 
WW 16-Mar-05 33.75 69.68 106.45 
WW 23-Mar-05 37.07 55.03 48.45 
CSIR 26-May-05 64.96 123.68 90.39 
CSIR 02-Jun-05 61.54 117.26 90.54 
CSIR 09-Jun-05 70.92 128.85 81.69 
CSIR 16-Jun-05 66.32 66.70 0.58 
CSIR 23-Jun-05 70.47 125.99 78.78 
CSIR 30-Jun-05 67.19 115.39 71.74 
CSIR 07-Jul-05 68.72 127.59 85.67 
CSIR 14-Jul-05 67.64 123.35 82.35 
CSIR 18-Jul-05 75.96 124.11 63.39 
Median 57.04 87.30 69.50 
Mean (SO) (n=24) - 53.65 (14.72)8 90.66 (29.26)b 69.02 
LSD 9.22 
a·b Means with different superscripts in the same row differ at P ::s; 0.05 . 
• CVAC =CV Analytical Consultants (pty) Ltd., P.O. Box 4936, Atlasville. 
CSIR =Bio/Chemtek, Food, Biological and Chemical Technologies, 15 lower Hope Road, Rosebank. 














Five sets of outliers were removed from the analyses for calcium content. Calcium 
content was significantly higher (P<0.OQ01) in the experimental compared to the control 
bread (131 (29.6) mg/100g vs 176 (63) mg/100g; mean difference of 45.6 mg/100g). The 
mean increase in calcium content of 34.8 % was lower than the targeted increase of 59 
% (Table 8). 
Table 8 
Laboratory analyses of calcium content of control and experimental bread 
. 
Laboratory Date Calcium content (mg/100g) 
Control Experimental % Reduction 
Target (calculated) 132.28 210.75 59.32 
CSIR 1-Mar-04 ,58.68 76.94 31.12 
CVAC 4-May-04 171.64 240.29 40.00 
CVAC 1-0ct-04 107.89 142.90 32.45 
WW 1-0ec-04 99.84 103.50 3.66 
WW 1-0ec-04 95.74 119.41 24.73 
WW 1-0ec-04 128.20 113.75 -11.27 
WW 27-Jan-05 146.82 155.48 5.90 
WW 3-Feb-05 167.82 198.20 18.10 
WW 10-Feb-05 158.61 164.44 3.68 
WW 17-Feb-05 145.56t 116.19 -20.18 
WW 23-Feb-05 128.52 167.74 30.52 
WW 3-Mar-05 125.10 126.69 1.27 
WW 10-Mar-05 147.69 136.96 -7.27 
WW 16-Mar-05 103.71 151.85 46.42 
WW 23-Mar-05 100.08 142.02 41.91 
CSIR 26-May-05 150.47t 281.96 87.39 
CSIR 02-Jun-05 134.71t 254.08 88.61 
CSIR 09-Jun-05 156.67t 291.04 85.77 
CSIR 16-Jun-05 146.89 241.46 64.37 
CSIR 23-Jun-05 ,155.46 273.09 75.67 
CSIR 30-Jun-05 144.67t 281.98 94.91 
CSIR 07-Jul-05 ,147.03 266.33 81.14 
CSIR 14-Jul-05 148.66 270.47 81.94 
CSIR 18-Jul-05 149.71 262.50 75.34 
Median 146.19 166.09 36.22 
Mean (n=19) 130.95 a 176.53 b 34.81 
SD 29.62 63.45 
LSD 22.41 
a·b Means with different superscripts in the same row differ at P ~ 0.05 . 
• CVAC =CV Analytical Consultants (Pty) Ltd., P.O. Box 4936, Atlasville. 
CSIR = Bio/Chemtek, Food, Biological and Chemical Technologies, 15 Lower Hope Road, Rosebank. 
WW =Woolworths, Wooltru House, 93 Long iMarket Street, Cape Town .. 
t Outlier values (removed for calculation of mean, but not median) 
(2) Dry goods and maragrine 
Reduced sodium varieties of three dry goods {soup mix, stock cubes, flavour enhancer 











of salt replacements were used in the development of the experimental food items, 
namely Solo® and Cerebos Low salt. Standard table salt (NaCI) contains 39.3 9 sodium 
per 100g. One teaspoon (6g) of salt provides approximately 2 400 mg Na (6 9 NaCI) per 
day. SOLO® Low Sodium sea salt is a UK-manufactured salt replacement, produced 
from Icelandic water, which provides 60 % less sodium than ordinary table salt. SOLO® 
comprises sodium chloride (41 %), potassium chloride (41 %), magnesium salts (17 %) 
and trace minerals (1 %). The following composition is provided (by the manufacturers) 
per 100g: Sodium = 16g; Potassium =21.7g; Magnesium = 19. Cerebos Low Salt, a 
loca"y manufactured product, comprises 48.5 % NaCI and 51.0 % KCI. Per 100g, it 
contains 19.4g Na, 27.03 g K, and only trace quantities of Ca «0.05 %) and Mg «0.10 
%). The cost of SOLO is approximately R40 per kg, compared to approximately R14 per 
kg for Cerebos Low Sodium salt and 65c per kg for regular salt. The cation content of the 
two salt replacements are compared with regular salt in Table 9 below. 
Table 9 
Cation content of salt and salt replacements used in manufacture of products in the diet 
and blood pressure trial 
Calion content (mg/100g) 

Na K Mg Ca 

Medium Food Grade salta >39200 <0.01% <0.01 % 
Solo sea saltb 16000 21700 1000 0 
Cerebos Low Salte 19400 27030 <0.10 % <0.05 % 
a Average Chemical analysis provided by Sun Salt Services, 7 Clarke Street South, Alberton (suppliers to 

Unilever Bestfoods Robertsons). 





C Average Chemical analysis provided by Cerebos Limited. 

A reduced salt version of both Knorr soup mix (Oxtail flavour), Knorrex stock cubes (Beef 
flavour), and Aromat was developed by Unilever Bestfoods Robertsons. SOLO® was 
used to replace regular NaCI in the soup mix (16.5 % salt) and Aromat (60.07 % salt) 
(Table 10). Both the soup mix and Aromat remained free-flowing. The taste perception 
was less salty and had a slight metallic aftertaste due to the mineral content of SOLO®. 
Regarding the reduced Na Knorrex stock cubes (Beef flavour), during the development 
phase, the experimental cubes were first made up using Solo in place of regular salt. 
However, the cubes were too moist and this resulted in the density of the cubes being 
too "fluffy" and crumbly, compared to the more crystalline structure of the cubes made 











packing characteristics of the cube mass. Thus, half of the salt level of regular cubes 
was replaced with Cerebos low sodium salt, resulting in a regular salt content of 28.3 % 
of product composition and a further 28.3 % comprising Cerebos Low Sodium salt (Table 
10). 
Table 10 
Composition and proportion of salt used in regular and experimental dry food products 
(recipe formulation) : 
% NaCI % Cerebos % Solo 
Low Salt 
Aromat (regular) 60.07 
Aromat (experimental) 60.07 
Knorr soup mix (oxtail} (regular) 16.5 
Knorr soup mix (oxtail) (experimental) 16.5 
Knorrox Beef Cube (regular) 56.59 
Knorrox Beef Cube (experimental) 28.3 28.3 
Margarine 
Brick (hard) margarine contributes 3 % of non-discretionary sodium intake in black 
subjects (data from baseline survey - Chapter 4). Fifty percent of the salt in normal brick 
Rama margarine was substituted with Solo salt replacement, providing an overall salt 
content of 28.9%. The method of introduction was to form a saturated brine with Solo 
and add this to the aqueous phase of the product. The structure of the product was not 
affected and no consumer trials were performed. 
Both regular (control) and reduced Na varieties of the test foods were sent to 
independent testing laboratories for arjlalyses of Na, K, Mg and Ca. Sodium was reduced 
by 51.1 % in Aromat; 68.8 % in the soup mix; 23.6 % in the stock cube; and 62.1 % in 
margarine (Table 11). Since the control versions of the foods did not contain K, 












Laboratory analyses of cation content of control and experimental foods 
Food item Cation content (mg/100g) 
Sodium Potassium Magnesium Calcium 

Theor- Lab Theor- Lab Theor- Lab Theor- Lab 

1 2 3 3etical tests etical tests etical tests etical tests
Aromat (control) 25733 22500 140 14 8.3 
Aromat (experimental) 11 040 11000 13035 10250 1 120 1 120 15 
% Reduction/increase -57.1 -51.1 +7221 % + 7 900 % +80.7 % 
Knorr soup mix (oxtail) 6724 8000 180 28 20.3 
(control) 
Knorr soup mix (oxtail) 5334 3500 3581 2340 165 345 39.3 
(experimental) 
% Reduction/Increase -20.7 -68.8 +1200 % +1 132 % +93.6 % 
Knorrox Beef Cube 24940 22250 80 19 
(control) 
Knorrox Beef Cube 16240 17000 7650 7670 15 
(experimental) 
% Reduction/Increase -34.9 -23.6 +9487 % -21.1 % 
Rama brick margarine 805 Regular variety not analysed by independent laboratory 
(control) 
Rama brick margarine 543 305 204 75.52 41 
(experimental) 
% Reduction/Increase -32.5 -62.1 





1 Average of analyses from two laboratories: Chem Science cc (380 Umbilo Rd, Durban) and Echalaz & 
Osbourne (E &0) Laboratory (499 Sydney Rd, Congella, Durban); 2Single analysis by E &0 Laboratory; 
3Average of 3 analyses (single E &0 Laboratory result and repeat tests on different days (23-03-2004 and 





We have developed a novel bread with a lowered sodium content, and an increased 
potassium, magnesium and calcium content. The bread has undergone extensive testing 
at the product development stage, with regard to baking properties and physical quality 
of the final product, required mixing times during dough production, sensory 
considerations, and ease of production in baking plants. Other products that were 
similarly modified in cation content include a brick margarine, an oxtail-flavoured soup 
mix, a beef stock cube, and a flavour enhancer (Aromat). 
The laboratory-based nutritional analyses of the experimental bread demonstrated a Na 
reduction of 32 %, which is slightly lower than the recipe formulated amount of 36%. 
Food labeling legislation is currently in the process of being revised in South Africa. The 
draft guidelines allow a comparative claim (Le. "reduced sodium") to appear on the 
packaging of a product only if that product is at least 25 % lower than the regular 











other food items developed in the study, since a product must contain less than 120 mg 
sodium per 100g in order to qualify for this claim. This level of sodium content is not 
feasible in terms of sensory and physical properties of the food items of interest. 
I 
The Na content of our experimental bread (342mg/100g bread, independent laboratory 
analyses) is in line with targets set by the Food Standards Agency (FSA) in the United 
Kingdom (UK), which stipulate 350mg Na per 100g bread. In the UK, the FSA and the 
Department of Health are currently undertaking a programme of work with the food 
industry to reduce the level of salt in processed foods. A model has been developed, and 
revised in February 20Q5, to demonstr;ate the types of reductions that would need to be 
made in foods to ensure that the 6g salt/day population average target intake value was 
achieved by 2010.21 
Sodium chloride is an important ingredient in bread due to its flavour enhancing 
I 
properties. It also regulates fermentation, and strengthens the gluten (protein) 
component of the flour, thereby enhancing the malleability of the dough and making it 
more stable. Ions may theoretically enhance either protein association or dissociation. 
When sodium chloride is present, protein association is enhanced as water absorption is 
reduced, in addition to the strengthening of the dough.22 The partial replacement of 
sodium chloride with other electrolytes instead of the mere reduction of sodium chloride 
in the dough recipe offers the opportunity to maintain the electrolyte concentration 
required for optimal baking outcomes, as well as being of potential benefit to health. A 
study in which either 20 %, 40 % or 100 % of the sodium chloride (2 % flour weight 
basis) was replaced with either an equivalent amount of potassium chloride, magnesium 
chloride, calcium chloride, magnesium acetate, magnesium sulphate or sodium sulphate 
was performed in Finland.23 At replacement levels of 20 and 40 %, magnesium chloride 
and calcium chloride weakened the physical properties of the dough, whereas 
magnesium sulphate and sodium $ulphate strengthened them. Replacement with 
potassium chloride or magnesium acetate had no significant effect on dough rheology. In 
the baking tests, provided that sufficient mixing times were used, no difficulties in baking 
performance were demonstrated at ;the level of 40 % replacement with potassium 
chloride, calcium chloride or magnesjumsalts. However, the flavour of these breads 
was poor.· Other authors have also demonstrated that bread baked with potassium 
chloride instead of sodium chloride is ~npalatable.24 
In the present study. baking performance of the experimental bread was similar to that of 
















cell structure between the experimental and control breads. Bread volume differed 
significantly between the control and experimental loaves, however the magnitude of the 
difference is of no practical importance. Internal quality control measures at Sasko 
Milling and Baking stipulate that a volume difference of 125 mm and above is considered 
unacceptable. Baking performance of the experimental bread remained similar to that of 
control bread after dough had been subjected to a standard drop test and neither bread 
types exceeded the critical volume difference of 125 ml. This demonstrates that the 
experimental bread would perform adequately in an industrial plant setting and, indeed, 
was successfully mass-produced, for use in a randomised controlled trial between March 
2004 and July 2005 (See Chapter 7). 
The lighter crumb and crust colour in the experimental bread may be related to the 
presence of insoluble calcium carbonate in the experimental. bread which would have 
been present in the dough as a white particle. The lower chloride content of the 
experimental bread, due to the partial replacement of sodium chloride with a combination 
of magnesium chloride hydrate, potassium chloride and magnesium sulphate, may have 
been expected to result in a darker, not lighter, bread.12 It is important to note that, 
despite colour differences being detected by a highly trained panel of baking experts, no 
sensory differences were identified between the experimental and control breads when 
subjected to a large consumer panel of 122 individuals. Sensory testing was performed 
on breads 24 hours after having being baked according to standard protocol in an 
industrial bakery, thus providing further evidence of the viability of the experimental 
bread production on a large scale. 
Food manufacturers are often resistant to reducing the sodium content of processed 
foods such as bread since the sodium content islargely perceived to be essential to the 
flavour and acceptability of the produCt.25.26 Sudden, large reductions in salt content may 
make foods less palatable and unacceptable to consumers,27 however small to moderate 
changes may be less noticeable.28 Sustained reductions in sodium consumption may 
lead to a preference for a lower salt diet. 29 There is some evidence that long-term 
adherence to a diet low in sodium can lead to a shift in taste perception whereby both 
normotensive30 and hypertensive31 persons develop an increased acceptance of foods 
with a reduced sodium content. Presumably, the salt taste receptors become more 












An Australian study has demonstrated that it is possible to deliver a one-quarter 
reduction in the sodium content of bread without detection by consumers if the reduction 
is gradual.32 In that study, over six consecutive weeks, the sodium content of bread was 
reduced from 2g salt per 100g flour to 1.5g salt per 100g flour, with cumulating 5% 
reductions each week. The intervention group were no more likely than the control group 
to report a difference in the salt content of the bread from week to week. Similarly, 
scores for flavour or liking of the bread over the study follow-up period did not differ 
between groups. However, saltiness scores recorded on a visual analogue scale did 
significantly decline in the intervention group compared with the control group. Another 
study has demonstrated that the sodil!Jm content of bread can be lowered by about one 
third, with no significantly detectable pisadvantage in bread taste, while the content of 
the nutritionally favourable potassium and magnesium can be increased by two-to three­
fold, a level representing that of dark European-type breads.33 The best results were 
found with the use of potassium chloride and magnesium chloride salts. 
There are some limitations in the. bread development process that need to be 
considered. The representivity of the consumer tasting panel warrants discussion. The 
panel comprised less than a quarter of individuals from the target black population. 
Acceptability of bread tastes may Qiffer from population to population and may be 
dependent on the types of breads usually consumed, the total salt content of the diet and 
the manner in which the bread is usually consumed (e.g. with margarine, as a snack or 
as a staple food). Brown bread was chosen as the type to be modified since this is the 
most commonly consumed bread by the majority of the South African population.9 
In South Africa, the level of added sodium chloride to bread has remained high for many 
decades (on average 2 % of flour weight [also referred to as bakers percentage] or 520 
mg Nal100g bread), despite an international recommendation made in 1977 to reduce 
the sodium chloride content of bread.34 The consumption of an average 150 g of bread 
per dal contributes 750 mg Na (1.9 g salt), which is almost a third of the maximum 
recommended intake of 6 g salt per day. It may therefore be assumed that consumers 
are used to the taste of bread with a high salt content. However, no taste differences 
were detected between the experimental bread compared to the standard variety in the 
consumer panel in the present study. Moreover, in a subsequent randomised controlled 
trial in which the reduced sodium bre<;id was used, 77.5 % of subjects reported that they 





















Assessment of the feasibility of launching such a staple product to the mass market on a 
widespread level requires consideration of factors other than flavour considerations. 
These include the cost of the ion replacements, acceptability of the formulation by local 
bakers using existing production lines, as well as the perceived need for the product and 
the perceived health benefits thereof by the target population. The latter investigation 
would require social marketing research, using in-depth techniques. 
Regarding cost considerations, the ingredient cost of a standard brown bread containing 
2% salt is RO.92294. The additional cost of the reduced sodium bread developed in this 
study was calculated to be RO.0891 per loaf, which exceeds the deviation of RO.007 per 
loaf that is considered by the baking industry to be acceptable in terms of expected profit 
margins. If 25 % of salt were to be removed from the standard bread formulation without 
replacement with other ions, as occurred in the Australian study,33 the cost increase per 
loaf would be negligible, at RO.00169 per loaf (ingredient cost of RO.92464), assuming a 
salt price of R0.47/kg. The retail-selling price of this type of reduced sodium bread would 
be R4.6232, compared R4.6142 for a standard loaf (cost calculations provided by 
Elizabeth MacGregor, Food Technologist at Sasko Milling and Baking, Pioneer Foods, 
Paarl). The cost of the experimental bread developed here may not be acceptable to the 
target population and investigations of other, more affordable types of reduced Na bread 
may be required in the South African context. 
A further limitation of the study relates to the methodological variability of the laboratory 
nutrient analyses. Substantial variation was found in the cation analyses of both the 
experimental and control versions of the study foods, both between and within the 
different testing laboratories used. Notably, values for calcium oontent increased 
substantially after 23 May 2005, when analyses were performed by the CSIR laboratory. 
Considering that the minerals were added as a cocktail in one premix, it is unlikely that 
the higher calcium measurements observed after this date were due to processing or 
dosing errors. If the latter was the cause for the increased calcium measurements, the 
other mineral measurements should have been also expected to increase proportionally 
(this was not the case). 
Despite stringent quality control processes being exercised during the production of the 
food items, laboratory values consistently differed from the recipe formulations. This 
poses the question of which values to use for the determination of the nutritional content 
of the food items. We have erred on the side of caution and taken the laboratory values 











experimental food products than was calculated from theoretical formulations. In terms of 
marketing and food labelling of such products, the legislating body of the Directorate of 
Food Control within the Department q>f Health in the country will require evidence of 
chemical analyses in order for a claim to be made on the packaging. Our data 
demonstrates that standardisation of analytical methods used by accredited testing 
laboratories would be required prior to commercialisation of reduced sodium bread that 
carries a nutritional content claim. 
As well as bread, we have also successfully developed reduced Na (and increased K, 
Mg, Ca) versions of a brick margarine, stock cube, soup mix, and flavour enhancer 
(Aromat). Brick margarine is the sixth most commonly consumed food in the diet of 
South Africans, consumed by 21 % of the total population, in average amounts of 199 
per day.15 In many countries, includin~ South Africa, specialist brands of margarine have 
been marketed as a functional food for some time already. The plant sterol-enriched 
margarine (Pro-Activ, Unilever Foods~ South Africa) is such an example, however this 
product retails at a vastly increased cost over its standard Flora Light low fat spread 
relative and is targeted specifically towards peo le with hypercholesterolaemia. Uptake 
by the majority, black population has been marginal (personal communication, Christine 
Broadhurst, Consumer Affairs Manag~r, Unilever South Africa Foods). 
Aromat (monosodium glutamate-bas$d product), together with stock cubes and soup 
mixes, is used as a flavour enhancer in many commonly consumed foods, particularly in 
maize-based dishes to provide a salty taste. In a study to determine nutrition knowledge 
and dietary practices of hypertensive adults attending blood pressure clinics at primary 
care facilities in the Cape Town metropole, a large percentage (34.1 %) of participants 
believed that flavour enhancers such as Aromat could safely be used instead of table 
salt.35 Thus, this is an appropriate food item to target for a modified cation content. 
The UK Food and Drink Federation, under their Project Neptune initiative, achieved an 
overall reduction in the sodium content of sauces and soups of 20% and 6%, 
respectively, in 2003. Project Neptune members aimed to achieve an overall 30% 
reduction in soups and meal sauces over 3 years between 2003 and 2005. In the 
present study, through the substitution of regular salt for SoloTM (a salt replacement 
mineral mix), we were able to achieve a 69 % and 51 % Na reduction in soup mix and 
Aromat composition, respectively, without any adverse effects on the production or 
quality of the items. The 24 % reduction in l\Ja content of the stock cube was achieved 















replacement containing -KCI) since the crystalline structure of the cube was altered with 
the use of Solo alone. A limitation of the study is that, unlike bread, the experimental dry 
goods and margarine did not undergo extensive consumer testing, which would be 
necessary prior to the commercialization of such products. 
In other countries, the food industry has made good progress in lowering the salt content 
of many processed foods. This has been achieved, to a large extent, due to active 
lobbying from consumer groups and government agencies. In the UK, a Consensus 
Action on Salt and Health (CASH) group has been set up, headed by Professor Graham 
MacGregor of St George's HospitallVledical School in London.36 Since 2005, CASH have 
co-ordinated an annual national Salt Awareness Day which is accompanied by extensive 
media coverage. 
In September 2004. the UK Food Standards Agency launched a "Sid the Slug" salt 
campaign. A consumer survey conducted by the Agency showed an upsurge in 
consumers making an effort to cut down on how much salt they eat and to change their 
shopping behaviour. Between August 2004 and January 2005, there was a 32% 
increase in people claiming to be making a special effort to cut down on their salt intake; 
a 31 % increase in those who look at labelling to find out salt content; and a 27% 
increase in those who say that salt content would affect their decision to buy a product 
"all the time".3? This provides encouraging evidence of a rapidly achieved change in 
consumer awareness related to salt intake behaviour associated with a campaign that 
involved effective partnerships between members of the food industry, academics, 
consumer bodies, retailers, trade associations, professional and non-governmental 
organizations and the Department of Health. Further, the change appears to be 
sustained - between September 2004 and September 2005, an increase of nearly 6 
million people or 12% of adults claimed to be trying to cut down the amount of salt they 
eat (total of 46% adult population).38 
Until now, the availability of reduced sodium products in South Africa has been limited. 
This is probably due, in part, to the lack of consumer lobbying and consumer demand for 
such products in the country. 
Conclusion 
The sodium content of food items frequently consumed by the South African population 
can successfully be reduced by between 24 % and 69 %, and partially replaced with 












quality. The blood pressure-lowering impact of substitution of these food items for the 
regular higher salt varieties needs to be tested in black South Africans in order to 
contribute to other non-pharmacological approaches to the management and prevention 
of hypertension. Thereafter, the challenge will be for the food industry to make such 
items cost competitive to the target pop>ulation, and, in collaboration with the Department 
of Health, to implement effective social marketing techniques to increase awareness of 
the health benefits of switching to these products. 
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The impact of dietary manipulation of 
sodium, potassium, calcium and magnesium 
on blood pressure in hypertensive black 













Earlier studies included in this thesis h~ve identified that ethnic differences exist in the 
habitual intake of dietary factors involved in blood pressure regulation. Mean urinary Na 
values equate to a daily salt (NaCI) intake of 7.8g, 8.5g and 9.5g in black, mixed 
ancestry and white subjects, respectively. In all three ethnic groups, sodium intake 
exceeded the recommended maximurn of 6 g/day, while potassium intake fell far below 
the recommended minimum of 90 m,mol/day. For calcium, both dietary and urinary 
parameters were lowest in black subjects. These data, together with findings from 
published dietary surveys conducted in black South Africans since 1975,1 indicate a 
need for population-based approaches to change dietary behaviour in order to both 
prevent the development of hyperte~sion and to improve blood pressure control in 
hypertensives. 
Since compliance with advice to restrict dietary sodium in adults, over the long term, is 
generally poor,2 it has been proposed that the only effective way to lower salt intake on a 
population level is through the reduction of the sodium content of processed foods.3A It 
has been demonstrated elsewhere in this thesis (Chapter 4) that the largest contributor 
to non-discretionary Na intake in the 'diets of South Africans is the bread and cereals 
food group, contributing between 49 - 54 % in the urban black population and 70 - 75 % 
in the rural black population. Bread is the single food item providing the highest 
proportion of non-discretionary Na, ranging between 41 - 52 % and 66 - 73 % in urban 
and rural dwellers, respectively. Other important food sources of Na in this population 
include soup powders (fifth highest ranking) and margarine (6th). Added salt intake was 
estimated to comprise 46 % of total sodium intake, which equates to a daily added salt 
(NaCI) amount of 4.1 g. This is a much higher proportion than that reported in affluent 
western countries, in which 75 - 85 % of salt is estimated to come from processed 
foods.5,6.? 
We hypothesize that a moderate reduction in sodium intake, in the presence of an 
, 
increased intake of potassium, magnesium and calcium, will reduce blood pressure 
levels in mild-to-moderate hypertensiv:es by a Clinically significant magnitude. 
As a result of a partnership with members of the food industry, novel varieties of the 
identified important food sources of ?alt were produced (see Chapter 6), which had a , 
reduced sodium, and increased potassium, calcium and magnesium content. A dietary 











foods, namely salt, bread, margarine, stock cubes, soup mixes and Aromat (a popular 
flavour enhancer comprising monosodium glutamate) and the addition of a high calcium 
fermented milk product (maas). The impact of the intervention on blood pressure was 
tested in an 8-week randomised controlled trial in black South African hypertensives. 
Methods 
A randomized, parallel group controlled trial was undertaken to investigate the impact of 
an 8-week feeding study (in which sodium intake is decreased, and potassium, 
magnesium and calcium intake is increased) on blood pressure in mild-to-moderate 
hypertensive black South Africans who have an habitually inappropriate intake of these 
cations. Eligible subjects completed a 3-week run-in period, during which time baseline 
screening measurements were obtained. Thereafter, subjects were randomized to either 
the intervention or control diet for 8 weeks. The study was conducted in 2 consecutive 
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Subjects and sampling 
Inclusion and exclusion criteria 
Black male and female residents of Lariga township on the outskirts of Cape Town, aged 
between 50 and 75 years, with drug-treated mild-to-moderate hypertension (BP: Systolic 
:s 160 mmHg and Diastolic :s 95 mm Hg) were eligible for participation in the study. 
Exclusion criteria included taking two I or more diuretics for treatment of hypertension; 
prescription of furosemide (Lasix) (presumed to be prescribed for cardiac failure); 
previous cerebral infarction or hemorrhage; renal impairment {serum creatinine> 114.4 
umol/l (1.3 mg/dl) and creatinine clean~nce < 50 ml/min) values; habitual consumption of 
> 3 alcoholic drinks per day; Type 1 di'abetes mellitus; impaired cognitive function; and a 
Body Mass Index (BMI) > 45. Creatinine clearance (mllmin) was estimated using the 
Cockroft- Gault equation: ({140 - age) x weight (kg) x [1 - {0.15 x sex)]}/0.814 x serum 
creatinine (umolll), where sex = 0 for male and 1 for female.s Cognitive function was 
assessed using a modified version of the six-item Cognitive Impairment test {6CIT).9 The 
first three items assess orientation in time, while the latter three items test memory and 
concentration. The 6CIT excludes items about current affairs, in order to facilitate both 
linguistic and cultural translation, and does not require the subject to be literate. The 
6CIT tool has been modified for use in African, Xhosa-speaking subjects and has been 
validated locally10 against the Bristol Activities of Daily Living Scale (BADL), which is 
developed specifically for people with dementia. 11 A local address has replaced the 
original 5-item memory phrase (UPumla/Zibi/Z69/Jama Road/ Khayelitsha"). Scoring on 
the test is weighted and inverse, amd measures the number of errors made by the 
subject for each question, with a maximum score of 28, which indicates severe 
dementia. A score of;:: 10 was consid~red to impaired cognitive function. 12 , 
Recruitment procedures 
The recruitment drive was primarily umdertaken at a church-based luncheon club, as well 
as a primary-care clinic that serves the residential area of Langa. In order to encourage 
participation in the study, an information session was given at the luncheon club, posters 
were placed at the clinic and an advertisement was published in the weekly local, free 
community newspaper. Two trained nurses measured the blood pressure of all 
volunteers who attended the study sit~ (N =225). At the recruitment drive stage, BP was 
taken according to study protocol (s\ge below) using an Omron automated device and 
weight and height was measured to determine BMI. A questionnaire was administered 
which included information on age, diagnOSiS of hypertension, previous history of stroke, 
continence, and habitual alcohol intake. Cognitive function was assessed using the 























invited to attend for the first of the three run-in visits. During this visit, as well as the 
measurements depicted in Figure 1, fasting blood was taken to assess creatinine 
clearance and detailed information on all prescribed medications was obtained from the 
drug packages which subjects were requested to bring to the visits. 
Samp/esize 
Sample size calculations were performed using the nQuery Advisor 5.0 program using 
the outcome estimate from a meta-analysis of RCTs of reduced dietary Na in 
hypertensives aged 45+ years (systolic BP change of -6.3 mm Hg (95 % CI :;:: -8.4 to -4.1 
mmHg».13 The trial was originally planned to be a two-armed cross-over design therefore 
sample size was calculated according to this methodology, assuming a common 
standard deviation of 12.0, and a two group t-test with a 0.050 two-sided significance 
level and 80 % power. The required 16 participants per cross-over arm (N :;:: 32) was 
increased to 20 per arm (N =40) to account for an expected 25 % drop-out. After 
eligibility testing and screening, 45 participants were randomized to either a low salt (n = 
23) or control diet (n :;:: 22) (See Figure 2). Four participants dropped out before the start 
of the trial and one participant was excluded during th  trial due to hospitalization for a 
stroke, leaving 40 who completed the trial. At the completion of the first arm, the 
assumption that there would be no carry-over effects in the second arm (after wash-out) 
was not met, and the study design was subsequently adapted to a 2-phased randomised 
controlled (parallel group) trial. Using the same parameters as for the first cross-over 
arm, the sample size was re-calculated to reflect the parallel group design, indicating that 
58 subjects per arm (N :;:: 116 in total) were required. However, data obtained in the first 
cross-over arm demonstrated that the variability of blood pressure measurements 
(difference between pre- to post intervention) was less than assumed at the start (SD 
closer to 8 mmHg than 12 mmHg). Using the same expected intervention effect as 
original (-6.3 mm Hg) and a SD of 10mmHg for being conservative. a sample size of 41 
subjects per arm (N :;:: 82 in total) was required. 
Data from the first cross-over arm (n :;:: 40) was included as "Phase 1" data in the final 
analysis. Thus. in Phase 2 an additional 47 subjects were randomized to a low salt (n = 
24) or a control (n :;:: 23) diet (Figure 2). Of these, five refused to start the trial while 
another 2 subjects defaulted during the trial leaving 40 subjects who completed the trial. 
Results are available for 80 subjects (N =40 per diet group). 
In total. after screening of subjects deemed to be eligible for the trial (n :;:: 113). a total of 














diabetes (ascertained from drug inforniation). three were taking furosemide, two were 
acutely ill at the beginning of the run-in, one subject lived outside Langa, and one subject 
was found to be normotensive (normal BP and not taking prescribed BP-Iowering 
medication). An additional 12 subjects v.}ere excluded during the 3-week run-in periOd for 
either defaulting (n = 8) or for being una:ble to comply with instructions on urine collection 
(n = 4) (Figure 2). 
Medication prescribed for hypertension, diabetes, atherosclerosis and asthma was 
classified according to the subclasses bf drugs for each condition using the Anatomical 
Therapeutic Chemical Classification (ATC) codes.14 
I 
Phase 1 Phase 2 
Figure 2 
Recruitment and screening of subjects:!Phase 1 and Phase 2 
Intervention 
The intervention comprised 7 commorly consumed food items, known to be important 
contributors to overall Na intake in theitarget population. The intervention diet provided a 
I . 
low Na salt replacement (SoloTM) an~ reduced Na versions of bread, margarine, stock 
cubes, soup mixes, and Aromat, plusi500 ml/day of maas (fermented milk). The cation 
content of all foods except maas was modified to be reduced in Na, and increased in 




















day (Paramalat) provides an additional 775 mg/day of calcium. which is almost double 
the current intake described in Chapter 4. A more detailed description of the intervention 
foods is provided in Chapter 6. The control diet provided the same quantities of these 
foods to subjects, but which were of standard commerical composition. Instead of maas, 
500 ml artificially sweetened cooldrink was provided in the control arm. in order to ensure 
equivalent fluid intake between the two diets. Being a group of low socioeconomic status, 
it was assumed that the foods provided would be consumed by all members of the 
family, therefore an average household size of 5 persons was taken into account and 
sufficient quantities of food items were provided to ensure that the research subjects 
would receive their required daily allocation of each of the food products. In an attempt to 
prevent the purchase of any of the foods included in the intervention from shops during 
the trial, subjects were able to request more of the food items should the amounts 
provided be insufficient to meet their household's needs. Subjects were instructed to 
consume quantities of the test foods that they would usually use. Average habitual 
amounts of each of the test foods were calculated from the baseline dataset (see 
Chapter 4). Calculation of the cation contributions of the six intervention foods to total 
daily intake, according to estimated usual intakes, are shown in Table 1. 
Substituting 4 grams of salt (213 tsp) per day (ie. habitual discretionary salt intake 
consumed by black subjects in baseline study) for SOLO® would reduce Na intake from 
1 633 mg Na to 640 mg (27.8 mmol) (ie reduction of 61%); increase K intake by 868 mg 
(22.2 mmol) and increase Mg by 80 mg (3.3 mmol). Overall. compared to the control 
diet foods, the intervention diet foods provide a 41 % (-1611 mg/day) reduction in Na; an 
826 % (+2432 mg/day) increase in K; a 388 % (+636 mg/day) increase in Ca; and a 368 
% (+241mg/day) increase in Mg. 
Blinding 
The trial was double blinded. The corresponding food items provided in each of the 
intervention arms had identical packaging. Subjects were allocated a study number and 
randomized to a diet by a statistician. Only the statistician and the dietician responsible 
for packing the food items had access to the subject's randomization number. All food 
was provided to subjects in a large, sealed shopping bag which had a label indicating 
their name, study code number, address and telephone number. After being packed, the 
food bags were zipped and unopened until the subject received, and Signed for their bag. 
A driver (who was also blinded to diet group allocation of subjects) was employed to 












investigator (KC) nor observers taking blood pressure and other measurements were 
aware of which types of foods the subjects were receiving at any given time. 
Table 1 
Contribution of cations from intervention and control foods, according to estimated 
consumption of quantities per day (independent laboratory analyses of food items)'" 
Food item and recommended Nci content! 
... 
K content! Ca content! Mg content! 
quantity per day Day Day Day Day 
1. Solo® salt replacement 640 mg 868 mg 80 mg 
(4 g/day) 
Normal table salt {4 g/daYl 1 554 mg 11.6 mg 
2. Reduced Na brown bread - 5 526mg 524 mg 249 mg 131 mg 
slices (5 x 30g = 150 g) 
Normal Sasko brown bread (150 735 mg 320mg 219 mg 86mg 
g/da~} 
3. Reduced Na margarine (Rama) 109 mg 41 mg 8.2mg 
20 g/dayt 
Normal Rama brick margarine {20g}t 161 mg 
4. Reduced Na Aromat (3g/day) 330mg 308 mg 0.45 33.6 mg. 
Normal Aromat {3g/daj"l 67511")9 4.2mg 0.25 0.4 mg 
5. Reduced Na soup mix 

(3 pkts/household/week = 180g). 





Normal Knorr soup mix 

(3 pkts/household/week = 180g). 





180 mg 120mg 2.0 mg 18 mg 
411 mg 9.2mg 1.5 mg 1.4 mg 
6. Reduced Na stock cubes (3 291 mg 131 mg 0.27 mg 0.64 mg 
cubes/person/week = 30g) 
Normal Knorrex stock cubes (3 381 mg 1.4 mg 0.35 mg 0.26 mg 
cubes/eerson/week =30g} 
7. Maas (500 ml/day) - supplied in 230mg 775 mg 605 mg 60mg 
intervention arm only 
TOTAL PER DAY 2306mg 2767 mg 857mg 331 mg 
Intervention diet .. (100.3 mmol) (70.9 mmol) (13.8 mmol) 
TOTAL PER DAY 3917 mg 335 mg 221 mg 90 mg 
Control diet .. (170.3 mmol) (8.6 mmol) (3.7 mmol) 
% Difference between Intervention -41 % +826% +388% +368% 
and Control diets 
* Amounts provided by intervention foods only 
t Recipe formulation 
Compliance ofsubjects 
Subjects were advised not to change their habitual intake of foods and beverages, other 
than the supplied intervention foods for the duration of the trial. Compliance was 
monitored using three methods. Firstly, at the beginning of each week subjects returned 
their salt and Aromat shakers, for weighing of remaining quantities and were provided 
with new, full shakers of each. Secondly, subjects completed interviewer-administered 











intake during the trial (average of both visits taken as intervention intake or "post"). 
Thirdly, corresponding 24-hour urinary electrolyte concentrations were assessed at 
weeks 4 and 8. 
Consumer acceptability of intervention foods 
Prior to commencement of the trial, the experimental reduced sodium bread was 
developed at the head office of Sasko Milling and Baking, Paarl. The infrastructure of 
Sasko's consumer testing facilities were used to test palatability of the regular brown 
Sasko loaf (Na content of baker's percentage of 2 % dry weight); and the reduced Na 
bread (Na content of baker's percentage of 1.28% dry weight) (See Chapter 6 for 
detailed methodology). During week 8, subjects were asked to rate the palatability of the 
trial foods, in comparison to the versions that they habitually consumed. This was 
assessed by completing a questionnaire with 5-point Likert scale ratings, according to 
the method described by Drewnowski and cOlleagues.15 
Outcome measures 

All clinical measurements and questionnaires were administered by trained fieldworkers, 

and interviews were conducted either in Xhosa or English, depending on subjects' 

preferences. All of the urinary and blood parameters were analysed by a central 

laboratory (National Health Laboratories Institute, based at Groote Schuur Hospital) 

which uses standard methods and quality control procedures. 

• Primary Outcomes 
Blood pressure 
Resting blood pressure was measured according to the American Heart Association 
Recommendations for Human BP Determination,16 using an automated Omron BP 
monitor. The Omron has been endorsed by the British Hypertension Association as 
being reliable for use in clinical trials. A large cuff was used for subjects with an arm 
circumference;c: 33 cm. Blood pressure was measured three times on each occasion and 
an average of the second and third measurements was taken. Blood pressure was 
measured weekly during the run-in period of 3 weeks, and on the first day of intervention 
(prior to receiving foods). The baseline ("Pre") BP was taken as the mean of 
measurements taken on these 4 occasions. Thereafter, BP was measured mid-way 
during the intervention (Le. at 4 weeks) and during the final, eighth week. For Phase II, 
BP measurements taken during the intervention period (Le. weeks 4 and 8) were 











subjects in Phase I had BP measuremeQts taken on single occasions only. 
24-h Ambulatory Blood Pressure (ABP) 
Average 24-hour ambulatory systolic an~ diastolic BP, awake and asleep BP, heart rate, 
and mean arterial pressure, was measyred at baseline and during the final week of the 
intervention, using an Oscar 2 (SunTech Medical) ABP monitor. The monitor was 
programmed t6 take readings every 20 . minutes during 'awake time' which was set 
between 06hOO and 22hOO (maximum Of 48 readings). 'Sleep time' was between 22hOO 
and 06hOO and blood pressure readings were taken every 30 minutes during this interval 
; 
(maximum of 16 readings). The approp~iate cuff size was placed on the subject's left arm 
and the monitor attached to the cuff. The Oscar 2 monitor was placed in a pouch and 
strapped over the subject's shoulder. tDetailed instructions were provided to subjects 
about the ABP monitoring process. Twenty-four hours later the Oscar 2 was removed 
and the data downloaded to a laptop, computer which was pre-programmed with the , 
Imonitor's software. 
• Secondary Outcomes 
Dietary Intake 
i 
Habitual dietary intake was assessed using repeated interviewer-administered, 
quantified 24-hour dietary recall met~odology.17 Subjects reported all food and drink 
items consumed during the past 24-hour period. The validated Dietary Assessment 
Education Kit (DAEK),18 which includes a manual of colour photographs of typical foods 
consumed by the South African popul~tion was used to determine intake and to quantify 
food portion sizes. The recorded quariltities of food consumed were converted to gram 
weights using the Medical Research Council (MRC) Food Quantities Manual. 19 Average
! 
daily nutrient intake was calculated· using the Foodfinder III computerised dietary 
assessment programme, which is based on the 1991 MRC Food Composition Tables,2o as 
well as later supplements to the original Tables.21 The 24-hr dietary recalls were 
performed the day following each of ttile 24-hr urinary collections, thus corresponded to 
I 
the period of urine collection. During the run-in period, habitual dietary intake was 
assessed from the mean of three repeated 24-hr recalls, each performed one week 
apart. 
Urinary Analyses 
Weekly 24-hr urinary samples were Icollected for electrolyte and creatinine analyses 
during the run-in period of 3 weeks, ~nd once at week 4 and week 8. For the baseline 
analyses, the mean of the 3 consecutive weekly measurements were used. 
I 
Completeness of 24-hr urine collectiom was assessed using the criterion of at least 500 






















0.12 mmollkg lean body mass/day (women).22 The following urinary analyses were 
performed using flame photometry: sodium, potassium, magnesium, calcium, and 
creatinine. 
Biochemical analyses 
Fasting blood samples were drawn once during the run-in period, and once during the 
last week of each of the intervention arms (i.e. at 8 weeks) for the following analyses 
performed on the Roche Modular auto analyser: serum creatinine (Jaffe reaction with 
rate-blanking and compensation); plasma glucose (enzymatic colorimetric assay with 
glucose oxidase (GOD-PAP method)); serum calcium (colorimetric assay with 
cresolphthalein complexone); and serum magnesium (colorimetric assay with xylidyl 
blue; Roche modular analyser. Plasma active renin (Nichols Institute IRMA kit) and 
plasma aldosterone (Diagnostic Products Corporation coated tube kit) were measured 
once in each subject, during the run-in period. 
Body Composition 
Anthropometric measurements were taken by trained interviewers during the run-in 
period, and at the end of each of the intervention anTIs. Standing height was recorded 
using a stadiometer and weight was recorded on a calibrated scale, to the nearest 100g. 
Body Mass Index was calculated as weight (kg)/ (height (m))2 and classified according to 
World Health Organization (1997) categories.23 Whole body bio-electrical impedance 
was measured at 50 kHz using a standard tetra polar bioimpedance monitor 
(BodystaUM), with the subject lying supine. Fat mass was obtained by subtracting Fat 
Free Mass (FFM) from total body mass and the fat percentage is obtained by expressing 
fat mass as a percentage of total body mass. 
Physical activity, alcohol intake and smoking 
Current habitual physical activity levels were assessed at baseline and at the end of the 
intervention period, using an interviewer-administered version of the Vale Physical 
Activity Survey (VPAS) for older adults.24 Individual weekly energy expenditure 
(kcal/week) was calculated for five activity domains: household chores, gardening, care­
giving, exercise and recreation. Subjects were asked whether they were regular 
consumers of alcohol, and if so, mean daily alcohol intake was assessed by quantifying 
usual weekly intake of alcohol-containing beverages and calculating grams of alcohol 
divided by 7. Subjects were asked whether they were current or past smokers of 
tobacco. 
Functional dependence and quality of life 
As a measure of functional dependence, ability to perform Activities of Daily Living were 
assessed using both the 6-item Katz25 ADL questionnaire and the 10-item Barthel26 ADL 











with a score of 6 indicating full function,' 4 indicating impairment, and 2 or less indicating 
severe impairment. For the Barthel ADL score, possible scoring ranged from 0 - 20, 
where a higher score indicates greater independence. The Instrumental Activities of 
Daily Living (IAoL) assessment scale27 was administered to determine ability to perform 
the more sophisticated tasks of everyd~y life. Scoring ranges from 0 (totally dependent) 
to a maximum of 16 (totally independ~nt). Self-perceived health status was assessed 
using a five-scale item, as well as a visual analogue scale based on the EQ-5o 
instrument, on which the subject was! required to rate their perceived current health 
status, ranging from 0 ("worst possible health state") to 100 ("best possible health 
state").28 
Ethical considerations 
The Research and Ethics Committee of the University of Cape Town approved the study 
protocol, and written informed consent was obtained from all participating subjects. 
I 
Regarding potential adverse effects of iNa restriction on the study subjects, patients were 
closely monitored for adverse effects and BP was monitored at 4 and 8 weeks in both 
the intervention and control arms. At all times during the study, subjects had access to 
both the fieldworkers and a back-up medical service. High-risk patients, such as those 
having previously had a cerebrovascu,lar accident or those with impaired renal function, 
were excluded from the study. In addi~ion, the BP criteria for entry to the study excluded 
subjects with uncontrolled hypertension at baseline (Le. > 160/95 mm Hg). At the end of 
the study, all participants received a written explanatory report of their BP measurements 
and their relevant blood, urinary and dietary parameters that were measured. 
Participants with previously undiagnosed or uncontrolled diabetes were referred to their 
primary health-care providers during the run-in screening period. 
Statistical analyses 
Analyses were performed on an intent~on to treat basis. Comparison of the diet groups at 
baseline was considered unnecessa(y. All the subjects included in the trial met the 
inclusion criteria and the randomisa'tion process was strictly followed. All statistical 
analyses were considered significant ~t the P<0.05 level. 
For the analysis of office (Omron) ~P, linear regression modelling was performed to 
assess the intervention effect The model had indicators for diet group, phase and time. 
The model also included the appropriate interaction effects for testing the consistency of 
I 
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over time in the two diets. The analysis accounted for the repeated nature of the BP 
measurements within each subject by using the generalised estimation equation (GEE) 
approach. From the results of this analysis, the difference in Omron BP measurements 
between baseline (mean of 4 repeated measurements) and the intervention period 
(mean of 2 repeated measurements) was calculated for each subject. These pre-post 
changes were compared between diet groups using the 2-sample t-test as a more robust 
and general comparison. 
For the analysis of 24-hr ABPM, a multivariate linear regression model was used to 
assess the intervention effect. The vector of 24-hr ABPM measurements obtained at the 
end of the interVention period was modelled on indicator variables for diet and phase as 
well as the baseline values of average 24-hr systolic and diastolic BP, 24-hr Mean 
Arterial Pressure (MAP). The vector of seven measurements consisted of the average 
systolic and diastolic BP, the wake and sleep systolic, the wake and sleep diastolic BP 
and the MAP. The multivariate approach utilized the strong correlation structure of this 
set of 24hr ABPM measurements. The set of covariates used for baseline adjustments 
were limited to the three variables described above to avoid the problem of co-linearity 
between the variables 
For both the Omron BP and 24-hr ABPM the intervention effect was estimated for the 
pooled data over both phases as well as for each phase separately. Confidence intervals 
(95%) were estimated to reflect the precision of these estimates for the trial. For both 
Omron and 24hr BP there was no significant interaction effects between Phase and 
intervention. Thus, the pooled estimates were presented since this improved the 
precision of the estimated intervention effects. 
For reported dietary intake changes and potential confounding variables (physical 
activity, self-rated health score, weight, % body fat), change from baseline was assessed 
using paired t-tests within diet groups (Pooled or Satterthwaite t-tests for parametric and 
non-parametric data, respectively). Between-diet group differences were investigated 
using independent t-tests. 
Change in 24-hour urinary excretion of Na, K, Mg and Ca, from baseline values (average 
of collections taken at 3 visits during run-in) to week 4, week 8 and 'Post' (average of 
week 4 and week 8 visits), was calculated according to Phase and diet group allocation 
using paired t-tests. Between-diet group difference in urinary cation change was 
assessed using independent t-tests. Change in both systolic and diastolic blood pressure 
168 
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was assessed according to change (baseline-post) in 24-hour urinary excretion of Na, K, 
Mg and Ca using multivariate linear ~egression modelling in which diet group and 
diet*urinary cation change interaction faftors were also included. 
Results 
Baseline sociodemographic characteristics of the subjects and lifestyle factors 
associated with blood pressure control ;are shown in Table 2. Mean age was 61.7 (7.9) 
I 
years, ranging from 50 - 76 years. When asked what they did to control their blood 
pressure, other than take medication, 47.5 % of subjects reported that they followed a 
low salt diet, 38.8 % claimed to exercise, 16.3 % took home remedies and 8.8 % 
I 
controlled their weight (unprompted responses). Only one subject (low salt group, Phase 
2) reported being a current consumer of alcohol, thus mean daily intake was not 
quantified. 
Anthropometric and body composition measurements, as well as plasma renin and 
aldosterone concentrations are shown lin Table 3. At baseline, the control group was on 
average 5kg heavier than the low salt group, which was reflected in their higher BMI and 
. I 
% fat mass. In Phase 2, control subjects had lower serum Mg concentrations than low 
salt subjects. Overall, 3 subjects in t~e control group and 2 in the low salt group had 



















Baseline sociodemographic characteristics of sample, lifestyle factors associated with 
hypertension control, self-perceived health status 
PHASE 1 PHASE 2 TOTAL 
Low salt Control Low salt Control Low salt Control 
N =20 N =20 N =20 N =20 N =40 N =40 
Age (years) (Mean (SO» 64.0 (6.4) 59.4 (8.7) 59.7(6.1) 61.4(5.7) 61.8 (6.6) 60.4 ( 7.4) 
Range 51 - 76 50 - 75 50 -72 51 - 71 50 - 76 50 - 75 
Female/male ratio 16/4 1614 17/3 18/2 33/7 34/6 
Literacy rate (ability to 100 100 95 90 97.5 95.0 
read) (% subjects) 
Highest level of education 
achieved (% subjects) 
No schooling 5 2.5 
Up to Grade 7 (primary) 5 35 45 35 25.0 35.0 
Grade 8 -10 50 35 25 45 37.5 40.0 
Grade 11 - 12 35 10 20 10 27.5 10.0 
Tertiary/diploma 10 20 10 5 10.0 12.5 
Employment status (% 
subjects) 
Employed 10 25 15 15 1.2.5 20.0 
Unemployed/Housewife 30 30 30 20 30.0 25.0 
Social (old age )grant 55 35 50 55 52.5 45.0 
Disability grant 5 10 5 10 5.0 10.0 
Type of housing (% 
subjects) 
Formal housing (privately 55 75 30 50 42.5 50.0 
owned) 40 15 20 10 32.5 10.0 
Council/core house 5 10 20 5.0 20.0 
Informal shack 5 5 35 20 20.0 20.0. 
Hostel 
No. rooms in house (mean 
(SO» 3.35 (1.46) 2.65 (1.56) 1.95(1.23) 2.45 (1.60) 2.65 (1.51) 2.55 (1.57) 
No. persons in HH 
(mean (SO» 5.40 (2.28) 4.65 (2.03) 5.0 (3.11) 5.05 (2.58) 5.05 (2.58) 4.85 (2.30) 
Housing density (No. 
persons/rooms) 2.06 (2.03) 2.19 (1.41) 3.51 (3.11) 2.77 (1.96) 2.77 (1.96) 2.48 (1.71) 
Previously diagnosed 
chronic conditions (% (n» 
HypertenSion 100 (20) 100 (20) 100 (20) 100 (20) 100.0 (40) 100.0 (40) 
Heart attack or angina 15 (3) 10 (2) 15 (3) 5 (1) 15.0 (6) 7.5 (3) 
Any other heart condition 15 (3) 10 (2) 5 (1) 0 10.0 (4) 5.0 (2) 
Hypercholesterolaemia 0 10 (2) 5 (1) 5 (1) 2.5 (1) 7.5 (3) 
Asthma 10 (2) 15 (3) 20 (4) 20 (4) 15.0 (6) 17.5 (3) 














Self-rated health status (% 
subjects) 
ExcellenWery good 5 5 0 10 2.5 7.5 
Good 40 75 50 45 45.0 60.0 
Fair 55 15 50 45 52.5 30.0 
Not good 0 5 0 0 0 2.5 
Self·rated health scale 
Mean score (SO) 71.8 (14.3) 60.3 (20.0) 59.8 (21.4) 70.5 (20.6) 65.7 (19.0) 65.4 (20.7) 
Range 40 - 90 30 - 90 10 - 100 50 - 100 10 - 100 30 -100 
Tobacco use (% (n» 
Current tobacco use 15 (3) 5 (1) 5 (1) 10 (2) 10 (4) 7.5 (3) 
Past smoker 5 (1) 0 5 (1) 10 (2) 5 (2) 0 
Physical activity 
Mean (SO) (kcal/wk) 2307(1274) 2393 (1607) 1350 (957) 1676 (1450) 1828 (1214) 2034 (1554) 
Range 422 - 5152 318 - 6307 110 - 3605 160 - 6377 110 - 6377 160 - 6377 
1 Data obtained from medication history during run-in period. plus one newly-diagnosed diabetic in low salt 












Weight, height, body composition, serum magnesium, plasma renin and aldosterone 
concentrations of subjects at baseline, by diet group and Phase 
PHASE 1 
Low salt Conkrol 
N =20 N = 20 
PHASE 2 
Low salt Control 
N =20 N = 20 
...--. 
TOTAL 
Low salt Control 
N=40 N =40 
Weight (kg) 84.2 (14.6) 91.7(14.0) 82.4 (13.0) 85.8 (16.8) 83.3 (13.7) 88.8 (15.5) 
Height (m) 1.60 (0.07) 1.60 (0.07) 1.59 (0.08) 1.57 (0.07) 1.60 (0.07) 1.59 (0.07) 
BMI 33.0 (6.2) 36.0 (6.4) 32.8 (5.6) 34.6 (5.6) 32.9 (5.8) 35.3 (6.0) 
Lean mass (kg) 46.1 (6.6) 47.5 (5.8) 44.3 (7.8) 43.3 (9.3) 45.2 (7.2) 45.3 (8.0) 
Lean mass (%) 54.6 (9.0) 53.2 (11.0) 54.7 (9.4) 50.8 (6.8) 54.7 (9.1) 51.9 (9.0) 
Fat mass (kg) 39.3 (12.4) 43.6 (14.8) 37.5 (11.7) 42.6 (11.0) 38.4 (12.0) 43.1 (12.8) 
Fat mass (%) 45.3 (9.0) 46.8 (10.9) 45.2 (9.4) 49.2 (6.8) 45.3 (9.1) 48.1 (9.0) 
Serum Mg (mmol/l) 0.81 (0.08) 0.83(0.11) 0.84 (0.07) 0.79 (0.07) 0.83 (0.08) 0.81 (0.10) 
Plasma renin (uU/ml) 35.5 (53.2) 68.1 (78.4) 47.1 (95.2) 56.4 (66.6) 41.3 (76.3) 62.3 (72.1) 
Plasma aldosterone 228 (149) 202 (142) 284 (264) 216 (156) . 256(213) 209 (148) 
(pmol/ml) 

Aldosterone:renin 14.3 22.3 (30.2) 14.7 (19.2) 18.3 (23.8) 12.0 (15.1) 
9.~ (9.3) I 
ratio 
Activities of Daily Living (ADL) and Ir-dependent Activities of Daily Living (IADL) 
, 
Level of independent functioning was high, with a mean Barthel ADL Index and Katz 
ADL score of 19.9 (0.3) and 5.90 (0.30), respectively in the low salt group and 19.6 (2.1) 
and 5.87 (0.79), respectively, in the control group. All subjects scored either 19 or 20 out 
of a possible 20 on the Barthel Index and had a Katz ADL score 2:: 5 which indicates no 
impairment, with the exception of one subject who had a score of 7 on the Barthel and 1 
on the Katz indices (control group, Ph~se 2). Out of a possible maximum score of 16 on 
the IADL index, mean score was 15.~ (0.6) and 15.5 (2.6) in the low salt and control 
groups, respectively. Regarding IADL, the same subject had a score of 0, indicating 
maximum impairment while most other subjects scored full points (ie.16) on the Lawton 
scale. All subjects reported being continent, both for bladder and bowel function. No 
differences in ability to perform ADL were found between diet groups in either Phase. 
Baseline blood pressure 
Baseline BP, measured using the Omron automated monitor and 24-hr AMBP is shown 
in Table 4. On average, 89 % of the number of BP readings attempted during the 24-hr 
period of wearing the Oscar /I device were successfully recorded. AMBP measurements 














Baseline blood pressure, as measured by Omron and 24·hour ambulatory Oscar 2, 

according to Phase and diet group (mean (SD)) 

PHASE 1 PHASE 2. TOTAL 
Low salt Control Low salt Control Low salt Control 
N =20 N =20 N =20 N =20 N =40 N =40 
OMRON (Office) BP 
Systolic BP 139.7 (15.7) 132.0 (19.0) 128.1 (11.1) 138.8 (13.8) 133.9 (14.6) 13504 (16.7) 
Diastolic BP 80.2 (9.6) 80.5 (7.0) 79.4 (7.6) 84.1 (7.7) 79.8 (8.6) 82.3 (7.5) 
24-HOUR AMBULATORY BP 
No. of readings 















Average Sys BP 13504 (13.8) 132.6 (16.5) 134.6 (13.6) 145.3 (15.5) 135.0 (13.5) 138.9 (17.0) 
Average Dias BP 78.1 (10.2) 76.6 (6.1) 8004 (7.1) 84.2 (9.7) 79.2 (8.7) 8004 (8.9) 
Wake Sys BP 139.5 (14.0) 136.1 (18.4) 137.8 (1404) 149.0 (15.4) 138.6 (14.0) 142.5 (18.0) 
Wake Dias BP 81.0 (11.1) 79.5 (7.0) 83.1 (6.6) 87.5 (10A) 82.0 (9.1) 83.5 (9.6) 
Sleep Sys BP 123.6 (13.3) 122.9 (13.6) 12404 (15.0) . 134.0 (18.0) 124.0 (14.0) 128.5 (16.7) 
Sleep Dias BP 69.0 (804) 68.8 (6.1) 71.7 (10.3) 74.7 (9.5) 7004 (9A) 71.S (SA) 
Medication status of subjects is shown. according to diet group, in Table 5. The average 
number of prescribed anti-hypertensive medications was 2.1 (0.9). The most common 
anti-hypertensive medication was low ceiling thiazide diuretics (76.2 % subjects). 
followed by ACE inhibitors (55.0 % subjects). Thirty percent (n = 24) of subjects were on 
a monotherapy regimen (n =15/24 were taking low ceiling diuretics, 
Table 5 
Number (%) of subjects taking regular prescribed medication for hypertension, diabetes 
and atherosclerosis 
Condition and type of drug Diet group Total 
Low salt Control N =80 
N=40 N =40 
'1\ 
Hypertension 
No. types of drugs (Mean (SD» 
Diuretics 
2.07 (O.86) 2.15 (0.92) 2.11 (O.89) 
Low-ceiling diuretics (thiazide, others) 
Other diuretics: High-ceiling diuretics; Potassium-sparing 
29 (72.5%) 32 (77.5%) 61 (76.2 %) 
agents; diuretics and potassium-sparing agents 
Beta-blocking agents 
Calcium channel blockers 
Agents acting on renin-angiotensin system (ACE 
4 (10 %) 
11 (27.5 %) 
11 (27.5 %) 
4 (10 %) 
13 (32.5 %) 
11 (27.5 %) 
8 (10 %) 
24 (30 %) 
22 (27.5 %) 
inhibitors) 
Anti-adrenergic agents - centrally acting (Reserpine) 
Agents acting on arteriolar smooth muscle 
23 (57.5 %) 
2 (5 %) 
3 (7.5 %) 
21 (52.5 %) 
1 (2.5 %) 
6 (15 %) 
44 (55.0 %) 
3 (3.7 %) 
9 (11.2 %) 
Diabetes (Biguanides/sulphonylureas)t 6 (15 %) 7 (17.5 %) 13 (16.2 %) 
Atherosclerosis 8 (15 %) 6 (15 %) 14 (17.5 %) 
Vasodilators; Platelet aggregation inhibitors; Aspirin; 
Cardiac glycosides; Antiarrhythmics 
t One subject was newly diagnosed as being diabetic in the run-in period, so was not taking hypoglycaemic 











. while the most common combination of antihypertensive drugs was low ceiling diuretics 
and ACE inhibitors (n =22/80; 27.5 %),followed by low ceiling diuretics, calcium channel 
blockers and ACE inhibitors (n = 8/80; 10 %), and then low ceiling diuretics and beta 
blockers ( n= 7/80; 8.8 %). No subject was taking a single agent which combined 
diuretics with either reserpine andlor a:vasodilator. an ACE inhibitor, or a beta-blocking 
I 
. agent, nor were peripherally acting anti-adrenergic agents or lipid-lowering drugs 
prescribed. Fourteen subjects (17.5 %, 7 in each diet group) had Type 2 diabetes and 
, 

were treated with oral agents (17.5 %).: 

Blood pressure 
Omron (office) blood pressure 
The mean BP at baseline (Week 1 - mean of 3 weekly repeated measurements plus Day 
1 of intervention). at Week 4 (after 4 ~eeks of consuming randomly assigned diet) and 
Week 8 (after 8 weeks of consuming randomly assigned diet) is shown in Table 6 and 
I 
demonstrated graphically in Figures 3 and 4, and. Results are combined for Phase 1 (N 
= 40) and Phase 2 (N = 40). 
Table 6 
Mean BP measurements (Omron) at baseline, week 4 and week 8, according to diet group 
(Phase I and II combined) 
Visit BP Low salt Control 
Valid N rean so Valid N Mean SO 
Baselinet SysBP 40 1;33.91 14.62 40 135.43 16.71 
DiasBP 40 79.82 8.58 40 82.26 7.47 
Week 4:): SysBP 40 1e5.74 19.17 40 136.75 22.14 
DiasBP 40 78.12 12.39 40 81.40 8.54 
Week 8:): SysBP 40 127.50 16.73 40 132.51 17.96 
DiasBP 40 [79.06 10.86 40 82.08 8.38 
t Mean of run-in visits (1,2,3) and visit 4 (qay 1 of intervention) 















Mean systolic BP (Omron) at baseline (Week 0), Week 4 and Week 8 of intervention, 

according to diet group allocation (Confidence intervals reflect SEM) 























Mean diastolic BP (Om ron) at baseline (Week 0), Week 4 and Week 8 of intervention, 

according to diet group allocation (Confidence intervals reflect SEM) 

































From Figures 3 and 4, it is evident tha~ most of the effect of the intervention had already 
! 
occurred within the first 4 weeks of the intervention. For systolic BP, the overall linear 
regression model showed a significant interaction (P = 0.0321) effect between diet and 
time which is what was expected ~rom a successful intervention. This interaction 
necessitated an investigation of the ~P between-diet group differences at each time 
point and within each diet group over time. The between-diet difference (estimated from 
the model) increases from 1.54 mm Hg at baseline to 10.4 mmHg at week 4 and then 
. drops to 5.4 mmHg at week 8 (Table 7~. 
Table 7 
Analysis of regression modelling of parameter estimates for change in Omron Systolic BP 
according to Diet*Time interaction effect (GEE approach) 
Group Time Estimate! SE P value 95 % CI estimate 
Control 1 - 4 -1.368 2.554 0.5923 -6.373; 3.638 
Within-group 
difference 










Low salt 1 - 4 7.521 1.977 0.0001 3.646; 11.396 
Within-group 
difference 




















-5.261 ; 8.360 
1.226; 19.649 
{Control-Low salt} 8 5.425 4.044 0.1797 -2.500; 13.351 
I 
For diastolic BP, the overall regression model did not find a significant interaction (P = 
0.9163) effect between diet and time, nor were any differences in BP found for either 
within- or between-diet groups over tinpe (Table 8). 
Table 8 
Analysis of regression modelling of pa~ameter estimates for change in Omron Diastolic BP 
according to Diet*Time interaction effect (GEE approach) 
I 
Group Time Estimate SE P value 95 % CI estimate 
Control 1 - 4 1.069 0.856 0.2118 -0.609; 2.748 










Low salt 1 - 4 1.248 1.185 0.2920 -1.073; 3.570 

































Since no difference was found in change from baseline between weeks 4 and 8 for both 
systolic (Table 7) and diastolic (Table 8) BP, the average BP of weeks 4 and 8 ("Post") 
was calculated and is shown in Table 9 and demonstrated graphically in Figure 5. 
Table 9 
Mean BP measurements for Pre and Post, according to diet group (Phase I and II 
combined) 
Visit BP LOW SALT CONTROL 
Valid N Mean SO Valid N Mean SO 
Pret SysBP 40 133.91 14.62 40 135.43 16.71 
DiasBP 40 79.82 8.58 40 82.26 7.47 
Postj: SysBP 40 126.62 16.32 40 134.34 18.48 
DiasBP 40 78.59 10.67 40 81.63 7.62 
t Baseline, mean of run-in visits (1,2,3) and visit 4 (day 1 of intervention) 
:I: Mean of Week 4 and Week 8 measurements. 
Figure 5 
Mean systolic and diastolic BP at Pre (baseline) and Post (mean of week 4 and week 8 
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The mean within-diet group difference In systolic and diastolic BP between Pre and Post 




Table 10 ! 

Mean change from baseline in blood pressure (Omron) associated with a reduced salt, 

compared to control, diet in black Soutt1 African hypertensives (Pre to Post)8 

N Mean BP Std. Std Error 
(mm Hg): Deviation Mean ( 
Systolic BP 
Low salt 40 . -7.288 10.961 1.733 
Control 40 -1.094 12.564 1.986 
Diastolic BP 
Low salt 40 -1.229 6.224 0.984 
Control 40 -0.634 4.514 0.714 
8 	 Pre = mean of run-in visits (1,2,3) and visit 4 (day 1 of intervention) 
Post = mean of Week 4 and Week 8 measurements. 
Table 11 
Mean net difference in blood pressure' (Omron) between the intervention and control diet 
groups (Pre to Post)8 . 












95 % Confidence 




test statistic ( 
tailed P-Value 
-2.349 (0.021 * 
Diastolic BPt 80 -0.595 !10.876 1.216 -3.019 1.829 -0.489 (0.626) 
8 	Pre = mean of run-in visits (1,2,3) and visit 4 (day 1 of intervention) 
Post =mean of Week 4 and Week 8 me~surements. 
• P<O.05; T-test performed assuming unequal variances. 
24-hr Ambulatory Blood Pressure 
Post-intervention, on average, 90.5 %1 (57.5/63.5) and 90.7 % (57.6/63.5) of the number 
of BP readings attempted during the i24-hr period of wearing the Oscar II device were 
successfully recorded for the low salt and control groups, respectively. One subject who 
had < 50 % potential readings necorded at first attempt repeated the AMBP 
measurement. Between-diet group change in 24-hr ambulatory BP from baseline is 
, 
shown in Table 12. The largest di~t effect was seen for wake systoliC BP (mean 
between-group difference of -5.14 (SE == 2.40) mmHg; P<0.05), followed by average 24­













Between-diet group differencet in 24-hour ambulatory blood pressure (General Linear 
Model, adjusted for baseline average 24-hr systolic BP, diastolic BP, MAP and Phase) 
Mean net SEM 95 % Confidence P valuet 
difference Interval of Difference 
(mm Hg) Lower Upper 
... Average Sys BP -4.527 2.269 -9.047 -0.006 0.050* 
Average Dias BP -2.494 1.338 -5.160 0.173 0.066 
Wake Sys BP -5.138 2.404 -9.928 -0.348 0.036* 
Wake Dias BP -2.661 1.457 -5.565 0.242 0.072 
Sleep Sys BP -3.465 2.540 -8.527 1.596 0.177 
Sleep Dias BP -1.790 1.679 -5.134 1.555 0.290 
MAPtt -3.113 1.583 -6.267 0.040 0.053 
t Low salt-control 
• P<O.05 for differences in BP between diet groups (baseline BP minus 8-week BP) 
tt Mean arterial pressure 
Compliance with dietary intervention 
• Reported dietary intake 
At baseline, there were no differences in reported energy, protein, fat, cholesterol, 
carbohydrate, Na, K, Ga or Mg intake between diet groups. Reported Na intake at 
baseline was similar for the low salt and control groups (1 694 mg/day (4.23 g NaGI) and 
1 912 mg/day (4.78 g NaGI), respectively). During the intervention, reported energy and 
carbohydrate intake increased significantly in both the low salt and control groups 
(Tables 13 and 14). Reported protein, fat and cholesterol intake remained unchanged 
during the intervention in both diet groups. 
Reported dietary Na intake increased Significantly (P<0.0005) by an 'average of 1 252 
(1403) mg (3.13 g salt) per day between baseline and intervention in the control group, 
but no change was seen in the low salt group. Reported K, Ga and Mg intake 
significantly «0.0001) increased by 897 (781) mg, 436 (280) mg and 84 (86) mg 

















Reported dietary intake at baseline and during week 4 and week 8 of the intervention, 

according to diet group (Phase 1 and 2 combined): Low salt group (N =40) 

Nutrient 	 BaseJine
a Week 4 WeekS Post!) Differencet P value* 
Energy (kJ) Mean 6440.7 7537.5 7202.4 7369.9 929.3 0.0267 
SO 1569.4, 2417.7 2405.3 2075.1 1839.7 
Median 6437.71 7886.1 6927.4 7431.3 
Protein (g) Mean 53.6: 61.0 62.1 61.6 8.0 0.0488 
SO 16.1 24.7 25.2 19.6 17.9 
Median 53.6 56.9 54.6 63.8 
Fat (g) Mean 48.2; 55.2 49.6 52.4 4.3 0.3039 
SO 18.0 
I 
25.8 23.4 18.8 18.4 
Median 46.3 55.7 48.1 53.1 
Cholesterol (mg) Mean 213.6 222.0 202.2 212.1 -1.5 0.9589 
SO 120.5 200.6 168.8 137.3 129.2 
Median 205.~ 162.1 150.7 170.2 
Carbohydrate (g) Mean 200.1' 251.7 241.2 246.5 46.3 0.0051 
SO 55.3 90.8 95.3 84.7 71.5 
: 
Median 197.1 242.2 234.0 236.7 
Na (mg) Mean 1693.8 1744.7 1811.9 1778.3 84.5 0.6487 
SO 724.:j 1031.4 1119.1 916.3 825.9 
Median 1502.~ 1601.2 1545.4 1656.0 
Ca (mg) Mean 385.1! 910.0 733.0 821.5 436.4 <0.0001 
SO 180.1 447.7 498.6 353.0 280.2 
Median 347.8 922.9 491.2 802.4 
K (mg) Mean 1831.1:\ , 2734.5 2723.1 2728.8 896.9 <0.0001 
SO 517.0 
I 
1068.6 1314.2 976.6 781.3 
Median 1762.9 2669.3 2513.0 2729.3 
Mg (mg) Mean 223,4 316.8 298.0 307.4 84.0 <0.0001 
SO 63.6 108.2 128.0 103.4 85.9 
Median 231 303.2 284.0 281.8 
a Baseline =average of visits 1,2 and 3 during run-in; b Post = average of week 4 and 8. 
t Difference = Post - Baseline 
* Independent t-test for difference in intake from baseline; Pooled for equal variances, Satterthwaite for 
unequal variances. P<0.05 values highlighted i~ bold. 
Table 14 

Reported dietary intake at baseline and during week 4 and week 8 of the intervention, 

according to diet group (Phase 1 and 2 combined): Control group (N =40) 

Nutrient 	 Baseline3 : Week 4 WeekS Post!) Differencet P value* 
Energy (kJ) 	 Mean 6432.5 7189.7 7823.3 7506.5 1074 0.0309 
SO 1902.~ 2569.8 2948.3 2435.9 2185.5 
Median 6098.9 7381.9 7646.7 7329.2 
I 
Protein (g) 	 Mean 57.4 56.6 61.2 58.9 1.4805 0.7933 
SO 29.6 24.3 23.2 19.7 25.172 
Median 52.9 53.8 61.8 56.8 
Fat (g) 	 Mean 50.5 54.9 59.7 57.3 6.8469 0.2043 
SO 22·1 24.8 35.1 25.1 23.921 
Median 50.6 53.1 49.0 54.8 
Cholesterol (mg) 	 Mean 224.2 210.0 242.1 226.0 1.8807 0.9603 












a Week 4 Week 8 Postli Differencet P value* 
Median 155.0 137.4 170.2 216.1 
Carbohydrate (g) Mean 194.1 236.5 255.5 246.0 51.966 0.0049 
SO 59.8 106.2 106.0 95.8 79.815 
Median 190.7 227.1 232.6 215.4 
Na (mg) Mean 1912.3 3215.2 3112.4 3163.8 1251.5 0.0002 
SO 922.4 1933.0 2095.1 1757.2 1403.3 
Median 1732.4 2826.9 3096.0 2813.4 
Ca (mg) Mean 406.9 505.0 561.3 533.1 126.26 0.1009 
SO 298.2 395.9 426.4 377.4 340.12 
Median 326.5 352.8 424.4 426.3 
K (mg) Mean 1825.5 1735.8 1977.9 1856.9 31.351 0.8420 
SO 587.6 879.0 936.3 798.7 701.1 
Median 1804.0 1590.8 1742.5 1725.8 
Mg (mg) Mean 221.5 219.4 250.7 235.0 13.561 0.4446 
SO 64.5 95.9 103.4 91.0 78.886 
Median 211.8 218.4 232.5 223.2 
a Baseline =average of visits 1,2 and 3 during run-in; b Post =average of week 4 and 8. 
t Difference =Post - Baseline 
• Independent t-test for difference in intake from baseline; Pooled for equal variances, Satterthwaite for 
unequal variances. P<0.05 values highlighted in bold. 
A significant (P<0.0005) difference between diet groups for change in intake of Na, K, Ca 
and Mg intake from baseline to intervention was found (Table 15). In order to account for 
the increase in energy intake, Na intake was expressed as mg/4 200 kJ. Mean difference 
in Na/4 200 kJ between intervention and baseline was a reduction of -104 (418) mg/4 
200 kJ for the low salt group and an increase of 558 (1058) mg/4 200 kJ for the control 
group, yielding a net between-diet difference of -661 (805) mg/4 200 kJ (P=0.0006). 
Table 15 
Between-diet difference in reported dietary intake between baseline and during 
intervention (average of weeks 4 and 8) (Phase 1 and 2 combined) 
Nutrient Mean difference P value* 
(Low salt group- Control group) 
Energy (kJ) -145 (1 973) 0.7437 
Protein (g) 6.5 (26.3) 0.2700 
Fat (g) -2.6 (24.7) 0.6409 
Cholesterol (mg) -3.4 (183) 0.9345 
Carbohydrate (g) -5.6 (77.8) 0.7473 
Na (mg) -1 167 (1532) 0.0012* 
Ca (mg) 310 (392) 0.0007* 
K (mg) 867 (890) <0.0001* 
Mg (mg) 70.5 (89.0) 0.0007* 
• Independent t-test for between-diet group difference in intake from baseline; Pooled for equal variances, 
Satterthwaite for unequal variances. P<0.05 values highlighted in bold. 
The average amount of food consumed from each food group at baseline and during the 











between diet groups at baseline regarding quantity of intake from any of the food groups. 
During the intervention, the low salt group had a significantly higher intake from the milk 
and dairy products group compared to the control group (P<0.0001). 
Table 16 
Reported amount of food (g/day) consumed from selected food groups at baseline and 
during the intervention, according to di~t groups: mean (SO) 
Food group low salt (N = 40) Control (N = 40) 
Grains and grain products 
Baseline8 394.3 (160.1) 351.2 (143.6) 
Follow-upb 368.5 (156.2) 362.7 (175.7) 
Vegetables 
Baseline 125.8 (89.7) 90.5 (71.7) 
Follow-up 94.6 (106.0)* 84.2 (104.8) 
Root vegetables 
Baseline 86.6 (69.5) 79.2 (65.1) 
Follow-up 84.9 (64.1) 84.6 (82.8) 
Fruits 
Baseline 112.8 (100.9) 130.1 (123.7) 
Follow-up 145.7 (110.8) 140.8 (138.0) 
Vegetable oils and spreads 
Baseline 9.7 (7.8) 12.3 (13.7) 
Follow-up 1~o4 (16.3) 23.5 (19.8)* 
Milk and dairy products 
Baseline 128.3 (92.6) 127.0(112.1) 
Follow-upt 319.0 (174.5)** 130.0 (180.3) 
Meat/poultry/offal 
Baseline, 9*.2 (63.8) 105.1 (76.1) 
Follow-up 13r2 (103.7) 16004 (93.5)* 
Fish 
Baseline ~.7 (30.5) 11.8 (22.7) 
Follow-up 1:p (40.2) 9.9 (27.3) 
Eggs 
Baseline 2~.1 (27.6) 15.8 (22.9) 
Follow-up 1~.9 (30.5) 21.9 (30.3) 
Legumes 
Baseline 1Q.6 (32.6) 9.0 (23.9) 
Follow-up 11;4 (38.1) 8.9 (35.4) 
Nuts, seeds 
Baseline 1.7 (4.8) 3.2 (6.8) 
FalIow-uj2 1.6 (5.13) 1.2 (304) 
a Mean of 3 repeated 24-hr recalls; b Mean of single 24-hr recall at week 4 and Week 8. 
* P<0.05; ** P<0.0001; Wilcoxon 2-sample t-test (two-sided) for difference between baseline and intervention 

for that diet group. 

t P<0.0001; Wilcoxon 2-sample Hest (two-sided) for difference between diet group at intervention. 

The average reported amount of individual foods that were provided as part of the 
intervention is shown, at baseline and during the intervention, according to diet group in 
Table 17. There were no differences between diet groups at baseline for quantity of 
intake from any of the food groups. During the intervention, the low salt group had a 
significantly higher intake of maas (P<0.0001) and a lower intake of margarine (P = 













Reported consumption of individual foods (g/day) that were provided during the study: at 
baseline and during the intervention, according to diet groups: mean (SO) 
Food group 	 Low salt (N =40) Control (N =40)• 
Baselinea 85.6 (52.4) 94.7 (55.8) 
Follow-upb 123.2 (72.2)* 129.4 (71.1)· 
Margarine (brick - Rama) • 	 Baseline 3.0 (5.5) 3.8 (6.5) 
Follow-up t 12.8 (14.6)** 21.7 (20.3)*· 
Maas 
Baseline 33.3 (56.7) 28.2 (70.0) 
Follow-up tt 215.4 (178.4 )*. 59.9 (132.9) 
Knorrox Stock cubes 
Baseline 0.67 (0.90) 0.93 (1.07) 
Follow-up 2.38 (3.37) 3.14 (4.18) 
Knorrox Soup mix 
Baselinec 0.4 (2.3) 5.0 (18.9) 
Follow-upd 37.3 (89.1)* 55.4 (93.2) 
Aromat 
Baseline 0.08 (1.16) 0.07 (0.24) 
Follow-up 0.41 (0.50)** 0.65 (0.65)** 
Table salt/Solo 
Baseline 1.12 (1.16) 1.33 (1.31) 
Follow-up 0.64 (1.02):t: 1.12 (1.44) 
Cooldrink 
Baseline 12.8 (35.3) 13.0 (47.8) 
Follow-up tt 17.3 (59.9) 376.8 (267.2) 
a Mean of 3 repeated 24-hr recalls; b Mean of single 24-hr recall at week 4 and Week 8. 
e Dry powder d Reconstituted with water. 
* P<O.05; ** P<0.0001; :t:P=0.054; Wilcoxon 2-sample t-test (two-sided) for difference between baseline and 

intervention for that diet group. 





There was a non-significant trend for mean daily intake of maize porridge and dishes 
(these were not provided as part of intervention) to decrease from baseline to 
intervention in both the low salt (115.0 (131.6) vs 77.9 (106.5) g/day; P ;; 0.0593) and 
control groups (84.8 (117.1) vs 65.5 (116.8) g/day; P =0.1729). 
• Average weekly usage of salt and Aromat 
In Phase 1, subjects assigned to the Control diet had a significantly higher average 
weighed weekly household intake of salt than subjects in the Low salt group, however 
this difference was not seen in Phase 2 (Table 18), and was not significant for both 
Phases combined (P = 0.139). No difference was found for Aromat usage between the 













Mean weekly intake of salt and Aromat of subjects' households, according to diet group 
and Phase 
Phase 1 (N = 40) Phase 2 (N =40) TOTAL (N = 80) 
SALT/SOLO (g/weeklhousehold) 

Low salt 65.42 (40.71) 71.79 (50.55) 68.61 (45.42) 





Low salt 4?19 (18.39) 47.25 (21.02) 44.72 (19.66) 

Control 46.78 (15.51) 45.39 (14.23) 46.08 (14.71) 

*P<0.05; Independent t-test for differences between low salt and control groups, for that Phase. 

• Consumer acceptability of intervention foods 
At the end of the intervention (week 8), subjects were asked to rate, on a 5 point Likert 
scale, each of the food items that had been provided to them, in comparison to the type 
of these foods that they usually ate. Most of the low salt group disliked the margarine 
(87.5 %) and the salt replacement (75 %), but reported preferring the other food items to 
the regular consumed varieties (Table 19). The control group reported that they preferred 
all of the food items provided, despite the fact that the foods were unaltered in cation 
content. 
Table 19 
Acceptability of foods provided in trial, compared to usual varieties eaten 
Food 	 Like a lot 
: 
Like a little Same Dislike a Dislike a 
better better little more lot more 
Bread 
Low salt diet 47.5 30.0 5.0 10.0 7.5 
77.5 10.0 5.0 5.0 2.5Control diet 
Margarine 
Low salt diet 	 5.0 5.0 7.5 12.5 75.0 
90.0 2.5 5.0 2.5Control diet 
Salt 
Low salt diet 	 15.0 7.5 2.5 22.5 52.5 
67.5 22.5 2.5 5.0 2.5Control diet 
Aromat 
Low salt diet 	 80.0 5.0 5.0 7.5 2.5 
82.5 12.5 	 2.5 2.5Control diet 
Stock cubes 
Low salt diet 67.5 10.0 7.5 10.0 5.0 
90.0 2.5 5.0 2.5Control diet 
Soup mix 
Low salt diet 	 62.5 20.0 2.5 7.5 7.5 













• Urinary cation excretion 
Change in 24-hour urinary excretion of Na, K, Mg and Ca, according to Phase and diet 
group allocation, is shown in Table 20. At baseline, mean Na excretion was similar 
between diet groups in Phase1, but in Phase 2 the low salt group had lower values than 
the control group. During the trial, there was a trend for a reduced l\Ja excretion in the 
low salt group, but the between-diet group difference was not significant. Between-diet 
group difference in 24-hour urinary K and urinary Mg excretion from baseline to 
intervention was 25 mmollday (p<0.0001) and 0.68 mmollday (P<0.005), respectively. 
No change in urinary calcium excretion was observed. Difference in excretion from 
baseline to visit 4 was similar to baseline-visit 5 difference for all cations investigated, 
except for urinary Na of control group in Phase 2 (P =0.045; Wilcoxon matched pairs 
signed rank sum test). 
The multiple- regression model, in which change in BP was investigated against change 
in urinary cation excretion, diet group, and urinary cation*diet group interaction factors, 
found that for systolic BP, the R2 value of the model indicated that 21.5 % of the variation 
in systolic BP change was due to the dietary components investigated (taking urinary 
excretion as a proxy for dietary intake). The only statistically significant item in the model 
was change in urinary potassium (P =0.002; increase in K associated with reduction in 
BP), with a trend towards an interaction effect between diet and change in urinary K (P = 
0.143). In regression models which excluded interaction terms, increase in urinary K 
remained the only significant predictor of both reduction in systolic BP (P = 0.006; model 
R2 =0.176) and diastolic BP (P =0.023; R2 =0.075), irrespective of diet treatment arm. 
The association between change in urinary K excretion and change in systoliC and 
diastolic BP is shown in Figures 6 and 7, respectively. Lines represent non-parametric 














Mean (SO) 24-hour urinary excretion of Na, K, Mg and Ca (mmol/day) 

Baseline
a Post- Intervention Mean Mean 
interventionb change from difference 
Week 4 WeekS baselinet between diet 
groupstt 
Urinary Na (mmoI/24-hr) 
Phase 1 
Low salt diet 182.4 (54.4) 165.2 (70.2) 170.5 (67.2) 164.7 (81.2) -12.4 (64.5) -1.9 (44.5) 
Control 178.6 (41.6) 168.0 (51.4) 166.3 (60.5) 171.6 (80.8) -10.6 (43.2) 
Phase 2 
Low salt diet 161.5 (52.4) 142.8 (56.4) 139.0 (62.6) 146.8 (66.8) -16.7 (43.8) -15.8 (45.0) 
Control 167.8 (62.0) 170.6 (65.2) 157.0 (86.5) 184.2 (69.7) -0.9 (64.8) 
Phase 1 & 2 
Low salt diet 171.7 (53.7) 154.3 (64.0) 155.2 (66.1) 156.0 (74.1) -14.6 (54.4) -8.7 (46.9) 
Control 173.2 {52.41 169.3 {57.7} 161.7 (7~.81 177.9 (74.7} -5.~ (54.31 
Urinary K (mmoI/24.hr) 
Phase 1 
Low salt diet 55.4 (11.7) 75.8 (21.8) 75.2 (18.2) 77.9 (32.0) +22.0 (19.9)** +26.8 (13.8)** 
Control 52.4 (14.3) 47.6 (8.8) 45.7 (11.1) 49.7 (13.9) - 4.8 (13.4) 
Phase 2 
Low salt diet 49.3 (9.6) 67.4 (28.8) 68.2 (28.7) 67.4 (34.3) +18.0 (25.7)* +22.4 (17.5)* 
Control 53.5 (15.5) 49.8 (18.7) 48.4 (18.7) 51.2 (21.8) - 4.3 (16.4) 
Phase 1 & 2 
Low salt diet 52.3 (11.0) 71.7 (25.5) 71.8 (23.8) 72.8 (33.1) +20.0 (22.7)** +24.6 (16.5)** 
Control 52.9 (14.7) 48.6 {14.3} 47.0 {15.2} 50.4J18.1} -4.6 (14.8} 
Urinary Mg (mmoIl24-hr) 
Phase 1 
Low salt diet 2.81 (0.85) 3.56 (1.20) 3.70 (1.28) 3.50 (1.35) +0.82 (0.89)** +0.69 (0.70)* 
Control 2.79 (0.74) 2.92 (0.92) 3.17 (1.00) 2.68 (1.19) +0.13 (0.83) 
Phase 2 
Low salt diet 2.91 (1.02) 3.83(1.91) 3.49 (1.64) 4.25 (2.65) +0.94 (1.47)· +0.68 (0.97) 
Control 2.78 (1.16) 3.09 (1.23) 2.96 (1.19) 3.21 (1.42) +0.26 (0.81) 
Phase 1 & 2 
Low salt diet 2.86 (0.93) 3.70 (1.57) 3.60 (1.45) 3.86 (2.09) +0.88 (1.20) +0.68 (0.88)* 
Control 2.79 (0.96} 3.00 (1.07) 3.07 (1.09) 2.95 (1.321 +0.19 (0.81) 
Urinary Ca (mmoIl24-hr) 
Phase 1 
Low salt diet 2.06 (1.52) 2.39 (1.86) 2.49 (2.02) 2.32 (1.91) +0.36 (1.07) 0.24 (0.74) 
Control 0.97 (0.66) 1.09 (0.75) 0.88 (0.66) 1.26 (1.01) +0.12 (0.73) 
Phase 2 
Low salt diet 1.78(1.19) 1.88 (1.28) 1.73 (1.07) 1.98(1.81) +0.20 (0.95) -0.34 (0.97) 
Control 1.81 (1.28) 2.38 (2.06) 2.16 (2.08) 2.61 (2.29) +0.54 (1.40) 
Phase 1 & 2 
Low salt diet 1.92 (1.35) 2.15 (1.61) 2.03 (1.62) 2.14 (1.83) +0.27 (1.00) -0.05 (0.91) 
Control 1.39 {1.72) 1.72 (1.65) 1.50 {1.61} 1.85 (1.86} +0.?2 (1.11) 
a Baseline =Average of run-in visits 1 ,2,3; b Post = Average of weeks 4 & 8. 

t Baseline minus Post; tt Low salt diet minus Control. 
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FigureS 
Association between change in urinary potassium and change in systolic blood pressure, 
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Potential confounders in the diet-BP association 
A small, but non-significant weight change was seen between baseline and the end of 
intervention (Table 21) in both the diet and control groups (Phase 1 and 2 combined). 
Neither 8MI nor % body fat (bioimped~ance method) changed during the study, for either 
of the diet groups. 
Table 21 
Change, from baseline, in weight, % bo~y fat, physical activity and self-perceived health 
status, according to Phase and diet gro.up 
PHAs~ 1 PHASE 2 TOTAL 
Weight (kg) 
Difference (Week 8 ­
Baseline) 
Between group difference 
in weight changet 
BMI (kglm2) 
Difference (Week 8· 
Baseline) 
Between group difference 
in weight changet 
% Body fat 
Difference (Week 8 ­
Baseline) 
Between group difference 
in weight changet 
Total physical activity 
(kcal/week) 
Difference (Week 8 ­
Baseline) 
Between group difference 
in physical activity scoret 
Health status score (self­
perceived) Difference 
(Week 8 - Baseline) 
Between group difference 
in health score! 
Low salt ¢ontrol Low salt Control Low salt Control 

N=20 ~=20 N=20 N=20 N=40 N=40 





P = 0.7267 

















12 (17.0)* -2.8 (20.0) 
14.8 (18.6)* 









































t Difference = Low salt group - Control 

*P<0.05; **P<0.001 for paired t-test of differenqes from baseline in that group. 

In all groups except for the low salt diet group in Phase 1, reported physical activity 
levels decreased during the intervention, but between-diet group differences were not 
significant. Self-perceived health status score improved significantly during the 
intervention in the low salt group, compared to the control group in Phase 1, but no 
between-diet differences were seen for the total group combined. 
ADL and IADL scores remained high ,during the study and there were no differences in 












a score indicative of impairment in functioning at baseline on the Barthel and Katz ADL 
indices, scored full points on both indices at follow-up. All subjects had a maximum Katz 
• 
 ADL score of 6 by the end of the intervention . 
-
Change in anti-hypertensive medication during the trial 
According to the medications that were presented to the fieldworkers at baseline and at 
week 8, twenty-two subjects had a change in anti-hypertensive medication during the 
trial (Table 22). Four categories were created to make a valid comparison between the 
diet groups (i.e. medications added; removed; combination of both; or no change). No 
significant difference in the profile of medication change was found between the two 
groups (Fisher's exact test P =0.0947). 
Table 22 
Change in anti-hypertensive medication between baseline and week 8, according to diet 
group (numbers of subjects) 
Type of drug Low salt (N =40) Control (N =40) 
Agents added during trial 
One agent (n =10) 
- ACE inhibitor 3 
- Low ceiling diuretic 2 1 
- High ceiling diuretic 1 
- B-blocker 1 1 
- Agent acting on arteriolar smooth muscle 1 
Two agents (n = 1) 
- ACE inhibitor + B-blocker 1 
Total - agents added 9 2 
Agents removed during trial 
One Agent (n =5) 
- ACE inhibitor 
- Low ceiling diuretic 
- Diuretic/K-sparing agent combination 
Anti-adrenergic, centrally acting 
Two agents (n = 1) 
- Diuretic/K-sparing agent combination + B-blocker 1 
Total - agents removed 3 3 
Agents added and removed during trial (n =5) 
(High ceiling diuretic + B-blocker added) - (low ceiling 1 
diuretic) 
(B-blocker added) (low ceiling diuretic) 
(High ceiling diuretic added) (low ceiling diuretic) 1 
(Ca channel blocker added) - (diuretic/K sparing agent) 1 
(B-blocker added) (ACE inhibitor + low ceiling diuretic) 1 
Total - agents added and removed 4 












The frequencies observed in Table 22 are thus no different from a chance event 
occurring in each of the medication change categories. For example. in subjects who 
added medication, the 95% confidence interval for having 9 subjects out of 11 (81.8 %) 
in one arm is 34.9 to 96.8%: This interval includes 50% - it is assumed that the outcomes 
that occurred across the two arms have the same underlying probability of 0.5. The 'no 
change' numbers are nearly identical between diet groups, which further confirms the 
equality between diet group allocation. The profile for the phases are the same as for the 
overall sample (data not shown) which again demonstrates consistency. 
Discussion 
This study demonstrates that in a low-+income community setting in a developing African 
country, in this case South Africa,a food-based dietary intervention resulted in a 
clinically significant reduction in office systolic BP of -6.2 mmHg over 8 weeks. The 
decrease in diastolic BP was small and not significant (-0.6 mmHg). Twenty-four hour 
ambulatory blood pressure monitoring (ABPM) yielded a slightly smaller magnitude of 
effect for systolic BP, but demonstrated a clinically significant (and marginally statistically 
significant (P = 0.072» reduction ,in diastolic BP (-5.14/-2.66 mmHg for waking 
measurements). In South Africa, the limited resources at primary health care level 
allocated to the prevention and management of hypertension necessitate a non­
pharmacological population-based approach to curb the escalating burden of 
cardiovascular disease. Our study offers evidence of an approach that may be useful in 
a poor community setting, but that requires partnerships between public health agencies 
and the food industry. 
The intervention was based on a limited number of affordable food items that are 
commonly consumed by the target population. Our baseline studies (Chapters 3 & 4) 
clearly demonstrated that black peri-urban dwellers in Cape Town consume excessive 
quantities of Na, accompanied by inadequate intakes of K, Mg and Ca. An important 
difference between the design of our study and that of other large food-based blood 
pressure trials29.30.31.32 is that we did not attempt to alter habitual food patterns, in either 
quantity or quality. Instead, regular v$rieties of 6 foods (bread, margarine, stock cubes, 
soup mix, flavour enhancer, table salt) were substituted with items that had an altered 
content of Na, K, and Mg. In addition, provision of an additional 500 ml maas per day (a 
fermented milk product commonly eaten with the staple maize porridge) contributed to a 
higher Ca intake in the intervention group. Manipulation of the electrolyte content of 
these food items has provided an opportunity for co-operation between scientific 

















Such academia-food industry partnerships are not common in South Africa and this 
study is landmark in this regard. For this trial, the third largest baking and milling 
company in the country (Sasko Milling and Baking, Pioneer Foods) developed a reduced 
sodium bread which underwent extensive technological and consumer testing prior to 
use. Another major food company in the South African market, Unilever South Africa 
Foods, was responsible for developing the rest of the study food items. These two 
companies together contribute a large proportion of processed food in the country, and 
are influential trend-setters to the rest of the food industry. The scientific results of the 
trial can be used by the food industry partners to promote widespread consumption of 
the novel foods for improved blood pressure profiles, and thus provide a competitive 
edge in the staple food mass market, while at the same time, enabling a socially 
responsible approach in terms of promoting health. 
The magnitude of the BP-Iowering effect is similar to the findings of a 24-week 
randomised trial conducted in 55 - 75 year old Dutch subjects with untreated mild-to­
moderate hypertension (mean reduction of -7.6/-3.3 mm Hg; N =97).33 In that trial, the 
same salt replacement used in this study (SOLO®) was provided to subjects and a 
number of processed foods containing the product were provided to participants, in place 
of the regular varieties. The DASH 8-week feeding study, demonstrated a BP reduction 
of -13.2/-6.1 mm Hg in the sub-group analysis for African-American hypertensives (N = 
56).34 All food and beverages were provided in the DASH study and subjects consumed 
one supervised 	meal a day at the research centre, thus increasing compliance with the 
allocated diet. 	 In trials such as PREMIER,32 where patients are required to follow the 
DASH diet whilst purchasing their own food, it has been demonstrated that the 
recommended number of daily servings of fruit and vegetables could not be met. Another 
important difference between the design of the DASH trial and the present study is that all 
hypertensives recruited to the DASH study were free of antihypertensive medication for at 
least 2 weeks prior to commencement of the trial, which probably magnified the BP­II.. lowering effect of the DASH diet. 
D 
.. 	 Few food-based trials have been conducted in developing countries. A randomized 8­
week crossover study of low-salt and high-salt intakes conducted in Jamaica and Nigeria 
demonstrated a mean between-diet change in systolic BP of approximately 5 mmHg in 
both country sites.35 The BP responses were consistent with studies performed in mostly 
white individuals in developed countries.36 Mean change in urinary Na excretion between 
the low-salt and high-salt phases was 70 mmol/day, with no change in urinary K 











participants were able to achieve sUbstantial reductions in Na by simply not adding salt. 
during meal preparation. In Jamaican participants, on the other hand, a wider variety of 
high sodium processed and convenience foods necessitated more extensive dietary 
changes to acheive a sustained 5Q mmol/day reduction in Na intake. Jamaican 
, 
participants substituted low-sodium; alternatives for table salt, restricted their 
consumption of fast foods and alsd adopted food preparation practices aimed at 
I 
reducing overall salt intake. In additionl subjects could purchase a reduced sodium lunch 
; 
as the choice of low sodium foods c<insumed away from home are severely limited in 
that population. 
In the present study, the reduction in systolic BP was similar or higher than blood 
pressure responses reported in a meta-analysis of randomised trials of either sodium 
reduction (N = 40 trials) or potassium supplementation (1\1 = 27 trials),37 despite much 
smaller changes in both urinary Na and K achieved in our study. The meta-analysis 
demonstrated that in hypertensive subjects a median Na reduction of 77 mmoll24 h is 
associated with a blood pressure change of -5.24/-3.69 mmHg while corresponding 
values for K increase (median =44 mmoll24 h) were -3.51/-2.51 mmHg. 
A food-based intervention, focussing on only a limited number of foods, has not 
previously been attempted in the country. It was not the purpose of the trial to determine 
the contribution of each dietary manipulation (ie decreased Na and increased K, Mg and 
Cal to blood pressure reduction, but rather to demonstrate effectiveness of a composite 
dietary approach that could be of publ:ic health significance in the target population. As a 
measure of compliance, both 24-hr l:Jrinary excretion and reported dietary intake was 
measured during the intervention. It is important to note that the study sample size was 
not powered to detect an association between BP reduction and change in urinary 
excretion of cations, thereby interpretation of the analyses in this regard is limited. 
Despite methodological limitations, it seems that in regression models, increased urinary 
K excretion contributed the most to the BP-Iowering impact of the intervention. 
The urinary excretion data suggests that the dietary intervention did not achieve the 
sodium reduction that was expected from the diet formulation. The intervention diet was 
calculated to provide a decrease in dietary Na intake of 70 mmollday, compared to the 
control diet (41 % reduction), but the urinary data demonstrates a (non-significant) mean 
difference of only 9 mmol/day between the groups. This suggests that subjects may not 
have been consuming the test foods in the anticipated quantities. Indeed, the provision 
. . 




























not included as part of the intervention. The 24-h dietary recall data found a significant 
increase in energy and carbohydrate intake in both diet and control groups. Food group 
analyses demonstrates that bread consumption was increased in both groups during the 
trial. It appears that the increased bread intake displaced other staple foods, notably 
maize meal, to which large quantities of salt are generally added.3s 
There are discrepancies between the urinary excretion and dietary intake data which 
may be related to methodological difficulties associated with the collection of both these 
variables, despite efforts made to reduce bias and to increase validity of results. For 
example, to minimize error associated with undercollection of urinary samples, we 
excluded measurements with urinary creatinine values below sex-appropriate minimum 
reference ranges, expressed per kg lean body mass. Urine samples with volumes less 
than 500 ml per 24-hr period were also excluded from the analyses. The two interviewers 
who administered the 24-hr dietary recalls underwent rigorous training, including role­
play to increase accuracy of dietary reporting~ The dietary data found a significant 
between-group reported difference in Na intake of 51 mmollday, and this difference 
remained even after controlling for an increased energy intake during the intervention 
(mean = -29 mmol per 4 200 kJ). The difference in Na intake was explained by an 
increase in reported Na intake in the control group, rather than a substantial reduction in 
the low salt group, presumably due to the increased consumption of free bread in both 
groups. 
For potassium. the urinary excretion data is confirmed by the 24-hr dietary recall data. 
Mean between-group difference in 24;.hr urinary K excretion was 25 mmol (575 mg), 
compared to an expected difference of 62 mmol/day. Similarly. the 24-hr dietary recall 
data found a mean between-group difference in K intake of 22 mmollday. Urinary Mg 
excretion differed significantly, by on average 0.68 mmollday, between diet groups 
during the intervention, whereas the dietary data found a higher between-group mean 
difference of 2.94 mmollday. For calcium, no difference in urinary excretion was 
observed between diet groups, however dietary intake data demonstrated a significant 
mean increase of 310 mg in the experimental compared to control group and, mean 
reported intake of maas increased from 33 to 275 g/day in the intervention group. 
Caution should be exercised in the interpretation of the urinary excretion data as a proxy 
for intake for calcium and magnesium. Unlike sodium and potassium, where more than 
98 % and 85 % of the daily ingested amount, respectively, is excreted in the urine,39 
urinary excretion of calcium and magnesium can vary widely, although it generally 











urinary calcium and magnesium are not quantitative and, at best, provide qualitative 
confirmation of compliance.41 Urinary calcium excretion is largely influenced by sodium 
chloride intake,42.43 thus in the control group who reported a substantial increase in 
dietary salt intake, it would be expecte:d that calcium excretion would also be increased, 
regardless of dietary intake. This interaction may explain the lack of relative difference in 
calcium excretion between the diet grollps. 
Thus, considering both urinary and dietary data, the dietary intervention achieved an 
overall increase in K, Mg and Ca but without a substantial decrease in the Na content of 
the diet. In effect, our trial simulated the high sodium arm (150 mmol Na/day) of the 
DASH-Sodium trial.30 Our sample had higher baseline Na excretion values (167 - 169 
mmol/day) than participants in either the DASH Sodium (152 - 158 mmol/day)30 or the 
original DASH dief9 (132 - 140 mmol/day) studies. Urinary Na excretion remained 
around the level of 150 mmol/day for: the low salt group during the intervention in the 
! . 
present study. Urinary K excretion of isubjects in the low salt arm increased during the 
trial to similar levels as those describJd for subjects following the DASH diet in both the 
original DASH study (74.5 mmollday) and the follow-up DASH-Sodium study (75.0 
mmol/day). Urinary Mg levels rose to similar concentrations found in the DASH study 
(4.03 mmol/day), but urinary Ca was considerably lower than DASH study participants 
(3.64 mmol) (Neither Mg nor Ca excretion were described for the DASH-Sodium study). 
We achieved similar BP reductions between diet-control groups as those reported in 
participants in the high-Na arm of the DASH-Sodium study (-5.9/-2.9 mmHg). Thus, 
simply by changing the cation content of 5 commonly eaten foods, providing a salt 
replacement, and the daily addition of a fermented milk drink, the effects of the DASH 
diet can be achieved in South African; black treated hypertensive subjects who consume 
I 
a high salt intake. . 
Regarding acceptability of the novel foods with an altered cation content, with the 
exception of margarine and the salt replacement, most participants in the experimental 
group preferred the food items to the usually consumed varieties. This subjective rating 
of foods was supported by the weekly measurement of returned salt shakers, whereby 
(at least in Phase 1 ) the average household intake of salt was significantly lower in the 
low salt compared to control group, Clearly, further technological development and 
consumer testing of these items in the target population is required before they could be 
commercially launched on a large-sc~le level. A possible reason why the control group 
reported that they preferred all of the food items provided, despite the fact that the foods 
I 











No change in body weight or body composition was found during the trial, despite a 
significantly increased reported energy intake in both diet groups. Participants were 
instructed to continue to consume their habitual diet, with the exception of substituting 
the 7 intervention foods for those provided. Average portion sizes of bread and 
margarine consumed by the target population were estimated using detailed dietary data 
obtained in the baseline survey (Chapter 4) as well as secondary analyses of other -

South African dietary datasets.44 In South Africa, multi-generational households are the I 

norm, especially in households where pensioners reside, and members of a household • 

tend to eat from a common pOt.45,46 In order to improve compliance, sufficient quantities 
of food for the whole family were provided to participants. A possible explanation for a 
lack of weight gain is that the magnitude of reported increased energy intake 
(approximately 1 000 kJ/day) was probably too small to result in weight increases over 
an 8 week period. Most of the test foods did not contribute significantly to kilojoule intake, 
namely salt, Aromat (flavour enhancer) and stock cubes. 
A number of methodological issues need to be considered. The most important of these 
is the measurement of the main outcome, blood pressure. Both office-based electronic 
measures and 24-hr ambulatory blood pressure monitoring (ABPM) were performed. For 
systolic BP, the magnitude of change associated with the dietary intervention was larger 
using office-based compared to ambulatory measurements. Three other studies of 
dietary intervention have also reported a smaller effect size measured by ABPM than 
that detected by standard measurements.47,48,49 ABPM is generally considered to be a 
preferable alternative to traditional methods for measuring BP in clinical trials.50,51,52,53 Its 
perceived benefits in this regard include enhanced precision, thus allowing for a reduced 
sample size and increased study power, elimination of observer bias, and identification 
of subjects with 'white coat' (or 'isolated office') hypertension.54,55,56,57 Importantly, there is 
evidence that ABPM reduces the variability of estimates of BP change in clinical 
trials.58,59,6o,61 The ability of ABPM to detect BP change in cornparison to multiple office 
based measurements has been investigated using data from the DASH feeding trial.62 
Both ambulatory and five daily pairs of random-zero (RZ) BP measurements were taken 
pre- and post-intervention in 321 participants. For systolic BP, the standard deviations of 
change in mean 24-h ambulatory BP were comparable or lower than the corresponding 
standard deviations of change in RZ-BP based on five daily readings. For change in 
mean waking ambulatory BP, the standard deviations were comparable to those 












efficient than three to four sets of daily RZ readings, in that a smaller sample size could 
detect a given BP change and less clinic visits were required. 
A major limitation of the study is that office measurements (Om ron) of BP were taken on 
only one occasion at each of the follIDw-up visits for Phase 1 participants, and at two 
occasions for Phase 2 participants. the intervention effect was calculated using the 
mean of three repeated measurements for the baseline measure and the mean of two 
repeated measurements (week 4 and week 8) as the 'post' BP measure, in an attempt to 
reduce variability. In contrast to other published studies,54-57 we did not find evidence of 
enhanced precision using the ABPM method compared to the automated Omron office 
measurement in a sample of older black hypertensive South Africans from a low income 
community, even when only between two and four repeated office measurements were 
taken. A very large variability in BP change was found using either the office 
measurement or ABPM, and this far exceeded that reported in hypertensives in the 
DASH study. For example, standard deviation of change in systolic BP in the present 
study was 20.3 mmHg and 23.6 mmHg for ABPM and Omron measurements, 
respectively, compared to 8 mmHg for 24-hr ABPM and 8.7 mmHg for 4 repeated 
measurements of RZ-BP in DASH participants.62 The unfamiliarity and anxiety of wearing 
the ABPM device may have contributed to a larger than expected variability in 24hr blood 
pressure measurements in our sample who were of low educational status. Indeed, in 
the DASH study, 50 - 55 % of particip~nts reported that the wearing of the ABPM device 
: 
interfered with their usual home and: work activities, while 15 - 20 % of participants 
reported that the monitor interfered iwith their sleep 'a 10t.62 In the present study, , 
compliance with ,instructions to wear t~e Oscar II device was good; between 88.8 % and 
90.7 % of a potential 63 reading~ were recorded for the 24-hr periods of BP 
measurement. Measurements were repeated in 9 subjects who had less than 50 % of 
potential readings at first attempt, a~d in all but one of these individuals the second 
attempt yielded at least 80 % of valid r~cordings. 
Vollmer et af'2 have demonstrated that in order to detect a between-group difference in 
BP of 5 mmHg (with study power of 90 %), 90 subjects per group are required if 2 sets of 
daily measurements are obtained. This reduces to 67 in the case of 5 daily 
measurements and the comparable sample size using a single 24-hr ABPM method is 
54 per group. These sample size calculations, extrapolated from the DASH data, were 
published only after the start of our trial. Notwithstanding, our sample size (N = 40 per 
group) was calculated using sound statistical methods, based on variability of BP in the 
target group. It can be hypothesized that an even larger magnitude of BP change 
195 
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associated with the dietary intervention may have been demonstrated if we had used 
more repeat office BP measurements. 
Generalizability of the results warrants consideration, with regard to the population-wide 
approach being recommended for improved BP control. Participants were older, black 
South African hypertensive patients who were receiving drug treatment for hypertension, 
mostly from the public health services. Extrapolation of the findings to the normotensive 
population and to those with severe hypertension cannot be assumed. In order to 
facilitate the practical delivery of the foods, participants were recruited from only one 
geographical area, Langa, one of the oldest (> 60 Y since settled) and more established 
peri-urban townships. Langa is located on the outskirts of Cape Town metropolis and 
has an estimated population of 46 505, mostly Xhosa-speaking Africans.63 Like most 
townships, Langa is a legacy of the South African apartheid system. The reason for 
including older study participants (50 to 76 years) who were likely to be unemployed or 
retired was an attempt to improve compliance with the study protocol. Good blood 
pressure control is rarely achieved in this high-risk group which may be attributed to 
social and economic factors,64 such as failure to return to health-care centres for follow­
up visits due to transport costs and time involved. A further consideration may be a lack 
of knowledge of the disease and its outcomes, in particular the risk of stroke. Poor 
service delivery has been identified as a major factor that contributes to the inadequate 
treatment of hypertension in patients at primary health-care level in South Africa.65 
Further, the relatively short duration of the trial (8 weeks) raises questions regarding 
compliance with the dietary changes over the longer term and the impact thereof on 
blood pressure. 
All subjects in the present study were receiving anti-hypertensive medication. It is well 
documented that, with the exception of calcium channel blockers,66 there is an interaction 
between antihypertensive medications and dietary interventions on blood pressure 
outcomes. Lowering the extracellular volume by limiting salt intake can have an 
additional benefit, enhancing the response to most antihypertensive drugs, including the 
thiazide diuretics, angiotensin converting enzyme (ACE) inhibitors, and I!-adrenergic 
blockers. For example, the antihypertensive effect of diuretics is dependent upon initial 
volume depletion, an effect that is enhanced by salt restriction.67 Salt restriction also 
increases renin release, making the BP more angiotensin II-dependent and therefore 












In line with the national guidelines for: the management of hypertension in the primary 
health-care settillg that recommend diWretic agents as the first-line drug for all patients 
with hypertension/o,71 86 % of subjects in the trial were being prescribed diuretics. 
Thiazide-type diuretics, the cheapest ahti-hypertensive agent available, were being used 
by over three-quarters of subjects. Reserpine (centrally-acting anti-adrenergic agent) is 
the cheapest second-line agent sugge~ted in the guidelines, but only 4 % subjects were 
being prescribed this drug. ACE-inhibitors were the second most commonly used anti­
hypertensive drug in our sample. Importantly, the type of antihypertensive medication 
use was similar between the control an:d intervention groups at baseline. 
Twenty-two subjects had changes to lheir anti-hypertensive medication during the trial 
(based on information provided on the packages that subjects brought to follow-up visits 
at the research facility). It is possible that some subjects may have forgotten to bring all 
of their medications to the visits, th\-ls introducing. reporter bias, but this cannot be 
verified. The types of medication change during the trial were similar between the 
intervention and control groups. The study is a pragmatic clinical trial in which analyses 
were conducted on an intention-tp-treat basis. It would therefore have been 
methodologically incorrect to remov~ subjects from the final analyses based on 
medication change. 
The study aimed to demonstrate effectiveness of a community-based dietary 
intervention, rather than its efficacy. lihe inclusion of treated hypertensives in the study 
demonstrates the additional benefits of dietary intervention in subjects receiving 
standard treatment. It is unethical to stop hypertensive medication for almost 6 months in 
study participants selected from a popi.Jlation known to be at high risk of cerebrovascular 
disease. It was also logistically not feasible to recruit a sample of untreated 
hypertensives in the South African coMtext. Subjects taking more than one diuretic were 
excluded as this is considered to be inappropriate management, based on national and 
international therapeutic guidelines. <:pur inclusion strategy is in line with international 
drug . trials in hypertension that currently enter patients already on multiple anti­
hypertensive drugs, such as the VALUE Trial.72 
The public health implications of the study's findings, in the context of the challenges for 
the various relevant roleplayers in the country such as the food industry and the 






















This randomised controlled trial provides evidence that the manipulation of the Na, K and 
possibly Mg content of commonly consumed processed foods, together with the 
provision of a salt replacement and daily consumption of 500 ml fermented milk, lowers 
BP in free-living, hypertensive black South Africans. The BP reduction was of a 
magnitude likely to have health outcome impacts and was achieved in the setting of 
treated hypertensive individuals who were taking combination blood pressure-lowering 
drugs. This data makes a case for more active dietary intervention in people with 
hypertension. The food industry needs to be lobbied to lower the Na content of their 
products, together with a concurrent increase in K, particularly in staple foods such as• 
bread. 
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8.1 	 Introduction: a need for a public health approach to prevent and 
manage hypertension in South Africa 
In South Africa, in relation to the qther competing groups of diseases, inadequate 
recognition is given to the magnitude of the burden of chronic diseases of lifestyle (COL) 
and subsequently the prevention of unhealthy lifestyles and early diagnosis and cost­
effective management of COL risk factors are low on the list of priorities. 1 A quadruple 
burden of disease in this region is characterised by a combination of poverty-related 
diseases together with the emerging chronic diseases associated with urbanisation, 
industrialisation and a westernised lifestyle, accompanied by high injury rates associated 
with the social instability of violence and high crime rates, and by the exploding epidemic 
of HIVIAIDS across the African continent. 1 The impact that the HIV/AIDS epidemic might 
have on the anticipated increase in COL warrants consideration in terms of future health 
care planning. The Actuarial Society of South Africa developed a model in 2000 
(ASSA2000) to project how the AIDS epidemic could affect the patterns of mortality. 
Although the model projects a tremendous increase in the mortality of young adults by 
2010,22 the data also demonstrates tI~at, irrespective of the deaths attributable to AIDS, 
there will continue to be a slight increase in the mortality in South Africa attributed to COL. 
The estimated age-adjusted prevalence of hypertension in the adult population is 21.1 %, 
which equates to an estimated 5.5 million South Africans with the condition.2 By far, the 
greatest number of hypertensives are from the black African sector of the population (3.8 
million) in whom BP levels are rarely ~ell controlled below 140/90 mmHg.6 Following stroke 
and ischaemic heart disease, hypertensive heart disease together with diabetes mellitus 
and chronic obstructive pulmonary disease were among the leading causes of non 
communicable diseases in 2000.3 Hypertensive heart disease death rates were about 3 
times higher in the black population compared to those for mixed ancestry and Indian 
South Africans, and nearly 10 times higher than the rate for the white population.4 The 
same study demonstrated that the rT10rtality rate for stroke in black South Africans was 
double that found among the white population. 
A two-pronged approach is required to address the rising burden of chronic diseases in 
South Africa. The first is the promotion of healthy lifestyles for the whole population (Le. 
primordial prevention), and the second, complementary approach, requires early diagnosis 
and cost-effective management of risk factors and disease. Both approaches need inter­
sectoral collaboration, underpinned by stronger leadership from policy makers, advocates 
I 











The work presented in this thesis has concentrated on the first approach, namely a health 
promotion strategy that could be implemented on a population level. The motivation for 
taking this approach is that in low- and middle-income countries, one of the major 
constraints for controlling hypertension is the limitation of resources for health care. A 
pragmatic CVD-Risk Management package has been developed by the World Health 
Organization (WHO) to facilitate cardiovascular risk assessment and management in low­
resource settings.6 However, cost-effective healthcare interventions to reduce the 
cardiovascular burden can only be implemented if the health services' policy, environment 
and financing enable implementation. The success of this approach will also depend on 
the capacity of primary heath care systems to deliver these interventions and serve the 
long-term needs of high-risk CVD patients. For many countries, including South Africa, the 
individual management of large numbers of patients with low CVD risk is simply not 
affordable. Since it is individuals at lower risk, and not those at high risk, that account for a 
greater share of the overall disease burden, the distribution of CVD needs to be shifted 
through population-wide strategies that address all major CVD risk factors, including 
hypertension.7 
Although the causes of hypertension are complex and multifactorial, the adoption of an 
unhealthy lifestyle is recognized as being a major risk factor in its development. The 
WHO's global strategy on diet, physical activity and health (2004) was endorsed by 
resolution WHA 57.17 of the World Health Assembly.8 This document highlights the 
responsibility of governments of member states, through co-operation with other 
stakeholders, to create an environment that empowers and encourages individuals, 
families and communities to make positive, life-enhancing decisions on healthy diet and 
physical activity. One of the four main objectives of the global strategy is to reduce the risk 
factors for noncommunicable diseases that stem from unhealthy diets and physical 
inactivity by means of essential public health action and health-promoting and disease­
preventive measures. The principles for action that underpin the global strategy stipulate 
that priority should be given to activities that have a positive effect on the poorest 
population groups and communities. Again, it is emphasized that such activities will 
generally require community-based action with strong government intervention and 
oversight. 
Regarding diet, a diversity of ethnic and cultural groups exists in South Africa, each with 
different eating patterns and at different stages in the nutrition transition (i.e change in diet 











sugar intake and a lower carbohydrat$ and fibre intake9). Urbanis.ation has a profound 
influence on the macronutrient profile qf the black population. In the early 1990s, Bourne 
and colleagues demonstrated that in C? sample of black adults residing in Cape Town, 
proportion of energy 'fron, fat increased las a function of time spent in the city.10 At present, 
only one nationally representative diet~ry study exists in South Africa, the National Food 
Consumption Survey, conducted in 1 - ~ year old children in 1999.11 However, many other 
dietary surveys exist that are geographically and ethnically representative of the areas 
where they were undertaken12 - collectively, these provide good estimates of 
macronutrient and micronutrient intake$, but as with all dietary surveys, fail to adequately 
measure salt intake. The baseline surveys in this thesis have provided valid estimates of 
habitual sodium intake. In South Africans from three ethnic groups, sodium intake was 
I 
found to be excessive and potassium intake was inadequate. For the first time, important 
sources of SOdium-containing foods in 'the local population were identified, which included 
food items such as bread, margarine, ~oup mixes, stock cubes and flavour enhancers. 
Thus, given the current magnitude and the projected increase in the prevalence of 
hypertension in the country, the inadequacy of health care resources to effectively manage 
the condition, and the burden of raised blood pressure on mortality and morbidity, together 
with evidence of a poor quality diet trat is high in sodium and low in potassium, public 
health measures to control blood pressure on a population level in South Africa are 
paramount. Even more so, perhaps, than in developed countries 13.14 it is critical that South 
Africa utilise its limited resources optimally and implement cost-effective health-promotion 
interventions timeously to prevent the predicted epidemic of CDL in the face of all the other 
health needs in this region. 
Challenges of health promotion in South Africa - a country of disparity 
At the beginning of the millennium an initiative called Healthy People 2010 was 
established in the US with the objectives to reduce heart disease and stroke by 20 % and 
to reduce the major causal factors associated with these elevated levels, such as excess 
sodium intake.15 Healthy People 2010' set two important goals: (1) increasing quality of life 
and years of life; and (2) eliminating health disparities. In 1993, South Africa was 
described by the World Bank as one ,of the world's most unequal economies with a Gini­
i 
coefficient for income as high as 0.S8 (World Bank, cited in May, 2004).16 Despite having 
been placed as one of the SO wealthiest nations in the world in 2001, with a per capita 
Gross Domestic Product (corrected for purchasing power parity) of US$11 240 per year,16 


























the third most unequal society in the world. 17 As expected, this degree of disparity is 
reflected in differences in blood pressure control between various sectors of the 
population. Secondary analyses of the SA Demographic and Health Survey (SADHS) data 
demonstrated that awareness of hypertension, the use of hypertension medication and the 
control of hypertension (cut-off point 160/95 mmHg) among subjects with hypertension 
increased with increasing wealth and were highest in the richest group.18 Antihypertensive 
medications can be costly, carry the potential for adverse side effects, and many patients 
fail to take medications as prescribed. Primary prevention of hypertension provides an 
attractive opportunity to prevent the continuing costly cycle of managing hypertension and 
its complications,19,20 particularly in a country with huge contrasts in the socio-economic 
indicators of its people. 
8.2 	 Challenge of implementing recommended dietary behaviour change in 
developing countries 
Undoubtedly, the Dietary Attempts to Stop Hypertension (DASH) trials have demonstrated 
that a carbohydrate-rich diet that emphasizes fruit and vegetables, low-fat dairy products 
and that is reduced in saturated fat, total fat and cholesterol substantially lowers blood 
pressure.21 ,22 This type of diet is effective, either with20 or without sodium restriction.21 
Although not tested for blood pressure-lowering effects in African populations, the diet has 
been shown to be extremely efficacious in Africa American individuals.23 Subsequently, the 
OmniHeart trial provided evidence that partial substitution of carbohydrate in a DASH diet 
with either protein or monounsaturated fat can further lower blood pressure, improve lipid 
levels and reduce estimated cardiovascular risk.24 
In developing countries, dietary patterns are largely determined by cost constraints and 
food availability, and tend to be low in dietary diversity. A positive association between 
socioeconomic status and dietary diversity has been demonstrated in other developing 
countries, namely Botswana,25 urban and rural Mali,26 Nepal27 and in a multi-country 
analysis of data from 10 countries.28 Data obtained from analyses included in this thesis 
demonstrate that few individuals consume the recommended number of servings from the 
various food groups according to the DASH diet principles, and that ethnic and urban/rural 
differences exist in eating patterns. For example, mean frequency of intake of dairy 
products ranged from 3.1 - 4.3 times per day in white groups, compared to 0.9 - 1.1 times 
a day in black urban dwellers, and less than once a day, on average, in black rural groups. 
Between 15.4 and 29.5 % of urban black South Africans, compared to 0.9 - 5.B % of their 











vegetable and fruit intake has been reported in many dietary surveys conducted in the 
adult black population. Secondary an~lyses of existing dietary databases in the country 
provide an overall picture of food group intake.29 In the total South African adult population, 
only 21.4 % consumed fruit (average of 287 (SD =187) g/day in consumers) and 44.8 % 
consumed vegetables (average of 166g (153) g/day in consumers) on the day of dietary 
reporting (24-hr recall method). The fbod items most commonly consumed by the adult 
population, in descending order, are l1laize porridge, white sugar, tea, brown bread, white 
bread, non-dairy creamer, brick margarine, chicken meat, full-cream milk, and green 
I 
leaves (wild greens/spinach).29 
Thus, promotion of the DASH eating plan in the South African context is clearly unrealistic. 
We propose a population-based approach to reduce sodium, while increasing potassium, 
magnesium and calcium through the modification of various processed foods. Data from 
the randomised controlled trial (RCT) included in this thesis has demonstrated that the 
substitution of limited number of commonly consumed food items (bread, margarine, salt, 
stock cubes, flavour enhancer, soup mix) in which the cation content had been modified 
for regular varieties, in the presence ~of the daily consumption of 500 ml fermented milk 
product (maas), lowered blood pressure by a clinically significant magnitude in free-living, 
hypertensive patients. The magnitude of the BP-Iowering effect is similar to that shown by 
the use of diuretic therapy, however tHe additional benefits were observed, over and above 
standard pharmacotherapy use. 
I 
I 
Our food-based study, conducted in a resource-poor community setting, showed that 
many of the beneficial nutrients obtained through the adoption of a DASH diet can be 
obtained simply by modifying existing food items. Such an approach will need to be 
accompanied by nutrition education activities, such as promotion of the Food Based 
Dietary guidelines, in order to improv~ the overall quality of the diet. 
The generalizability of the RCT results warrants consideration, with regard to the 
primoridal, population-wide approach :that is being recommended here for improved blood 
pressure control. Our study included only people with drug-treated hypertension, and a 
strong case has been made for more active dietary intervention in this group. Howev~r, 
extrapolation of the findings to the normotensive South African population may be 
questioned. Data from other developing countries has demonstrated that a short-term salt­
restricted diet resulted in a reduction iin systolic blood pressure of approximately 5 mmHg 











Meta-analyses of high quality studies of sodium restriction, in both normotensive and 
hypertensive samples,31.32.33.34.35 support the blood pressure-lowering benefits of a 
population-wide strategy to reduce salt intake. Generally, a lower blood pressure reduction 
occurs in normotensive, compared to hypertensive individuals. In their meta-analysis of 32 
randomized clinical trials, Cutler et al.36 concluded that a daily decrease in sodium intake 
of 100 mmol lowers blood pressure by 5.8/2.5 mmHg in hypertensive individuals and by 
2.3/1.4 mmHg among those without hypertension. This level of reduction in diastolic blood 
pressure could result in an overall 15 % reduction in stroke risk. 37 There is evidence that in 
older adults, similar falls in blood pressure can be achieved with a modest salt restriction (10 
g to 5 g per day) in both normotensive and (untreated) hypertensive subjects.38 
Original data from Chapters 3 and 4 identified that both normotensive and hypertensive 
South Africans from three ethnic groups had an excessive intake of sodium and an 
inadequate intake of potassium.· A low potassium intake has been shown to amplify the 
blood pressure response to sodium in normotensive African-American men. A 
metabolically controlled study demonstrated that, when potassium intake is even 
marginally deficient, an elevated blood pressure response to sodium occurs in black, but 
not white, normotensive men.39 The response was dose-dependently suppressed when 
dietary potassium was increased within its normal range. Thus, based on the findings 
presented in this thesis and studies elsewhere, in the South African context, a population­
wide strategy to lower the sodium content of processed foods while simultaneously 
increasing the potassium, magnesium and calcium content thereof appears warranted to 
have a beneficial impact on cardiovascular risk reduction. 
8.3 	 International trends and strategies that influence blood pressure 
through dietary measures 
International consensus exists that a modest dietary sodium reduction for people with 
normal and raised blood pressure has a large enough benefit on blood pressure to justify a 
guideline adVising restraint for the entire population.4o.41 ,42,43 One of the five dietary 
recommendations for populations and individuals outlined in the WHO's global strategy on 
diet, physical activity and health is to limit salt (sodium) consumption from all sources and 
ensure that salt is iodized.8 Reduction of sodium intake to s 100 mmol per day (2.4 g 
sodium or 6 g sodium chloride) is one of the five lifestyle-related approaches to preventing 
and managing hypertension outlined in the internationally accepted JNC7 guidelines.44 
Decreased sodium consumption can be accomplished by changing the population's 











to a public health solution. However, th~ success of this intervention can only be achieved 
with close collaboration between the D,epartment of Health, members of the food industry 
, 
and food regulating bodies. 
It has been recognized for some time now that policies affecting food consumption 
patterns are cost effective ways to ch9nge risk factors for chronic diseases. For example, 
the implementation of policy to reduce salt content in manufactured foods would result in a 
leftward shift in the population distribution of blood pressures and a surprisingly large 
reduction in cardiovascular disease.45i Similarly, another population-level policy measure 
that would have a profound influence bn the distribution of a population's 8MI levels, and 
hence largely determine its level of typ~ 2 diabetes, is that affecting energy intake (such as 
the availability and price of energy-de;nse foods) and/or energy expenditure (such as the 
level of motorization and mechanization).46 
While global economic development may ease some of the health challenges in 
•developing countries, chronic disease? have been exacerbated.47 Important factors in this 
regard include urbanization, trade, foreign investment and promotional marketing. In South 
Africa, globalisation influences nutrition patterns through the establishment of multi­
national corporations in the country. For example, McDonald's opened their first outlets in 
South Africa in 1995 and by the end tDf 2002 had about 100 branches in the country, with 
plans to expand to other countries in tre region. The advertising and marketing budgets of 
these large corporations are enormous, often exceeding the budgets of some countries in 
sub-Saharan Africa. The annual advertising budget in 2003 in the US for Coca-Cola, 
Burger King and McDonald's wer~ $473 million, $524 million and $619 million, 
respectively.48 In contrast, in the same country only 2.2 % of food advertising spending is 
used to promote the consumption of unrefined foods, such as fruits, vegetables,
j 
wholegrains and beans.49 The eduqation component of the National Cancer Institute­
sponsored Five-a-Day campaign to promote fruit and vegetable consumption is under $1 
miilion.50 Food marketing is particularly effective at influencing the behaviour of children 
and adolescents.51 
i 
Despite arguments that multinational food companies promote the abolishment .of 
agricultural subsidies in developing countries, back free. trade and support the importation 
of cheaper, frequently subsidised fo(l)ds and other goods from industrialised countries,52 
globalisation may be favourable in the case of reducing the salt content of processed 
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foods. In this regard, international trends in the food industry may be applied to develop 
food products locally. 
It is useful to identify strategies that have been used in other countries to improve blood 
pressure control through dietary measures. These will be discussed under the sub­
headings of lobbying and advocacy, government support/food industry control, food 
labelling and health education. 
• Lobbying and advocacy 
Largely as a result of the lobbying of consumer pressure groups in other countries, 
particularly in the United Kingdom and other European countries, impressive strides have 
been made by the food industry in reducing the amount of salt in their products. In order to 
ensure economic viability of reduced sodium products, and to maintain market 
competitiveness, large food companies use consumer panels to identify the point at which 
the reduction in foods can be detected. 
Perhaps the most successful example of food industry commitment to reduce salt content 
in processed foods is seen in the UK. In that country, the Food Standards Agency has 
worked closely with food manufacturers and their trade bodies, governmental 
organizations, retailers, the catering and food service sector, academia, and consumer 
groups to facilitate their strategy to lower salt intake on a population level. Following a 
public consultative process, voluntary salt reduction targets for food manufacturers and 
retailers were published by the Agency in March 2006 to further encourage salt reduction 
in a wide range of processed foods.53 The targets apply to salt levels in the 85 food 
categories that contribute most to the amount of salt in the UK diet. Everyday foods such 
as bread, bacon, ham, breakfast cereals and cheese are included in the targets, as well as 
convenience foods such as pizza, ready meals, savoury snacks, cakes and pastries. The 
industry-related activities of the Food Standards Agency have been accompanied by an 
ongoing consumer salt awareness campaign (started in September 2004) and research 
activities to track behaviour and attitudes related to salt intake. 
To date, the results of the Food Standards Agency's lobbying have been impressive. Most 
of the country's major supermarket chains (e.g. ASDA, Marks and Spencer, Sainsbury's, 
Tesco and Waitrose) offer low salt products, such as bread and ready-meals, as well as 
products such as canned vegetables with no added salt. The Association of Cereal Food 
Manufacturers has reduced the levels of salt in breakfast cereals by 33 % since 1998, the 
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Federation of Bakers have agreed to a further 5 % salt reduction in bread to result in an 
overall 30 % reduction since the late 1980s, Kraft has lowered the salt in its cheese 
spreads and snack products by arouJ;ld a third, while members of the Food and Drink 
Federation have sought to reduce the salt in soups and sauces by 30 %. Many other 
sectors of the food industry have committed to long-term salt reduction in their products. 
There is evidence that consumers are not only being exposed to salt reduction in 
processed foods, but are also adding less discretionary salt to their foods. In October 
2005, an estimated 22 million people {46 % of adults) in the UK reported that they were 
trying to cut down on their salt intake -:an increase of nearly six million (or 12 %) since the 
start of the Agency's salt awareness campaign in September 2004,54 while 34 % of 
consumers claim to be checking food labels for salt content.55 In addition, retail sales of 
salt indicate a reduction from £23m in 2003 to £20m in 2005.56 
Unilever, the company that developed the dry goods (stock cubes, flavour enhancer and 
soup mix) and margarine that were modified in cation content for use in our randomized 
blood pressure controlled trial, has already been proactive in the salt reduction arena in 
other countries for some time. In the United Kingdom, in 2002, the company focused their 
attention on soups and sauces within their Knorr range (same range as available in South 
Africa) as a first step in reducing the salt content of their products. Unilever approached a 
number of other leading manufacturers of branded soups and sauces to develop an 
initiative (Project Neptune) across the industry and received widespread support and 
collaboration from Heinz, Baxter's, Campbells and Pataks, as well as the food industry's 
trade associ~tion, the Food & Drink IFederation. These member companies agreed with 
the need to lower salt, but acknowledQled that any reduction needed to be gradual in order 
to maintain palatability and thus prevent customers from switching to brands with higher 
salt contents. The group committed to a three-year programme, with the aim of reducing 
salt by 10% in 2003, and thereafter reductions of a similar magnitude over the following 
two years, subject to consumer acceptance. The project is on track to achieve its 
objectives. Unilever achieved a 10% reduction across soups and sauces in 2003 and a 
similar reduction was made in 2004.. In addition, their range of Birds Eye ready-meal 
products now contain less than a third of the recommended daily intake (RDI) of salt for an 
adult and the children's range products were reduced to provide 25% of the RDI for 4-6 
year olds and 15% of the RDI for 7-10year olds. 
Heinz, another food giant, recently launched a reduced sugar and salt version of its baked 
beans, with 50 % lower salt than its standard baked beans, in the UK and the US. The 
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company simultaneously introduced a "salt equivalent" labelling on each pack to increase 
consumer awareness and to simplify interpretation of nutritional information. 
Further innovation by the food industry to develop quality food products that are in line with 
the WHO Global strategy on diet, physical activity and nutrition requires scientific 
understanding of food structure, functionality of food ingredients, composition and 
nutritional, physiological and psychological properties. The taste, texture and appearance 
of foods are central to their acceptance. Novel technologies need to be developed to 
deliver the appropriate sensory attributes while reducing fat, sugar and salt. 
• Examples of the role of governments in influencing the food industry 
In Finland, government intervention to regulate salt levels in some foods, together with 
voluntary changes by the industry, has led to an overall reduction in salt consumption. A 
salt substitute, Pan SaltTM (Kallo Group Ltd), which is a blend of sodium chloride, 
potassium chloride, magnesium sulphate and lysine hydrochloride is now being used by 
manufacturers in that country. Pan Salt contains 43 % less salt than common table salt. In 
1996, Pan Salt™ was used in around 500 products in Finland and at the end of 1998, in at 
least 200 products in the UK.57 
In the UK, over a decade ago, the 1992 Health of the Nation White Paper8 advised a 
reduction in salt consumption in the context of reducing coronary heart disease and stroke, 
as "excessive consumption of alcohol and sodium, together with obesity, contribute to 
raised blood pressure, which is the main risk factor for stroke." The Govemment's target 
was to reduce mean systolic blood pressure in the adult population "by at least 5mm Hg" 
by 2005. The first "Eat Well!,,59 action plan from the Nutrition Task Force (NTF) (set up to 
achieve the Health of the Nation targets) was published in 1994. It commented that "the 
evidence for a link between salt intake and raised blood pressure was not thought strong 
enough to warrant a specific target at the time of the publication of the White Paper." But, 
the report noted that reaching the blood pressure target "will require a nutritional 
contribution from sodium intake as well as alcohol and obesity." A product development 
project team was set up under the auspices of NTF, with a remit determined by NTF "to 
support and monitor an industry led initiative for a detailed scrutiny. .... which will seek to 
identify the scope for changes in the fat balance of products, and for reductions in salt 
content." By 1996, the Eat Well 1I!60 report stated that the manufacturing sector felt "unable 
to accept the inclusion of salt within the 'scrutiny' at this time. The industry takes the view 











salt consumption on a population bas/so Nevertheless, a number of manufacturers and 
retailers are reducing the salt content of their products in response to consumer 
demand ... .." Subsequent policy (October 1997) on salt labelling on food products in the 
UK was in accordance with the Europ:ean Economic Community (EEC) Directive 90/496 
on nutrition labelling. This led the Eurqpean Commission to conclude that "the risk of the 
sodium component of salt in the diet is dependent on intake which, in tum, is determined 
by dietary habits." The Commission wils satisfied that current regulations were adequate, 
but proposed to "harmonise conditions,for the use of the term "Iow-sodium" on the basis of 
relevant reports." In 2003, the Scienfific Advisory Committee on Nutrition published a , 
report on salt and health, under the· auspices of the Food Standards Agency and the 
Department of Health.61 
An excellent example of how government support can open up the food/nutrition/health 
debate and provide an opportunity for a partnership between Government (UK & European 
Union), food growers, food processor~, food manufacturers, retailers, nutrition and health 
professionals and consumers is proviqed in the UK white paper 'Choosing Health: Making 
healthier choices easier (2004).62 Accompanying the White Paper is an action plan, 
Choosing a Better Diet,63 that summarises how the Government will deliver the 
commitments on nutrition presented in the public health white paper over a 3':'year period. 
The document sets out the Governmert's plans to encourage and co-ordinate the action of 
a range of organisations to improve n0trition and health in England and includes action on 
advertising and promotion of foods to children, simplified food labelling, obesity education 
and prevention, and nutritional standClrds in schools, hospitals and the workplace. One of 
the six objectives of the action plan i~ to reduce average salt intake from the current 9.5 
g/day to 6 g/day by 2010. The nutrition action plan is backed up by two other 
comprehensive action plans, "Delivering Choosing Health: making healthier choices 
easier' and "Choosing Activity: a physical activity action plan." 
i 
• Food labelling and nutrition logos 
The Codex Alimentarius is the international body established in 1962 by the Food and 
Agricultural Organization (FAO) and ithe WHO to develop international food standards. 
Many countries, including South Africa, base their national food regulations and food 
labelling laws on Codex standards. In South Africa and many other countries, food 
labelling is required by law only for those products that make nutritional claims such as 
























nutritional labelling among industry. The Food and Drink Federation (UK) has made more 
informative labelling one of the commitments in its Food and Health Manifesto.64 
In the United Kingdom, the Department of Health is taking steps to pressure the European 
Union (the legislating body) to simplify and clarify food labelling, and to make it mandatory 
on all packaged foods.65 In the consultative process around development of the white 
paper "Choosing Health," there was evidence that consumers are calling for simpler and 
clearer labelling, that recognizes inequalities in literacy and numeracy levels, and that are 
more in keeping with consumers' lifestyles. The Institute of Grocery Distribution's 
Consumer Watch report of June 2003 found that 34 % of consumers identified clearer food 
labelling as the main way that the food industry could help them make healthier food 
choices.66 
In addition to mandatory food labelling regulations that may exist, some countries have 
also adopted nutrition-related logos to help consumers make healthy food choices. For 
example, in New Zealand, the Pick the Tick programme of the National Heart Foundation 
serves as a 'nutrition signpost' for consumers and appeals to the food industry as a tool for 
marketing food products. In a 1-year period (1998/99), Pick the Tick influenced food 
companies to exclude about 33 tonnes of salt from the food supply in New Zealand 
through the reformulation or new formulation of 23 breads, breakfast cereals and 
margarines.67 Similarly, in Australia in 1997, Kellogg reformulated 12 of their breakfast 
,. 
cereals to provide an average sodium reduction of 40 %, without compromising consumer 
taste appeal.S8 As a result, 235 tonnes of salt were removed annually from the food supply 
and five more products were able to carry the Pick the Tick logo (i.e. sodium content < 
400mg/100g). In the United Kingdom, the House of Commons Health Committee Inquiry 
into obesity recommended the introduction of 'traffic lighting' or signposting.69 Recent Food 
Standards Agency (FSA) research has suggested that consumers would like simple 
labelling signposts to help them make informed and healthier food choices?O 
Further research is being conduced by the FSA to identify which formatting and logo 
choices work best, and to identify nutritional criteria for the use of the 5 A DAY logo on 
composite foods that contain added fat, sugar and salt in addition to fruit and vegetables. 
• Health education 
Health promotion activities can be a cost-effective way to improve lifestyles and thereby 











mass media, combined with various other methods, to reach the target population. During 
, 
the 1980s in the United States, three!major projects were conducted, the Stanford Five-
City project,73 the Minnesota Heart H~alth Programme74 and the Pawtucket Heart Health 
I 
Programme,75 with the aims of lowering blood pressure, blood cholesterol and body 
weight, reducing smoking rates and ejncouraging greater levels of physical activity. Each 
programme lasted 5 - 8 years. An analysis of the combined results of the three studies 
found that improvements in the outcomes of interest were of very low magnitude and were 
not statistically significant, while the e~timated risk of coronary heart disease mortality was 
unchanged.76 Two other community intervention projects, the Heart to Heart project in 
Florence77 and the Bootheel Heart He:alth project in Missouri78 also showed little success. 
However, there are examples of community projects that have achieved benefit. The most 
well known of these is the North K~relia project in eastern Finland, in which nutrition 
education was an important component of the intervention.79 Two other European stUdies 
in which positive results were demonstrated were the German Cardiovascular Prevention 
Study (1985 - 1992),80 conducted in six regions of the former West Germany and Action 
Heart81 in Rotherham, England. 
As outlined in the UK "Choosing Hea"th" white paper,65 the problem of health education is 
not so much a lack of information,· but that health messages can be inconsistent or 
uncoordinated or out of step with the way people live their lives. Surveys of consumer 
awareness, such as the UK Food Standards Agency (FSA) Consumer Attitudes Survey 
I 
2003,82 show that most respondents i know what constitutes a healthy diet, but that they 
often lack the ability to translate knowledge into practice. Evidence from the Unites States 
shows that increasing consumer awareness can influence consumption patterns. 
Evaluation of the National Cancer Institute's 5 A DAY for Better Health campaign83 found 
that the strongest predictors of dietary change were: knowledge of the recommendation to 
eat five or more servings of a variety of fruit and vegetables per day; taste preferences; 
and self efficacy, in particular, confide,nce in preparing and consuming fruit and vegetables 
in different situations. 
Influencing people's attitudes to the; choices they make is the first step in successful 
behaviour change associated with health education strategies.84 In acknowledgement that 
food industry advertising budgets are many times that which the UK Government spends 
on healthy eating campaigns (£74~ million was spent by the UK food industry on 
advertising of food, soft drinks, chain restaurants in 2003, compared to £7 million for 




















industry how it might contribute to promoting positive health information and education.86 
In that country, the Food Standards Agency will also continue its public health campaign to 
reduce high salt consumption. The first phase of the campaign, described earlier, included 
television and print advertising, as well as a full media relations campaign and dedicated 
website. The second phase was launched in late 2005. In addition, the Department of 
Health has also appointed the National Consumer Council,87 an independent body, to help 
develop a social marketing strategy that promotes health by influencing people's attitudes 
to the choices they make. The social marketing strategy will build on previous marketing 
communications activities such as 5 A DAY, salt reduction, smoking cessation, mental 
wellbeing and sexual health. Another innovative way of communicating nutrition and health 
messages is the introduction of the Department of Health-accredited online practical health 
assessment, the Personal Health Guide. The guides will be tools to assist people in 
planning for health. and will provide opportunity for self-assessment of health, goal-setting 
and determining what action an individual wants to take. Further, the "Choosing Health" 
white paper outlines governmental plans to restrict advertising and promotion to children of 
those foods and drinks that are high in fat, sugar and salt.88 
8.4 	 Food industry trends and challenges in South Africa with regard to 
lowering sodium content of processed foods 
Salt is added to food to preserve it, and to give flavour and texture. It is widely used in 
d<;:liry products, meat and fish products, canned vegetables, bakery products, 
confectionery, pickles and sauces, as well as savoury biscuits and crackers, crisps and 
snacks, and canned and packet soups. Salt's use as a preservative is related to its ability 
to reduce water activity thereby inhibiting or slowing the growth of food-poisoning or 
spoilage micro-organisms. 
Bread is a staple food, together with maize meal porridge, in the black South African 
population. The baseline studies of this thesis indicated that bread was the single most 
important contributor to non-discretionary sodium intake, while also providing a large 
proportion of total magnesium, potassium and calcium intake. Thus, bread is an ideal food 
to target to replace some of· the sodium with the beneficial cations. Even prior to 
mandatory fortification of bread flour which was introduced in October 2003, bread was 
already an important source of micronutrients (15.6 % of iron; 16.9 % of zinc; 19.5 % of 
niacin; and 15.6% of thiamin intake) in the diets of South African children aged 1 - 9 years, 
an age group that provides an indication of household eating patterns.89 
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In bread, salt plays an important role i~ flavour. Without salt, or additional sodium derived 
from baking soda and other leavening agents, bread and similar products are described as 
tasting insipid. As well as affecting thelflavour profile of bread, salt also influences starch 
properties, dough rheology, baking properties and bread quality characteristics. It reduces 
crumb stickiness in dough, and breatt baked without salt has a coarse, unacceptable 
crumb structure. However, this effect appears to be related in part to ionic strength rather 
than the presence of sodium ions part1icUIarly, so that up to 40 % replacement of sodium 
chloride with potassium, calcium or Imagnesium salts has been reported to have no 
adverse effect on baking performance, provided optimum mixing times are used, although 
the flavour of the test breads was poor.90 By contrast, the need for salt is greatly reduced 
i
in rye breads and sour dough breads, and good sensory characteristics have been 
obtained with 0.75% NaCI. 
The sodium content of bread in South Africa has remained higher than in many other 
I 
countries, at the level of 2% salt, which equates to approximately 520 mg per 100g bread. 
From figures obtained from nutritionali labeling on various types of breads, it is estimated 
that 3 - 4 slices of bread per day will provide between 480 - 675 mg sodium (1.2 - 1.7 g 
salt). The addition of 30 g margarine tb this amount of bread will provide an extra 480 mg . I 
of sodium (1.2 g salt), which totals 2.9 g salt - almost half of the US dietary guideline of 
the maximum recommended intake pf 6g salt per day.44 In the UK, the British Retail 
Consortium (which represents food manufacturers) published its salt policy in February 
2004, setting upper values for the saltllevels in 9 key product categories for members. For 
bread, the upper level was 440 mg sqdium (1.1 g salt) per 100g, with 50 % of plant bread 
I 
containing no more than 350 mg sod,ium (0.9 g salt) per 100g. The UK Food Standards 
Agency has recommended an upper level of salt in bread as 350 mg per 100g as the 
target for manufacturers to aim towar~s. There is no equivalent body in South Africa that 
interfaces between government and. the food industry to lobby food manufacturers to 
reduce salt in their products. 
In collaboration with a major bread b~ker in South Africa, we have shown that sodium in 
bread can be reduced by 32 % with I a simultaneous increase in potassium, magnesium 
and calcium of 55%, 69 % and 35 %, respectively. This modified bread demonstrated 
acceptable performance with regard '0 baking properties and physical quality of the final 
product, required mixing times during 60ugh production, sensory considerations, and ease 
of production in baking plants. Howev~r, in order for a staple food item to have widespread 
























cost associated with the novel bread was 8.9 cents per loaf, substantially higher than the 
0.7 cents deviation that was considered to be of significant economical consequence to 
the bread company involved in its development. Use of a salt replacement instead of a 
locally formulated cation mix would have greatly increased the cost of the novel bread -
SOlOTM (The low Sodium Sea Salt Company, UK) is available at approximately 10 times 
the cost of normal salt to food processors (leslie Wilson, personal communication). The 
cost calculation of 36 % reduced Na bread using SOLO ™ as the salt replacement was an 
increase of 30.1 cents per loaf. 
A cheaper option may be to achieve a sodium reduction of 25 % without replacement with 
other cations. This would incur a negligible additional cost of only RO.00169 per loaf 
(ingredient cost of RO.92464), assuming a salt price of R0.47/kg. The retail-selling price of 
this type of reduced sodium bread would be R4.6232, compared R4.6142 for the regular 
standard brown bread. In terms of the proposed new food labeling legislation (see later), a 
comparative nutritional claim could be made on the food packaging, thus providing the 
company with a marketing edge and enabling the consumer to make an informed food 
choice. However. the blood-pressure lowering effect of such a bread cannot be 
extrapolated from the results of our trial in which a composite food package was provided 
to participants for 8 weeks. Further research would be required in this regard. 
It is feasible that the baking industry could produce 25 % reduced sodium bread for the 
mass market, while at the same time producing a more specialized product, similar to the 
one used in our trial, for niche markets. The findings of our randomized controlled trial 
suggest that, of the four cations that were modified in the food products, increased 
potassium intake was the greatest predictor of blood pressure reduction. It has been 
reported by other authors that a low potassium intake and a high urinary sodium to 
potassium ratio are related to rise in blood pressure in childhood and may be important in 
the early pathogeneSis of primary hypertension.91 
Another strategy to lower blood pressure may be through the consumption of foods that 
are comparatively rich in potassium yet moderate in sodium content. The use of 
commercial salt substitutes that contain potassium chloride, such as SoloTM, in part 
substitution for regular salt in processed foods, is a possible way of substantially 
increasing the potassium content of foods, albeit at a cost premium as described above. 
Potassium salt substitutes supply 390 - 507 mg potassium per gram; an average teaspoon 




















sodium in food often causes the food tp have a bitter taste, although this is not detectable 
by all people. There is concern by some bodies such as the EU Scientific Committee on 
Food (SCF), that the indiscriminate use of such measures (Le. the use of potassium salts 
as substitutes for sodium) could result i,n intakes (above 5 - 7 g/day) at which toxicity might 
I 
develop in individuals with undetected renal problems and abnormal retention of 
potassium.92 In our randomised controlled trial, subjects in the intervention group who 
received foods that had some of the 'sodium chloride replaced with potassium chloride, 
either by the use of Solo ™ (soup mix; margarine, Aromat) or LoSaltTM salt replacements 
i 
(stock cubes) or another cation mix (bread) reported average intakes of 2 .7 g K per day 
and had urinary K excretion valueS of 71.7 mmol/day (2.B g) which is below the 
recommended daily intakes for either Europe (3.1 - 3.5 g/day)93 or the Unites States (4.7 
g/day).94 
Public health recommendations to fodd manufacturers encourage a gradual reduction in 
I 
the amount of added sodium across a wide range of products, in the knowledge that the 
preference for sodium is quickly reduaed when less sodium is ingested.95 This requires a 
I 
long-term commitment by food industry members and accountability to a central regulating 
body that monitors salt content in various food categories. 
To be an effective way to reduce bloqd pressure on a population-wide scale, consumers 
need to purchase the modified food products in place of the regular alternatives. 
Regarding acceptability of the novel fpods with an altered cation content, no differences 
could be detected by a large consumer testing panel between the reduced sodium bread 
developed for the purpose of our Istudy and the standard control variety. Indeed, 
participants in the randomised controlled trial rated most of the cation-modified food 
products as being preferable to the; regular varieties they usually consumed, with the 
exception of margarine and the salt replacement. 
While by no means being as progressive as many European equivalents, the South 
African food industry recognize the need to develop product ranges with a reduced sodium 
content, but the motivation to do so has been slow, probably due to the lack of pressure 
from government, health organizationJ, retailers and consumers themselves. 
Unilever South Africa Foods (Pty Ltd.) have recently launched a 25% reduced salt stock 
cube in their Knorrox range. Under the auspices of the parent trans-national company, 
i 




















fat in their products to bring them in line with the World Health Organization global strategy 
'on diet, physical activity and health.8 The company is currently reviewing their local 
product portfolio to see where these ingredients can be reduced without compromising on 
taste (Personal communication, Christine Broadhurst, Consumer Affairs Manager, Unilever 
South Africa Foods Pty Ltd.). 
Heinz, despite being active in reducing the salt content of its products in many other 
countries, has yet to introduce its low salt range in South Africa. The marketing manager 
for Heinz Foods South Africa, Anthony West, reports that South African consumers are 
more concerned about issues around organics and kilojoule content than sodium, and that 
demand for low-salt versions of foods is presently low (cited in Food Review, Nov/Dec 
2004).96 This sentiment is shared by Greg Anderson, the development and research 
director for Tiger Brands, a company which has a major market share in grain products 
such as porridge oats, pasta, rice, snacks and treats, as well as some processed meats 
and baby foods in South Africa (cited in Food Review, Nov/Dec 2004).96 He points out that 
South African consumers are predominantly concerned about sugar and fat levels in 
foodstuffs. These quotes from leaders in local food companies identify a need for public 
education awareness campaigns on the negative effects of salt on blood pressure. 
There may be beneficial spin-offs from the development of specialist food ranges by 
certain retailers. For example, Woolworths, a chain which caters for the upper 
socioeconomic strata, began the process of measuring and reducing sodium levels of 
many of its products when it introduced its Count On Us low kilojoule· range in 2002. The 
health range required specialist sodium measurement equipment to analyse product and 
now the sodium content of all products is measured and awareness has been raised 
regarding the need to lower salt. 
8.5 Future policy needs and strategies to address dietary strategies to 
lower blood pressure in South Africa 
Some recommendations for policies that influence the food supply which can be adopted 
and implemented are presented below. 
• Fiscal policies and levies 
The introduction of fiscal policies that influence the food supply to ensure that the 
population has access to safe and affordable foods, while discouraging the over­











An Australian study has demonstrated that food shoppers with low levels of education, and 
I ' 
those residing in low-income households, were least likely to purchase foods that were 
comparatively high in fibre and low in fat, salt and sugar.98 
The use of taxation and subsidies, In combination with food-related legislation, is a 
i 
powerful tool of the government to influence dietary behaviour change. Policy 
recommendations to use taxes and subsidies as a means of inducing many people to shift 
their diets in a healthier direction were advocated by the World Health Organization (WHO) 
at the Adelaide conference in 198899 and more recently in the 2004 WHO global strategy 
on diet, physical activity and health.9 Siince the primary business of the food industry is to 
sell food to consumers and generate profit, not to improve the health of the nation, the 
introduction of legislation or incentives: may be necessary to encourage the food industry 
to be more proactive in their product development, as well as their marketing and pricing 
strategies.. 
A food-related legislative measure that has been effective in reaching the poor in South 
I 
Africa is the exemption of basic foo~s from Value Added Tax (VAT).100 These foods 
include brown bread, brown bread flour (excluding bran), eggs, dried beans, maize meal, 
tinned pilchards, mealie (maize meal)! rice, milk, cultured milk (maas), milk powder and 
dairy powder blend, dried mealies, samp, fresh/frozen fruit and vegetables, lentils, rice, 
vegetable oil (excluding olive oil), edible legumes and pulses of leguminous plants.101 
A lesson can be learned from the imp,act that effective legislation in tobacco control and 
I 
pricing has had on changing smokin~ behaviours in the country. In 1993, South Africa 
passed a Tobacco Products Control Act, to which extensive amendments to strengthen 
the bill were made in 1998. The impact of this legislation, which among other things bans 
advertising and marketing of tobacco products, has led to a marked reduction in tobacco 
I 
consumption shown both by a reduced prevalence of tobacco smoking and reduced 
amount of tobacco sold in the country.16 There is convincing evidence that price hikes are 
an effective means to reduce smoking rates 102 and that this measure is a far more effective 
means of tobacco control than education or media campaigns.103 It has been estimated 
that a 10 % increase in price reduc?s tobacco consumption by about 5 %, especially 
among the lower socioeconomic groupS.104 Similarly, alcohol intake shows a similar price 
















A review of tobacco control in South Africa, Brazil, Thailand, Poland, Bangladesh and 
Canada showed that tobacco prevalence can be reduced cost-effectively in high, middle 
and low income countries. 106 The high cost effectiveness of other preventive measures for 
chronic diseases has been demonstrated by Yach.107 
• 	 Effective communication strategies to influence consumers to change dietary 
behaviour 
Food labelling and claims, health logos 
Food labelling legislation in South Africa falls under the Foodstuffs, Cosmetics and 
Disinfectants Act of 1972 and is the mandate of the Directorate of Food Control of the 
Department of Health. The food labelling regulations are currently in the process of being 
revised, and a draft of the proposed new regulations was circulated for consultation in 
2002.108 In that draft, the categories that were proposed for sodium, with regard to nutrient 
content claims allowed on food packaging, are described in Table 1: 
Table 1 
Proposed nutrient content claims (draft food labelling regulations, 2002)108 for sodium 
proposed nutrient content claim (2002) 	 Sodium content of food 
Low sodium Not more than 120 mg Na (300 mg salt) per 100g 
Very low sodium Not more than 40 mg Na (100 mg salt) per 100g 
Virtually sodium free or sodium free Not more than 5 mg Na (12.5 mg salt) per 100g 
As well as nutrient content claims, nutrient function claims will also be allowed on food 
packaging provided that the nutrient of interest is present in high amounts in the food item. 
Nutrient content of a food is considered to be high if it meets 30% of Recommended 
Dietary Allowance (RDA) per 100g or per single serving. The nutrients of interest in terms 
of blood pressure control, and which relate to the modification of cations undertaken in the 
intervention foods in our randomised controlled trial are potassium, magnesium and 
calcium. Proposed nutrient function claims that will be allowed for these nutrients are 
described below in Table 2. 
Foods which contain < 120mg sodium per 100g may be allowed to display the following 
health claim: "Diets low in sodium may reduce the risk of high blood pressure, a disease 
associated with many risk factors." Our data suggests that foods that are high in 
potassium will improve blood pressure control in the management of hypertension and it is 











Table 2 I 
Proposed nutrient function claims (draft food labelling regulations, 2002)108 for calcium, 
magnesium and potassium i 
Nutrient Proposed nutrient function claim (2002) 
Helps maintain healthy bones and teeth, and a healthy nervous system. 
Important for healthy regljJlar heartbeat.
Calcium 
Needed for muscular gro'fVth and contraction and prevents muscle cramps. 
Essential in blood clotting. 
Magnesium 
Potassium 
Helps to utilise carbohydrates, proteins, fats & minerals; aids as vital catalyst in 

enzyme activity, especially those enzymes involved in energy production. 

Helps maintain a healthyimuscle and nervous system. 

Assists in calcium and potassium uptake and plays role in formation of bone. 

Plays role in transmission of nerve and muscle impulses, therefore preventing 

irritability and nervousne~s. 

Aids in maintaining proper pH balance and normal bod,,-y..:.:te:c:..:mc.:.<p:...;:ec;..:ra::..:t.=.:urc.=e-=-.______ 

Important for healthy nervous system. 

Important for regular heart rhythm and maintenance of stable blood pressure. 

Aids in proper muscle contraction. 

Works with sodium to control body's water balance. 

Aids in transmitting electr,ochemical impulses. 

I 
Introduction of mandatory reporting of sodium on food labels will require a standardized 
approach by industry, (for example wh:ether sodium or salt (sodium chloride) content is 
displayed, and whether the units are giVen in millimoles or milligrams), and will need to be 
accompanied by extensive consumer training if it is to be effective at changing dietary salt 
I 
I 
intake behaviour. The upper recommenoed limit for sodium intake that will appear on food 
labels is the internationally recognised g:uideline of <2 400 mg Na per day.19-check 
Nutrition and health logos 
I 
In South Africa, non governmental org~nizations such as the Heart Foundation and the 
Cancer Association provide their logos to food products which meet certain specified 
health claims and nutritional standards, The purpose of these logos is to increase the 
awareness of consumers by acting as an easily identifiable 'nutrition signpost' and to also 
provide the food industry with a tool for marketing food products. In this way, the health 
i 
logos may provide an incentive to some food manufacturers to improve the nutritional 
content of their foods. 
The heartmark logo of the Heart Foundation indicates that a food is lower in cholesterol, 
I 
lower in saturated fat, lower in salt and high in fibre (where applicable). The upper limit for 
salt content depends on the category of food. Nutritional criteria for Heart Foundation­
approved products are provided in Table 3 below for three of the food item categories 











are presently not eligible for the Heartmark logo, nor are flavour enhancers such as 
Aromat-type products, presumably due to their very high sodium content. 
Table 3 
Guidelines for the nutrient content of selected food categories that would be eUgible to carry 
the Heartmark logo of the South African Heart Foundation 
Food 
Nutrient content guidelines for Heartmark approval 
category Fat Sodium Fibre Added sugar 
Bread 5% or less 450 mg/100g or 
less 
3g/100g or more 5 % or less 
Margarine 
Saturated + trans fats 
= maximum 28 % total 
fats. 
400 mg/100g (salt 









In addition to nutrient content, nutrient function claims, and disease-specific claims there is 
ongoing discussion between Medical Research Council researchers involved in the 
present randomized controlled blood pressure trial (Charlton, Steyn), food technologists 
and managers from Pioneer Foods (Sasko Milling and Baking) and the Directorate of Food 
Control (Antoinette Booysen) regarding approval of a composite claim on the combined 
effects of sodium reduction and increased potassium, magnesium and calcium on blood 
pressure control. Suggested wording in this regard could be "Diets reduced in sodium and 
increased in potassium, magnesium and calcium can lower blood pressure. " Should such 
a claim be approved, this could provide an incentive to the food industry to not only lower 
sodium content of foods, but to replace some of the sodium with other beneficial cations. 
Marketing and advertising standards 
It has been demonstrated that the most frequently encountered source for information on 
nutrition in urban black South African women is the media, with the radio and TV being the 
most frequently accessed media sources.109 Information from these sources are perceived 
as being highly reliable and trustworthy.109 Consumers, particularly those with lower 
educational levels, may not be able to distinguish between information provided in 
marketing campaigns, and that of valid nutrition education activities. The high frequency of 
access to the media for nutrition information is to be expected, given that expenditure on 
electronic and print media related to food sales exponentially exceeds that available to 
government agencies for health education.110.111 The impact of commercial advertising 
(through TV and radio media, as well as written media (magazines, newspapers, and 











of South African adults and children has not received much attention and warrants 
investigation. 
Advertising of energy~dense, high fat and high sugar foods on television to young children 
has been shown to be an effective way to persuade young children to make undesirable 
and unhealthy food choices.97 Regulations that ban the marketing of unhealthy food items, 
including foods that are high in salt, may influence individuals to make better food choices. 
To date, no such regulations exist in South Africa. Intemationally, it has been suggested 
that the feasibility of codes of practice in food advertising should be explored through the 
Codex Alimentaris international foods standard~setting body.8 
I 
Nutrition education: Directorates of Nutrition and Health Promotion 
I 
! 
Adult black South Africans living in urb~n areas have been shown to consume a diet that is 
not in line with healthy eating guidelines,112,113 while the National Food Consumption 
Survey (which was conducted in a representative sample of 3 120 children aged 1 - 9 
years) found that the majority of South African children, particularly black children, have 
poor dietary intakes from many of the food groups.114 It is the role of nutrition professionals 
to translate nutrient-based dietary goals into practical and achievable food-based dietary 
messages for various target audiences. The World Declaration and Plan of Action for 
Nutrition, adopted at the Intemational Conference on Nutrition in Rome in 1992, includes a 
I 
number of goals aimed at eliminating Dr substantially reducing famine and famine-related 
deaths, chronic malnutrition, micronutrient deficiencies and diet-related communicable and 
non-communicable diseases. One strategy that was suggested to achieve these goals is 
the promotion of appropriate diets and lifestyles. In response to this, together with 
recognition of a need for more effective nutrition education interventions, the World Health 
Organization (WHO) and Food and A9ricultural Organization (FAO) of the United Nations 
convened an intemational consultation in 1995 to discuss the development of Food Based 
I 
Dietary Guidelines (FBDGs) as an effe;ctive nutrition education tool.115 
I 
I 
After extensive development and cohsumer testing across all socio-economic spectra 
within South Africa,116,117,118 the first set of FBDGs for healthy South Africans aged 7 years 
and older was approved and adopted as national dietary guidelines by the Department of 
Health (Nutrition Directorate) on 9 May 2003.119 One of the eleven FBDGs relates 
specifically to the reduction of salt intake {"Use salt sparingly,)120 while another 
encourages an increased intake of potassium-rich fruit and vegetables ("Eat plenty of 

























nutrient-based dietary guidelines, the current South African food based dietary guideline 
on salt intake has not adopted a quantitative approach, with regard to an upper 
recommended intake per day. The wording "use salt ... " may impart the message to the 
public that it is only salt added to foods at the table and in cooking that needs to be used 
cautiously. However, accompanying consumer education materials produced by the 
Department of Health provide detailed information on food sources of salt and how to 
make appropriate dietary changes. Perhaps controversially, and in contrast to many other 
countries' FBDGs, there is no guideline that addresses calcium-containing foods. 
The 2003 FBDGs are the first single set of national dietary guidelines in the country. Prior 
to the democratic elections of 1994, when three racially disparate Health Departments 
existed to address the needs of black, mixed ancestry/Indian, and white populations 
separately, nutrition educators throughout South Africa made use of separate nutrition 
education tools for various socio:..economic groups. A three food-group approach was used 
for lower socio-economic groups, while a five food-group approach was adopted for upper 
socio-economic groups. The early 1990's saw the impl mentation of these decisions in the 
various publications issued at the time, such as "A Guide for Healthy Eating" (for white 
; 
South Africans; Department of Health Services and Welfare, 1993), "Self-Help in Health" 
(for black South Africans; Department of National Health and Population Development, 
1991) and "Think Healthy, Think Food, Think Three Food Groups" (for mixed ancestry 
South Africans; Wheat Board, 1990). The FBDGs provide an opportunity for nutrition 
educators to provide consistent nutrition messages in a non-segregating manner. 
Most of the foods which were modified in cation content in the present body of work, apart 
from bread and margarine, are very high in sodium content (stock cubes, Aromat flavour 
enhancer, soup mix, table salt). It may be argued that consumers, especially those at high 
risk for hypertension and its associated health conditions, should be advised to avoid these 
foods altogether. In the diets of people from the lowest socioeconomic strata, there is 
evidence that these food items are widely used to provide taste to otherwise bland dishes, 
such as maize meal porridge, particularly when complementary vegetables or protein sources 
are unavailable. 
Current confusion and poor knowledge related to diet and blood is demonstrated in a small 
survey conducted in 85 hypertensive adults in the Cape Metropole.122 Despite fruit and 
vegetables being perceived as having a beneficial effect on hypertension, only 15 % of the 














Knowledge regarding salt usage indicat~d that over a third (34.1%) of participants believed 
that monosodium glutamate-containing flavour enhancers, such as Aromat or Fondar, 
could safely be used instead of table salt. 
Role ofhealth care providers in prontoting healthy eating practices 
It is known that quality of health care is dependent upon the knowleqge, attitudes and 
practices of both physicians and health-care workers. One of the critical roles of primary 
health care in the management of blood pressure and prevention of stroke is education of 
I 
the patient. Health-care professionals at all levels need to continually reinforce the 
message that stroke can largely be prevented by the control of blood pressure and by 
maintaining a satisfactory body weight and following a healthy Iifestyle.123 In South African 
clinics, staff are poorly motivated and ill-equipped to adequately counsel patients on 
behaviour modification techniques required to bring about changes in lifestyle, including 
diet, required for lowering of cardiovascular risk.128 The inclusion of community health 
workers (CHW) as part of the health team is being considered in many provinces. In a 
study which investigated the knowledg~, beliefs and attitudes of community health workers 
, 
about hypertension in the black townships in the Cape Peninsula, an enormous need to 
train CHWs in the care of patients with hypertension was identified.124 Many of the CHWs 
interviewed believed in traditional medicines and home-brewed beer as the best treatment 
for hypertension. 
Optimal control of blood pressure in patients with hypertension requires both adherence to 
a healthy lifestyle and the regular use of prescribed blood pressure medication. Social and 
economic factors contribute to the mpny reasons for lack of blood pressure control in 
i 
South Africa.125 Patients frequently do: not return to the health-care centres for follow-up 
visits because of the costs incurred b~ transport to facilities, as well as the long waiting 
time involved. 
In the late nineties, the Department of Health developed, in a consultative process, guidelines 
on the prevention management of hypertension, along with similar guidelines for diabetes, 
hyperlipidaemia and overweight. However, these guidelines were distributed widely in the 
public health sector without a systemati¢ educational intervention, a prerequisite for change in 
the practice of health care providers.126 iThe guidelines are largely inadequate in their content 
on lifestyle management related to these conditions and there is evidence that health-care 
workers do not access these guidelines in the daily management of patients.123 Two 
qualitative studies conducted with a purposeful sample of doctors, professional nurses and 
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pharmacists for hypertension and diabetes management in the public health sector in Cape 
Town have provided insight into the determinants of care delivered to patients with these 
conditions.127,128 Perceived barriers to providing adequate patient care included increasing 
patient numbers, dramatic budget cuts and acute staff shortages. Staff, particularly nurses, 
felt inadequately trained and not sufficiently empowered to be effective patient educators 
and counsellors. Another study in which a validated questionnaire was used to assess the 
knowledge and practices regarding healthy lifestyles of doctors and nurses in public sector 
community clinics has identified a poor practical knowledge of nutrition.129 Added to the 
problem is a dearth of appropriate and culturally acceptable patient education materials.123 
It is clear that training of health care workers in the non-pharmacological management and 
prevention of hypertension is urgently required, accompanied by the development of 
educational aids in the language of the patient group being served (there are 11 official 
languages in South Africa). 
• Integrated approach 
Our approach (Le. partnership with the food industry to modify the cation content of 
commonly consumed foods, as well as promotion of an increased consumption of fermented 
~ilk and the possible use of a salt replacement) should be used in conjunction with other 
policies and strategies to address the promotion of healthy diets. To date, various strategies 
aimed to eliminate micronutrient deficiencies in the country have been undertaken. The 
implementation of fortification schemes have been successfully implemented through the 
Department of Health. The iodation of salt became compulsory in 1995, while the fortification 
of maize and wheat flour to provide 33 % of the RDA per serving of 8 micronutrients (i.e. 
vitamin A, thiamine, riboflavin, niacin, folic acid, vitamin 86, iron and zinc) at the point of 
consumption130 became compulsory in October 2003. Supplementation programmes that are 
currently operated through primary care health facilities include vitamin A and iron 
supplementation. 
All health promotion activities need to embrace the principles of the Ottawa Charter for 
Health Promotion, within the social, economic, and political context of countries.20 The 
successful implementation of health promotion· materials and programmes at both the 
population-wide level (blanket coverage) and within the health care services (targeted 
coverage), requires careful consideration of the local culture and the circumstances of 















The promotion of the daily consumptjo~ of 500 ml fermented milk (maas) is a realistic and 
achievable dietary message. Maas is commonly eaten with soft maize meal porridge by 
the black population. McCarron & H,eaney (2004) generated first-year and fifth-year 
healthcare cost savings that would accrue if adult Americans simply increased their intake 
of dairy foods to the currently recommended 3 to 4 servings/day. Using conservative 
estimates of potential benefit and accumulated data from prospective longitudinal studies 
and randomized controlled trials, they projected first-year savings of approximately 26 
billion dollars and 5-year cumulative savings in excess of 200 billion dollars in terms of 
I 
outcomes on obesity, hypertension. type 2 diabetes. osteoporosis. kidney stones. certain 
outcomes of pregnancy. and some ca~cers.131 
Conclusion 
The group of studies presented in this thesis. which culminated in a randomised controlled 
trial. have demonstrated that free-hving black hypertensive taking anti-hypertensive 
medication can lower their blood pressure further by consuming their usual foods which have 
been modified to contain lower levels 9f sodium and higher levels of potassium, magnesium 
and calcium. These findings have shown, for the first time in South Africa, that the 
I 
improvement of the cation content. of processed foods, together with the increased 
consumption of fermented milk, can lower blood pressure. An imperative need for South 
African food companies to improve staple food products in the country, particularly bread, has 
been identified. The recommended public health strategy approach also identifies a need for 
the Department of Health to ensure fhat the necessary regulations are in place to enforce 
such improvements and to develop supporting health education messages and activities to 
accompany the intervention. 
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Appendix A: Salt intake questionnaire (N =42 items) 
NUTRITIONAL AND LIFESTYLE HABITS Office use 
The following questions are about your dietary and life-style habits. All your answers will be strictly confidential 
Study number: I I 3 
During the PAST 7 days (1 week) did you eat any of the following? IF YES, ASK HOW OFTEN 
(Ifno, circle nevef) [DO NOT PROtvlPT THE AI\ISWER OPTIONS BELOW] 
NOT EVERY DAY EVERY DAY 
Food item NEVER 1-3 times 4-6 times 1 time 2 times 3+ times 
per per 
a day a day a day
week week 
White bread/ white bread rolls 0 1 2 3 4 5 4 
Brown/wholewheat bread/ Rolls 0 1 2 3 4 5 
Breakfast Cereal (processed) 0 1 2 3 4 5 
Breakfast Cereal (weetbix, muesli) 0 1 2 3 4 5 
Crackers (ProVita etc) 0 1 2 3 4 5 
Cookies, biscuits,rusks 0 1 2 3 4 5 
Cake/scone/ muffin/ 
0 1 2 3 4 5puddings/pancake/fruit pie/koeksister 
Roti/ samoosa/springroll/doughnut 0 1 2 3 4 5 
Pizza 0 1 2 3 4 5 
Pasta/noodle dishes with cheese sauces 
(macaroni cheese, lasagne, noodle salad 0 1 2 3 4 5 
etc.) 
Popcorn 0 1 2 3 4 5 
Crisps (Simba and Niknaks etc.) 0 1 2 3 4 5 
Sausage (wors) 0 1 2 3 4 5 
Polony/salami/bacon/salami/pork suasages 
(processed meat, cooked, smoked and 0 1 2 3 4 5 
canned) 
Meat or chicken pies/sausage rolls 0 1 2 3 4 5 
Chicken - battered (KFC etc). and chicken 
0 1 2 3 4 5burger only 
Meat and meat dishes (steaks, minced 
meat, cottage pie, mince, meatballs, stew, 0 1 2 3 4 5 
bobotie etc.) 20 
Gravy, made with stock or gravy powder 0 1 2 3 4 5 
Biltong/dry wors/bokkems 0 1 2 3 4 5 
Milk (all types, also dairy fruit juice, malted 
0 1 2 3 4 5milk milk shakes) 
Maas 0 1 2 3 4 5 
Cheese 0 1 2 3 4 5 
Yoghurt 0 1 2 3 4 5 
Eggs 0 1 2 3 4 5 
Tinned fish (pilchards/tuna, etc.) 0 1 2 3 4 5 
Other fish and seafood 0 1 2 3 4 5 
Potato chips/french fries and potato salad 0 1 2 3 4 5 
Canned vegetables, inc!. Baked beans, 
0 1 2 3 4 5tomato paste sweetcorn etc. 
Soup (all types) 0 1 2 3 4 5 
Salad dressing/mayonnaise 0 1 2 3 4 5 












Beer and cider 
